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Abstract 
Limited data exist on the facilitators and barriers to implementing electronic 
systems for medicines management in hospitals. Whilst numerous studies 
advocate system use in improved patient safety and efficiency within the health 
service, their rate of adoption in practice has been slow. The aim of this doctoral 
research was to explore this under-researched area in three phases.  
 
Phase one  
Phase one focused on critically appraising and synthesising the available 
evidence on healthcare professionals’ perceptions, attitudes, and views of the 
facilitators and barriers to implementing electronic prescribing, electronic 
dispensing, and/or electronic administration of medicines in the hospital setting. 
The review protocol was registered with the Centre for Reviews and 
Dissemination and conducted according to best practice. Key facilitators included 
systems improved patient safety and provided better access to patients’ drug 
records and that team leadership and hardware/software availability and 
reliability were essential for successful implementation. Key barriers consisted of 
hardware and network problems, altered work practices, and weakened 
interpersonal communication between healthcare professionals and with patients. 
 
Phase two  
This phase employed a qualitative phenomenological design to gain original 
insight into the perceptions of local key stakeholders towards the facilitators and 
barriers to implementing prescribing, robotic pharmacy systems, and automated 
medication storage and retrieval systems in public hospitals in Ireland using 
Normalization Process Theory as a theoretical framework. Individual face-to-face 
semi-structured interviews were conducted in three public hospitals in Ireland 
with 23 consenting participants: nine nurses; four pharmacists; two pharmacy 
technicians; six doctors; and two hospital Information Technology managers. 
Enhanced patient safety and efficiency in healthcare delivery emerged as key 
facilitators to system implementation, as well as the need to have clinical 
champions and a multidisciplinary implementation team to promote engagement 
and cognitive participation. Key barriers included inadequate training and 
organisational support, and the need for ease and confidence in system use to 
achieve collective action.  
 iv 
Phase three  
A similar qualitative methodology was employed in phase three of this research 
in order to explore the perceptions of national key stakeholders and eHealth 
leads towards the facilitators and barriers to system implementation. Sixteen 
consenting invitees participated: eight hospital leads, four government leads, two 
regulatory leads, and two academics. Key facilitators included enhanced patient 
safety, workflow efficiencies, improvements in governance, and financial gains. 
Perceived barriers included the introduction of new drug errors, loss of patient 
contact, initial time inefficiencies, and issues with the complexity of integration 
and standardisation of work processes. 
 
Overall, adequate technology, stakeholder involvement, and organisational 
leadership and support are required at a national and local level to drive the 
eHealth agenda forward. Testing at scale, contingency plans, and ongoing 
evaluations will assist in determining success or otherwise of system 
implementation.  
 
This research has generated novel findings with many potentially transferable 
themes identified which extend the evidence base. This will assist organisations 
to better plan for implementation of medication-related eHealth systems. 
 
Keywords:  ePrescribing, robotic pharmacy systems, automated medication 
storage and retrieval systems, implementation, qualitative, healthcare 
professionals, barriers, facilitators, hospital, NPT 
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exploring facilitators and barriers to implementing electronic systems for 
medicines in hospitals in Ireland.  
 
The title of this research is influenced by my background, firstly with a degree in 
psychology and a higher diploma in computer science from University College 
Cork, followed by a masters in IT from National University of Ireland Galway, a 
degree in pharmacy from Trinity College Dublin, and a masters in clinical 
pharmacy from Robert Gordon University. I have been working full-time as a 
senior antimicrobial pharmacist for the previous eight years, currently in 
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experiencing first-hand the continuous inefficiencies of manual medicines 
management systems from prescribing to procurement to dispensing to 
administration having spent most of my 10-year pharmacy career in a hospital 
setting. This really motivated me to want to contribute to improving medicines 
delivery and utilise the skills I had acquired academically by combining the 
qualitative aspect of psychology with the IT aspect of electronic systems for 
medicines to the overall pharmacy focus. This was an ambition from early in my 
pharmacy career when I choose as my preregistration project ‘A business case 
for the implementation of an automated medication storage and retrieval system 
in the Midland Regional Hospital Tullamore’. In addition, having achieved a 
distinction in the masters in clinical pharmacy, I was encouraged to consider PhD 
studies. Thereafter I conducted a scoping review on the topic which identified a 
gap in the literature indicating an area for research. Five years later I have never 
looked back, again all credit to the support of my experienced supervisory team 
of whom I had previously worked with during the masters. 
 
My principal supervisor, Dr Scott Cunningham, is a senior lecturer and group 
leader for Clinical Pharmacy and Pharmacy Practice with research interests 
spanning pharmacist prescribing, reclassified medicines, and chronic medication 
services. Dr Antonella Tonna is a lecturer with a key interest in qualitative 
research. Professor Derek Stewart was my principal supervisor for my master’s 
thesis with a research focus in pharmacy practice development, implementation, 
and evaluation. With over 100 peer reviewed papers published, his general 
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interests lie in health services research methodologies. Professor Alison Strath’s 
research interests are rooted in the development of healthcare policy, technology 
enhanced care, and the provision of a sound evidence base. 
I am a member of the Council of Clinical Information Officers which was 
established in 2015 to provide clinical governance in the delivery of eHealth 
solutions in Ireland. Its role is primarily advisory and includes participating in 
several meetings per year with clinical leaders and professionals with successful 
programme delivery experience. I have also become involved in upgrading our 
current hospital pharmacy dispensing system to a superior integrated electronic 
system with a plan to implement ePrescribing in the near future. Other related 
projects include upgrading our pharmacy medicines information intranet to a new 
operating system inclusive of data restructuring, and leading on the 
implementation of automated medication storage and retrieval systems. 
As the end of my PhD studies approaches I am certain my involvement with 
electronic systems for medicines will continue and expand. 
 
 
 
 
 
 
 
  
 xi 
Key abbreviations 
BCMA     Barcode Medication Administration  
CASP     Critical Appraisal Skills Programme  
CDS      Clinical Decision Support  
CDSR     Cochrane Database of Systematic Reviews 
CPOE     Computerised Physician Order Entry  
CRD    Centre for Reviews and Dissemination 
DARE     Database of Abstracts of Reviews of Effects 
DoH     Department of Health  
ED     Emergency Department  
EHR     Electronic Health Record  
eMAR    Electronic Medication Administration Record  
ePrescribing   Electronic Prescribing 
EC     European Commission  
EU     European Union 
HIQA     Health Information and Quality Authority 
HR     Human Resources 
HSE     Health Service Executive  
HTA     Health Technology Assessment 
ICT     Information and Communication Technologies 
IHI     Individual Health Identifier  
IPA    International Pharmaceutical Abstracts  
IT    Information Technology  
JBI    Joanna Briggs Institute  
NCHD    Non-Consultant Hospital Doctors 
NHS     National Health Service  
 xii 
NPT     Normalization Process Theory 
OCIO     Office of the Chief Information Officer  
PRISMA Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses  
PROSPERO Prospective Register of Systematic Reviews  
PSI Pharmaceutical Society of Ireland  
RCPI    Royal College of Physicians in Ireland  
RCT    Randomised Controlled Trial  
RGU    Robert Gordon University 
TDF    Theoretical Domains Framework 
UK    United Kingdom 
USA    United States of America 
 
 
 xiii 
Table of contents 
Abstract ............................................................................................. iii 
Keywords ........................................................................................... iv 
Acknowledgements  ............................................................................. v 
External outputs ................................................................................. vi 
Foreword ........................................................................................... ix 
Key abbreviations ............................................................................... xi 
Table of contents .............................................................................. xiii 
List of figures ................................................................................... xix 
List of tables ..................................................................................... xxi 
List of appendices ........................................................................... xxiii 
 
Chapter 1: General introduction 
1.1 Introduction .............................................................................. 1 
1.2 Search strategy ......................................................................... 1 
1.3 Definitions ................................................................................. 2 
1.3.1 Patient safety ................................................................. 2 
1.3.2 eHealth .......................................................................... 2 
1.3.3 Medicines management ................................................... 3 
1.3.4 Medication errors ............................................................ 3 
1.3.5 Electronic health record ................................................... 7 
1.3.6 Electronic prescribing ...................................................... 7 
1.3.7 Robotic pharmacy systems ............................................. 14 
1.3.8 Automated medication storage and retrieval systems ........ 16 
1.4 Overview of the current medicines management system in  
hospitals in Ireland ................................................................... 18 
1.5 Irish national eHealth initiatives ................................................. 19 
1.5.1 Current eHealth infrastructure ........................................ 19 
1.5.2 National eHealth programmes ......................................... 21 
1.5.3 Clinical engagement initiatives ........................................ 25 
1.6 International eHealth initiatives ................................................. 26 
1.7 Facilitators to system implementation ......................................... 27 
1.7.1 Driving factors for successful system implementation ........ 28 
1.8 Evidence of the challenges to system implementation ................... 30 
1.9 Gaps in the literature ................................................................ 33 
 xiv 
1.10 Overall research aim and objectives............................................ 34 
1.10.1 Research aim ................................................................ 34 
1.10.2 Research objectives ....................................................... 34 
1.11 Chapter summary ..................................................................... 38 
 
Chapter 2: Methodology 
2.1 Introduction ............................................................................. 39 
2.2 The selection of a research approach .......................................... 39 
2.3 Philosophical paradigms ............................................................ 39 
2.3.1 The positivist paradigm .................................................. 40 
2.3.2 The post-positivist paradigm ........................................... 40 
2.3.3 The interpretivism paradigm ........................................... 40 
2.3.4 The pragmatic paradigm ................................................ 41 
2.3.5 Overall philosophical paradigm employed in current 
research ....................................................................... 42 
2.4 Methodology and method .......................................................... 44 
2.4.1 Overall research methodologies employed in current 
research ....................................................................... 45 
2.5 Systematic reviews ................................................................... 45 
2.5.1 Scoping reviews ............................................................ 47 
2.5.2 Overcoming challenges of systematic reviews in 
qualitative research ....................................................... 47 
2.5.3 Narrative approaches to synthesis of qualitative evidence ... 48 
2.6 Qualitative methodology............................................................ 49 
2.6.1 Main features of qualitative research ................................ 49 
2.6.2 Qualitative methods ....................................................... 51 
2.6.2.1 Data generation .............................................. 51 
2.6.2.2 Sampling in qualitative research ....................... 54 
2.6.2.3 Sample size in qualitative research .................... 56 
2.6.2.4 Approaches to data analysis in qualitative  
research ........................................................ 56 
2.7 Trustworthiness and rigour in qualitative research ........................ 59 
2.8 Theory in qualitative research .................................................... 63 
2.8.1 Theoretical domains framework ....................................... 67 
2.8.2 Normalization process theory .......................................... 67 
 xv 
2.8.3 A general theory of implementation ................................. 70 
2.9 Chapter summary .................................................................... 70 
 
Chapter 3: Systematic review  
3.1 Introduction ............................................................................ 73 
3.2 Phase one objectives ................................................................ 73 
3.3 Method ................................................................................... 74 
3.3.1 Research team .............................................................. 74 
3.3.2 Database search for pre-existing systematic reviews ......... 74 
3.3.3 Review protocol ............................................................ 74 
3.3.4 Inclusion and exclusion criteria ....................................... 74 
3.3.4.1 Types of participants ....................................... 74 
3.3.4.2 Phenomena of interest..................................... 75 
3.3.4.3 Types of studies ............................................. 75 
3.3.4.4 Language ....................................................... 76 
3.3.4.5 Context ......................................................... 76 
3.3.5 Search strategy ............................................................ 76 
3.3.5.1 Databases ...................................................... 76 
3.3.5.2 Manual searching of journals ............................ 78 
3.3.5.3 Conference abstracts ....................................... 79 
3.3.5.4 Other sources ................................................. 79 
3.3.6 Study selection ............................................................. 79 
3.3.7 Data extraction ............................................................. 80 
3.3.8 Quality assessment of identified studies ........................... 80 
3.3.9 Data synthesis .............................................................. 80 
3.4 Results ................................................................................... 81 
3.4.1 Study origin ................................................................. 81 
3.4.2 Design ......................................................................... 83 
3.4.3 Study population ........................................................... 83 
3.4.4 Types of system implementation ..................................... 83 
3.4.5 Implementation phase ................................................... 83 
3.4.6 Data analysis ................................................................ 89 
3.4.7 Quality assessment ....................................................... 89 
3.4.8 Facilitators and barriers to implementation ....................... 94 
3.4.8.1 Facilitators to implementation .......................... 98 
 xvi 
3.4.8.2 Barriers to implementation ............................. 101 
3.5 Discussion of the findings ........................................................ 106 
3.5.1 Consideration of strengths and limitations ...................... 109 
3.6 Further work .......................................................................... 110 
3.7 Chapter summary ................................................................... 111 
 
Chapter 4: Interviews with local key stakeholders 
4.1 Introduction ........................................................................... 112 
4.1.1 Phase two objective ..................................................... 112 
4.2 Method ................................................................................. 113 
4.2.1 Research design .......................................................... 113 
4.2.2 Setting ....................................................................... 113 
4.2.3 Research governance ................................................... 118 
4.2.4 Participant inclusion and exclusion criteria ...................... 119 
4.2.5 Participant sample ....................................................... 119 
4.2.6 Sample size ................................................................ 120 
4.2.7 Invitation ................................................................... 121 
4.2.8 Development of interview schedules .............................. 122 
4.2.9 Pilot interviews............................................................ 124 
4.2.10 Data generation .......................................................... 125 
4.2.11 Data management and analysis .................................... 126 
4.2.12 Promoting research quality ........................................... 129 
4.3 Findings from the qualitative interviews: general analysis ............ 130 
4.3.1 Participant demographics ............................................. 130 
4.3.2 Interview and transcription length ................................. 134 
4.3.3 Type of systems participants discussed .......................... 134 
4.4 Findings from the qualitative interviews: thematic analysis .......... 134 
4.5 Discussion ............................................................................. 146 
4.5.1 Statement of key findings ............................................. 146 
4.5.2 Consideration of strengths and limitations ...................... 148 
4.5.3 Interpretation of findings .............................................. 151 
4.6 Further work .......................................................................... 155 
4.7 Chapter summary ................................................................... 155 
 
 
 xvii 
Chapter 5: Interviews with national key stakeholders and eHealth  
leads 
5.1 Introduction ........................................................................... 157 
5.1.1 Phase three objective ................................................... 157 
5.2 Method .................................................................................. 157 
5.2.1 Research design ........................................................... 157 
5.2.2 Setting ....................................................................... 157 
5.2.3 Research governance ................................................... 158 
5.2.4 Participant inclusion and exclusion criteria ....................... 158 
5.2.5 Participant sample ........................................................ 158 
5.2.6 Sample size ................................................................. 159 
5.2.7 Invitation .................................................................... 159 
5.2.8 Development of interview schedule ................................ 159 
5.2.9 Pilot interviews ............................................................ 160 
5.2.10 Data generation ........................................................... 160 
5.2.11 Data management and analysis ..................................... 160 
5.2.12 Promoting research quality ............................................ 161 
5.3 Findings from the qualitative interviews: general analysis ............ 161 
5.3.1 Participant demographics .............................................. 161 
5.3.2 Interview and transcription length .................................. 166 
5.4 Findings from the qualitative interviews: thematic analysis .......... 166 
5.5 Discussion .............................................................................. 179 
5.5.1 Statement of key findings ............................................... 180 
5.5.2 Consideration of strengths and limitations ......................... 182 
5.5.3 Interpretation of findings ................................................ 182 
5.5.4 Further work ................................................................. 184 
5.6 Chapter summary ................................................................... 185 
  
Chapter 6: General discussion 
6.1 Introduction ........................................................................... 186 
6.2 Aim, objectives, and key findings .............................................. 186 
6.2.1 Phase one: systematic review ......................................... 187 
6.2.2 Phase two: interviews with local key stakeholders .............. 188 
6.2.3 Phase three: interviews with national key stakeholders and 
eHealth leads ................................................................ 189 
 xviii 
6.3 Overall strengths and limitations of programme of research ......... 189 
6.3.1 Originality .................................................................... 189 
6.3.2 Study design ................................................................ 190 
6.3.3 Trustworthiness ............................................................ 191 
6.3.4 Participant inclusion ...................................................... 193 
6.3.5 Recruitment ................................................................. 194 
6.3.6 Settings ....................................................................... 194 
6.3.7 Transferability .............................................................. 195 
6.3.8 Bias ............................................................................. 195 
6.4 Interpretation of findings within the three research phases .......... 196 
6.5 Key recommendations for future system implementation in hospitals 
in Ireland .............................................................................. 200 
6.6 Impact of findings .................................................................. 201 
6.6.1 Academic impact ........................................................... 202 
6.6.2 Economic and societal impacts ........................................ 203 
6.6.3 Pathway to impact ........................................................ 203 
6.7 Further work .......................................................................... 204 
6.7.1 Healthcare professionals’ views and experiences of the 
impact of implementing an ePrescribing and robotic 
pharmacy system on work practices in a public hospital in 
Ireland ........................................................................ 204 
6.7.2 Patient perceptions of an EHR ......................................... 205 
6.8 Conclusion ............................................................................. 206 
 
References ................................................................................... 207 
 
  
 xix 
List of figures 
Figure 1.1 Components of medicines management .................... 3 
Figure 1.2 Example of the design of an ePrescribing interface...... 9 
Figure 1.3 Components of an ePrescribing system ................... 10 
Figure 1.4 Example of the design of a robotic pharmacy 
system ................................................................ 14 
Figure 1.5 Components of a robotic pharmacy system .............. 15 
Figure 1.6 Example of the design of an automated medication 
storage and retrieval system .................................. 16 
Figure 1.7 Components of a medication storage and retreival 
system ................................................................ 17 
Figure 1.8 Manual medicines management system in hospitals 
in Ireland ............................................................ 19 
Figure 1.9 Key national eHealth strategic programmes  ............ 22 
Figure 1.10 Interrelated technical, social, and organisational 
factors over time in eHealth innovations  ................. 30 
Figure 1.11 Barriers to eHealth ............................................... 32 
Figure 1.12 Schematic representation of evolution of research 
aim, objectives, and methods ................................ 36 
Figure 1.13 Overview of the phases of the doctoral research ....... 38 
Figure 2.1 Paradigms, methodology, and methods in research 
phases ................................................................ 72 
Figure 3.1 PRISMA flow diagram of literature search ................ 82 
Figure 3.2 Stacked bar chart representing quality of qualitative 
studies as per CASP checklist ................................. 91 
Figure 4.1 Map of location of selected hospitals ...................... 115 
Figure 4.2 Summary of the framework approach to data 
analysis in this research ....................................... 127 
Figure 4.3 Qualitative process: method of data generation and 
analysis .............................................................. 128 
Figure 4.4 Participant sample ............................................... 131  
Figure 5.1 Participant sample ............................................... 162 
Figure 5.2 Steps towards confirmation of data saturation ......... 163 
Figure 6.1 Summary of research phases ................................ 187 
Figure 6.2 Human factors framework .................................... 197 
 xx 
Figure 6.3 Pathways to impact ............................................. 202     
 
  
 xxi 
List of tables 
Table 1.1 Search terms used for retrieving relevant 
background information .......................................... 1 
Table 1.2 Examples of medication errors ................................. 4 
Table 1.3 Benefits of ePrescribing for key stakeholders............ 12 
Table 1.4 European hospital survey: benchmarking 
 deployment of eHealth services (2012-2013) ........... 13 
Table 1.5 National demographic trends for 2017 ..................... 21 
Table 1.6 eHealth national initiatives ..................................... 24 
Table 1.7 Summary of key facilitators for successful system 
implementation .................................................... 29 
Table 1.8 Challenges to system implementation in Ireland ....... 33 
Table 2.1 Fundamental beliefs in research paradigms .............. 42 
Table 2.2 Research methodologies ........................................ 45 
Table 2.3 Tools and techniques for narrative synthesis ............ 49 
Table 2.4 Qualitative research methodologies ........................ 50 
Table 2.5 Strengths and weaknesses of focus groups and in-
depth interviews ................................................... 53 
Table 2.6 Comparisons of different interview types ................. 54 
Table 2.7 Non-probability sampling ....................................... 55 
Table 2.8 Phases of thematic analysis ................................... 57 
Table 2.9 Phases of the framework approach to data analysis .. 58 
Table 2.10 Constructs to ensure high quality in research ........... 59 
Table 2.11 Types of bias in qualitative research ....................... 61 
Table 2.12 Quality framework in qualitative research ................ 63 
Table 2.13 Five categories of theories, models, and frameworks 
used in implementation science .............................. 66 
Table 2.14 NPT constructs and components applied to this 
doctoral research .................................................. 69 
Table 3.1 Search terms using MEDLINE via EBSCOhost ........... 78 
Table 3.2 Description of studies included in systematic review . 84 
Table 3.3 Quality assessment of qualitative studies as per 
CASP checklist ..................................................... 90 
Table 3.4 Facilitators and barriers to system implementation ... 96 
Table 4.1 Summary of hospital characteristics ....................... 117 
 xxii 
Table 4.2 Mapping of concepts in the interview schedules to 
NPT ................................................................... 123 
Table 4.3 Key recommendations for developing interview 
questions in qualitative research ........................... 123 
Table 4.4 Quality framework in qualitative research .............. 129 
Table 4.5 Participant characteristics .................................... 132 
Table 4.6 Demographic data and codes for interviewees ........ 133 
Table 4.7 Type of systems participants discussed .................. 134 
Table 4.8 Summary of key facilitator and barrier themes 
related to NPT constructs and components ............. 135 
Table 5.1 Participant characteristics .................................... 164 
Table 5.2 Demographic data and codes for interviewees ........ 165 
Table 5.3 Summary of key facilitator and barrier themes 
related to NPT constructs and components ............. 167 
Table 6.1 Main findings in research phases: comparisons with 
all phases and specific findings with interviews in 
Ireland .............................................................. 199 
   
 
  
 xxiii 
List of appendices 
Appendix 2.1 Relevant training completed by primary researcher 
during the course of the PhD ................................. 245 
Appendix 3.1 Systematic review protocol registered with 
PROSPERO .......................................................... 247 
Appendix 3.2 Medline search string ........................................... 253 
Appendix 3.3 Blank data extraction form ................................... 257 
Appendix 3.4 Data extraction form for included paper ................. 261 
Appendix 3.5 Blank quality assessment form .............................. 268 
Appendix 3.6 Quality assessment form with included paper .......... 269 
Appendix 3.7 Data extraction form summary of papers excluded .. 272 
Appendix 4.1 Research project proforma .................................... 274 
Appendix 4.2 RESSA form ........................................................ 282 
Appendix 4.3 Letter of invitation ............................................... 288 
Appendix 4.4 Participant information sheet ................................ 289 
Appendix 4.5 Interview consent and copyright clearance form for 
participant .......................................................... 291  
Appendix 4.6 Interview consent and copyright clearance form for 
researcher .......................................................... 292  
Appendix 4.7 Reply slip ........................................................... 293 
Appendix 4.8 Letter of invitation reminder ................................. 294 
Appendix 4.9 Interview confirmation letter ................................. 295 
Appendix 4.10 Response from ethical approval application in RGU. . 296 
Appendix 4.11 Ethical approval RGU ........................................... 302 
Appendix 4.12 Letter to the general manager on research for 
information ......................................................... 303 
Appendix 4.13 Ethical approval Hospital A ................................... 304 
Appendix 4.14 Ethical approval Hospital B ................................... 305 
Appendix 4.15 Ethical approval Hospital C ................................... 307 
Appendix 4.16 Initial draft of interview schedule ........................... 308 
Appendix 4.17 Interview schedule with expert comments .............. 311 
Appendix 4.18 Interview schedule after expert comments ............. 317 
Appendix 4.19 Background questionnaire .................................... 321 
Appendix 5.1 Ethical approval RCPI  .......................................... 322 
Appendix 5.2 Initial draft of interview schedule ........................... 323 
 xxiv 
Appendix 5.3 Interview schedule with expert comments ............. 325 
Appendix 5.4 Interview schedule after expert comments ............. 334 
 1 
Chapter 1:  General introduction 
 
1.1 Introduction 
This chapter describes eHealth and medicines management in terms of electronic 
prescribing (ePrescribing), robotic pharmacy systems, and automated medication 
storage and retrieval systems, and provides an in-depth review of policy 
documents from Ireland and internationally. After identifying both facilitators and 
barriers to system implementation and gaps in the literature, the aim and 
objectives of this research are offered inclusive of its novelty and contribution to 
original knowledge.  
 
1.2 Search strategy  
Google and google scholar were mostly used to retrieve articles and relevant 
information to be included in this introductory chapter. A wide variety of search 
terms were combined within each of the three main concepts: implementation, 
facilitators, and barriers; ePrescribing, electronic dispensing of medicines, and 
electronic administration of medicines; and hospital setting. The search strategy 
is summarised in Table 1.1 which was conducted between July 2012 and August 
2017. 
 
Table 1.1:  Search terms used for retrieving relevant background information  
 Search terms (limit English language) 
 
1 eHealth AND/OR electronic prescribing AND/OR automated dispensing 
systems AND/OR medication storage and retrieval systems AND/OR 
pharmacy robotics AND/OR electronic dispensing AND/OR electronic 
administration AND/OR health information technology AND/OR mobile 
technology  
 
2 Implementation AND/OR adoption AND/OR facilitator AND/OR acceptance 
AND/OR advantage AND/OR benefit AND/OR barrier AND/OR inhibit 
AND/OR obstacle AND/OR disadvantage 
 
3 Hospital AND/OR secondary care AND/OR tertiary care AND/OR ward 
 
4 1 + 2 + 3 
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1.3 Definitions 
1.3.1 Patient safety 
Patient safety has been defined by the World Health Organization as “the 
prevention of errors and adverse effects to patients associated with healthcare”  
(1). Emphasis is placed on the system of care delivery that prevents errors, 
learns from errors that do occur, and is built on a culture of safety that involves 
healthcare professionals, organisations, and patients (2). Healthcare delivery has 
become more complex with greater use of new technologies, medicines, and 
treatment options which requires more decision-making capability and healthcare 
priorities. Many patient safety initiatives, such as the use of electronic systems 
for medicines management, have been considered as possible strategies to avoid 
patient safety errors and improve healthcare processes. 
 
1.3.2 eHealth  
Internationally there is widespread investment in eHealth, defined as “the 
exploitation of information and communication technologies (ICT) in healthcare 
to enhance the quality and safety of patient care” (3). Embedded in the 
management of delivery processes, eHealth is fundamental to ensure continuous 
improvements in patient safety and efficiency, and underpins organisational 
transformation and development (4). Eysenbach states that eHealth represents 
not only a technical development, but also a mindset, a method of thinking, an 
attitude, and a commitment to improve healthcare (5). This involves 
considerable change to working practices and culture.  
 
Successful reform and delivery of healthcare systems is highly dependent on 
realising the potential of eHealth as a change catalyst. The emphasis for many 
countries, including Ireland, is on the development of eHealth building blocks 
such as ePrescribing and electronic health records (EHRs) in order to improve the 
management of information and reduce medication errors and cost. A properly 
executed implementation plan must involve all stakeholders and feature strong 
clinical engagement and a willingness to embrace eHealth systems from the 
outset (6). 
 
 
 
 3 
1.3.3 Medicines management 
Medicines management in hospitals incorporates the entire process of how 
medicines are selected, procured, delivered, prescribed, administered, and 
reviewed to achieve informed and desired patient outcomes. The various 
components involved in this process are illustrated in Figure 1.1 adopted from                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
the Joint Commission (7).  
Figure 1.1:  Components of medicines management adopted from the Joint 
Commission (7) 
 
Whilst the use of medications is currently increasing in number and complexity 
which potentially amplifies medication error risks, systems for prescribing, 
dispensing, and administering medicines in Ireland have remained largely 
unchanged over the last few decades (8). For example, the annual cost to the 
Irish State for medicines is approximately two billion euros, a greater than 
sixfold increase over the past decade (9)(10).  
 
1.3.4 Medication errors 
Medication errors refer to any unintended consequences arising in the medication 
use process, regardless of whether an injury transpired or whether the potential 
for injury was present (11)(12). These include mistakes in prescribing, 
dispensing, and/or administering medication, as well as patient adherence. Most 
definitions of patient safety and medication errors recognise that organisational 
factors interact with human factors to facilitate and mitigate medication-related 
errors (13). Examples are illustrated in Table 1.2 adopted from Black et al (14). 
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Table 1.2: Examples of medication errors adopted from Black et al (14) 
 
Miscommunication of drug orders due to poor handwriting, confusion between drugs 
with similar names, misuse of zeroes and decimal points, confusion of metric and 
other dosing units, and inappropriate abbreviations 
 
 
Inappropriate drug selection due to incomplete patient data such as 
contraindications, drug interactions, known allergies, current and previous diagnoses, 
current and previous therapies, and test results 
 
 
Miscalculation of drug dosage due to incorrect selection of route of administration, 
mistakes with frequency or infusion rates 
 
 
Out-of-date drug information, for example, in reference to alerts, warnings, or 
information on newly approved drugs 
 
 
Monitoring failures due to laboratory test results and drug administration monitoring 
not considered 
 
 
Inappropriate drug selection due to clinical incompetence 
 
 
 
Estimating the true incidence of medication-related errors can be problematic 
due to the various definitions and methodologies used to detect or measure their 
occurrence. In addition, many are never discovered, acknowledged, or reported 
(15). Medication errors in hospitals are highly underreported if healthcare 
professionals perceive no harm to the patient or the incident is not considered 
significant enough to report (16)(17)(18)(19).  
 
Prescribing and drug administration processes have traditionally been recognised 
as accounting for the greatest proportion of all medication errors, independent of 
whether harm is caused (20)(21)(22)(23)(24). Lewis et al conducted a 
systematic review in 2009 on the prevalence, incidence, and nature of 
prescribing errors in hospital inpatients and reviewed 65 studies mostly from the 
United States of America (USA) and the United Kingdom (UK) (25). These 
studies excluded ePrescribing systems. They reported a median prescription 
error rate of seven percent with incorrect dosage being the most common error. 
Another systematic review by Ross et al in 2009 reviewed 24 studies of non-
consultant hospital doctors (NCHDs) and reported an error rate of  two to 514 
per 1000 items prescribed and four percent to 82% of patient prescription charts 
reviewed (26). A more recent prospective study by Ashcroft et al in 2015 on the 
prevalence, nature, severity, and risk factors for prescribing errors in 20 UK 
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hospitals found a mean error rate of nine percent (27). Error rates for doctors in 
training were significantly higher than medical consultants and prescribing errors 
were 70% more likely to occur at the time of hospital admission (27). 
 
The transition between hospital and community settings is prone to medication 
errors due to incomplete medication records, lack of communication between 
healthcare providers, missed patient follow-up, inadequate patient education, 
and the absence of patient involvement in the medicines management process 
(28). ‘Medication reconciliation’ performed by nurses, doctors, or pharmacy staff 
at hospital admission, on the wards, and at transfer and discharge to primary 
care is an effective strategy for reducing medication errors (29). Researchers 
have found hospital pharmacists are uniquely positioned to lead and support 
patients and inter-professional teams with medication reconciliation based on 
their education and expertise in medicines management (30) resulting in better 
accuracy and improved clinical and economic outcomes 
(31)(32)(33)(34)(35)(36). However, this three step process of verifying 
medication use, identifying variances, and rectifying medication errors at 
interfaces of care is not provided by pharmacy staff in all hospitals, is limited to 
within pharmacy opening hours, and is dependent on staff compliments. For 
example, a survey by Stein et al in 2015 reviewing pharmacy involvement in 
hospital medication reconciliation programmes across the USA found a mere 
53% of hospitals had dedicated pharmacy staff to perform medication 
reconciliation (37). Barriers include cost, time, inadequate staffing, unreliable 
patient information, lack of programme ownership by a particular discipline, and 
difficulty relaying information between hospital and outpatient settings (38). 
These inefficiencies highlight the need for electronic systems for medicines 
management. 
 
Systematic reviews of medication administration error prevalence in healthcare 
settings found their occurrence common (39)(40)(41), with an estimated median 
of 19% of ‘total opportunities for error’ in hospitals (39). Specific to causes of 
medication administration errors in the hospital setting, a systematic review by 
Keers et al in 2013 identified 54 studies and found error-provoking conditions 
influencing administration errors included inadequate written communication 
pertaining to prescriptions, documentation, and transcriptions; problems with 
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medicines supply and storage relating to pharmacy dispensing errors and ward 
stock management; high workload; and concerns with ward-based equipment 
with access and functionality (42). Other issues included patient availability and 
acuity; staff fatigue and stress; and interruptions and distractions during drug 
administration (42). The above systematic reviews found ePrescribing and a 
closed loop ePrescribing, electronic dispensing, and electronic administration 
system may improve the prescribing process (39)(40)(42). 
 
A review of the literature on the incidence of dispensing errors by James et al in 
2009 identified 60 papers and found dispensing errors in hospital pharmacy 
ranged between 0.02–2.7% (43). A systematic review of the nature of 
dispensing errors in hospital pharmacies by Aldhwaihi et al in 2016 identified 15 
studies with the most frequent errors reported pertaining to dispensing the 
incorrect medicine, strength, and dosage form (44). The most common factors 
associated with dispensing errors included high workload; low staffing; mix-up of 
look-alike/sound-alike drugs; lack of knowledge and experience; distractions and 
interruptions; and communication problems within the dispensary team (44).  
 
In an Irish context, a collaborative study of medication safety in four Irish 
hospitals by Kirke et al in 2007 found prescribing was responsible for 
approximately 50% of overall incident/near miss reports, dispensing 10%, and 
administration 30% (45). The remaining incidents/near misses included ordering 
and monitoring of drugs. More recently the first national report on the frequency 
and nature of adverse events in hospitals in Ireland by Rafter et al in 2016 found 
the third leading category of adverse events was medication-related (46). These 
findings were similar to other international studies (47)(48)(49). The Institute of 
Medicine further estimate at least one medication error per hospital patient 
occurs each day (50) which would potentially equate to over three million 
medication errors in Irish public hospitals every year (51).  
 
Medication errors are common, costly, and an important source of iatrogenic 
harm (14). Detailed analysis and classification of errors in medicines 
management suggest prevention strategies targeting systems rather than 
individuals are more likely to prove effective in reducing error rates (24).  
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1.3.5 Electronic health record 
The Health Information Management Systems Society defines an EHR as: 
 
“...a longitudinal electronic record of patient health information generated 
by one or more encounters in any care delivery setting. Included in this 
information are patient demographics, progress notes, problems, 
medications, vital signs, past medical history, immunizations, laboratory 
data and radiology reports” (52). 
 
These records streamline workflow and support other care-related activities 
directly or indirectly via interfaces including evidence-based clinical decision 
support (CDS), quality management, and outcomes reporting. 
 
1.3.6 Electronic prescribing 
Articles recommending the use of electronically generated prescriptions can be 
traced back in the literature to the early 1980s (53). Relatively sophisticated 
systems were employed by the early 2000s to facilitate ePrescribing and CDS. In 
more recent years, there have been widespread national and international 
initiatives to implement ePrescribing, these systems having the potential to 
significantly improve the quality and safety of patient care through facilitating 
evidence-based prescribing and reducing medication errors 
(13)(14)(24)(54)(55)(56). ePrescribing can also facilitate extensive 
improvements in dispensing and administration processes, including shorter 
process turn-around times, enhanced communication among healthcare 
professionals, reductions in paperwork, and improved audit trails and drug 
utilisation reviews (14). 
 
There is no universally agreed definition of ePrescribing, this term having the 
potential to denote different meanings depending on the context in which it is 
applied. Various definitions have been put forward by governing bodies 
internationally for both hospital and community settings. The Centre of Medicare 
and Medicaid Services in the USA defines the ePrescribing process as: 
 
“the transmission, using electronic media, of prescription or prescription-
related information between a prescriber, dispenser, pharmacy benefit 
manager, or health plan, either directly or through an intermediary, 
including an ePrescribing network...” (57). 
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The National Health Service (NHS) Connecting for Health in the UK define 
ePrescribing as: 
 
“the utilisation of electronic systems to facilitate and enhance the 
communication of a prescription or medicine order, aiding the choice, 
administration, and supply of a medicine through knowledge and decision 
support and providing a robust audit trail for the entire medicines use 
process” (58). 
 
The Department of Health (DoH) and Ageing’s Pharmacy and Government 
Arrangements in Australia define ePrescribing as: 
 
“an electronic prescription which is generated in accordance with a process 
by which a prescription is electronically generated by a prescriber, 
authenticated (electronically signed), securely transmitted (either directly or 
indirectly) for dispensing and supply, and seamlessly integrated into the 
pharmacy dispensing software...” (59).  
 
For the purpose of this doctoral research, ePrescribing encompasses the latter 
definition, a technology framework that facilitates a prescriber to securely 
generate and transmit prescriptions to a pharmacy dispensing software 
electronically. This definition was thought to relate the most to the content of 
this thesis which explores the facilitators and barriers to electronic systems for 
medicines management with a focus on ePrescribing, robotic pharmacy systems, 
and medication storage and retrieval systems. ePrescribing systems which 
integrate with pharmacy systems have also been found to have the greatest 
benefits to improve patient safety and quality of care through better access to 
data, exchange of data, and enhanced communication (60). 
 
An illustration of an ePrescribng interface is provided in Figure 1.2. 
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Figure 1.2:  Example of the design of an ePrescribing interface   
 
Components that need to be considered when implementing an ePrescribing 
system are illustrated in Figure 1.3. These comprise the technology itself, the 
healthcare providers who interact with it, and where this exchange takes place. 
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Figure 1.3: Components of an ePrescribing system 
 
Evidence of ePrescribing effectiveness can be found in a UK study by Donyai et al 
in 2008 which highlighted a significant reduction in both prescribing errors and 
pharmacists’ clinical interventions for hospital inpatients following 
implementation (60). Another UK study by Shulman et al in 2005 comparing the 
impact of ePrescribing with handwritten prescribing on the frequency, type, and 
outcome of medication errors also found medication errors were significantly 
lower with ePrescribing (61). Franklin et al in 2007 assessed the impact of a 
closed-loop ePrescribing and automated medication storage and retrieval system 
on prescribing errors, administration errors, and staff time in a UK hospital and 
found a reduction in prescribing errors, medication administration errors, and 
increased confirmation of patient identity before administration (62).  
 
A literature review by Niazkhani et al in 2009 on the impact of ePrescribing on 
inpatient clinical workflow identified 51 publications with workflow advantages of 
legible orders, remote accessibility of systems, and shorter order turnaround 
times (63). Another systematic review by Eslami et al in 2009 on the impact of 
ePrescribing in hospitalised patients identified 67 articles with overall positivity in 
the category of adherence to guidelines, cost, organisational efficiency, usability, 
and satisfaction (63). A study by Mitchell et al in 2004 evaluating an 
ePresciribing and electronic medication administration record (eMAR) system in a 
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UK hospital found omissions of patient and drug information were less frequent 
with system implementation (64).  
 
From a time efficiency perspective, prescription monitoring and alterations were 
reduced to less than 10% in a UK hospital with system implementation which 
facilitated pharmacists to spend 70% of their time on direct patient care (65). 
This is a significant advancement considering the report A Spoonful of Sugar: 
Medicines Management in NHS Hospitals, published by the Audit Commissioner in 
2001 found pharmacists only contributed 5-20% of their time to direct clinical 
care (66). A USA study by Murray et al in 1998 found pharmacists spent 46% 
more time problem solving and 34% less time filling in prescriptions with system 
implementation (67). Other studies have also demonstrated an increase in time 
for direct and indirect patient care and a reduction in pharmacist interventions 
for prescriptions (68)(69). The main advantages of implementing ePresribing for 
the benefit of key stakeholders are summarised in Table 1.3 adopted from the 
Health Information and Quality Authority (HIQA) (70). 
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Table 1.3:  Benefits of ePrescribing for key stakeholders adopted from HIQA (70) 
Receiver Benefits 
Patients  Reduced transcription errors  
 Improved legibility and precision of prescriptions 
 Accuracy and speed of dispensed prescriptions through more 
efficient processes 
 
Doctors, 
nurses, other 
prescribers 
 Reduced interruptions from pharmacies querying prescriptions and 
fewer prescriptions returned to prescribers for non-compliance with 
legal or subsidy requirements 
 Better clinical decision-making leading to safer and higher quality 
of care through timely access to patient information 
 
Pharmacy 
staff 
 Use of a common list of medicines in both prescriber and pharmacy 
systems to improve efficiency 
 Improved quality of prescription information and a reduction in 
time spent contacting prescribers to clarify or correct prescriptions 
 Ability to download prescription details facilitating efficiency with 
less potential for error 
 
Organisations  Improved health information flow efficiency and a reduction in 
duplicate prescribing 
 Efficiency gains enabling pharmacists to provide other patient-
centered services 
 Improved consistency with the adoption of ePrescribing standards 
 Better understanding and control of policies, processes, and 
mechanisms that ensure the privacy of ePrescribing 
 
 
Even with such potential benefits, digital transformation in health service delivery 
is not realised in many countries. The Prescription for Excellence report by the 
Scottish Government in 2013 states ePrescribing and related CDS has only been 
implemented in a select few acute hospitals in Scotland and not to its full 
potential (71). Based on the European Hospital Survey: Benchmarking 
Deployment of eHealth Services (2012-2013) report published by the European 
Commission (EC) in 2014, Ireland lags behind many European states with 
ePrescribing implementation (Table 1.4) (72). No Irish hospital in the public 
sector and only a small number of UK hospitals have introduced hospital-wide 
integrated ePrescribing systems between prescribers and dispensers (73). 
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Table 1.4:  European hospital survey: benchmarking deployment of eHealth 
services (2012-2013) adopted from the EC (72) 
Country ePrescribing CDS 
Denmark 94% 56% 
Estonia 100% 42% 
Sweden 85% 27% 
Finland 81% 27% 
Hungary 95% 23% 
Iceland 67% 33% 
Netherlands 69% 19% 
Greece 94% 7% 
Austria 16% 26% 
Belgium 46% 22% 
Luxembourg 67% 67% 
Croatia 27% 36% 
Spain 67% 35% 
Italy 51% 25% 
United 
Kingdom 
20% 9% 
Portugal 93% 15% 
Norway 33% 0% 
Czech 
republic 
45% 35% 
France 39% 24% 
Germany 9% 24% 
Romania 84% 22% 
Ireland 
(Leader) 
9% 
(Estonia: 100%) 
9% 
(Luxembourg: 67%) 
Malta 0% 0% 
Slovakia 21% 9% 
Lithuania 13% 22% 
Cyprus 8% 8% 
Poland 17% 12% 
Latvia 5% 11% 
Bulgaria 21% 6% 
Slovenia 0% 17% 
 
Contributory factors to implementation delay may be due to financial constraints, 
lack of product offerings to deliver benefit, and regulatory barriers. Beyond those 
challenges, prescribers have also been slow to embrace new systems that 
require changes in workflow and investment in training. A perception that 
systems are technically challenging, that other systems need to be in place 
before these systems are rolled out, or that the culture change required for 
adoption into clinical practice is too complex can lead to resistance (73)(74). 
However, drawing on the understanding and experiences of hospitals who have 
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implemented ePrescribing in England, the report Electronic prescribing in 
hospitals: challenges and lessons learnt published by the NHS Connecting for 
Health in 2009 conveys ePrescribing is achievable and beneficial with careful 
planning and a multidisciplinary team effort (73). 
 
1.3.7 Robotic pharmacy systems 
Core to pharmacy work is a modern and effective pharmacy system from 
tracking stocked medicines through to patient dispensing and ward delivery. 
Robotic pharmacy systems automate routine tasks performed in pharmacy and 
have been shown to reduce the incidence of dispensing errors, improve the 
speed and efficiency of the dispensing process, and optimise pharmacy space 
(75).  
 
An illustration of a robotic pharmacy system is provided in Figure 1.4. 
 
 
Figure 1.4:  Example of the design of a robotic pharmacy system  
 
Components that need to be considered when implementing a robotic pharmacy 
system are illustrated in Figure 1.5.  
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Figure 1.5: Components of a robotic pharmacy system 
 
Since publication of A Spoonful of Sugar: Medicines Management in NHS 
Hospitals which advocates the use of automation to transform pharmacy services 
(66), a number of UK hospitals have installed robotic pharmacy systems (76). In 
the USA, a national survey of hospital pharmacy practice in 2011 found robotic 
systems were used in 11% of hospitals (77). Similarly, a European survey of 30 
countries on hospital pharmacy in 2010 identified the implementation of robotic 
dispensing in seven percent of hospitals, mainly in The Netherlands, Portugal, 
and Spain (78). On a national level, a baseline study of hospital pharmacy in 
Ireland published by the Pharmaceutical Society of Ireland (PSI) in 2012 
reported one public hospital had invested in robotic dispensing (8). However, 
considerable interest has been expressed in the acquisition and implementation 
of robotic dispensing systems across other hospitals nationally (8) and to date 
two public hospitals out of 48 have utilised such technology. Technology was 
viewed by pharmacists as having the capacity to decrease workload and allow for 
the development of more clinical pharmacy services (8). In particular, this view 
was expressed by pharmacists who had worked in the UK and had extensive 
experience using robotic dispensing systems. In another survey conducted in the 
USA on hospital technology by Schumock et al in 1999, pharmacists considered 
medication safety to be one of the most important issues facing pharmacy 
services (79). Significant investment in technology will be required over the 
Technology 
Robotic pharmacy 
technology 
Location 
Pharmacy  
 
People 
Pharmacy staff 
 
 16 
coming years to assist hospital pharmacies in delivering services both safely and 
efficiently.  
 
1.3.8 Automated medication storage and retrieval systems 
Hospital pharmacies have traditionally provided medications for patients by 
dispensing and delivering medications which are stored in medication cabinets or 
carts on the wards. Automated medication storage and retrieval systems provide 
computer-controlled storage, dispensing, and tracking of medications and have 
been recommended as a potential mechanism to improve efficiency and patient 
safety (80). These systems are also described as unit-based cabinets, automated 
dispensing devices, automated distribution cabinets, or automated dispensing 
machines (81). Approximately 97% of USA hospitals and 11% of European 
hospitals have adopted automated medication storage and retrieval systems 
mainly for ease and accuracy of the medication administration process (78)(80). 
In Ireland, five public hospitals have systems implemented on hospital wards. An 
example of the design of these systems is provided in Figure 1.6. 
 
 
Figure 1.6 Example of the design of an automated medication storage and 
retrieval system 
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Components that need to be considered when implementing a medication 
storage and retrieval system are illustrated in Figure 1.7.  
 
 
Figure 1.7: Components of a medication storage and retrieval system 
 
It has been reported that automating the storage and retrieval of medicines can 
enhance first-dose availability and facilitate the timely administration of 
medications by increased accessibility on the wards during and outside of 
pharmacy opening hours (82). However, several reviews on system impact have 
demonstrated a lack of evidence of an increase in medication safety attributable 
to stand-alone systems without the integration of an EHR or ePrescribing system 
(82)(83)(84)(85)(86)(87). A number of reports have identified medication errors 
created by these systems and time delays in drug administration to patients 
(82)(85)(88). This suggests automated medication storage and retrieval systems 
may promote a safer medicines management system if they are part of an 
overall strategy that includes ePrescribing systems with CDS and preferably an 
EHR. 
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1.4 Overview of the current medicines management system in 
hospitals in Ireland 
Prescribers in hospitals in Ireland routinely hand write prescriptions onto a 
medication chart which is also utilised by pharmacists to screen and supply 
medication, by nurses to review and record administration times of medicines, 
and by other healthcare professionals as required. Whilst the use of patient’s 
own medication is not routinely recommended in the hospital setting in Ireland 
due to its associated risks, few hospitals have developed a drug formulary which 
leads to pharmacy ordering, stocking, and supplying large quantities of 
medicines at a substantial cost. Hospitals in Ireland also rely on manual 
distribution systems where requisition books with a hand written list of 
medications are received in the pharmacy department from each ward and are 
then generally dispensed in bulk supply to the wards and not per patient name. 
In addition to being labour-intensive and costly, this leads to nurses over 
ordering medications, overcrowding of medications in the nursing presses, added 
time spent locating drugs or re-ordering drugs, and returns to pharmacy of 
medicines not required or out of date. Other significant concerns include 
transcription errors, illegible written requests, delays or omissions in the delivery 
of doses, ‘borrowing’ of patients’ medications, inaccurate drug charges, and no 
tracking of drugs and drug wastage.  
 
Medication reconciliation led by pharmacy staff is also delivered haphazardly 
despite the publication of a Health Service Executive (HSE) Report of the 
National Acute Medicine Programme in 2010 which states medication 
reconciliation is immediately mandated on patient arrival into hospital or as soon 
as possible (89). The PSI’s Future Pharmacy Practice in Ireland – meeting 
patients’ needs report published in 2016 promotes medication reconciliation but 
recognises resourcing currently does not allow for this mandate (90).  
 
Limitations of the current medicines management system were highlighted in a 
five-year review of national clinical incidents, claims, and costs between 2010 
and 2014 published by the States Claims Agency in 2017 (91). They found 
medication-related incidents, which included incorrect dosage, missed 
medication, and incorrect or not reconciled medication on 
admission/transfer/discharge accounted for 15% of the ten most common clinical 
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incidents in Ireland (91). Recommendations for implementation of an EHR and 
ePrescribing system with CDS nationally were proposed.  
 
There are known problems with this system and errors can occur at any stage of 
the medication management cycle posing a significant safety risk for patients. A 
summary of the inefficiencies involved in manual medicines management 
systems in hospitals is illustrated in Figure 1.8 adopted from eHealth Ireland 
(92). 
 
Figure 1.8: Manual medicines management system in hospitals in Ireland 
adopted from eHealth Ireland (92) 
 
1.5 Irish national eHealth initiatives 
1.5.1 Current eHealth infrastructure 
Three types of hospital provisions exist in Ireland: 
 
 The HSE provides and funds all public health services in hospitals and 
communities across the country. The Minister for Health has responsibility 
for its overall governance.  New structures are currently in the process of 
formation with the establishment of six Hospital Groups as a transition to 
Independent Hospital Trusts and the government’s overall commitment to 
reform the current highly criticised health service (93).  Each with their own 
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governance, management, and primary academic partner, the 
establishment of Hospital Groups is potentially a key enabler for 
reorganisation of services across hospitals with associated benefits of high 
quality patient care in a cost efficient manner. These changes will bring 
many challenges to an already strained system and will require increased 
investment in eHealth systems, change management, and implementation 
support infrastructure.  
 Voluntary public hospitals, most of whose income comes from state funds, 
are sometimes owned by private bodies such as religious orders. Other 
voluntary public hospitals are incorporated by charter or statute and are run 
by boards often appointed by the Minister for Health. Both HSE public 
hospitals and voluntary public hospitals operate in a similar way (94). 
 Private hospitals receive no state funding and operate independently of the 
state with separate governance policies (94). 
 
This thesis focuses on the 48 HSE/voluntary public hospitals in Ireland as they 
cover the majority of hospital types nationally and are guided by national 
eHealth programmes and availability of government funding which impacts on 
decisions to invest in eHealth systems.   
 
The current eHealth infrastructure in Ireland’s healthcare sector is fragmented 
which prevents the safe and effective transfer of information and results in 
service users being requested to provide the same information on multiple 
occasions. Healthcare delivery is continuously transforming due to various 
demographic, organisational, and resourcing dynamics as well as from the 
increasing proliferation of technology. Demographic changes are as a result of 
ageing populations, rising chronic diseases, and increased demand and 
complexity of healthcare services (91). With an estimated population of four and 
a half million, Table 1.5 illustrates the estimated national demographic trends for 
2017 and its impact on hospital services adopted from Smyth et al (96).  
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Table 1.5: National demographic trends for 2017 adopted from Smyth et al (96) 
 The population is projected to increase by four percent or 190,600 people between 
2017 and 2022 
 
 There will be 131,600 additional people aged 65 years and over by 2022 
 
 There will be 16,100 additional people aged 85 years and over by 2022 
 
 Life expectancy in Ireland has increased. At 79 years for males and 83.1 years for 
females, it is now above the average for the European Union (EU) 
 
 Approximately 65% of people aged 65 years and over have two or more chronic 
conditions which equates to 404,470 people. Using population projections, in 2017 
this will rise by 12,830 additional people and a further 72,080 by 2022 
 
 25% of children aged three, five, and nine years are overweight or obese 
 
 In 2016 the healthcare budget had decreased by 15% from 2010 and demographic 
pressure had increased by 9% 
 
 
Between two to three percent of government budgets are spent on 
implementation of Healthcare ICT globally (95), with Luxembourg, Norway, and 
the Netherlands allocating more than five percent of their hospital budget to 
eHealth systems (72). In Ireland, investment in Healthcare ICT is approximately 
0.85% (95) which accounts for one of the lowest levels in Europe and 63% of 
hospitals dedicate less than one percent of their budget to IT (72). 
 
1.5.2 National eHealth programmes 
Hospital medication management processes are typically complex, making 
standardisation more complicated. Fundamental building blocks required to be in 
place prior to ePrescribing implementation include unique health identifiers for 
individuals, healthcare professionals, and organisations; an interoperability 
framework and messaging standards to facilitate the secure transfer of 
prescriptions between prescribers and dispensers; and a data model to support 
the implementation of a standardised national medicinal product catalogue (97). 
Other prerequisites include stakeholder engagement and privacy impact 
assessments.  
 
In recent years, the National eHealth Strategy published by the HSE in 2013 
identified ePrescribing as a key priority for Ireland (95). The Knowledge and 
Information Strategy by the HSE launched in 2015 outlines how integrated 
technology will support the delivery of innovative, safe, and high quality patient 
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care and identifies capability requirements and a vision for healthcare delivery in 
the future (98). HIQA is also addressing the current fragmented ICT 
infrastructure and working to ensure high quality health information is available 
to support the delivery, planning, and monitoring of services. This  statutory  
government-funded agency has undertaken multiple projects in the area of 
ePrescribing and medication safety (70)(97)(99)(100)(101)(102)(103). On par, 
the Health Research Board is a statutory agency under the DoH and is the main 
national funding agency for health research. Its five-year strategy between 
2016-2020 emphasises the importance of research in technology to improve 
patient care (104). eHealth Ireland was also established in 2015 to focus on the 
promotion and implementation of patient-centered technology through 
measurable cultural change (92).  
 
Various national eHealth initiatives are either at the implementation stage or 
being planned as a part of the overall eHealth agenda in Ireland, as outlined in 
Figure 1.9 (92).  
 
 
 
Figure 1.9:  Key national eHealth strategic programmes adopted from eHealth 
Ireland (92) 
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ePharmacy focuses on the development of a national medicinal product 
catalogue and deployment of digital solutions across different care settings to 
allow the delivery of safer and more efficient pharmacy services. The availability 
of drug catalogues and pharmacy solutions are key enablers for developing the 
medication management and ePrescribing capabilities. Progress on other national 
eHealth initia2tives are summarised in Table 1.6 adopted from the Office of the 
Chief Information Officer (OCIO) EHR Strategic Business Case in 2016 (105) and 
the National Service Plan 2017 (106).  
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Table 1.6:  eHealth national initiatives adopted from the OCIO and HSE 
(105)(106) 
Individual 
Health 
Identifier (IHI) 
Uniquely identifies individuals, has the capability to share 
patient data across systems in a national portal, 
implementation in progress 
 
EHR Investment of €875 million over a ten-year period, plan 
includes a national summary EHR available by 2019, 
incorporates real-time patient-centered records across 
hospital and community care settings, maintains integrity 
and security of data, can lead to a 68% reduced likelihood of 
medication errors, 76% reduction in errors in discharge 
summaries, and 11% reduction in drug costs. EHR lighthouse 
projects covers three clinical areas: epilepsy, haemophilia, 
and bipolar disorder 
 
Maternal and 
Newborn 
Clinical 
Management 
System  
EHR which incorporates ePrescribing for all women and 
babies in maternity services in Ireland, allows all information 
to be shared with relevant providers, first introduced in Cork 
University Maternity Hospital in December 2016 
 
Medical 
Oncology 
Clinical 
Information 
System 
Patient-centric information system solution, tracks oncology 
drug usage, forms part of the longitudinal view of care 
delivered to patients, work to commence in 2017 and the 
overall project will take 4 years to deliver 
 
National 
Medical 
Laboratory 
Information 
System  
Replaces all laboratory systems with a single national 
solution, ensures 24-hour access to accurate laboratory data 
across all sites, phase one implementation will commence in 
2018 
 
eReferrals   Facilitates general practitioners to submit an electronic 
referral from their practice management system to hospitals 
using the HIQA approved referral form, all public hospitals 
now receiving eReferrals 
 
Open Data Identifies current datasets, establishes a plan to structure 
and publish further datasets over time, provides a valuable 
resource that can drive innovation 
 
eHealth 
priorities for 
2017 
 Further develop ePharmacy 
 Continue to build the foundations for the implementation 
and integration capability of an EHR for Ireland  
 Deliver phase one of the patient portal for IHIs and 
connect 50% of health user systems to the IHI service 
 Develop the framework for a single information services 
function for health including business intelligence tools 
 Analyse and deploy the next phase of the data 
governance programme in conjunction with the DoH’s 
requirements and needs and the HSE’s own capability 
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1.5.3 Clinical engagement initiatives 
Many studies have demonstrated that the implementation process for hospital 
eHealth systems is central to determine overall success 
(6)(107)(108)(109)(110). An important theme has been the problem of 
resistance or refractory behaviours of healthcare professionals and the 
assumption that their attitudes to eHealth are the root problem (4). The 
identification of pre-existing barriers and obstacles, and the investigation of the 
diverse concerns and perceptions of different groups are crucial steps in 
implementing change (91)(111). Healthcare professionals, educators, and 
researchers also increasingly recognise the value of human factors/ergonomics, a 
discipline which examines the design of a system and people’s interactions with 
it, and treats the system as holistic rather than concentrating on individual 
components (112)(113). It explicitly recognises that systems change and modify 
in light of circumstances and events, thus showing emergent properties relevant 
to the dynamic field of eHealth. A systematic review by Yusof et al in 2010 on 
eHealth adoption identified 55 studies and concluded that technology, human, 
and organisational factors are equally important, in addition to the fit between 
them (114). This alignment appears to be achieved easier in small-scale, 
organic, incrementally developed systems in contrast to larger more ambitious 
eHealth projects that are now increasingly being parachuted into complex 
environments (115). 
 
The concept of human factors has been recognised by the eHealth Ireland 
programme which has put significant focus on clinical engagement. The Council 
of the Chief Information Officer (CCIO) was established in 2015 to provide 
clinical governance in the delivery of eHealth solutions in Ireland. With over 300 
voluntary members, including the primary researcher, its role is primarily 
advisory and includes participating in several meetings per year with clinical 
leaders and professionals who have successful programme delivery experience. 
In addition, the eHealth Ecosystem conferences were established in 2015 by the 
DoH and the HSE to connect communities involved in eHealth and address 
themes aligned to ePharmacy, clinical engagement, research, and the EHR 
programme. Technology has also been recognised as a key enabler of future 
pharmacy practice in the PSI’s Future Pharmacy Practice in Ireland – meeting 
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patients’ needs report to allow for operational efficiencies and greater focus on 
clinical and patient facing activities. 
 
Successful implementation will largely depend on this ongoing support, a highly 
committed collaboration from all stakeholders, and the willingness of healthcare 
professionals to integrate new work practices. Other requirements include 
effective leadership and clinical champions, the availability of high quality 
eHealth systems, the development of appropriate skills and training for those 
impacted by the new system, and consideration to systems ergonomics in 
totality (116). 
 
1.6 International eHealth initiatives 
Global healthcare needs are changing. The increasing demands of managing an 
aging population, rising expectations, and advances in life and engineering 
sciences are complex and logistically challenging (116)(117). Healthcare 
strategists worldwide increasingly promote the adoption of eHealth to deliver a 
modern and effective healthcare system and are investing heavily in the area 
(118)(119)(120).  
 
Implementation of eHealth is influenced at a micro-level by interpersonal factors 
such as individuals' attitudes and beliefs, at a meso-level by operational aspects 
such as readiness and resources, and at a macro-level by socio-political forces 
(121). At a macro-level, many countries including the USA, the UK, Canada, 
Australia, and Estonia have been at the forefront of attempts to embed eHealth 
into routine healthcare (70)(122)(123)(124), exemplified by hospitals in England 
who expect to be paperless by 2020 (125). Almost all European countries have 
detailed documents outlining concrete eHealth goals including ePrescribing 
adoption which is among the key activities identified in the ECs eHealth Action 
Plan 2012-2020 (119), the Digital Agenda for Europe (126), and the World 
Health Organization-International Telecommunication Union National eHealth 
Strategy Toolkit (127). A recent UK report Operational productivity and 
performance in English NHS acute hospitals: Unwarranted variations published 
by the DoH in 2016 recommend the adoption of digital information systems 
including integrated ePrescribing systems within an EHR in all trusts by October 
2018 (128). 
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Despite this political commitment and substantial investment, there has been 
significant variability in the success of different eHealth implementations 
internationally (4). For example, the NHS invested over €11 billion over 10 years 
in the national programme for Information Technology (NPfIT) for an EHR which 
failed to be delivered (91). This was mainly due to haste with unrealistic 
timelines, limited engagement with users, inadequate preliminary work, and 
failure to test systems and check progress against expectations (129). Other 
limitations included confidentiality issues, a failure to recognise the risks or 
limitations of big information technology (IT) projects, lack of clear leadership or 
understanding of the aim of the project, insufficient budget allocation with 
treasury emphasis on price over quality, and lack of training or contingency plans 
(129). Difficulties in eHealth implementation are an international phenomenon 
and have been widely reported, with the EU stating adoption of eHealth 
strategies “has almost everywhere proven to be much more complex and time-
consuming than initially anticipated” (130). 
 
1.7 Facilitators to system implementation 
Enablers to successful system implementation include end-users’ attitudes 
towards the innovation, end-users’ capacity and competence, strategic project 
management, effective leadership and communication, continual quality 
improvement, and evaluation (14). Assessing and fostering readiness for system 
implementation appears to be particularly important.  
 
Implementation and dependability of eHealth systems draw on a wide range of 
insights and disciplines (131)(132). Healthcare professionals are continually 
exposed to new research findings that could contribute to more effective patient 
care. However, with only 55% adherence to evidence-based medicine, this gap 
between what healthcare professionals know and what they do challenges 
effective and efficient healthcare delivery (133)(134)(135). To bridge this gap 
between 'the known and the done', a commonly suggested strategy is to identify 
facilitators and barriers for changing practice and then implement interventions 
to enhance enablers and reduce identified barriers (136). As these systems 
promise much in terms of reduction in clinical risk and process inefficiencies, it is 
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important that perceptions of healthcare professionals are reflected in system 
design, development, implementation, and sustainability. 
 
1.7.1 Driving factors for successful system implementation 
International practice and broader engagement with clinical, technical, and 
economic stakeholders have informed key aspects that underpin successful 
system implementation (98). These include good governance and integrity, the 
design and delivery of systems which supports the strategic vision for healthcare, 
clinical leadership for effective delivery, and readiness for change which requires 
significant commitment, motivation, and capability to change (95)(98)(137).  
 
In a recent systematic review of 44 studies by Ross et al in 2016 on factors that 
influence the implementation of eHealth, key facilitators for effective 
implementation included the need for adequate infrastructure and resources, 
engagement of key personnel, and consideration to the fit of eHealth systems 
with current organisational workflow (138). The prevailing focus on 
organisational issues included the need for financial resources, policy support, 
standards and interoperability, management of expectations, and evaluating 
system use. Klynveld Peat Marwick Goerdeler (KPMG) has also proposed key 
facilitators to system implementation in their report Accelerating innovation: the 
power of the crowd published in 2012 on global lessons learnt in eHealth 
implementation as summarised in Table 1.7 (139).  
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Table 1.7:  Summary of key facilitators for successful system implementation 
adopted from KPMG (139) 
 Developing and communicating strong management support throughout the 
organisation and identifying champions, preferably senior prescribers  
 
 Estimating necessary financial resources such as hardware, software, 
additional human resources (HR), training, and technical support with an 
emphasis on patient safety benefits and efficiencies to justify financing 
 
 Fostering a culture of change by placing value on the system and promoting 
and supporting implementation 
 
 Adequate, timely, and ongoing on-site training and technical support with 
protected time for training  
 
 Reconfiguring roles, responsibilities, and work tasks 
 
 Assessing and managing unrealistic expectations and concerns pre-
implementation with clear goals and anticipated benefits 
 
 Ensuring system backup as well as considering workflow design as part of 
the implementation process 
 
 Developing formal goals, objectives, and key indicators of success 
 
 Anticipating challenges in the implementation process  
 
 
An interpretative review by Cresswell and Sheikh in 2013 specific to 
organisational issues in the implementation of eHealth innovations identified 13 
systematic reviews (140). They concluded that consideration to the complex 
relationship between technical, social, and organisational dimensions is essential 
in ensuring systems are useful, usable, and support the organisation within 
which patients and healthcare professionals operate (Figure 1.10).  
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Figure 1.10:  Interrelated technical, social, and organisational factors over time 
in eHealth innovations adopted from Cresswell and Sheikh (140) 
 
A careful balance between organisational demands such as resources, social 
demands such as user requirements, and technical demands such as 
interoperability and performance will be required. 
 
1.8 Evidence of the challenges to system implementation 
Complexity often increases by the integration of technology into healthcare 
delivery due to significant process changes and required expertise in both 
technical considerations and clinical practice. There is a general consensus that 
organisational issues are central to problems with system implementation and 
adoption (138)(141). Such issues that pertain to eHealth innovations cover a 
multidisciplinary field inclusive of organisational psychology, change 
management, and human factors. Additional workload at the initial stages of 
implementation, critical workflow changes, negative emotions, and unexpected 
alterations in power structures can result in significant barriers to adoption 
(138)(141). 
 
The impact on patient safety with system implementation has been the subject 
of many reviews (142)(143)(144)(145)(146)(147)(148)(149). Whilst system 
adoption should in theory enhance healthcare delivery, it may introduce new 
unanticipated negative consequences. These include unfavourable workflow, 
continuous system demands, issues with paper persistence, untoward changes in 
communication practices, negative emotions, unexpected changes in power 
structures, and overdependence on technology (150). Generation of new kinds of 
Pre-implementation  
Post-implementation  
Implementation  
Adequate 
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errors may also be evident exemplified by incorrect decision support, inaccurate 
patient data input, and erroneous orders selected (151). Donyai et al found 10 
new errors created by the use of ePrescribing in a UK hospital (60). These 
included selection of incorrect drugs, frequency, and formulation. Koppel et al 
also found 22 types of medication error risks with the use of a computerised 
physician order entry (CPOE) system in a tertiary teaching hospital in the USA 
(152). Fragmented displays preventing a coherent view of patients’ medications, 
double dosing and incompatible orders, and inflexible ordering formats 
generating wrong orders were reported (152). However, whilst often cited, this 
study has been much criticised due to the high risk of bias with key findings.   
 
A systematic review by Mair et al in 2007 included 19 reviews mostly conducted 
in the USA on understanding the implementation and integration of eHealth 
services (153). Key barriers identified related to inadequate information 
management, insufficient inter-agency cooperation, intrusive technology/rigidity 
of system, cost, and lack of testing systems (153). Another systematic review by 
Gagnon et al in 2009 on the effectiveness of interventions to promote the 
adoption of ICT by healthcare professionals included 10 studies mostly from the 
USA (154). Concerns specific to eHealth innovations related to application design 
and usability. They concluded poorly designed systems and a failure to recognise 
cultural aspects associated with adoption can inhibit successful implementation 
and introduce new risks to patient safety (154) .  
 
Researchers have also found risks to patient safety can transpire from lack of 
system usage (155)(156)(157)(158). Wang et al assessed the capabilities of 
ePrescribing systems in 2005 and found a mere 50% of recommended 
capabilities were fully implemented (159). There were substantial discrepancies 
between capabilities that vendors claimed for their products and capabilities that 
were actually identified. Another study found systems permitted the entering of 
unsafe orders and some applications were not pre-programmed with a set of 
mandatory fields (160).  A systematic review of randomised controlled trails 
(RCTs) by Mollon et al in 2009 on features predicting the success of CDS for 
prescribing identified 41 studies and found no consistent translation into 
improved patient outcomes (161). The included studies did not adequately report 
or give sufficient attention to features of system design or implementation (161).  
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Time issues have been identified as further barriers. An early USA study by 
Tierney et al in 1993 reported doctors spent 33 minutes longer during a 10-hour 
observation period writing orders into an ePrescribing system (162). Bates et al 
in 1999 also found junior doctors took twice as long to input medications 
electronically than the traditional paper-based method (163). However, almost 
half the time was recovered due to the facilitation of some administrative tasks. 
With regard to drug administration ward rounds, Almond et al in 2002 found the 
time to complete this task by nurses had doubled in a UK hospital (164).  
 
Another well documented contribution to potential errors is overriding alerts due 
to alert fatigue (165)(166)(167). Studies addressing user response to alerts in 
ePrescribing applications identified most alerts were ignored with clinical 
‘irrelevance’ being the main reported reason for overriding (143)(167).  
 
Several additional factors that surfaced include concerns regarding the privacy 
and confidentiality of patient information, lack of standards for data coding and 
exchange, and challenges during the transition from paper to electronic systems 
(103)(168)(169)(170)(171)(172). Various barriers with eHealth adopted from 
KPMG are illustrated in Figure 1.11, the most prominent being finance and 
professional attitudes (139). 
 
Figure 1.11: Barriers to eHealth adopted from KPMG (139) 
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From an Irish perspective, reluctance to invest in such systems with medium to 
longer term returns may be due to lack of prioritisation with ever increasing 
pressures in Emergency Departments (EDs), public waiting lists, and late hospital 
discharges, as well the recent economic difficulties within the Irish economy 
(90). System suitability where systems may have been designed for a different 
healthcare market may also be problematic and not fit for purpose. In addition, 
major lessons were learnt from the failure of the abandoned national personnel 
payroll and related system (PPARS), a HSE personnel and payroll electronic 
system estimated to cost approximately €150 million over a 10-year period up to 
2005. This failure was similar to NPfIT and was mainly due to lack of a clear 
vision, substantial variation in pay and conditions between and within health 
agencies, a desire to implement the system quickly, and lack of readiness of 
health agencies to adapt to the changes required (173)(174). Taking account of 
the particular landscape in Ireland and from the experiences of other countries, 
the likely major challenges of system implementation are provided in Table 1.8. 
 
Table 1.8:  Challenges to system implementation in Ireland 
 Maintaining alignment with the eHealth vision 
 
 Addressing any public or healthcare provider concerns over data privacy and the 
sharing of information 
 
 Maintaining stakeholder support 
 
 Having the capacity to absorb change across the health service 
 
 Providing required resources including clinical and management resources 
 
 
1.9 Gaps in the literature  
As previously described, ePrescribing, robotic pharmacy systems, and automated 
medication storage and retrieval systems have the potential to ensure 
continuous improvements in patient safety and efficiency. Whilst there is a 
plethora of literature regarding evaluation of these systems and 
recommendations for adoption from national and international policy documents 
and government strategies, a limited number of studies have been published on 
system implementation processes in hospitals and none have been identified in 
Ireland. There is a clear need to explore facilitators and barriers to system 
implementation and provide original insight into this complex area in a hospital 
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setting to inform policymakers, implementers, and end-users of mechanisms for 
successful system adoption. 
 
1.10 Overall research aim and objectives 
1.10.1 Research aim 
Gaps identified within the literature evolved into the overall novel aim of this 
thesis, namely:  
 
 To explore the facilitators and barriers towards implementation of electronic 
prescribing, dispensing, and administration of medicines in hospitals in 
Ireland  
 
The focus is process driven rather than outcome-based and specifically explores 
technologies relating to ePrescribing, robotic pharmacy systems, and automated 
medication storage and retrieval systems. 
 
1.10.2 Research objectives 
As anticipated, the original research objectives which emerged during work in the 
earlier stages of this research programme have subsequently evolved, 
transformed, and been refined. The original research aim formed in 2012 was to 
explore the current and future role of eHealth in prescribing, dispensing, and 
administering medicines in acute hospitals in Ireland incorporating three phases. 
The first phase was to conduct an outcome-based systematic review on the 
benefits and drawbacks of system implementation. Subsequently it became 
evident that several outcome-based reviews had been published and that it 
would be more timely and beneficial to review implementation processes as 
Ireland had limited experience of system adoption and momentum had started to 
emerge nationally for progress in this arena. Evolution into a process-based 
systematic review on healthcare professionals’ perceptions of the facilitators and 
barriers to system implementation emerged as an area under-researched and 
highly significant.  
 
The second phase of this research initially consisted of conducting postal 
questionnaires with chief pharmacists in public hospitals in Ireland to establish 
the adoption of eHealth initiatives. Shortly after considering this proposal a 
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baseline study of hospital pharmacy in Ireland was published by the PSI in 
December 2012 which provided similar information (8). This phase also included 
interviewing chief pharmacists, local eHealth leads, and national eHealth leads to 
explore their views and experiences of system implementation. This was 
modified and evolved into a more exploratory approach involving two cohorts 
namely local key stakeholders, and national key stakeholders and eHealth leads.  
 
The original third phase involved exploring the structures, processes, and 
outcomes of currently established eHealth systems in hospitals in Ireland and 
selected international sites. At the time of the research, no public sector hospital 
in Ireland had a hospital-wide integrated ePrescribing system, one public sector 
hospital had a robotic pharmacy system, and four public sector hospitals had 
implemented automated medication storage and retrieval systems. The research 
team felt it was not feasible to conduct a case study as there were no suitable 
hospitals to choose from and in addition, several case studies had been 
previously conducted internationally, this it was not thought to significantly add 
to the novel focus of this research (139)(175)(176)(177)(178)(179)(180)(181).  
 
Figure 1.12 illustrates the research approach which has developed with an 
emphasis on theory-based qualitative rich data generation and analysis. 
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Figure 1.12:  Schematic representation of evolution of research aim, 
objectives, and methods 
 
 
 
 
Original research aim 
To explore the current and future 
role of eHealth in prescribing, 
dispensing, and administering 
medicines in acute hospitals in 
Ireland 
 
Systematic review 
Outcome-based 
evaluation on the 
benefits and drawbacks 
of system 
implementation  
 
National exploration   
1. Postal questionnaire to chief 
pharmacists to establish the 
adoption of eHealth initiatives 
2. Interviews to explore the 
views and experiences of chief 
pharmacists to system 
implementation 
3. Interviews to explore the 
views, experiences, and vision 
of eHealth local and national 
leads towards system adoption 
 
 
National & 
international case 
studies  
Explore the structures, 
processes, and 
outcomes of currently 
established eHealth 
systems in hospitals in 
Ireland and selected 
international sites 
 
 
Modified 
Modified 
Discarded 
Systematic review 
Several outcome-based 
reviews published – 
evolved to process-
based facilitators and 
barriers to system 
implementation which is 
under-researched and 
highly significant  
 
Face-to-face interviews               
More exploratory approach to 
research with 
multidisciplinary local and 
national key stakeholders 
and eHealth leads 
 
No Irish hospital has 
integrated ePrescribing 
and limited hospitals 
have robotic pharmacy 
systems or automated 
medication storage and 
retrieval systems so not 
feasible, many case 
studies previously 
conducted internationally 
 
   Refined research aim  
 
To explore the facilitators and barriers towards implementation of 
electronic prescribing, dispensing, and administration of medicines in 
hospitals in Ireland 
to implementing electronic systems for medicines in 
hospitals in Ireland 
 
 
 37 
Phase one objective: systematic review 
 Identify and critically appraise the available evidence on healthcare 
professionals’ perceptions, attitudes, and views of the facilitators and 
barriers to implementing ePrescribing, electronic dispensing, and/or 
electronic administration of medicines in the hospital setting.  
 Synthesise and present the available evidence on healthcare professionals’ 
perceptions, attitudes, and views of the facilitators and barriers to 
implementing ePrescribing, electronic dispensing, and/or electronic 
administration of medicines in the hospital setting. 
 
Phase two objective: interviews with local key stakeholders  
 To explore the perceptions of local key stakeholders towards the facilitators 
and barriers to implementing ePrescribing, robotic pharmacy systems, and 
automated medication storage and retrieval systems in public hospitals in 
Ireland using Normalization Process Theory (NPT) as a theoretical 
framework.  
 
Phase three objective: interviews with national key stakeholders and eHealth 
leads  
 To explore the perceptions of national key stakeholders and eHealth leads 
towards the facilitators and barriers to implementing ePrescribing, robotic 
pharmacy systems, and automated medication storage and retrieval 
systems in public hospitals in Ireland using NPT as a theoretical framework.  
 
Figure 1.13 depicts each incremental phase of the doctoral research. 
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Figure 1.13: Overview of the phases of the doctoral research  
 
It is evident from reviewing the literature that this area is under-researched. This 
exploration aims to provide a unique insight into facilitators and barriers towards 
system implementation in hospitals in Ireland and make a significant contribution 
to original knowledge and impact on the research subject. System-users, 
implementers, and evaluators will be able to use this research when planning, 
implementing, maintaining, and sustaining these systems. Findings can then be 
used to improve the current system in hospitals and maximise the 
implementation and potential use of these systems in the future. As this area is 
dynamic in nature, the evolving nature of technological, social, and 
organisational dimensions needs to be taken into account.   
 
1.11 Chapter summary 
A number of recommendations and issues to consider when embarking on 
system implementation have been provided in the literature. There is potential to 
significantly improve patient safety and efficiency through enhanced access and 
exchange of clinical data using interoperable ePrescribing, robotic pharmacy 
systems, and automated medication storage and retrieval systems. Benefits are 
likely to be dependent on how systems are implemented, supported, and used in 
practice.  
Phase 1 
• Systematic review: Healthcare professionals’ perceptions of the 
facilitators and barriers to implementing electronic systems for 
prescribing, dispensing, and adminstering medicines in hospitals 
Phase 2 
• Qualitative research: In-depth exploration of local key 
stakeholders' perceptions towards the facilitators and barriers of 
system implementation 
Phase 3 
• Qualitative research: In-depth exploration of national key 
stakeholders and eHealth leads'  perceptions towards the facilitators 
and barriers of system implementation 
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Chapter 2:  Methodology  
 
2.1 Introduction  
Chapter 2 reviews and justifies the research philosophy, methodology, methods, 
and theory applied throughout this doctoral research. The processes for data 
sampling, generation, analysis, and quality assurance are described along with 
the reasoning for the choice of such approaches. 
  
2.2 The selection of a research approach 
Research approaches are types of inquiry that provide specific direction that 
range from broad assumptions to detailed methods of data generation, analysis, 
and interpretation. The researcher should provide detail on which philosophical 
assumptions, procedures of inquiry, and specific research methods are to be 
applied to the study. Three approaches include qualitative research which 
focuses on words and text, quantitative research which centres on numbers and 
statistics, and mixed methods research which resides in the middle of this 
continuum incorporating elements of both qualitative and quantitative 
approaches (182). A strong distinction is usually apparent between these 
methods due to their differences in characteristics and techniques for analysis. 
Natural science has typically focused on quantitative positivist analysis which was 
adopted from the human sciences until its limitations became apparent. As 
subjective human feelings are difficult to quantify, a more personal approach 
evolved into qualitative anti-positivist analytical methods. Its historic origin 
comes from anthropology, sociology, the humanities, and evaluation (183).  
 
2.3 Philosophical paradigms 
The nature of scientific inquiry is a large subject area in itself, and one that has 
been addressed and contested from many positions. Approaches to research 
involve the influence of distinct philosophical paradigms, a set of beliefs that 
guide action through four elements: ontology; epistemology; axiology; and 
methodology (184)(185)(186)(187).  
 
Researchers from different disciplines have their own approach to viewing ‘their 
world’. This is sometimes referred to as ontology, the ‘reality’ that researchers 
investigate and the nature of what exists (188). Epistemology considers what is 
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acceptable knowledge and the relationship between reality and the researcher 
and the possible ways of knowing social reality. Axiology is more concerned with 
the role of values and ethics in research and the researcher’s stance. 
Methodology is the technique used by the researcher to investigate that reality 
(183)(189). Diverse techniques of viewing phenomena are frequently 
complementary and an array of researchers from different backgrounds may be 
involved in addressing many issues in pharmacy practice research.  
 
Four common philosophical paradigms, each relating to different epistemological 
and ontological positions, include positivist, post-positivist, interpretivist, and 
pragmatic (183). 
 
2.3.1 The positivist paradigm 
Assumptions and beliefs of the positivist paradigm, otherwise known as naïve 
realism, revolve around an objective reality typically expressed by quantitative 
experimental methods (190)(191)(192). Rooted in the ontological principle, 
reality is free and independent of the researcher and knowledge is objective and 
quantifiable. Hypotheses are tested via inductive reasoning during the research 
process and presented by empirical means.  
 
2.3.2 The post-positivist paradigm 
The post-positivist paradigm, also referred to as critical realism, connects more 
with quantitative than qualitative research. The key assumptions of this position 
are that knowledge is conjectural and that the absolute truth can never been 
found. It is for this reason that a hypothesis is not proven. Instead, a failure to 
reject the hypothesis is indicated.  Researchers objectively make claims, test 
theories, and seek to develop relevant true statements that describe the causal 
relationship of interest (183). Evidence and rational considerations shape 
knowledge to ensure validity and reliability of data. This is in contrast to 
positivist beliefs in quantitative research where the researcher is removed from 
the subject being investigated and becomes an objective observer (188). 
 
2.3.3 The interpretivism paradigm 
This worldview is often seen as an approach to qualitative research and is mostly 
related to phenomenology which assumes that people construct social reality as 
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they interpret the world around them, interact with each other, and assign 
meaning to their perceptions and experiences (193). An interpretivism 
perspective, also referred to as constructivism, is based on an epistemology 
which considers social realities to be constructed out of individual’s experiences 
of phenomena and not from discrete tangible facts that can be measured (183). 
Individuals seek understanding of the world in which they live and construct 
meanings as they engage and make sense of it based on social perspectives and 
interactions. Interpretivism dictates research should be conducted in the natural 
environment to encourage active engagement between the researcher and 
research participants and requires the researcher to be central in the research 
process in order to understand the social world (183)(194). Engagement and 
personal experiences of the researcher are acknowledged as important in 
understanding the issues under study (195). 
 
2.3.4 The pragmatic paradigm 
As a philosophical underpinning for mixed methods studies which arises from 
different dimensions in the research process, the pragmatic paradigm is not 
committed explicitly to any one philosophy as one philosophy cannot fit all (196). 
The truth is what works at that time. Both quantitative and qualitative 
approaches to address research questions are valid which underscores the 
pragmatic philosophy of mixed methods research.  It focuses on pluralistic 
approaches to derive knowledge about the problem where researchers use all 
available strategies to address the issues (183). The task of finding answers to 
research questions via induction, deduction, and abduction drives knowledge 
acquisition and takes precedence over philosophical arguments (197).  
 
Table 2.1 summarises the various research paradigms and fundamental beliefs 
adopted from Wahyuni (198) and based on Saunders et al (199), Guba and 
Lincoln (200), and Hallebone and Priest (201). 
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Table 2.1:  Fundamental beliefs in research paradigms adopted from Wahyuni 
(198) 
Fundamental 
beliefs  
Positivism 
(Naïve 
realism) 
Post-positivism 
(Critical realism) 
Interpretivism 
(Constructivism) 
Pragmatism 
Ontology 
position on 
the nature of 
reality 
External, 
objective, 
independent 
Objective, 
independent, 
interpreted 
through 
experiences 
Socially 
constructed, 
subjective, may 
change, multiple 
options 
External, 
multiple use in 
order to best 
answer the 
research 
question 
Epistemology 
view on what 
constitutes 
acceptable 
knowledge 
Observable, 
measurable, 
can provide 
credible data, 
cause and 
effect 
Observable, can 
provide credible 
data in context 
Subjective, focus 
on details and 
meaning behind 
details 
Observable 
and/or 
subjective 
depending on 
research 
question, focus 
on integrating 
different 
perspectives to 
interpret data 
Axiology 
role of values 
in research 
and the 
researcher’s 
stance 
Objective, 
value-free 
and etic 
Value-laden and 
etic, researcher 
biased  
Subjective, value-
bond and emic  
Objective and 
subjective, 
value-bond 
and etic-emic  
Methodology 
model behind 
the research 
process 
Quantitative Quantitative or 
qualitative 
Qualitative Quantitative 
and qualitative 
(mixed or 
multimethod 
design) 
 
2.3.5 Overall philosophical paradigm employed in current research 
The research objective terms for all phases of this research inclusive of explore, 
perceptions, facilitators, barriers, reject the positivist and post-positivist 
paradigms which are typically quantitative in nature and reflects the 
interpretivist paradigm which is typically qualitative in nature.  
 
Phase one: systematic review 
The first objective of the systematic review was to broadly identify and critically 
appraise the available evidence on healthcare professionals’ perceptions, 
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attitudes, and views of the facilitators and barriers to implementing ePrescribing, 
electronic dispensing, and/or electronic administration of medicines in the 
hospital setting. The second objective was to synthesise and present the 
available evidence on healthcare professionals’ perceptions, attitudes, and views 
of the facilitators and barriers to system implementation. While a systematic 
review can relate to any or all of the above paradigms, the systematic review 
objectives in this research were exploratory in nature and therefore focused on 
qualitative research and aligned to the interpretivist paradigm.  
 
Phase two: interviews with local key stakeholders  
The objective of phase two was to explore the perceptions of local key 
stakeholders towards the facilitators and barriers to implementing ePrescribing, 
robotic pharmacy systems, and automated medication storage and retrieval 
systems in public hospitals in Ireland using NPT as a theoretical framework. 
NPT is a sociological theory used to understand the implementation, embedding, 
and integration of new technologies and organisational innovations which is 
further detailed in this chapter along with the rationale for selection. An 
interpretivist paradigm was again appropriate for phase two which considered 
findings from phase one and sought to explore perceptions. Meaning was 
constructed by participants in the research. Other paradigms did not fit the 
research objective as hospitals in Ireland have had limited experience with 
implementing ePrescribing, robotic pharmacy systems, and medication storage 
and retrieval systems and a more explorative interprtivist approach was 
considered the most suitable paradigm in order to understand the perceived 
facilitators and barriers to implementation.  
 
Phase three: interviews with national key stakeholders and eHealth leads  
The objective of phase three was to explore the perceptions of national key 
stakeholders and eHealth leads towards the facilitators and barriers to system 
implementation in public hospitals in Ireland using NPT as a theoretical 
framework. This explorative research also maps to the interpretivist paradigm in 
order to answer the research question appropriately. Other paradigms did not 
match the research objective as Ireland was at the stage of building momentum 
towards implementation of electronic systems for medicines management and a 
more explorative interprtivist approach was considered the most suitable 
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paradigm in order to understand the perceived facilitators and barriers to 
implementation. 
 
2.4 Methodology and method 
Research methodology is a systematic way to answer a research question. It 
covers the logic surroundings of how new knowledge is generated, justified, and 
critically analysed (188). The scope of research methodology extends beyond 
research methods which are task oriented techniques for collecting and analysing 
data (202) and includes philosophical paradigms that govern these techniques as 
a basis for selecting appropriate methods in research.  
 
Methodologies for undertaking research include quantitative, qualitative, and 
mixed methods research, all with certain strengths and weaknesses. 
Consideration to the different types of methodologies and associated methods 
will assist in ensuring the optimum approach is selected when constructing the 
research design to answer the required research question, as provided in Table 
2.2 adopted from Creswell (183). Whilst mixed methods research designs have 
grown in popularity in recent years in health services, this methodological 
approach should only be applied if deemed the most relevant and appropriate to 
address the research aim and objectives (203). Combining methodologies has 
also been difficult because of the view that quantitative and qualitative 
methodologies belong to separate and incompatible paradigms. Researchers 
subscribing to this view argue it is not possible to combine both methodologies 
as they represent essentially different and conflicting ways of viewing the world 
and how data is generated (203).  Other researchers take a more pragmatic 
view, believing that these concerns of incompatible worldviews can be lessened if 
the combination of quantitative and qualitative designs addresses the research 
question effectively. 
 
The topic of this research merits a qualitative approach as the research aim is 
exploratory in nature. Little research has been previously carried out in this area 
necessitating further understanding and in-depth rich descriptions characteristic 
of qualitative research. Aspects relevant to this thesis will now focus on the 
rational for selecting the methodology and methods employed in order to justify, 
guide, and achieve the objectives set out at the onset. 
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Table 2.2:  Research methodologies adopted from Creswell 
Quantitative Qualitative Mixed Methods 
Experimental designs 
Non experimental designs 
e.g. surveys 
Narrative research 
Phenomenology 
Grounded theory 
Ethnographic 
Case study 
Convergent 
Explanatory sequential 
Exploratory sequential 
Transformative, embedded, 
or multiphase 
 
 
 
 
2.4.1 Overall research methodologies employed in current research 
Phase one 
Content of the systematic review was qualitative in nature and employed a 
narrative design. 
 
Phase two  
Qualitative interviews with local key stakeholders utilised a phenomenological 
design with the phenomenon being perceptions of implementing ePrescribing, 
robotic pharmacy systems, and automated medication storage and retrieval 
systems in public hospitals in Ireland. 
 
Phase three  
Phase three consisted of interviews with national key stakeholders and eHealth 
leads and was also qualitative in nature, utilising a similar phenomenological 
design. 
 
These qualitative methodologies and methods are now described and justified in 
greater detail. 
 
2.5 Systematic reviews 
Systematic reviews occupy the highest hierarchy in terms of quality of evidence 
and are a cornerstone of the evidence-based practice and policy movement. 
Cochrane describes systematic reviews as: 
 
“a high-level overview of primary research on a particular research question 
that tries to identify, select, synthesize, and appraise all 
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high quality research evidence relevant to that question in order to answer 
it” (204).  
 
Narrative reviews provide an overview of research methodologies, methods, 
findings, and interpretation within a research field by experts using their 
knowledge and experience which can introduce a high degree of bias (205). In 
contrast, a systematic review attempts to cover all known literature on the 
specific topic and details its design and methods explicitly for future quality 
assessment. Several organisations have been established to support systematic 
reviews in healthcare inclusive of the Cochrane Database of Systematic Reviews 
(CDSR), the University of York’s Centre for Reviews and Dissemination (CRD), 
and the Joanna Briggs Institute (JBI). 
 
The CDSR is a database of primary research systematic reviews in healthcare and 
health policy provided by the Cochrane Collaboration which has been established for 
over 20 years (206). Cochrane Ireland supports activities of the Cochrane 
Collaboration in Ireland by providing training and support to ensure systematic 
reviews underpin policy, practice, and decision-making. The primary researcher 
undertook a two-day Cochrane Systematic Review course in Ireland prior to 
commencing phase one (Appendix 2.1).  
 
The CRD was also established over 20 years ago and aims to provide evidence-
based systematic reviews and meta-analysis of healthcare interventions via three 
databases: Database of Abstracts of Reviews of Effects (DARE); NHS Economic 
Evaluation Database (NHS EED); and Health Technology Assessment (HTA) 
Database. The systematic review protocol in phase one of this research was 
registered with the CRD (Appendix 3.1) and is available online (207). 
 
The JBI collaborates with over 80 entities globally to promote and support the 
synthesis, transfer, and use of evidence through identifying effective healthcare 
practices to assist in the improvement of healthcare outcomes internationally 
(208). This includes translational science, synthesis science, implementation 
science, software for healthcare professionals, and promoting evidence-based 
practice. The JBI is affiliated with the Scottish Centre for Evidence-based Multi-
professional Practice in Robert Gordon University (RGU) which includes training 
in conducting systematic reviews and promotion of implementation of findings 
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into practice (209). The primary researcher undertook training with JBI in RGU 
prior to commencing phase one (Appendix 2.1). 
 
2.5.1 Scoping reviews 
A fundamental step in the systematic review process is to comprehensively 
define the scope of the research aim. This requires consideration of existing 
literature, including gaps in the literature, clarification of definitions related to 
the research aim, and an understanding of how these are conceptualised within 
existing literature (210). An increasingly popular way to retrieve background 
information and obtain existing evidence is to conduct a scoping review, defined 
as a process of mapping the existing literature or evidence base (211). Scoping 
reviews are commonly used to clarify working definitions and conceptual 
boundaries of a field and are particularly useful for determining the value and 
probable scope of a full systematic review (212). 
 
2.5.2 Overcoming challenges of systematic reviews in qualitative 
research 
Qualitative research has been increasingly recognised as having a distinctive and 
important contribution in healthcare research as a means to explain processes 
and outcomes, and enhance the link between evidence and practice (213)(214). 
Qualitative research can contribute to systematic reviews by (214)(215): 
 
 informing reviews and ensuring reviews include appropriate studies to 
maximise relevance 
 enhancing reviews by synthesising evidence  
 extending reviews by undertaking a search to address research questions 
 supplementing reviews by synthesising evidence within a stand-alone, but 
complementary, qualitative review to address research questions 
 
Nonetheless, evidence-based practice, defined as “the conscientious, explicit, 
and judicious use of current best evidence in making decisions about the care of 
individual patients....from systematic research” (216), strongly asserts that 
primary research based on RCTs is the most appropriate method to determine 
the effectiveness of interventions (217). Qualitative research has traditionally 
been excluded from systematic reviews and concerns have been documented 
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about the scope of this evidence base, including the need to incorporate more 
qualitative research in clinical practice (218)(219). For example, only five 
qualitative studies out of 76 studies investigating potential barriers to guideline 
adherence were included in a systematic review by Cabana et al in 1999 (220) 
and no Cochrane review template is currently in place for qualitative evidence 
exclusively (214). 
 
Much effort is now being invested into resolving the methodological and 
epistemological challenges associated with more inclusive forms of review, such 
as methodological prejudice, problems with searching for qualitative evidence, 
and issues with synthesising qualitative data (213)(221). 
 
2.5.3 Narrative approaches to synthesis of qualitative evidence 
The synthesis of qualitative research is an area of debate and evolution (214). 
 
In this research, a narrative synthesis of the systematic review was carried out 
to provide an analysis of included studies, and an overall assessment of the 
rigour of the evidence.  Narrative synthesis relies primarily on the use of words 
and text to summarise and explain, or to ‘tell the story’, of findings of multiple 
studies (222). 
 
Weaknesses of this type of synthesis include potential lack of transparency and 
clarity of methods employed (221) and formal guidance used on how to conduct 
such synthesis (223). Guidance from Popay et al (222) was applied to this 
systematic review which provides details on how narrative synthesis can be 
conducted in a more systematic and transparent way, focusing on 
implementation of interventions (Table 2.3).  
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Table 2.3:  Tools and techniques for narrative synthesis adopted from Popay et 
al (222)  
Element of synthesis  Suggested tools and techniques 
Developing a preliminary 
synthesis of findings  
Textual description of studies, tabulation, transforming 
data into a common rubric, thematic and content 
analysis for translating data 
Exploring relationships in 
the data 
Subgroup analyses, idea webbing and conceptual 
mapping, qualitative case descriptions, investigator 
triangulation 
Assessing robustness of 
synthesis 
Weight of evidence, best evidence synthesis, validity 
assessment, reflecting critically on the synthesis 
process, checking the synthesis with authors of 
primary studies 
 
2.6 Qualitative methodology  
2.6.1 Main features of qualitative research 
Qualitative research is interested in idealism and inductive reasoning and is an 
approach for exploring and understanding the meaning individuals ascribe to a 
social or human dilemma. This type of research has been defined as inductive, 
subjective, and contextual (183). The process of research is flexible in structure 
and involves emerging questions to data analysis where the researcher interprets 
meaning of the data. Hence, the researcher is characteristically involved in a 
continued and intensive experience with participants and acts as the instrument 
of data generation.  
 
Table 2.4 provides an overview of qualitative research methodologies adopted 
from Creswell (183). Included are narrative, phenomenology, grounded theory, 
ethnography, and case study designs. Starks et al propose phenomenology and 
grounded theory are most suitable for qualitative research in healthcare (224).  
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Table 2.4:  Qualitative research methodologies adopted from Creswell (183) 
Design Narrative Phenomenology  
 
Grounded 
theory  
Ethnography  Case study  
Aim 
 
Exploring  the 
life of 
participants 
  
 
 
Understanding 
experiences about 
a phenomenon 
usually obtained 
by interviews  
Developing a 
theory grounded 
from data in the 
field via multiple 
data generation 
periods  
Study of a 
culture or 
social group 
in the natural 
environment 
of participants  
In-depth long-term study of 
a single case or multiple 
cases  
 
Main methods 
of data 
generation  
Story 
collection via 
interviews 
and document 
analysis  
Interviews and 
focus groups  
Interviews and 
focus groups 
Observations 
and 
interviews  
Document analysis, archival 
records, interviews, and 
observations  
Approaches to 
data analysis  
Stories and 
historical 
content 
Statements, 
meaning, essence 
description, 
themes and 
coding  
Open coding, 
axial coding, 
selective coding, 
and conditional 
matrix  
Detailed 
description of 
setting/group, 
analysis, and 
interpretation 
Detailed description of   
setting/ 
individual, themes, and 
assertions  
Approaches to 
data 
interpretation  
 
Conceptual to 
form a 
detailed 
picture of a 
participants 
life  
Themes 
categorised  and 
described 
Probability of 
concepts or a 
theoretical 
model 
Themes 
categorised 
and described 
 
Themes categorised and 
described  
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In comparison to quantitative studies which generate findings from statistical 
analysis, qualitative research investigates the why and how of decision-making. 
Smaller more focused samples are typically used covering a range of philosophies, 
research designs, and specific techniques where data are either naturally occurring, 
such as observation and document analysis, or generated, such as in-depth 
interviews intended to elicit views and opinions from participants (136)(214)(222). 
Little emphasis is put on predefined concepts of a research project. Instead, 
hypotheses are developed and refined as the research progresses (195). 
 
Like all research approaches, advantages and limitations arise depending on the 
type of research methods selected. The main drawbacks in qualitative research 
relate to data generation and analysis being relatively time consuming and 
dependent on the skills of the researcher to extract valuable information (197). It 
does however provide depth and detail on little known topics or complex issues and 
stimulates participants’ individual experiences in a natural environment creating an 
openness to related issues (194)(200).  As a result, qualitative research has gained 
in popularity for studying complex human interactions in health services (225).  
 
Grounded theory was rejected in this doctoral research as there was no attempt to 
generate theory. Instead, a qualitative phenomenological approach was employed in 
phase two and phase three to facilitate generation of in-depth rich data to 
understand and describe participants’ perceptions towards the facilitators and 
barriers to system implementation in hospitals in Ireland. Moustakas describes this 
approach as returning to the participants’ experience in order to obtain 
comprehensive descriptions which then provide the basis for a reflective structural 
analysis to portray the essences of the experience (226).  
 
2.6.2 Qualitative methods  
2.6.2.1 Data generation 
Healthcare professionals seek evidence to substantiate the worth of interventions, 
thus the type of evidence needed depends on the purpose and nature of the activity 
under enquiry. The most common approaches to interpretive phenomenology 
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include focus groups and in-depth interviews to elicit perceptions and views from 
participants.  
 
Focus group discussions have gained in popularity for the initial exploratory phase 
of research to develop topics for inclusion in surveys (227). This approach explicitly 
uses group interactions as part of the method, usually with six to eight participants 
(183). Individual participants are encouraged to ask questions, exchange 
anecdotes, and comment on each others’ experiences and points of view (228). 
Focus groups have been reported to require greater skills on the part of the 
researcher to control group discussions, manage any effect of dominant group 
members, and encourage reserved participants to express their opinions 
(229)(230). In addition, micro-analysis of the differences in individual views is 
difficult to undertake (231). 
 
Individual face-to-face interviews have been the dominant mode of data generation 
and many authors hold this method of interviewing in qualitative research as the 
gold standard to elicit comprehensive exchanges between the researcher and 
participants (232)(233). Researchers can take added advantage of non-verbal cues 
from participants to gain in-depth insight into the data. Limitations include both 
time and expense (234). The use of online interviews via video conferencing is 
another adaptation to qualitative data generation brought about by technological 
advances in the research world which overcomes time, financial, and geographical 
constraints. However, the relative anonymity of online interactions may increase 
presentation of self and authenticity compared with face-to-face interviews (235). 
Telephone interviews are an equally efficient and cost-effective method but are 
largely neglected in qualitative research literature as an alternative to face-to-face 
interviewing due to the absence of visual cues and loss of contextual and nonverbal 
data potentially compromising rapport, probing, and interpretation of responses 
(236). A study by Irvine in 2011 reviewing the duration, dominance, and depth of 
talk between researcher and participant when comparing telephone and face-to-face 
interviews found telephone interviews were typically shorter as a result of 
participants speaking for less time and providing relatively less detail or elaboration 
(237).  
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Table 2.5 illustrates the strengths and weaknesses of focus groups and in-depth 
interviews adopted from Creswell (183), Bowling (194), and Irvine (238). 
 
Table 2.5:  Strengths and weaknesses of focus groups and in-depth interviews 
adopted from Creswell (183), Bowling (194), and Irvine (238) 
Type Appropriate for Strengths  Weaknesses 
Focus groups Identifying group 
norms  
 
 
 
 
Eliciting opinions on 
group norms  
 
Discovering variety 
within a population 
Elicits information 
on norms and 
opinions in a short 
time  
 
 
Group dynamic 
stimulates 
conversation, 
reactions 
Requires a good 
interviewer to guide 
group and extract 
maximum relevant 
information  
 
Trustworthiness 
can be reduced 
as participants 
may only offer 
desirable 
answers in a 
group setting   
 
In-depth interviews Eliciting individual 
experiences, 
opinions, feelings 
 
Addressing 
sensitive topics 
Eliciting in-depth 
responses 
 
 
Explores interpretive  
perspectives, e.g. 
the connections and 
relationships 
individuals see 
between particular 
events, phenomena, 
and beliefs 
Can be costly and 
labour intensive  
 
 
In jeopardy of 
personal biases and 
poor interview skills  
 
Participants may 
have poor recall of 
important 
information  
 
 
The format is typically structured, semi-structured, or unstructured where 
interviews are recorded and transcribed, as summarised in Table 2.6 adopted from 
Bowling (194). 
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Table 2.6:  Comparisons of different interview types adopted from Bowling (194) 
Type Structured Semi-structured Unstructured 
Description A set of 
predetermined  
questions on a 
specific topic asked 
in a standard way 
 
A set of 
predetermined 
questions with the 
ability for more in-
depth questioning as 
topics arise 
 
Open questions for in-
depth responses from 
participants usually 
about a relatively 
unknown topic  
 
Data 
generation tool 
Questionnaire Interview schedule Interview guide 
 
Advantages Interviewer 
predetermines fixed 
questions with fixed 
order, control lies 
with interviewer 
 
More open 
questioning, order can 
vary, control lies with 
interviewer and 
participant 
Non leading in-depth 
interviews, control lies 
with participant 
Disadvantages Data likely to be 
coded in advance, 
lacks flexibility 
limiting depth   
May be time 
consuming, reliant on 
skill of interviewer for 
trustworthy responses 
 
Lack of consistency in 
approach and fixed 
order of questioning 
 
As focus groups are more suitable for studying how views are created and modified 
and may potentially inhibit participants when openly sharing information with others 
(233)(238)(239), individual face-to-face semi-structured interviews were considered 
the most appropriate method for phase two and phase three to achieve the overall 
research aim. This in-depth approach allows participants time to express their own 
views on the subject and facilitates the generation of high quality, comparable data 
which is useful for understanding the viewpoint and experiences of individuals.  
 
2.6.2.2 Sampling in qualitative research 
Most research methods require sampling due to large population sizes and inability 
to research select groups in its entirety. Qualitative research seeks to understand 
complex human issues through a detailed study of several participants rather than 
capturing a representation of the general population. Non-probability sampling is 
commonly employed in qualitative research using non-random techniques to select 
participants, such as purposive sampling, snowball sampling, and convenience 
sampling as illustrated in Table 2.7 adopted from Morgan (240).  
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Purposive sampling entails selecting participants intentionally based on their 
experiences and interest in the subject, often chosen to reflect varied perspectives 
in order to achieve maximum variability and enhance data quality (241)(242). 
Starks et al suggest purposive sampling should be used in qualitative research in 
healthcare settings to capture participants who have knowledge of the investigated 
experience (224). Snowball sampling, also referred to as chain referral sampling, is 
a type of purposive sampling that relies on recruiting well-informed participants who 
then suggest other people of interest to be recruited. Participants are usually 
difficult to find or not easily accessible through other sampling strategies 
(183)(194)(243). Both sampling types are vulnerable to selection bias and 
confounding variables. Convenience sampling, the selection of the most accessible 
subjects, is resource efficient in terms of time and economics but is the least 
rigorous technique as participants are not necessarily representative of the 
population which may result in poor data quality (241). 
 
Table 2.7:  Non-probability sampling adopted from Morgan (240) 
 Description 
 
Common 
Usage  
Strengths  
 
Weaknesses  
 
Purposive  
 
Participants 
selected based 
on a particular 
goal and their 
perceived 
relevance to the 
study 
 
Small, specific 
populations 
with a certain 
goal, more 
accurate 
findings 
Often cheap and 
efficient, more 
accurate results 
with select 
group 
Vulnerable to 
research bias, 
high risk of 
sampling error  
Snowball Subsequent 
participants 
identified from 
response of 
initial 
participants 
Small, difficult 
to access 
populations  
Low cost, access 
to difficult to 
reach 
participants 
 
High risk of 
sampling error, 
subject to 
participant bias, 
limits 
transferability 
Convenience Participants 
selected based 
on ease of 
accessibility 
 
Pilot studies  
 
Easy to recruit, 
efficient, cheap  
 
Least dependable, 
high risk of 
sampling error 
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Purposive sampling was employed in phase two and phase three of this research in 
order to explore a range of key stakeholders’ perceptions towards system 
implementation and generate rich data. 
 
2.6.2.3 Sample size in qualitative research 
Debates continue about what constitutes an adequate sample size in qualitative 
research which is predominantly dependant on judgement, experience, research 
design, methods, and philosophical beliefs (244)(245). The intent of data generation 
is to gather extensive information from a sample size appropriate to answer the 
research question. Issues such as ethics, time, and cost may arise if the sample is 
larger than required.  Creswell states that sample size depends on the qualitative 
design employed and that narrative research generally includes one or two 
individuals, phenomenology typically ranges from three to 10 participants, grounded 
theory varies from 20 to 30, ethnography examines one single group, and case 
studies includes approximately four to five cases (183). Another approach to sample 
size is data saturation derived from grounded theory where data generation ceases 
when themes are saturated with no new insights (183)(246)(247). Francis et al 
propose specifying a minimum sample size for initial analysis for theory-based 
studies and then specifying how many more interviews will be conducted without 
new ideas emerging, referred to as the stopping criterion. They found data 
saturation was achieved after 17 interviews and suggest using an initial analysis 
sample of 10 and a stopping criterion of three (246).  
 
2.6.2.4 Approaches to data analysis in qualitative research 
With the exception of grounded theory, data analysis in qualitative research 
involves reducing large data generations and coding data into a small number of 
themes via relevant theoretical frameworks. Creswell suggests an average of five to 
seven themes as an appropriate number (183). Qualitative software programmes, 
such as QSR NVivo, are a popular method to organise, sort, and search for data in 
text databases.  
 
Methods of data analysis include content analysis, grounded theory, thematic 
analysis, and framework analysis (194). Content analysis is a method used to 
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identify patterns across qualitative data by coding data to themes and analysing 
accordingly (230). This type of analysis tends to focus at a micro-level, often 
providing counts (248), and allows for quantitative analysis of initially qualitative 
data (249). Grounded theory analysis commences as soon as data generation 
begins and involves searching for codes, concepts, and categories within the data 
with no preconceived hypothesis (250). The coding approach is a form of content 
analysis.   
 
Thematic analysis is the most traditional method of analysis for qualitative studies 
which consists of arranging data content into themes (251). The six phases in 
thematic analysis adopted from Braun and Clarke are illustrated in Table 2.8 (251). 
 
Table 2.8:  Phases of thematic analysis adopted from Braun and Clarke (251) 
Phase Description 
 
Familiarisation of 
data 
Transcribing data, reading and rereading the data, 
noting down initial ideas 
 
Generating initial 
codes 
 
Coding interesting features of the data in a 
systematic way across the entire data set, collating 
data relevant to each code 
 
Searching for themes 
  
Collating codes into potential themes, generating all 
data relevant to each potential theme 
 
Reviewing themes 
 
Checking the themes work in relation to the coded 
extracts and the entire data set, generating a 
thematic ‘map’ of the analysis 
 
Defining and naming 
themes 
 
Ongoing analysis to refine the specifics of each 
theme, generating clear definitions and names for 
each theme 
 
Producing report 
 
Selection of vivid, compelling extract examples, final 
analysis of selected extracts, relating back analysis 
to the research question and literature, producing a 
scholarly report of the analysis 
 
 
The framework approach is another method of data analysis similar to thematic 
analysis, the terms often used interchangeably. Ritchie and Lewis define the 
framework approach as:  
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“a matrix based analytic method which facilitates rigorous and transparent 
data management such that all the stages involved in the ‘analytic hierarchy’ 
can be systematically conducted” (252).  
 
This approach is increasingly used in health research where data is sifted, charted, 
and sorted in accordance with key themes using five steps as illustrated in Table 2.9 
(252). Generation of descriptions, categories, explanations, and typologies are 
important features of the framework approach (253). The analytical process begins 
during transcribing by listening to recordings and reading transcriptions 
continuously to immerse the researcher in the data. This involves coding of data, a 
common inductive technique, by reducing data into smaller numbers of themes 
guided by the research objectives and interview schedule (202). Key themes are 
listed in columns with each participant assigned to rows usually facilitated through 
computer assisted qualitative data analysis software such as QSR NVivo®. The 
framework approach is better adapted to research with defined objectives, a limited 
time frame, a pre-designed sample, and a priori issues (254). 
 
Table 2.9: Phases of the framework approach to data analysis adopted from 
Ritchie and Lewis (252) 
Phase Description 
Familiarisation  
 
Transcribing and reading data 
 
Thematic framework  
 
 
Initial coding framework via a priori and 
familiarisation phase 
Indexing 
 
 
Thematic framework applied to data via codes 
corresponding to differing themes 
Charting Creating thematic charts for each theme across 
all respondents or case charts for each 
respondent across all themes  
 
Mapping and interpretation Searching for patterns, associations, concepts, 
and explanations in data via visual aids 
 
 
The framework approach to data analysis was considered the most appropriate 
method in phase two and phase three of this research to complement the research 
phenomenological methodology. It facilitates rigorous and transparent data 
management ensuring all steps of analysis are systematically conducted 
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(252)(254). This approach was also considered most suitable since the research was 
led by predefined objectives and semi-structured interview schedules, thus giving 
the research more structure.  
 
2.7 Trustworthiness and rigour in qualitative research 
Evaluating the quality of research is necessary if findings are to be utilised in 
practice and incorporated into healthcare delivery. Reliability, validity, and 
objectivity are common concepts employed by both positivist and post-positivist 
investigators in order to define the integrity of the research process (255). Many 
naturalistic researchers have, however, preferred to use alternative terminology to 
distance themselves from the positivist paradigm and differing ontological and 
epistemological beliefs. Frameworks for ensuring rigour in qualitative research 
include Guba’s four constructs which correspond to the criteria employed in 
quantitative research, as illustrated in Table 2.10 and described by Shenton (255). 
Unlike quantitative researchers who apply statistical methods for establishing 
validity and reliability of research findings, qualitative researchers aim to apply 
methodological strategies to ensure ‘trustworthiness’ of findings (256).  
 
Table 2.10:  Constructs to ensure quality in research adopted from Shenton (255) 
Qualitative research Quantitative research 
Credibility  Internal validity 
Transferability  External validity/generalisability 
Dependability Reliability 
Confirmability Objectivity 
 
Qualitative research is often criticised for lacking scientific rigour with poor 
justification of methods applied, lack of transparency in the analytical process, and 
findings subject to researcher bias (257)(258). However, qualitative researchers 
have made provisions to promote credibility and ensure the phenomena under 
scrutiny has been accurately described, recorded, and analysed. The design, 
method, and interpretation of data should be systematic and avoid as much 
researcher bias as possible (194).  
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Participants should be encouraged to be frank from the outset to ensure honesty of 
data through direct instructions, developing rapport, and opportunities to withdraw 
from the study (255). Applying a reflective commentary where the researcher seeks 
to evaluate the project as it develops with emerging inferences as well as scrutiny of 
the research by the research team, colleagues, peers, and academics should further 
enhance credibility. Researchers can also request participants to comment on data 
transcription and interpretation (255). 
 
Triangulation is a powerful strategy for enhancing credibility, based on the idea of 
convergence of multiple perspectives for mutual confirmation of data to ensure all 
aspects of a phenomenon have been investigated (259). Denzin (260) and Patton 
(261) categorised four different triangulation techniques: triangulation of data 
methods; triangulation of data sources; theoretical triangulation; and triangulation 
of investigators. The former is the most commonly employed, where data generated 
by various means such as interviews and observations are compared in order to 
contribute to in-depth understanding of the topic under investigation. Triangulation 
of data sources capitalises on the range of data that may contribute to complete 
understanding of the concept and is reliant on variety in time, space, and person. 
Examples of triangulated sources include sampling of a range of heterogeneous 
participants in different organisations to form a rich picture of the perceptions and 
needs of those being interviewed. This may reduce local factors specific to an 
establishment and provide a variety of perspectives to achieve a more 
comprehensive view of ‘reality’. Theoretical triangulation allows ideas from diverse 
or competing theories be tested. Triangulation of investigators occurs in a study in 
which data are analysed by a research team, often with a diversity of approaches, 
rather than by a single individual (259)(260)(261). 
 
Bias arises when systematic error is introduced by selecting or encouraging one 
outcome or answer over another and is a threat to credibility (262).  This can 
transpire at any phase of research, including study design, data generation, data 
analysis, interpretation, and publication, as illustrated in Table 2.11 adopted from 
Bowling (194). In all steps, the qualitative researcher remains aware and sensitive 
to any personal presumptions, biases, and potential influences on response of 
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participants and considers the degree to which bias was prevented or minimised by 
appropriate study design and implementation, and how bias might influence a 
study's conclusion (263).   
 
Table 2.11:  Types of bias in qualitative research adopted from Bowling (194) 
Type of bias 
 
Description  
Acquiescence 
response set  
 
Tendency of a participant to agree with a statement when in doubt, 
‘yes-saying’  
 
Design bias  
 
Use of inappropriate methods, sampling, or analysis  
 
Evaluation 
apprehension  
 
Anxiety may result in participants providing responses which they 
feel are expected rather than their actual opinion on the topic in 
question 
 
Interviewer bias  
 
A partiality towards a preconceived response based on the 
structure, phrasing, or tenor of questions asked by the interviewer 
e.g. leading questions  
 
Non-response bias  
 
Effective sample size reduced due to invitees not responding  
 
Publication  bias 
 
Published literature likely to contain only positive results and not 
negative studies  
 
Recall (memory) 
bias  
 
Selective memories in recalling previous occurrences, experiences, 
and conduct  
 
Reporting bias  
 
Failure of the participant to reveal full information or disclose 
requested information  
 
Sampling bias  
 
Non-representative selection of participants. Unequal opportunity 
for all of the population of interest to be included in the sample  
 
 
Transferability describes the extent to which findings can be applied to other 
contexts and settings. Silverman considers the ability of the researcher to relate 
findings to an existing body of knowledge as a key criterion for evaluating 
qualitative inquiry (264). As the tendency to use small sample sizes in qualitative 
research can make transferability difficult, the provision of background data to 
establish the context of the research and a detailed description of the phenomenon 
in question should assist in transferability and allow comparisons be made with 
other research (255). This detail should include the number and location of 
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organisations participating, participant inclusion and exclusion criteria, sample size, 
and data generation such as the number and length of interviews and the time 
period over which the data will be collected to convey the boundaries of the study 
(255). Awareness of potential ethical issues with identification of data sources such 
as participants or settings should be considered when detailing the phenomenon. 
 
Dependability can be increased by providing in-depth methodological descriptions of 
the research inclusive of design, details of data generation, and reflective appraisal 
of the research. This in-depth methodological description and self-reflection of the 
effectiveness of the data generation process will facilitate repeatability (255). It can 
also enhance confirmability by allowing integrity of the findings to be scrutinised 
from data generated rather than the biases and preconceived notions of the 
researcher. Techniques for promoting confirmability include triangulation, self 
reflection and awareness of ethical issues, and details of all research processes 
(255).  
 
The principles provided in Table 2.12 adopted from Creswell (183) and Guba (255) 
have been applied in phase two and phase three of this research as detailed in 
Chapter 4 and Chapter 5. The consolidated criteria for reporting qualitative research 
(COREQ) was also applied which comprises a 32-item checklist for in-depth 
interviews. The checklist relates to important aspects of sampling method, setting 
for data generation, method of data generation, respondent validation of findings, 
method of recording data, description of the derivation of themes, and inclusion of 
supporting quotations (265).   
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Table 2.12:  Quality framework in qualitative research adopted from Creswell (183) 
and Guba (255) 
Quality Framework Researchers’ responsibility 
Credibility  Adoption of appropriate research methods 
 Familiarity with the culture of participating organisations 
 Appropriate sampling e.g. purposive  
 Triangulation of data sources via different participants and 
settings 
 Strategies to assist in the honesty of participants e.g. 
use of probing questions to elicit information from interviewees 
 Use of reflective commentary and scrutiny of project 
 Background, qualifications, and experience of researcher 
 Checks of data generated and interpretations formed 
 Examination of previous research to frame findings 
Transferability  Background data and thick description of phenomenon under 
scrutiny and study design 
Dependability  Employment of overlapping methods 
 In-depth methodological description to allow the study be 
repeated 
 Content credibility and regular reflection of interview schedules 
by research team 
Confirmability  Triangulation of data sources to reduce effect of researcher 
bias 
 Admission of researchers’ beliefs and assumptions 
 Recognition of limitations in methods  
 In-depth methodological description to allow integrity of 
research results be scrutinised 
 Transcriptions and interview recordings reviewed for 
dependability by research team  
 
2.8 Theory in qualitative research 
There are numerous definitions of theory. Meleis defines theory as:  
 
“An organized, coherent, and systematic articulation of a set of statements 
related to significant questions in a discipline that are communicated in a 
meaningful whole. It is a symbolic depiction of aspects of reality that are 
discovered or invented for describing, explaining, predicting, or prescribing 
responses, events, situations, conditions, or relationships. Theories have 
concepts that are related to the discipline's phenomena” (266). Creswell states 
theory is “a scientific prediction or explanation for what the researcher expects 
to find” (183).  
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Theories can provide useful ‘lenses’ to assist researchers in focusing on particular 
aspects of complex systems and enhance rigour and impact of findings. Adopting 
this theoretical perspective can be applied at various stages of the research process 
and can offer a rationale for conducting the study, determining the research aim 
and questions, defining the methodology, developing data generation instruments, 
and providing a framework for data analysis and interpretation (267)(268)(269). 
The criteria for ‘good theory’ has been expressed as being explanatory by providing 
reasoning around variables and effects; plausible by providing meaningful 
explanations which are consistent with existing evidence; explicit by summarising, 
explaining, and organising facts; and parsimonious by using variables which are 
arranged simply to explain effects (270)(271).  
 
In qualitative research, theory is influenced considerably by ontological and 
epistemological positioning and its associated methodologies (272)(273)(274). 
Sandelowski states theory provides justification for the methodological approach 
and is derived from the researcher itself or enters from the outside (275). Theory 
may also be central or only peripheral to the phenomena under study, thus, it is not 
always clear when theory entered or left a study (275). 
 
Despite significant promises for improved healthcare quality and efficiency with 
eHealth technologies, concerns about the large numbers of pilot studies that fail to 
lead to sustainable services are repeatedly expressed (276). The bridge between 
research evidence and practice remains wide (111).  In attempting to address such 
problems, the field of ‘implementation science’ is now fast growing as researchers 
investigate issues relating to the implementation of healthcare interventions and the 
science behind implementation processes via the application of theory. Nilsen 
describes five categories of theoretical approaches that can be used in 
implementation science: process models; determinant frameworks; classic theories; 
implementation theories; and evaluation frameworks, as illustrated in Table 2.13 
(277). Other theoretical diversity include approaches relating to technology design 
and its relationship with human actors (278)(279), and psychological theory on 
individuals attitudes and behaviours (280)(281), particularly with regard to 
healthcare professionals’ perceptions towards evidence-based practice (282)(283). 
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These theoretical approaches conceptualising the interaction between technology, 
human factors/ergonomics, and organisations include diffusion of innovations; 
sensemaking; social shaping of technology; sociotechnical changing; technology 
acceptance model; and the notion of ‘fit’ (140). 
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Table 2.13: Five categories of theories, models, and frameworks used in 
implementation science adopted from Nelsen (277) 
Category Description Examples 
 
Process 
models 
Specific steps in the process of 
translating and implementing 
research into practice 
The Canadian Institutes of Health 
Research Model of Knowledge Translation; 
the Knowledge to Action Framework; the 
Stetler Model; the Academic Center for 
Evidence-Based Practice (ACE) Star Model 
of Knowledge Transformation; the Iowa 
Model; the Ottawa Model; the Quality 
Implementation Framework 
 
Determinant 
frameworks 
Understand and explain 
influences on implementation 
outcomes, e.g. predicting or 
interpreting outcomes 
retrospectively by specifying 
enablers and barriers 
(independent variables) that 
influence implementation 
outcomes (dependent variables) 
 
Consolidated Framework for 
Implementation Research; Theoretical 
Domains Framework (TDF); Promoting 
Action on Research Implementation in 
Health Services; Active Implementation 
Frameworks; Understanding-User-Context 
Framework; Conceptual Model; Cochrane 
Framework; Ecological Framework 
 
Classic 
theories 
Theories that originate from 
fields external to 
implementation science, e.g. 
psychology, sociology, and 
organisational theory, to provide 
understanding and explanation 
of aspects of implementation 
 
Theory of Diffusion; social cognitive 
theories; theories concerning cognitive 
processes and decision-making; social 
networks theories; social capital theories; 
communities of practice; professional 
theories; organisational theories 
 
Implementat
ion theories 
Theories developed by 
implementation researchers  to 
provide understanding 
/explanations of adoption 
NPT; Implementation Climate; Absorptive 
Capacity; Organizational Readiness; 
Capability, Opportunity, Motivation, 
Behaviour (COM-B)  
 
Evaluation 
frameworks 
Specify aspects of 
implementation to evaluate 
implementation success 
Reach Effectiveness Adoption 
Implementation Maintenance (RE-AIM); 
Predisposing Reinforcing and Enabling 
Constructs in Educational/Environmental 
Diagnosis and Evaluation-Policy 
Regulatory and Organizational Constructs 
in Educational and Environmental 
Development (PRECEDE-PROCEED) 
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Overall, there is no overarching conceptual framework in relation to eHealth 
implementation. The main tensions of various theoretical considerations include: a 
focus on relatively linear stages and integration of technology over time, with some 
theories focusing on exploring one feature of the lifecycle in detail; a focus on 
individual adopters in isolation; a focus on complexity and unpredictability of the 
change process; and frameworks seeking to be as inclusive as possible resulting in 
less specificity (140). 
 
With consideration to the above and additional theories researched, three of the 
most suitable theoretical frameworks were contemplated to best match the overall 
research aim and the objectives for phase two and phase three: TDF; NPT; and a 
general theory of implementation. 
 
2.8.1 Theoretical domains framework 
TDF was developed in 2005 by a group of psychological theorists, health service 
researchers, and health psychologists as a framework rather than a theory to 
“…simplify and integrate a plethora of behaviour change theories and make theory 
more accessible to, and usable by, other disciplines” (284). TDF is derived from 33 
theories of behaviour change used extensively within healthcare intervention 
implementation (285)(286). However, many healthcare interventions are more 
complex than just the behaviour of individuals, such as systems ergonomics and 
socio-organisational factors.  
 
2.8.2 Normalization process theory  
Interventions aimed at changing the behaviour of healthcare professionals have had 
limited success (135)(287)(288). A lack of robust research-based theoretical 
frameworks to explain change beyond the narrow focus of individual behaviour is of 
particular significance given the current need for systematic, theoretically informed 
studies on the applicability of research-based knowledge to routine clinical practice 
(289)(290). NPT, a middle-range theory of socio-technical change, provides one 
such framework for understanding why healthcare interventions are accepted and 
embedded routinely in organisations and others rejected (291). It focuses on work 
that individuals and organisations must perform for a new technology or practice to 
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become embedded and sustained in routine practice and is used as a conceptual 
framework to explore the gap between health research evidence, policy, and 
practice (292). It targets implementation of an intervention into routine practice 
through four generative constructs: coherence (sense-making, shared beliefs of 
process aims); cognitive participation (relational work, who does what); collective 
action (operational work, what they do); and reflexive monitoring (appraisal work, 
how outcomes are assessed). The principal constructs and components of NPT are 
summarised in Table 2.14 adopted from Mair et al (141). Interventions are more 
likely to be sustained with consideration to these aspects. 
 
NPT concentrates on what people actually do rather than what they think. It helps 
to explain which factors promote and prevent the adoption of innovations with an 
emphasis on early and subsequent phases of implementation that lead to new ways 
of working and long-term sustainability. It can be used to develop interview 
schedules, coding and analytical frameworks, and considers the interpretation and 
impact of research findings. A NPT user manual is available online with further 
explanations of its use (293).  
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Table 2.14: NPT constructs and components applied to this doctoral research 
adopted from Mair et al (141) 
Coherence 
(Sense-making 
work) 
Cognitive 
participation 
(Relationship 
work) 
Collective action 
(Enacting work) 
Reflexive 
monitoring 
(Appraisal work) 
 
Differentiation 
Is there a clear 
understanding of 
how the new 
eHealth system 
differs from existing 
practice? 
 
Communal 
specification 
Do individuals have 
a shared 
understanding of 
the aims, 
objectives, and 
expected benefits of 
the eHealth system? 
 
Individual 
specification  
Do individuals have 
a clear 
understanding of 
their specific tasks 
and responsibilities 
in system 
implementation? 
 
Internalization  
Do individuals 
understand the 
value, benefits, and 
importance of the 
eHealth system?   
  
 
Enrolment 
Do individuals buy-
in to the idea of the 
eHealth system? 
 
 
 
 
Activation 
Can individuals 
sustain     
involvement? 
 
 
 
 
 
 
Initiation 
Are key individuals 
willing to drive 
implementation? 
 
 
 
 
 
 
Legitimation 
Do individuals 
believe it is right for 
them to be 
involved? 
             
Skill set 
workability 
How does the 
eHealth system 
affect roles and 
responsibilities or 
training needs? 
 
Contextual 
Integration 
Is there 
organisational 
support? 
 
 
 
 
 
Interactional 
workability 
Does the eHealth 
system make 
people’s work 
easier? 
 
 
 
 
Relational 
integration 
Do individuals have 
confidence in the 
new system? 
 
Reconfiguration 
Do individuals try to 
alter the new 
service? 
 
 
 
 
Communal 
appraisal 
How do groups 
judge the value of 
the eHealth system? 
 
 
 
 
 
Individual 
appraisal 
How do individuals 
appraise the effects 
of the eHealth 
system on them and 
their work 
environment? 
 
 
 Systematization 
How are benefits or    
problems identified 
or measured? 
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NPT is being used in a wide variety of studies inclusive of the implementation of 
eHealth in secondary care (141). Given its sociological origins, this theory does not 
focus on the relationship between individual attitudes, intentions, and behavioural 
outcomes but pays attention to how knowledge is held, transferred, and created 
within and across professional groups. It also seeks to understand the work that 
prescribers, implementers, and patients alike have to engage in to implement new 
knowledge in practice. NPT was applied in phase two and phase three of this 
doctoral research to compliment and best fit the objectives.  
 
2.8.3 A general theory of implementation 
NPT has been further extended to include a general theory of implementation 
developed by May comprising four constructs: capacity which is dependent on 
individuals working together collectively to make implementation successful; 
potential which is dependent on individual’s ability to implement or use the complex 
innovation; capability which concerns whether the innovation is workable in practice 
and if it can be subsumed into the local context; and contribution which is 
dependent on individuals continuing to engage and develop the complex 
intervention (294). A literature search identified this theory has had limited use in 
eHealth implementation. 
 
2.9 Chapter summary 
The alignment of philosophical belief with the research aim and objectives puts 
forward qualitative methodology as the most suitable approach. Phase one, the 
systematic review, was exploratory in nature and aligns to the interpretivist 
paradigm employing a narrative design. Interpretive phenomenology of individual 
face-to-face semi-structured interviews was selected for phase two and phase three 
so that the perceptions of key stakeholders involved in system implementation 
could be fully understood and described. NPT was selected as the theoretical 
framework of choice for designing the interview schedules and analysing findings. 
This explanatory framework was applied in order to assist in understanding 
perceived facilitators and barriers described within this research and inform future 
implementation. The framework approach to data analysis was considered the most 
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appropriate method to complement the research phenomenological methodology 
and semi-structured interview schedules, thus giving the research more structure.  
 
Trustworthiness and rigour were addressed in the form of Guba’s four constructs: 
credibility; transferability; dependability; and confirmability (255). These constructs 
were enhanced by triangulation of data methods involving the use of findings from 
the systematic review and individual face-to-face semi-structured interviews; 
triangulation of data sources comprising heterogeneous participants in diverse 
settings; and triangulation of investigators with multiple research team analysts. 
This assisted in understanding the perceptions of healthcare professionals 
responsible for system delivery as well as end-users, and in enhancing the 
contextual data relating to individual organisations.  
 
Peer and academic scrutiny of the research project continued to be welcome in 
order to refine the methods employed, develop a greater explanation of the 
research design, and strengthen arguments as necessary. A reflective commentary 
inclusive of progressive subjectivity and monitoring of the primary researchers 
developments via research experience and expanding research skills further 
assisted in ensuring trustworthiness and credibility. Examination of previous 
research findings allowed comparisons and contrasts to be made to current findings 
with reasons provided.  
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Figure 2.1 summarises the paradigms, methodologies, and methods applied to 
phase one, phase two, and phase three of this research. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1:  Paradigms, methodology, and methods in research phases 
 
 
 
 
 
 
  
Phase one 
Paradigm – interpretivist 
Methodology – qualitative research (systematic review) 
Method – critical appraisal, data synthesis 
 
Phase two 
Paradigm – interpretivist 
Methodology – qualitative research (phenomenological design) 
Method – individual face-to-face semi-structured interviews 
 
Method – individual face-to-face semi-structured interviews 
 
Phase three 
Paradigm – interpretivist 
Methodology – qualitative research (phenomenological design) 
Method – individual face-to-face semi-structured interviews 
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Chapter 3:  Systematic review 
 
3.1 Introduction 
There are increasing opportunities in the hospital setting to improve medicines 
management due to advances in eHealth such as the use of ePrescribing, robotic 
pharmacy systems, and automated medication storage and retrieval systems. 
Whilst numerous studies advocate the use of these systems in enhanced efficiency 
and effectiveness of medicines management and decision-making, their rate of 
adoption in practice to date has been slow (54)(295). An important theme has been 
the problem of resistance or refractory behaviours of healthcare professionals and 
the assumption that their attitudes to eHealth are the root problem (296). Several 
studies have demonstrated that the implementation process for hospital eHealth 
systems is important to determine overall success (6)(107)(108)(109)(110).  
 
While several systematic reviews have been published on outcomes such as the 
effects of ePrescribing, electronic dispensing, or electronic administration of 
medicines on medication errors and cost, no systematic review and few primary 
studies have been conducted on healthcare professionals’ perceptions of system 
implementation in a hospital setting (146)(297)(298)(299). Studies that only 
focused on system implementation were therefore included. Understanding 
healthcare professionals perceived benefits and concerns could assist in informing 
and strengthening implementation strategies. It is hoped that findings will be used 
to improve the current system in hospitals and maximise the adoption and potential 
use of these eHealth systems in the future.  
 
3.2 Phase one objectives 
 Identify and critically appraise the available evidence on healthcare 
professionals’ perceptions, attitudes, and views of the facilitators and barriers 
to implementing ePrescribing, electronic dispensing, and/or electronic 
administration of medicines in the hospital setting.  
 Synthesise and present the available evidence on healthcare professionals’ 
perceptions, attitudes, and views of the facilitators and barriers to 
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implementing ePrescribing, electronic dispensing, and/or electronic 
administration of medicines in the hospital setting. 
 
3.3 Method 
3.3.1 Research team 
The research team consisted of the primary researcher, three research team 
members [SC, AT, and AS], and two experts as required [DS and VP].  
 
3.3.2 Database search for pre-existing systematic reviews 
In addition to a comprehensive literature search, Medical Literature Analysis and 
Retrieval System Online (MEDLINE), CDSR, Cumulative Index to Nursing and Allied 
Health (CINAHL), the International Prospective Register of Systematic Reviews 
(PROSPERO), and the CRD inclusive of the DARE and HTA were searched for pre-
existing systematic reviews on the research subject prior to commencing the 
review. The initial scoping exercise revealed an under-researched area with the 
potential for original findings to inform system implementers and end-users of the 
various facilitators and barriers to adoption. 
 
3.3.3 Review protocol  
A systematic review protocol was developed and agreed by all members of the 
research team. The format of the protocol was based on the CRD’s guidance for 
undertaking reviews in healthcare and principals from the Cochrane Handbook for 
Systematic Reviews of Interventions (214)(300). The protocol was then registered 
with PROSPERO (301). This international database aims to provide a comprehensive 
list of registered healthcare-related systematic reviews in order to avoid duplication 
and compare submitted review methods with the planned protocol (302). Minor 
formatting amendments to the review were reported to PROSPERO during the 
review process (Appendix 3.1). 
 
3.3.4 Inclusion and exclusion criteria 
3.3.4.1 Types of participants 
All doctors, nurses, pharmacists, and other allied healthcare professionals inclusive 
of dieticians, podiatrists, physiotherapists, and pharmacy technicians involved in 
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prescribing, dispensing, and/or administering medicines were included in the 
review. Non-healthcare professionals were excluded. 
 
3.3.4.2 Phenomena of interest 
An exploration of healthcare professionals’ perceptions of the facilitators and 
barriers to implementing ePrescribing, electronic dispensing, and/or electronic 
administration of medicines in the hospital setting was the main focus of this 
review. Perceptions included healthcare professionals’ attitudes, beliefs, and views. 
This phenomenon of interest excluded other eHealth systems such as EHRs, CDS, 
and electronic discharge prescriptions. Studies that did not focus on 
implementation, for example, clinical and fiscal outcomes and effects on patients 
and resources, were also excluded. 
 
3.3.4.3 Types of studies 
Any study which focused on the phenomena of interest was reviewed. Whilst the 
area of interest is likely to identify qualitative studies, a broad range of study types 
included any: 
 
 evaluative study design e.g. RCTs and derivatives 
 quasi-experimental studies e.g. non-RCTs, before and after studies  
 observational studies e.g. cohort, case-control, case series, and cross-sectional 
studies 
 qualitative studies 
 qualitative/narrative reviews  
 systematic reviews 
 
Only full text papers were included in the review. Summaries of the literature for 
the purpose of information or commentary, editorial discussions, and papers whose 
abstract identified them as reviews but lacked supporting evidence in the main text 
were excluded. Relevant studies not meeting the inclusion criteria were 
supplemented where appropriate in the doctoral research. 
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3.3.4.4 Language 
Only studies published in the English language were considered. 
 
3.3.4.5 Context 
All types of hospital settings were included. Nursing homes, ambulatory care 
settings, rehabilitation, and step-down units were excluded. 
 
3.3.5 Search strategy 
The following healthcare sources were considered to be the most relevant to identify 
literature pertaining to the inclusion criteria.  
 
3.3.5.1 Databases 
 MEDLINE [via EBSCOhost]  
MEDLINE is produced by the United States National Library of Medicine and contains 
over 14 million references to journal articles in life sciences with citations from over 
5,600 worldwide journals (303). 
 
 CINAHL [via EBSCOhost]  
CINAHL is produced by EBSCO Publishing Inc. and has more than three million 
records and indexing for more than 3000 journals relating to allied health-related 
topics with a focus on nursing literature. It also indexes book chapters, 
dissertations, evidence-based care sheets, audio-visuals, and journals from 17 allied 
health disciplines (304). 
 
 International Pharmaceutical Abstracts (IPA) [via EBSCOhost]  
IPA is produced in conjunction with the American Society of Health-System 
Pharmacists and contains 500,000 abstracted and indexed records from over 800 
journals in the areas of pharmaceutical, medical, and health disciplines (304). 
 
 PsycArticles [via EBSCOhost]  
PsycARTICLES is a database produced by the American Psychological Association, 
the Canadian Psychological Association, and the Hogrefe Publishing Group with 
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access to the full text of nearly 200,000 articles from more than 100 journals in 
behavioural science and related fields including nursing and pharmacy (305). 
 
 PsycINFO  
PsycINFO is produced by the American Psychological Association and has more than 
three million records of peer reviewed literature in behavioural science and mental 
health (306).  
 
 CDSR  
CDSR is part of the Cochrane Library produced by John Wiley & Sons and 
publishes systematic reviews of primary research in human healthcare and health 
policy. They are internationally recognised as the highest standard in evidence-
based healthcare (204). 
 
 CRD 
The CRD database is produced by the University of York and provides access to over 
30,000 quality assessed healthcare-related systematic reviews, over 13,000 
summaries of completed and ongoing health technology assessments, and the 
summaries of all Cochrane reviews and protocols (307). 
 
A wide variety of search terms were combined within each of the three main 
concepts: healthcare professionals; ePrescribing, electronic dispensing of medicines, 
or electronic administration of medicines; and hospital setting. A MEDLINE search is 
provided in Appendix 3.2 and summarised in Table 3.1. In order to capture all 
relevant data, the primary researcher completed a comprehensive tutorial using 
EBSCOhost. This online information resource is widely used by institutions 
worldwide allowing for full text journal and electronic book searches (308). No date 
limitation was applied to the search which was conducted in 2013. 
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Table 3.1:  Search terms using MEDLINE via EBSCOhost 
MEDLINE Search terms (limit English language) 
 
1 (MH healthcare professionals+ OR MH health care professionals+ OR MH 
healthcare providers+ OR MH health care providers+ OR Healthcare N8 
profession* OR Health care N8 profession* OR Health profession* OR 
Healthcare N8 provider* OR Health care N8 provider* OR Health provider* 
OR MH doctors+ OR doctor* OR MH clinicians+ OR Clinician* OR MH 
prescribers+ OR prescriber* OR MH physicians+ OR Physician* OR MH 
pharmacists+ OR Pharmacist* OR Chemist OR Druggist* AND Apothecary* 
OR hospital N8 pharmacist* OR Dietician* OR Nutritionist* OR Pharm* N8 
technician* OR Chiropodist* OR Podiatrist* OR Physiotherapist* OR MH 
nurse+ OR (Nurse OR nurses) OR (Dentist OR dentists) OR Radiographer* 
OR Optometrist*) 
 
2 (MH electronic prescribing+ OR e-prescri* AND eprescri* OR OR robot* 
AND pharmacy OR medic* OR electronic transfer of prescription* OR ETP 
OR Electron* N8 prescri* OR E N8 prescri* OR MH electronic 
administration+ OR electronic administ* OR automated dispens* OR 
automated dispens* system* OR ((electronic administ*) AND (medic* OR 
drug* or tablet* OR remed* OR treat* OR dos*)) OR ((bar N5 code N5 
administ*) AND (medic* OR drug* or tablet* OR remed* OR treat* OR 
dos*)) OR electron* N8 prescrib* OR e N8 prescrib* OR ((e N8 admin*) 
AND (medic* OR drug* or tablet OR remed* OR treat* OR dos*)) OR 
Ehealth* OR E health* OR Health information technolog* OR HIT OR Mobile 
technolog* OR Mobile health*) 
 
3 (MH hospital+ OR hospital* OR secondary N3 care OR tertiary N3 care OR 
ward*) 
 
4 1 + 2 + 3 
 
 
3.3.5.2 Manual searching of journals 
Core journals relating to eHealth were searched electronically and by hand for 
relevant articles inclusive of: 
 
 International Journal of Medical Informatics 
 American Journal of Health-System Pharmacy 
 International Journal of Health Care Quality Assurance 
 International Journal of Pharmacy Practice  
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3.3.5.3 Conference abstracts 
The following conferences were searched for relevant abstracts both by attendance 
and electronically. 
 
 International Pharmaceutical Federation Congress 
 Health Services Research and Pharmacy Practice Conference  
 Healthcare Informatics Society of Ireland Annual Conference, Scientific 
Symposium & Exhibition  
 All Ireland Pharmacy Conference  
 Electronic Prescribing in Hospitals: Moving Forward, Healthcare Conferences 
UK, London 
 Hospital Pharmacy Association of Ireland Conference  
 
3.3.5.4 Other sources 
Online theses from RGU OpenAir, Electronic Theses Online Service, the Directory of 
Open Access Repositories, Networked Digital Library of Theses and Dissertations, 
OAIster, Intute, TROVE, and WorldCat were searched for relevant titles.  
 
The bibliographies of relevant full text literature were also screened. Alternative 
spellings including US and British English variants, abbreviations, synonyms, 
geographical variation, and changes in terminology over time were accounted for 
when selecting free text terms.  
 
3.3.6 Study selection 
 Stage 1: All identified articles for potential inclusion in the systematic review 
were imported into ‘Refworks’ and thereafter exported to Microsoft Excel for 
title/abstract screening by the primary researcher. Ten percent of the studies 
were independently screened by SC for relevance in order to enhance 
trustworthiness of included studies. 
 Stage 2: Full texts/abstracts were sought for all studies appearing to meet the 
inclusion criteria and a final selection for data extraction and quality 
assessment was independently made by the primary researcher and both SC 
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and AT by equally dividing the papers between the two research team 
members to enhance rigour of included studies.  
 
3.3.7 Data extraction 
As all eligible studies identified were qualitative in nature, a data extraction form for 
qualitative studies was developed by the primary researcher and agreed by SC, AT, 
and AS. The form was designed from a combination of extracts from the CRD’s 
guidance for undertaking reviews in healthcare (300), the JBI Reviewers' Manual 
(309), and the Cochrane Collaboration Qualitative Methods Group Supplementary 
Guidance for Inclusion of Qualitative Research in Cochrane Systematic Reviews of 
Interventions (214). The final studies deemed relevant were extracted 
independently by the primary researcher and two members of the research team 
[SC and AT] using the data extraction form and scored for inclusion as either yes, 
no, or unclear depending on the quality of the study: 0-4 poor quality; 5-6 average 
quality; 7-10 good quality. Appendices 3.3-3.4 provide a blank data extraction form 
and a data extraction form for an included paper (310) in the systematic review as 
examples of this rigorous process. 
 
3.3.8 Quality assessment of identified studies 
In order to promote best practice at all stages of the systematic review and consider 
the trustworthiness of the findings from each of the studies, papers were quality 
assessed as per the Critical Appraisal Skills Programme (CASP) checklist for 
qualitative research (311) and scored for inclusion as either yes (2 points), 
somewhat (1 point) or unclear (0 points). A blank quality assessment form and a 
completed form for an included paper in the systematic review (310) are provided in 
Appendices 3.5-3.6 as examples of this rigorous approach. 
 
3.3.9 Data synthesis 
Narrative synthesis of the results was conducted involving the collation, 
combination, and summary of the findings using text and tables. This type of 
synthesis combines the results of multiple studies and relies primarily on the use of 
words and texts to summarise and explain findings of the review (222)(312).  As all 
included studies were qualitative in nature, which are commonly text-based and 
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adopt a narrative approach, this type of synthesis was believed to be the most 
appropriate. The Guidance on the Conduct of Narrative Synthesis in Systematic 
Reviews was used as a framework which provides guidance on how narrative 
synthesis can be conducted in a systematic and transparent way that reduces the 
potential for bias (222). 
 
3.4 Results 
3.4.1 Study origin 
A total of 2566 study titles were identified as potentially relevant from seven 
different databases. Twenty-nine papers were thereafter identified as potentially 
relevant on the basis of full text. Independent screening resulted in 21 studies being 
discarded due to inappropriate setting, inappropriate systems, lack of focus on 
healthcare professionals’ perceptions, or mainly due to the retrieval of studies not 
centred on implementation but focused on outcomes. Eight papers were included for 
data extraction and quality assessment. Three studies were excluded thereafter due 
to poor methodological approaches and a lack of integrity of the results post 
independent analysis by the primary researcher and two membettrs of the research 
team [SC and AT] (313)(314)(315). Reasoning for exclusion is summarised in 
Appendix 3.7. Disagreement on inclusion for one paper was independently screened 
by AT and agreement was reached. 
 
Figure 3.1 illustrates a preferred reporting items for systematic reviews and meta-
analyses (PRISMA) flow diagram which represents the flow of information through 
the different phases of a systematic review and maps the number of records 
identified, included, and excluded (316). Five studies were included in the final 
systematic review of which three studies were based in the USA, one in Sweden, 
and one in Australia. Grey literature and manual searching of key journals did not 
provide additional literature.   
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Figure 3.1: PRISMA flow diagram of literature search 
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3.4.2 Design 
Qualitative approaches were employed in all five studies included in the systematic 
review: semi-structured individual interviews (n=3); semi-structured individual 
interviews and focus groups (n=1); and open-ended individual interviews and 
observations (n=1). Table 3.2 provides a summary of the study authors, year, and 
country of origin, the types of participants, the types of systems, the context, the 
aim of the studies, the research methods used, and the main findings from each of 
the included studies. 
 
3.4.3 Study population 
Studies focused primarily on nurses, doctors, and pharmacy staff: nurses (n=2), 
doctors (n=1), and a mix of nurses, pharmacy staff, doctors, managers, and IT staff 
(n=2). Snowball technique was employed to identify participants in a nursing 
specific study (317) and chain referral sampling and purposive sampling techniques 
were used in a study which focused on a mix of healthcare professionals (318). 
Interview subjects were selected using purposive sampling in a study with a mix of 
healthcare professionals (319) and by convenience sampling in a study targeting 
nurses (320). All doctors agreed to participate in a medical specific study which was 
based in an ED (310). 
 
3.4.4 Types of system implementation 
An ePrescribing system with CDS and electronic transfer of prescriptions to 
pharmacy (310), an ePrescribing system with CDS (318), an automated medication 
storage and retrieval system (317), an eMAR system with CDS (320), and a barcode 
medication administration (BCMA) system (319) were included. 
 
3.4.5 Implementation phase 
Two studies focused on the pre-implementation phase (310)(318), one study 
centred on the initial week of implementation with a follow up after three months 
(317), and the remaining two studies focused on the post-implementation phase at 
six months and 18 months (320), and more than six years after implementation 
(319). 
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Table 3.2: Description of studies included in systematic review 
Authors, 
year, 
country 
Participants Type of 
system 
Context Aim  Research 
methods 
used 
Main findings 
Rahmner 
et al,  
2004, 
Sweden 
(310) 
21 ED 
physicians 
ePrescribing 
system with 
CDS and 
electronic 
transfer of 
prescriptions 
to pharmacies 
This pre-
implementation study 
was conducted in the 
largest ED in the 
Nordic countries with 
approximately 90,000 
visitors per year. 
Physicians hand write 
prescriptions  and use 
a dictaphone for 
medical record 
documentation 
To identify   
physicians’ 
perceptions of the 
various facilitators 
and barriers prior 
to system 
implementation 
Semi-
structured 
individual 
interviews 
Facilitators identified 
included: easy access to a 
patients’ drug history; 
enhanced pharmacological 
knowledge from medication 
alerts; readily accessible 
information; and time 
efficiencies 
 
Barriers identified included: 
technical problems; alerts 
signalled too frequently; 
shortage of computers in the 
ED; an alteration to routine 
and habits resulting in 
diminished patient contact 
 
Technical prerequisites 
formed the base for 
successful implementation 
where time was perceived as 
a necessary requirement to 
adapt to new ways of 
working 
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Authors, 
year, 
country 
Participants Type of 
system 
Context Aim  Research 
methods 
used 
Main findings 
Malato 
and Kim, 
2004, 
USA 
(317) 
12 nurses  Automated 
medication 
storage and 
retrieval 
system 
This initial and 
post-
implementation 
study was 
conducted in two 
acute care units in a 
large 600-bed 
public acute 
hospital. Nursing 
staff administer 
approximately 300 
medications per 
hour. A paper-
based medication 
system had been 
replaced by 
implementation of 
this system 
To examine 
nurses’ 
perceptions of 
system 
implementation  
Open-
ended 
individual 
interviews 
 
Observation 
Barriers identified included: 
end-user perceptions of 
inadequate training; negative 
experiences of 
implementation; perceived 
deficiencies in quality of 
technology; perceptions of 
lack of participatory design; 
and an ensuing 
circumvention of the new 
system 
 
Facilitators were not included 
in the scope of this study 
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Authors, 
year, 
country 
Participants Type of 
system 
Context Aim  Research 
methods 
used 
Main findings 
Georgiou 
et al, 
2009, 
Australia 
(318) 
50 
managerial, 
medical, 
nursing,  and 
pharmacy  
staff  
ePerscribing 
system with 
CDS 
This pre-
implementation 
study was 
conducted in a large 
teaching hospital. 
Initial planning for 
the new system had 
been underway for 
over two years and 
training had not yet 
begun for a large 
majority of staff. 
The hospital already 
had a CPOE system 
in place involving 
ordering pathology 
and radiology tests, 
and diet and allied 
health requests. 
Existing medication 
management was 
performed using 
paper charts 
To identify the 
main barriers of a 
broad range of 
hospital staff 
prior  to system  
implementation 
 
20 semi-
structured 
individual 
interviews 
 
6 focus 
groups, 
with a total 
of 30 
participants 
Barriers identified included: 
alteration to work practices; 
software/hardware concerns; 
alteration to 
relationships/communication; 
requirements for education 
and training; inexperienced 
staff ability; and deskilling  
 
Four interrelated constructs 
highlighted what participants 
were concerned about: if it 
would help; if it would work; 
if they could cope; and if it 
would impair existing 
interactions 
 
Facilitators were not included 
in the scope of this study 
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Authors, 
year, 
country 
Participants Type of 
system 
Context Aim  Research 
methods 
used 
Main findings 
Culler et 
al, 2011, 
USA 
(320) 
14 nurses eMAR 
system with 
CDS 
This post-
implementation 
study was 
conducted in two 
large paediatric 
hospitals which 
provides for 
470,000 patient 
visits, 23,000 
hospital admissions, 
and >128,000 
inpatient days 
 
Interviews were 
conducted at six 
and 18 months after 
system 
implementation 
To describe the 
various 
facilitators and 
barriers by 
nurses to system 
implementation in 
two paediatric 
hospitals 
Semi-
structured 
individual 
interviews 
Facilitators included 
identified: systems ability to 
improve patient safety; 
accessibility of patient 
information 
 
The most significant barrier 
to adoption was excessive 
time for logging into the 
system 
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Authors, 
year, 
country 
Participants Type of 
system 
Context Aim  Research 
methods 
used 
Main findings 
Spetz et 
al, 2012, 
USA 
(319) 
118 nursing, 
pharmacy, 
medical, IT, 
and 
managerial 
staff 
BCMA 
system 
This post-
implementation 
study was 
conducted in seven 
of the 162 Veteran 
Affairs hospitals. 
Site selection was 
based on staff 
satisfaction, survey 
data, staff turnover, 
geography, and the 
level of care 
provided. A 
computerised 
patient record 
system was 
implemented over a 
decade from the 
early 1990s. The 
BCMA system was 
implemented over a 
one year period 
To identify factors 
and strategies 
associated with 
successful system 
implementation in 
Veteran Affairs 
hospitals and how 
these might apply 
to other hospitals 
Semi-
structured 
individual 
interviews 
Five broad themes arose as 
factors that affected the 
process and success of 
implementation: 
organisational stability and 
implementation team 
leadership; implementation 
timelines; hardware/software 
availability and reliability; 
staff training; and changes in 
workflow 
  
89 
3.4.6 Data analysis 
Thematic analysis (310)(319), content and descriptive analyses (320), concurrent 
and content analyses (318), and domain analysis (317) were conducted in the 
included studies. 
 
3.4.7 Quality assessment 
The quality of included studies is provided in Table 3.3 and Figure 3.2 and detailed 
in the quality assessment form of an included paper (Appendix 3.6).  
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Table 3.3: Quality assessment of qualitative studies as per CASP checklist (311) 
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Was there a clear statement of the aim of the research? 
 
Y Y Y     Y     Y 
Was a qualitative methodology appropriate? 
 
Y Y Y     Y     Y 
Was the research design appropriate to address the aim of the 
research? 
 
S Y S     Y     Y 
Was the recruitment strategy appropriate to the aim of the 
research? 
 
S Y S     Y     Y 
Were data generated in a way that addressed the research 
issues? 
 
S S Y     Y     Y 
Was the relationship between researcher and participants 
adequately considered? 
 
S S U     S     S 
Were ethical issues taken into consideration? 
 
S U S     S     S 
Was the data analysis sufficiently rigorous?  
 
Y U Y     S     S 
Was there a clear statement of findings?  
 
S S Y     S     Y 
Total score 
 
12 11 13      14      15 
Y: Yes (2 points);  S: Somewhat (1 point); U: Unclear (0 point)
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Figure 3.2:  Stacked bar chart representing quality of qualitative studies as per 
CASP checklist (311) 
 
One paper was assessed as poor quality, one as average quality, and three as good 
quality. All of the studies were explicit in their aims/objectives and rationale for 
study method. Limitations of the design were stated in four of the five studies. 
Whilst the study by Rahmner et al did not document limitations or potential for bias 
when exploring physicians’ perceptions of the possibilities and obstacles prior to 
implementing an ePrescribing system with CDS, the study methods and analysis 
were well documented and identified that themes were comparable with other 
research (310).   
0% 20% 40% 60% 80% 100% 
Was there a clear statement of the aim of 
the research? 
Was a qualitative methodology appropriate? 
Was the research design appropriate to 
address the aim of the research? 
Was the recruitment strategy appropriate to 
the aim of the research? 
Were data generated in a way that 
addressed the research issues? 
Was the relationship between researcher 
and participants adequately considered? 
Were ethical issues taken into 
consideration? 
Was the data analysis sufficiently rigorous? 
Was there a clear statement of findings? 
Yes 
Unclear 
Somewhat 
  
92 
The research design was appropriate to address the aims of the research in three of 
the studies and partially in two studies. Rahmner et al justified the research design 
and methods employed but as previously stated, no limitations of research design 
were outlined (310). The use of quality criteria inclusive of credibility, dependability, 
confirmability, and transferability was clearly documented. In the study by Spetz et 
al, 118 participants were interviewed in order to establish factors associated with 
successful implementation of a BCMA system (319). Whilst participants were 
heterogeneous in nature which possibly requires more interviews to be conducted, 
and whilst there is no set number of participants required to conduct individual 
semi-structured interviews, this number appears to be large for both recruiting and 
analysing results. Also, the study was retrospective which is limiting in that 
memories of implementation may have been inaccurate or biased by the passage of 
time and some staff may not have been available to be interviewed. However, this 
concern was addressed in the limitations section. Although one of the objectives 
was to determine how successful system implementation might be applied to other 
hospitals, the researchers stated their hospital structure provided valuable 
information regarding implementation for hospitals in the private sector. This was 
not comparable with the initial objective and the researchers did not directly discuss 
whether or how findings could be transferred to other hospital settings. 
 
Rationale for selecting the study population was provided in three studies whilst one 
study did not offer this information and it was not clear in another. Spetz et al 
explained how participants were selected but the number of participants from each 
discipline was not documented (319). Rationale for the setting and selection of 
nurses in the target sample was provided but no reasons for including other 
disciplines were offered. There was no discussion around recruitment and if/why 
some people chose not to take part. Vague and general descriptions of the study 
locations were provided in order to represent a range of implementation timelines, 
geography, and staff characteristics. Details of the seven selected hospitals were 
not specified, for example, the numbers that were teaching hospitals, rural 
hospitals, or urban hospitals, the size of hospitals, or their location. The basis for 
inclusions and exclusions were not outlined.  
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Researchers in the study by Rahmner et al explained how ED physicians were 
selected which was post system training (310). They did not explicitly detail why 
physicians were the most appropriate participants to provide the type of knowledge 
sought by the study, presumably because they prescribe. The researchers discussed 
recruitment and that all physicians agreed to participate. A comprehensive 
description of the study location characteristics was provided but no detail was 
offered of exactly how and why this hospital and ED were chosen. In the study by 
Georgiou et al which explored the main barriers prior to implementation of an 
ePrescribing system with CDS by a broad range of hospital staff, it was not clear 
which participants were categorised in the ‘senior staff predominantly in 
management’, ‘senior clinical management staff’ and ‘predominantly clinical staff’ 
(318). For example, it was unclear if senior pharmacists were categorised in the 
‘senior clinical management staff’ or the ‘predominantly clinical staff’ category. 
 
Three studies provided justification around appropriateness of sample size and data 
saturation and all studies stated the recruitment strategy. The relationship between 
the researcher and participants in terms of data generation was not adequately 
portrayed in any of the studies. Four studies partially described ethical 
considerations whilst it remained unclear in one study. Measures to enhance rigour 
of the data collection tool were outlined in four studies whilst it remained unclear in 
one paper. Data analysis was performed independently with several analysts in 
three studies, with one analyst in one study, and it was not stated in another paper. 
Only one study was explicit in explaining bias arising from the analyst position. 
Limitations of the findings were discussed in three papers and conclusions were 
made relevant to the research question in four studies. All studies discussed 
theoretical transferability of the findings as either a possibility or limitation.  
 
A clear statement of findings was evident in two studies and partially in three 
studies.  In the study by Malato and Kim which explored nurses’ perceptions of an 
automated medication storage and retrieval system post-implementation, the 
findings were explicit and well formatted and there was discussion of the evidence 
both for and against the researchers arguments (317). However, the authors did 
not discuss the credibility of their findings, for example, triangulation, respondent 
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credibility, or if there was more than one analyst. There was no description of any 
formalised appraisal criteria used, when generated, how, and by whom.  
 
Whilst the findings by Spetz et al provide details of five themes that emerged which 
were supported by various quotes, it was not hugely explicit and remained unclear 
as to who said what (319). The researchers discussed the credibility of their findings 
via triangulation and multiple analysts.  There was no evidence of respondent 
trustworthiness. Findings were discussed in relation to the original research topic 
and the literature review summarised knowledge to date and key issues raised by 
previous research. Thematic analysis was based on notes taken by the investigators 
rather than full transcriptions.  
 
Findings by Culler et al which explored nurses’ perceptions and experiences with the 
implementation of an eMAR system with CDS were explicit and provided a clearly 
constructed thematic account with key messages highlighted and summarised 
(320). The researchers described how the data was analysed via content analysis 
using a grounded theory approach. They also discussed the credibility of their 
findings via triangulation and by using more than one analyst as well as member 
checks during the interviews. However, there was little discussion of the evidence 
both for and against the researcher’s findings and of key issues raised by previous 
research. The researchers also stated one limitation of the study which was the 
relatively small sample size. This appears to be a quantitative limitation as 14 
interviewees is a comprehensive number in qualitative research 
(183)(190)(241)(321)(322)(323). No bias or conflict of interest was likely in any 
study included in the systematic review.  
 
3.4.8 Facilitators and barriers to implementation 
A total of 21 facilitators and barriers were identified from the included studies by 
nursing, medical, and pharmacy staff regarding the implementation of ePrescribing, 
electronic dispensing, and/or electronic administration of medicines in the hospital 
setting. Using a narrative approach, all studies were combined for synthesis. Whilst 
more barriers than facilitators were identified, two studies focused solely on barriers 
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with the remainder focusing on both barriers and facilitators. These studies are 
listed in Table 3.4 and further described in the sections that follow. 
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Table 3.4: Facilitators and barriers to system implementation 
Facilitators to implementation 
 
Barriers to implementation 
Increased patient safety: decreasing medication errors 
by reducing transcription errors (320) 
 
Technical problems: logged out and information not saved; 
malfunctions and cumbersome access procedures; poorly 
functioning proximity badges; fear of a slow system with poor 
functionality and integration with pharmacy systems; 
cumbersome process for co-signing medications; miscoded 
medications, items not scanned, empty unit-dose packages 
delivered to wards, batteries not holding charges or recharged 
regularly; mobile carts large and difficult to move; network 
trouble and problems with patient wristbands 
(310)(317)(318)(319)(320)  
 
Better access to patient’s drug records: 
comprehensive patient overview and easier to alter 
patients drug list (310)(320) 
Altered work practices: effect on ward rounds and remote 
ordering potential for errors; total patient care at risk, task 
allocation practice; computer illiteracy making training difficult; 
time pressure on using system and less time on wards; time 
pressure with no allocation of extra staff (318)(319)(320) 
 
Organisational stability and implementation team 
leadership: teamwork and involvement of end-users 
(319) 
Weakened interpersonal communication: less face-to-face 
interaction between healthcare professionals and patients; loss of 
an unofficial means of communication; potential for exposing 
knowledge deficits and increasing conflicts (310)(318)  
 
Hardware/software availability and reliability: 
adequate access to and reliability of hardware and 
computer network; need to be intuitive and user-
friendly (310)(319) 
 
Practice-related medication errors: administer medications at 
the incorrect time, rely on technology (320)(310)  
Adequate staff training: classroom training; one-on-
one training; 24-hour support; availability of superusers 
(319)(320) 
 
Poor access to systems: long wait times; priority issues 
(318)(320) 
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Facilitators to implementation 
 
Barriers to implementation 
Flexible implementation timelines: time to gain 
experience; adapt to new ways of working (310)(319)  
Logistics of education and training: training staff prior to and 
during system implementation problematic due to shift work; 
resistance or busy schedules; healthcare professionals spending 
time to train others (318)(319)  
 
Improved pharmacological knowledge: via 
automatically generated interaction alerts and producer-
independent drug information (310) 
 
Unsupportive management teams: more challenging both 
during and after implementation (319) 
Time efficiency:  reduce duplication of administrative 
work; ease of locating chart information (310)(320)  
Implementation roll out: time for potential stress and errors; 
short implementation timelines increased pressure (318)(319) 
Improved interdepartmental communication:  
information exchange between departments coupled 
with the ability to quickly and easily communicate with 
pharmacy (320) 
 
Cost: cost of the system; cutting cost resulting in an inferior 
system (318)  
 Circumvention of the system: misuse or non-use of key 
elements due to poor implementation management; lack of 
training; lack of input into the design and deficiencies in quality 
of technology (317) 
 
 Security: online patient medication details more accessible and 
visible than paper charts (318) 
 
 Deskilling: becoming dependent on the system (318) 
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3.4.8.1 Facilitators to implementation 
Nine main themes emerged from three studies that focused on facilitators to 
system implementation: increased patient safety; better access to patient’s drug 
records; organisational stability and implementation team leadership; 
hardware/software availability and reliability; adequate staff training; flexible 
implementation timelines; improved pharmacological knowledge; time efficiency; 
and improved interdepartmental communication (Table 3.4). Two studies focused 
on nursing (320) and nursing, medical, and pharmacy staff (319) post system 
implementation whilst the third study centred on physicians’ perceptions prior to 
system implementation (310). Themes overlapped between the different 
implementation phases and healthcare professionals.  
 
Two studies that explored participants perceived benefits to system 
implementation found increased patient safety, improved pharmacological 
knowledge by physicians, enhanced interdepartmental communication between 
physicians and nurses, and time efficiencies (310)(320). Successful system 
implementation depended on many facets including staff training, appropriate 
workflow adaption, reliability of medication safety alerts, and team leadership. 
Spetz et al detailed the perceived structures needed to be in place to determine 
successful system implementation such as organisational stability and 
implementation team leadership (319). They found successful system adoption 
depended on: support for change from both leaders and end-users; development 
of a gradual and flexible implementation approach; allocation of adequate 
resources for hardware/software, infrastructure, hands-on support, and 
deployment of additional staff; and implementation team planning for setbacks 
and thereafter for achieving success. A description of each of the facilitators 
perceived by healthcare professionals is now detailed. 
 
Increased patient safety  
Nurses perceived decreasing medication errors by reducing transcription errors 
as the most significant facilitator of the eMAR system with CDS six months post-
implementation (320). This facilitator translated into immediate benefits by 
increasing patient safety.  
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Better access to patient’s drug records 
Rahmner et al identified the greatest facilitator perceived by physicians prior to 
implementing the ePrescribing system with CDS was gaining better access to 
patient’s drug records (310). Physicians anticipated attaining this data would 
provide an enhanced overview of the patient’s health status and assist in altering 
medications easily for optimum treatment.  
 
“It is difficult and it takes time to check the patient’s drug list…often we 
find patients don’t need that many drugs”. (Physician, pre-
implementation) (310) 
 
However, the proposed ePrescribing support system in this study was not 
developed for accessing drug histories and could not fulfil this requirement. 
Similarly, improved accessibility to patient’s drug information was perceived as a 
key facilitator by nurses with the implementation of the eMAR system with CDS 
(320). 
 
Organisational stability and implementation team leadership 
Implementation teams which led in the adoption of a BCMA system were central 
to its success (319). Participants recognised that pharmacy and IT staff had to 
be partners in the process and that nursing involvement was fundamental: 
“success is all about teamwork”. Physicians and nurses in visible roles during 
implementation achieved buy-in from other healthcare professionals more easily. 
 
Hardware/software availability and reliability  
Adequate access to and reliability of hardware and software inclusive of 
computer networks were essential during system implementation (319). This was 
echoed in the study by Rahmner et al where a prerequisite for physicians to 
accept system adoption was that it functioned technically (310).  
 
Adequate staff training 
A combination of classroom training and one-on-one training during medication 
delivery was perceived by nurses, doctors, and pharmacy staff  as a criterion for 
successful implementation of the BCMA system (319). Training teams also 
assisted nurses for a fixed number of medication administration cycles, or until 
each nurse was comfortable with the system. The 24-hour support available 
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post-implementation was universally noted as “essential” and that “everyone is 
less stressed when 24-hour help is provided”. Nurses in another study by Culler 
et al specifically indicated that the availability of superusers in the clinical setting 
during the transition period assisted in ensuring quick resolution of 
implementation issues (320). 
 
Flexible implementation timelines 
Regardless of how the implementation was specifically planned, flexibility in 
implementation helped healthcare professionals adapt to the system (319). Time 
to gain system experience using a gradual ward-by-ward rollout worked 
effectively as well as introducing the system in wards with relatively stable 
populations. Rahmner et al also highlighted time needed to be allocated to users 
to adapt to new ways of working and that shortcuts resulted in system failure 
(310).  
 
Improved pharmacological knowledge 
Another possibility of the ePrescribing support system perceived by physicians 
pre-implementation included enhancing their pharmacological knowledge via 
access to automatically generated interaction alerts and producer-independent 
drug information (310). 
 
Time efficiency  
All physicians indicated the duplication of administrative work associated with 
manual drug prescribing was both time-consuming and laborious. 
 
“To prescribe drugs doesn’t take so much time. What takes time is finding 
out the patient’s drug list…the best thing would be to have these lists in 
the computer so that you could print them”. (Physician, pre-
implementation) (310)  
 
Nurses also believed time efficiency was facilitated post system implementation 
by ease of locating chart information and the systems ‘‘user-friendly design” and 
overall ‘‘ease of navigation” (320). 
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Improved interdepartmental communication  
Improved information exchange between departments coupled with the ability to 
quickly and easily communicate with pharmacy was identified as a benefit to 
adoption. 
 
“Communication is great; all you have to do is write a message and hit 
send”. (Nurse, post-implementation) (320) 
 
3.4.8.2 Barriers to implementation 
Difficulties in implementing ePrescribing, electronic dispensing, and/or electronic 
administration of medicines in hospitals consisted of obstacles at both an 
individual and organisational level. Healthcare professionals faced numerous 
challenges with various system implementations. As illustrated in Table 3.4, 12 
main themes emerged when synthesising findings from a combination of all 
studies: technical problems; altered work practices; weakened interpersonal 
communication; practice-related medication errors; poor access to systems; 
logistics of education and training; unsupportive management teams; 
implementation roll out; cost;  circumvention of the system; security; and 
deskilling. Several themes that were viewed as facilitators by healthcare 
professionals were also perceived as barriers to system implementation inclusive 
of interpersonal communication, patient safety, time availability, information 
access, and staff training. A description of each of the barriers perceived by 
healthcare professionals is now detailed. 
 
Technical problems  
The greatest obstacle physicians perceived prior to system implementation was 
technical malfunctions (310). Physicians expressed concern with the integration 
of the new and current system in relation to being logged out and information 
not saved. Nurses complained about the associated complication of workflow due 
to malfunctions and cumbersome access procedures post-implementation of the 
automated medication storage and retrieval system. 
 
“There is great potential for abuse. Narcotics are exposed because of 
drawer malfunctions, and wastes are not being witnessed until later, 
because it takes too long to find a finger that works”. (Nurse, post-
implementation) (317)  
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Nursing staff also identified problems with poorly functioning proximity badges 
which resulted in an inability to log into the eMAR system with CDS (320). 
 
Doctors and nurses protested that they would not tolerate a slow system prior to 
implementation of the ePrescribing system with CDS (318). Other concerns 
centred on functionality such as how the system would cope with access to a 
patient’s chart by different users at the one time, and whether the entire 
medication record would be visible on one screen. Pharmacists voiced the added 
problem of current pharmacy information systems not being able to integrate 
with the proposed new system resulting in pharmacists having to work in 
different system environments. Network and hardware problems were also 
identified by healthcare professionals post-implementation of the BCMA system 
(319). Difficulties with miscoded medications, items not scanned, and empty 
unit-dose packages delivered to wards were identified. Batteries that did not hold 
charges or were recharged regularly, mobile carts that were large and difficult to 
move, and network problems were additionally voiced as problems by healthcare 
professionals. Nurses stated that they had “a computer that is buggy”, that the 
“computer would just kick you out”, and that “the machine will crash in the 
middle of a medication pass”. Problems with scanning patient wristbands were 
also reported. 
  
Altered work practices  
A concern expressed by doctors, nurses, and pharmacists was the effect of 
system implementation on ward rounds (318). Traditionally, written changes to 
patient’s medications are documented during a ward round contemporaneously 
with medical decisions. There was apprehension that the new system would not 
facilitate this process, with participants doubting the system would have enough 
mobility or flexibility. Concern was verbalised that “remote ordering”, when 
changes are made to a patient’s medication chart away from the patient or ward, 
could introduce new errors as doctor-patient contact declines. Some nurses 
perceived the current model of total patient care in which a number of patients 
are allocated to one nurse could be at risk and expressed unease regarding the 
possibility of the re-emergence of task allocation practice. Included in this area of 
discussion was the anxiety that some staff were “computerphobic” and would not 
use the system resulting in a model of care delivery that moved away from a 
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patient-centered approach. There was also apprehension that agency staff would 
be unable to use the system and that permanent staff members would be 
relegated to performing their medication administration work. Some staff had 
little prior contact with computers resulting in concern that there was a level of 
computer illiteracy that would make training difficult. Participants expressed 
apprehension towards the limited access to computers and the time taken to log 
on or off resulting in fewer opportunities to scan through a patient’s record 
online. Pharmacists also expressed disquiet regarding changes that may ensue, 
mainly centred around time available on the wards.  
 
Use of the BCMA system interrupted the flow of care for many physicians and 
nurses (319). Nearly all staff found the system placed substantial demands on 
their time during implementation, but most sites could not allocate additional 
nursing or pharmacy staff during this time. A number of nurses used terms such 
as “frightened”, “nervous”, and “scary” to describe how they felt about the 
system at first. The most resistant nurses and physicians reportedly left the 
organisation through retirement or turnover. Managers reported older nurses 
were less likely to be comfortable with technology. 
 
Excessive time for logging into an eMAR system with CDS was also identified by 
nurses as a significant barrier to implementation and a deterrent to documenting 
patient medications at the point of care (320). 
 
‘‘Log-in times slow you down…it’s too slow…you tend to wait until you can 
chart more than one patient…’’. (Nurse, post-implementation) (320)  
 
The cumbersome process of co-signing orders was also considered time 
consuming and an additional barrier. 
 
Weakened interpersonal communication 
Healthcare professionals perceived more time would be spent on technology and 
less time on face-to-face interaction with system implementation (318). 
Pharmacists were particularly concerned that their visibility on the wards would 
decrease resulting in less personal communication with other professionals and 
patients, and less opportunities for informal discussions around medication 
issues. 
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“Face-to-face is less confronting than on the phone…lots of doctors say 
that whenever the pharmacist’s number comes up on their pager, they 
think oh, what have I done now?”. (Pharmacist, pre-implementation) 
(318) 
 
This feeling of preference for face-to-face communication was reinforced by 
doctors. Loss of an unofficial means of communication using paper medication 
was also expressed as a barrier by healthcare professionals as well as reduced 
contact with patients as routinely paper charts are located at the patient’s 
bedside which directs doctors, nurses, pharmacists, and other allied healthcare 
professionals towards the patient. For similar reasons, diminishing patient 
contact was identified as challenging by physicians in the study by Rahmner et al 
(310). A lack of physicians’ knowledge when communicating with staff was also 
perceived to be more exposed with system implementation causing potential 
conflict. 
 
Practice-related medication errors 
Nurses identified an increased potential to administer medications at the 
incorrect time as a barrier to adoption as drug times appeared in the system 
without a record of when the last dose was administered (320). This was 
especially problematic with new admissions and in departments not linked to the 
eMAR system with CDS. 
 
In contrast to relying on technology, physicians perceived important factors 
when choosing medications depended on personal experience, knowledge, 
patients desires, and consulting colleagues and guidelines (310).  
 
Poor access to systems  
Another perceived barrier by nursing staff was long wait times in the medication 
room for electronic access.  
 
‘‘I think it has slowed down our work processes…for example, in our unit 
medications are centrally located, and if four nurses are in the medication 
room waiting to get on the system at 10am, they may get impatient...’’. 
(Nurse, post-implementation) (320)  
 
These problems were frustrating to participants during the implementation period 
when more time was needed to become familiar with the technology (320). 
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Medical, nursing, and pharmacy staff also expressed concerns about access to 
computers and who would get priority if multidisciplinary professionals requested 
use at the same time (318).  
 
Logistics of education and training  
Healthcare professionals envisaged training staff prior to and during system 
implementation would be problematic (318).  It was also acknowledged that 
training within a hospital might be difficult due to shift work. Some participants 
reported difficulty in getting staff to attend training due to resistance or busy 
schedules (319). Many healthcare professionals believed support staff would 
need to be available after training and system implementation (318). Concern 
was expressed regarding ward staff having to spend time training others at the 
expense of their own work (318).  
 
Unsupportive management teams 
More challenges were evident both during and after implementation of the BCMA 
system with unsupportive management teams or where staff did not respect the 
ability of management.  
 
“If nurse managers were in support you could get a lot further”. (Leader, 
post-implementation) (319) 
 
Implementation roll out 
The implementation period prior to the introduction of an ePrescribing system 
with CDS was perceived to be a time for potential stress and errors, in particular 
with a phased roll out with areas both on-line and off-line (318). Healthcare 
professionals with system implementation experience believed short timelines 
increased pressure. 
 
“The software wasn’t ready, and the hardware had not been researched”. 
(Staff member, post-implementation) (319)   
 
Cost  
Healthcare professionals raised concern about the cost of the ePrescribing 
system with CDS and feared cutting cost may result in the implementation of an 
inferior system (318).  
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Circumvention of the system 
Circumvention of the automated medication storage and retrieval system was 
verbalised by nurses three months post-implementation (317). Even though the 
system was designed to track and supply medications through a biometric 
scanner where nurses specify medications to be removed at that time and return 
for additional medications as required, they accessed medications on override or 
retrieved more medications than entered. Interview findings and observations 
demonstrated misuse or non-use of key elements of the system by nurses such 
as retrieving all medications required for an entire shift. 
 
“We find ourselves breaking a lot of rules just to help our patients get 
meds on time”. (Nurse, post-implementation) (317) 
 
Nurses shared perceptions of "learning to live with the system" and this "black 
hole" in the process was viewed as a failure of management, lack of training, 
lack of design input, and a deficiency in the quality of the technology itself.  
 
Security  
Participants perceived online patient medication details may be more visible to 
others than paper charts and that networked information could be accessible 
either legitimately or illegitimately (318). 
 
Deskilling  
Doctors felt they may become dependent on the ePrescribing system with CDS 
and would be unable to function confidently in another hospital without the same 
level of decision support (318). 
 
3.5 Discussion of the findings 
This is the first published systematic review conducted on healthcare 
professionals’ perceptions, attitudes, and views of the facilitators and barriers to 
implementing electronic systems for prescribing, dispensing, and/or 
administering medicines in the hospital setting. Available evidence was 
synthesised in order to describe and understand these perceptions for future 
exploratory work.  
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A very limited number of studies were identified, few of which have been carried 
out in Europe.  Whilst a comprehensive search strategy with effective search 
terms was adopted, a limited number of studies met the inclusion criteria despite 
a large volume of papers initially screened for possible inclusion. This was due to 
inappropriate setting, inappropriate systems, lack of focus on healthcare 
professionals’ perceptions, and/or the retrieval of studies not centred on 
implementation. No systematic reviews were identified for inclusion. Similar to 
statements from Creswell, research in exploratory qualitative studies most likely 
offers limited literature at the outset given the lack of research in the subject 
area (183). 
 
A narrow range of methods were adopted from the identified literature, namely 
qualitative face-to-face interviews, focus groups, and observational studies. This 
may be due to the exploratory nature of the topic researched. Differences in 
study settings and countries, sampling, and bias around participant selection 
may explain variations in facilitators and barriers. Further qualitative studies may 
best identify the nature of these changes. 
 
No study was identified for inclusion that explored the perceptions of pharmacy 
staff on the facilitators and barriers towards the implementation of electronic 
systems for dispensing medicines in the pharmacy department. More barriers 
were identified than facilitators possibly due to all five studies focusing on 
barriers and three studies focusing on facilitators and barriers to system 
implementation. Studies reflect healthcare professionals perceived systems 
improved patient safety and enhanced access to patient’s drug records and that 
team leadership and hardware/software availability and reliability were essential 
for successful adoption. Effectiveness, ability to work with existing practices, and 
appropriate management of systems were major constructs identified in this 
review. Applying a participatory approach in system design and providing user 
support through training were key lessons learnt. Key barriers included hardware 
and network problems, changes to routine work practices, weakened 
interpersonal communication between healthcare professionals and with patients, 
and resistance to technology and training. Technology anxiety was expressed by 
a variety of healthcare professional groups and was not specific to any one 
profession. 
  
108 
Building eHealth systems for prescribing, dispensing, and administering 
medication requires designs that provide significant advantages in comparison to 
traditional methods in order to prevent medication errors, increase efficiency, 
produce cost savings, and ultimately improve patient care delivery. Comparable 
with study findings from Rahmner et al (310), Schiff and Rucke found sufficient 
electronic access to patient’s drug records had the potential to significantly 
improve patient safety and the working environment for prescribers (324).  
 
It is important to use pre-implementation findings to assess whether new 
technology fits the existing model of healthcare provision. A consistent feature in 
study findings that focused on system pre-implementation was the unease on 
whether implementation would deliver the necessary hardware requirements and 
the potential changes in multidisciplinary group interactions (318)(310). Doubts 
about the ability to cope with new technology were also voiced as concerns which 
related to the availability of sufficient training, support, and recognition of major 
work changes. Adequate preparatory training was recognised as a chief concern 
among doctors, nurses, and pharmacists, and the implementation period as a 
time for potential stress and medication errors.  
 
Similar to findings from this systematic review, Pare et al identified lack of 
project champions was perceived to be an important cause of problems with 
implementation, followed by lack of dedication from top-level management 
(110). Previous research has further documented issues with degraded 
communication between nurses and doctors, nurses failing to complete care 
duties due to excessive workload created by new systems, and an increased 
focus on managing systems rather than patient needs (325).  
 
Perceptions of inadequate training, deficiencies in quality of technology, and lack 
of participation were evident by a variety of healthcare professionals. A study by 
Johnson found the most significant barrier to adoption was doctors lack of 
knowledge or training on how to use the systems effectively as well as financial 
challenges and difficulties with access to technology (326). 
 
In a descriptive questionnaire-based study by Cresswell et al in 2013 that 
primarily investigated the current implementation status of ePrescribing systems 
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in NHS hospitals, lessons learnt from early implementation included the need for 
increased guidance in relation to implementation strategies, adequate system 
choice, and top-level management support to sufficiently resource adoption 
(327). Parallel to findings in this systematic review, desired functionalities 
included integration with existing local systems and a more sophisticated 
decision support. The researchers also found that unrealistic expectations 
surrounding the capabilities of systems may inadvertently result in 
disappointment and disillusioned stakeholders (327).    
 
The elucidation and understanding of healthcare professionals’ perceptions of the 
positivity and concerns can assist in informing, strengthening, and sustaining 
implementation strategies. A key finding from human factors literature is the risk 
of failure of eHealth systems if managers, designers, and implementers fail to 
pay adequate attention to the aspirations, beliefs, perceptions, and experiences 
of end-users (131). As these systems become more embedded within work 
processes, understanding the organisational context assumes greater importance 
for successful adoption (14)(131). It is important that implementers 
systematically plan for all aspects of the implementation process inclusive of staff 
training, support, workflow changes, and communication. Success requires a 
high-level of collaboration and negotiation across departments and between IT, 
end-users, and management, as well as a requirement to provide reassurance 
that staff will be supported. 
 
3.5.1 Consideration of strengths and limitations 
Conducting systematic literature reviews are a fundamental scientific activity 
(328). All types of research methods were searched, though due to time 
constraints, papers that were not in English were not considered.  
 
A wide range of databases were used to search the literature. Manual searching 
of core journals for relevant titles and searching of conference proceedings and 
online theses led to no studies considered for potential inclusion which raises 
issues around adoption of such methods in the future. However, literature 
searching is a highly developed skill and even trained experts may only identify 
50% of relevant literature (329). Three researchers working independently 
added to the rigour of the literature inclusion and exclusion decisions. In 
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addition, this strengthened the review process in terms of data extraction and 
quality rating. Structured data extraction forms ensured no relevant data were 
missed.  Development of a quality assessment form as per standard guidelines 
helped to ensure important elements around study quality were properly 
scrutinised (214)(300)(309). A narrative synthesis of findings allowed results to 
be tabulated and categorised in a comprehensive manner. Meta-analysis of the 
results was not necessary due to the nature of the research methods included.  
 
An unambiguous, externally validated protocol documenting the process in every 
aspect of the systematic review allowed any deviations from the set procedures 
to be recorded which increased transparency (301). 
 
Limitations of the included studies related to a general lack of rigour with one 
paper assessed as poor quality, one as average quality, and three as good 
quality. As discussed in Chapter 2, another possible limitation may be the 
inclusion of all qualitative studies in the systematic review. Nonetheless, it is 
increasingly recognised that evidence from qualitative studies that explore 
implementation of interventions and experiences of those involved in providing 
and using interventions have a significant role in ensuring data are of maximum 
value to policy, practice, and decision-making (223)(330)(331). The 
methodology and method selection in this phase of the research resulted in the 
generation of original, novel data which contributes significantly to the published 
literature. 
 
3.6 Further work 
A reflective approach has been employed throughout this doctoral research with 
consideration to the research aim, objectives, systematic review findings, and 
implications for the next phase of this study. From the results of this review and 
due to the limited number of studies included, it was clear that further qualitative 
work in the form of individual face-to-face semi-structured interviews with key 
stakeholders would provide much needed novel in-depth knowledge on 
facilitators and barriers to system implementation in an Irish setting. This will 
provide important information on successful system implementation for 
policymakers and healthcare organisations in order to improve patient safety and 
healthcare delivery. 
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3.7 Chapter summary 
A very limited number of studies were identified on healthcare professionals’ 
perceptions of the facilitators and barriers to system implementation in hospitals. 
It is evident from findings of this review that successful system implementation 
will largely depend on effective leadership, the availability of high quality 
systems, and the development of appropriate skills and training for end-users. 
Another important determinant of successful adoption is to ensure end-users are 
well informed of the potential benefits of the system for their own work practice.   
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Chapter 4: Interviews with local key stakeholders 
 
4.1 Introduction 
Chapter 4 includes phase two of this research, namely in-depth qualitative 
interviews. A summary of the rationale for conducting this research, which is 
underpinned by NPT, along with the objective is provided. A description of the 
method, results, and interpretation of findings is subsequently detailed. 
 
Implementation of eHealth solutions has the potential to ensure continuous 
improvements in the quality of healthcare delivery (332)(333)(334). Whilst the 
use of medicines is currently increasing in number and complexity (335) which 
potentially amplifies medication error risks, systems for prescribing, dispensing, 
and administering medicines in Ireland and the UK have remained largely 
unchanged over the last few decades (8)(73)(336).  As identified in the 
systematic review in phase one of this research, lack of system implementation 
may be due to a range of inter-related technical, social, and organisational 
factors with the multi-level complexity of integrating new technology into 
existing work practices (337). Implementation of electronic systems for 
medicines in hospitals in Ireland is further complicated by the immaturity of the 
IT systems market, the variable levels of commercial and organisational 
expertise, and the overall limited investment in healthcare ICT which accounts 
for one of the lowest levels in Europe (72)(116). However, support for eHealth 
adoption in recent years through publication of a national eHealth Strategy and 
the establishment of eHealth Ireland has been a positive progression and 
considerable interest has been expressed in the acquisition of these systems 
nationally (98)(116). This next phase of the programme of research 
complements the systematic review by providing depth and further novel insights 
into issues involved in implementation of electronic systems for medicines 
management. 
 
4.1.1 Phase two objective 
 To explore the perceptions of local key stakeholders towards the facilitators 
and barriers to implementing ePrescribing, robotic pharmacy systems, and 
automated medication storage and retrieval systems in public hospitals in 
Ireland using NPT as a theoretical framework.  
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This work is timely as it has the potential to inform future implementers on 
factors that influence facilitators and barriers to adoption in a country with 
limited experience of such systems and in a field under-researched.   
 
4.2 Method 
4.2.1 Research design 
The rationale for advancing with interpretative phenomenological methodology 
using individual face-to-face interviews has been previously described in Chapter 
2. In summary, aligned to the constructivist approach, interpretative 
phenomenology seeks to generate rich descriptions and understanding of the 
phenomenon in question. Conducting individual face-to-face semi-structured 
interviews with local key stakeholders in three hospital sites using NPT as a 
theoretical framework was considered the most appropriate method to support 
the research aim, primarily to facilitate in-depth rich data capture and analysis. 
This method was believed to be more fitting than employing other methods such 
as individual phone interviews, focus groups, or naturally occurring data such as 
observational studies, as it facilitates more detailed data sharing and data 
retrieval by participants. It allows participants to converse in their own words 
without the risk of potential inhibition when openly discussing and sharing 
information with others in a focus group. For example, nurses may not discuss 
important concerns with automated medication storage and retrieval systems in 
the presence of a chief pharmacist or senior manager responsible for system 
implementation reducing rigour and trustworthiness. In addition, all five papers 
included in the systematic review in phase one used individual interviews as a 
research method, indicating this would be a suitable method for this phase of the 
research.  
 
4.2.2 Setting 
Three general hospitals which provide acute services in the public sector in 
Ireland were the focus for interviews with local key stakeholders due to the 
nature of the eHealth technology employed. Private hospitals were excluded from 
this phase of the research as they operate independently of state health services 
with different financial structures and governance policies and are therefore not 
comparable to public hospitals. 
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Of the 48 hospitals in the public sector in Ireland (338), no hospital has 
implemented an integrated hospital-wide ePrescribing system linking 
prescriptions electronically between prescribers and dispensers. Stand-alone 
ePrescribing systems are in place in a limited number of large public hospitals in 
specialist areas such as Intensive Care Units (ICUs). It was therefore not possible 
to select a public hospital with an integrated ePrescribing system. At the time of 
this study, one hospital in the public sector had implemented a robotic pharmacy 
system and three public hospitals had introduced automated medication storage 
and retrieval systems, two hospitals within the previous eight months. Opting for 
a hospital with a robotic pharmacy system would limit participants to pharmacy 
staff and prohibit site triangulation. Therefore, to capture a broad range of 
perspectives from participants with and without system experience and facilitate 
site triangulation and diversity in terms of maturity of system implementation, 
two hospitals that had introduced automated medication storage and retrieval 
systems at different implementation stages (over 10 years and seven months), 
and one hospital which was considering implementation were selected.  
 
Hospital A is a 340-bedded acute general hospital in the HSE public sector with a 
catchment area of approximately 150,000 people situated in the North West of 
Ireland. Part of the Saolta Hospital Group, this institution has over 10 years’ 
experience in implementing automated medication storage and retrieval systems 
in several wards and was the first hospital in the public sector in Ireland to 
implement such systems in 2006. With their extensive experience and vision, the 
research team felt including this hospital in the study would enhance, enrich, and 
contribute to data analysis.  
 
Hospital B is a 260-bedded acute general hospital in the HSE public sector with a 
catchment area of approximately 150,000 people situated in the North East of 
Ireland. Part of the Royal College of Surgeons Hospital Group, a manual 
medicines management system is predominantly utilised for prescribing, 
dispensing, and administrating medicines. One automated medication storage 
and retrieval system was implemented in June 2015 in a 31-bedded ward with a 
mixture of medical, surgical, and gynaecological inpatients. The plan is to 
introduce more systems in the near future. With experience at the early stages 
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of system adoption, the research team believed including Hospital B in this study 
would further enhance data analysis.  
 
Hospital C is a 340-bedded acute general hospital in the HSE public sector with a 
catchment area of approximately 150,000 people situated in the North West of 
Ireland. Part of the Saolta Hospital Group, it relies solely on a manual medicines 
management system but is planning to introduce automated medication storage 
and retrieval systems and a stand-alone ePrescribing system in ICU. In order to 
select similar type hospitals that have experience and have no experience but 
plan implementation, this final hospital was believed to be of equal benefit in 
understanding perceptions pre-implementation.  Figure 4.1 maps the location of 
selected hospitals.  
 
Figure 4.1:  Map of location of selected hospitals 
 
Hospital A 
Hospital C 
Hospital B 
     
Dublin 
 
 
 
Location of   
primary 
researcher  
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Site triangulation was achieved by the participation of a range of professionals 
within these hospitals so as to reduce the effect of local factors particular to one 
institution. Findings can then be understood within the context of the particular 
characteristics of the organisation. Table 4.1 provides a summary of the hospital 
characteristics. 
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Table 4.1: Summary of hospital characteristics 
Characteristics 
 
Hospital A Hospital B Hospital C 
Type 
 
Acute general hospital 
in the public sector 
 
Acute general hospital 
in the public sector 
Acute general hospital 
in the public sector 
Size  
 
340 beds 260 beds 340 beds 
eHealth system Automated medication 
storage and retrieval 
system 
(Omnicell©) 
 
Automated medication 
storage and retrieval 
system 
(Omnicell©) 
Relies solely on a 
manual medicines 
management system  
Implementation  
phase  
Late: 
>10 years post-
implementation 
 
Early: 
7 months post-
implementation 
Pre-implementation 
planning stage 
Number of 
systems 
 
7 
 
1 0 
Location of 
systems 
ED, acute medical 
assessment unit, 
haematology and 
oncology ward, and 
four medical 24-
bedded inpatient 
wards 
 
31-bedded mixed ward 
with medical, surgical, 
and gynaecological 
inpatients 
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4.2.3 Research governance 
This research was conducted in accordance with the ethics and research 
governance policies of RGU (339) and the HSE (340). A research degree 
registration form was submitted to the Research Degrees Office in RGU within 
three months of commencing the research to ensure ethical principals were 
adhered to. A research ethics: students and supervisor appraisal (RESSA) form 
was also submitted which aims to promote good ethical practice in the conduct of 
academic research and enable researchers to undertake an initial self-
assessment of ethical issues in their research. 
 
Ethical approval was a lengthy process, with applications taking 10 months to 
obtain all the necessary approvals. The project was approved initially by the 
ethical review panel of the School of Pharmacy and Life Sciences, RGU. A 
detailed research project proforma for ethical approval was completed by the 
primary researcher, reviewed by all research team members, and submitted to 
the ethical review panel (Appendix 4.1), along with an updated RESSA form 
(Appendix 4.2). A letter of invitation; participant information sheet; interview 
consent and copyright clearance form for participant and researcher; reply slip; 
letter of invitation reminder; and interview confirmation letter were also 
submitted (Appendices 4.3-4.9). 
 
Minor amendments were required and completed as detailed in Appendix 4.10. 
The application was re-submitted and approval was received four weeks later, 
the process taking a total of 12 weeks (Appendix 4.11).  
 
Each of the three hospitals required individual ethical review applications and had 
independent ethics review committees. Approval was sought and obtained from 
each hospital which included submission of:  
 
 Ethical approval letter from the School of Pharmacy and Life Sciences at 
RGU (Appendix 4.11) 
 A 84-page standard application form for ethical review of health-related 
research studies 
 Research project proforma for ethical approval (Appendix 4.1) 
  
119 
 Letter of invitation; participant information sheet; interview consent and 
copyright clearance form for participant and researcher; reply slip; letter of 
invitation reminder; and interview confirmation letter (Appendices 4.3-4.9) 
 Letter to the general manager on research for information (Appendix 4.12) 
 Curriculum Vitae 
 
Ethical approval from Hospital A, Hospital B, and Hospital C is provided in 
Appendices 4.13-4.15, respectively. All approvals were granted prior to recruiting 
any participants.  
 
Throughout this study, the research ethics and governance policies at RGU and 
the HSE were adhered to by prioritising the dignity, rights, safety, and well being 
of the participants at all times and by using and protecting the research data 
appropriately (339)(340). The Irish Data Protection (Amendment) Act 2003 was 
also adhered to (341). This primarily states data may only be used for the 
specific purposes for which it is collected, data must not be disclosed to other 
parties without the consent of the individual to whom it concerns, individuals 
have a right of access to the information held about them, and adequate security 
measures are in place for holding personal information. Furthermore, in 
accordance with this Act, data will not be retained for longer than necessary in 
order to fulfil the purpose for which data were originally collected. The equivalent 
Health Research Authority approval for NHS in England or the NHS management 
permission in Scotland, Wales, or Northern Ireland does not exist in the Republic 
of Ireland.  
 
4.2.4 Participant inclusion and exclusion criteria 
Individuals directly or indirectly involved in medicines management working in 
the chosen hospital sites were included in the sample. Those not involved in 
medicines management working within or outside of these hospital sites were 
excluded. 
 
4.2.5 Participant sample  
Purposive sampling was employed in order to identify a range of relevant 
heterogeneous local key stakeholders for participation. As described in Chapter 
2, this is a non-probability sampling technique typically used in qualitative 
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studies with the expectation that each participant will provide unique and rich 
information (3)(243)(342). Sample size is determined by data saturation and not 
by statistical power analysis. This approach was selected in place of other 
sampling techniques as it was most suitable to meet requirements of the 
research objective, qualitative design, and in generating rich data from a variety 
of participants’ perceptions towards system implementation. 
 
Purposive sampling conducted using pre-specified ‘stratification’ factors can lead 
to heterogeneity in the sample (246). The main stratification factors employed 
were: potential key implementers and operational end-users working in a 
hospital before system adoption; key implementers and operational end-users 
working in a hospital after system implementation; profession; and grade. This 
included both senior and junior employees from nursing, pharmacy, medicine, 
and IT. ‘Implementers’ were viewed as individuals in a role with responsibility for 
implementation, such as nurse and pharmacy managers. End-users were 
considered the main operational users of the system, for example, staff nurses 
and pharmacy technicians. The research team felt including participants without 
experience was equally as important as including participants with experience in 
order to identify perceived facilitators and barriers prior to implementation  and 
understand its likely impact, success, and sustainability. Most invitees were 
known by the primary researcher. The remaining eight professionals from 
multidisciplinary backgrounds were identified through recommendations from 
senior pharmacists via verbal contact once they had agreed to participate. It is 
recognised that this recruitment method is dependent on the opinions of senior 
pharmacists on whom they consider to be appropriate participants.  
 
The risk of sampling bias was minimised by the type of participants invited for 
interview as it was anticipated they would express many positive and negative 
perceptions and experiences of adoption as implementers, end-users, and 
potential adopters.  
 
4.2.6 Sample size 
In terms of sample size, Marshall states that data quality is more important than 
either the number of participants or volume of data in qualitative research, and 
that a sufficient sample size is reached when the research question is answered 
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adequately (241). Pharmacy researchers have routinely interviewed between 15 
and 50 participants (343), whilst suggested numbers in phenomenology have 
been five to 25 (190) and at least six (321). Guest found in one study of 60 
subjects, data saturation occurred after approximately 12 interviews which 
elicited 97% of the codes (322). The number usually becomes obvious as new 
categories, themes, or explanations stop emerging from the data (323)(241). 
Francis et al emphasise the importance of reaching data saturation to ensure 
content credibility has been achieved, and propose agreeing the minimum 
number of interviews to be analysed and then stating the number of further 
interviews to be completed without any new ideas being voiced. This method 
may not be suitable for interviews with subgroups but a modified version may be 
applicable (246).  
 
The research team agreed that a modified approach was to interview an initial 
sample of 24 senior and junior participants comprising nine nurses, six 
pharmacists/pharmacy technicians, six doctors, and three hospital IT managers, 
equally divided per site. This number was expected to capture a broad variety of 
perceptions towards system implementation from the heterogeneous participants 
and assist the research team in identifying common and diverse themes and 
reaching data saturation. More nurses were included than other healthcare 
professionals as nurses are predominantly ward-based end-users and may 
provide further insight of system implementation and facilitate rich data analysis.  
 
4.2.7 Invitation 
Project information was posted to local key stakeholders’ work addresses. This 
method of delivery was felt to be more personal than emailing potential 
interviewees. Included were a letter of invitation with a background to the 
project, objective of the study, and criteria for selecting them as interviewees; 
participant information sheet; consent/copyright clearance forms; reply slip; and 
a prepaid envelope (Appendix 4.3-4.7). Prospective participants were informed of 
the potential benefits of the project and the mechanism of disseminating results.  
 
Individuals were requested to mail the reply slip either accepting or rejecting 
participation, with the most convenient date, time, and location for taking part in 
the interviews along with the consent/copyright clearance form if they were 
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willing to participate. Reminders were sent to non-respondents two weeks after 
mailing the first invitation followed by telephone contact to confirm they had 
received correspondence (Appendix 4.8). A confirmation letter was then sent to 
participants who agreed to take part with details of the interview appointment 
followed by an email 24 hours before the interview to confirm participation 
(Appendix 4.9).  
 
4.2.8 Development of interview schedules 
A qualitative systematic review by McEvoy et al in 2014 using NPT to research 
implementation processes identified 29 papers and found coherence and 
cognitive participation relate more to the ‘planning’ stages of implementation, 
and collective action and reflexive monitoring relate more to ‘experiences’ post-
implementation (344).  Two interview schedules were therefore developed by the 
research team for participants working in hospitals with and without system 
implementation. 
 
Content of the interview schedules was underpinned by NPT and informed by the 
research objective and existing literature inclusive of the systematic review 
findings from phase one to ensure a consistent and systematic approach. As 
described in Chapter 2, the application of a theoretical framework provides a 
useful structure for complex studies (141)(267)(268)(269)(291). A considerable 
body of research now supports NPT as valuable for explaining processes of 
normalising practices associated with complex eHealth interventions and 
understanding the dynamics of: implementation and bringing new practices into 
action; embedding practices into routine everyday work of individuals and 
groups; and integration and sustainability of practices (293)(345). It goes 
beyond the narrow focus of individual behaviour and proposes implementation 
should be understood by the work that people do (293). Mapping of NPT 
constructs to the interview schedules is provided in Table 4.2. These four 
generative constructs comprise: coherence, the ‘sense-making’ work such as 
shared understanding; cognitive participation, the ‘relational work’ such as 
enrolment; collective action, the ‘operational work’ such as training and 
competency; and reflexive monitoring, the ‘appraisal work’ such as evaluating 
effectiveness. New systems are more likely to be normalised with consideration 
to these constructs.  
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Table 4.2:  Mapping of concepts in the interview schedules to NPT 
NPT constructs  
 
Interview schedule concepts 
Coherence  
Sense-making work that people do 
individually and collectively at the planning 
stages of implementation  
 
 
Perceptions of the overall goals of 
implementation e.g. patient safety, 
increased efficiency 
 
Cognitive participation  
Relational work that people do to enrol and 
engage with the planning of 
implementation  
 
Responsibility for implementation e.g. 
implementers driving it forward, end-users 
buy-in to implementation  
 
Collective action  
Operational work that people do to enact 
the new system 
 
Tasks carried out in delivering the 
implementation process e.g. training, 
policies  
 
Reflexive monitoring  
Assess and understand the outcomes of 
implementation 
 
Monitoring the effectiveness of 
implementation e.g. individual and 
collective feedback 
 
 
Particular attention was paid to Creswell’s key recommendations in developing 
the interview schedule, as provided in Table 4.3 (346). 
 
Table 4.3:  Key recommendations for developing interview questions in 
qualitative research adopted from Creswell (346) 
 Ask no more than five to seven sub-questions in addition to central questions 
 
 Relate the central questions to the specific qualitative strategy of inquiry 
 
 Begin the research questions with the words ‘what’ or ‘how’ to convey an open 
and emerging design 
 
 Focus on a single phenomenon or concept 
 
 Use exploratory verbs that convey the language of emerging design, use non-
directional rather than directional words 
  
 Expect the research questions to evolve and change during the study in a manner 
consistent with the assumptions of an emerging design 
 
 Use open-ended questions without reference to the literature or theory unless 
otherwise indicated by a qualitative strategy of inquiry  
 
 Specify the participants and research site for the study if not already provided 
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The initial interview schedules were developed by the primary researcher and 
reviewed several times for rigour and trustworthiness of content by all four other 
members of the research team who are experienced in research using qualitative 
methods [SC, AT, DS, and AS] (Appendix 4.16). An introductory general 
question around the participants’ role was sought followed by more focused 
semi-structured questions specific to constructs of NPT. The interview schedules 
were then reviewed and refined further by all members of the research team 
followed by five expert reviewers both internal and external to academic staff at 
RGU.  These experts were identified by members of the research team [SC and 
DS] as having vast experience in the topic under investigation: 
 
- Professor Charles Swainson, eHealth clinical lead, General Council of the 
University of Edinburgh, Faculty of Medical Leadership and Management, 
University of Edinburgh 
- Dr Lisa Kidd, reader, School of Nursing and Midwifery, Faculty of Health & 
Social Care, RGU 
- Ian Rudd, director of pharmacy/CD accountable officer and HIV pharmacist, 
NHS Highland 
- Dr Katrina Forbes-McKay, lecturer, RGU 
- Pamela Mills, PhD student, RGU 
 
In addition to two interview schedules, the expert reviewers were provided with 
background information on the subject via email communication from SC. They 
were requested to comment on the content of the questions in relation to the 
research objective and NPT. The interview schedules were modified with minor 
changes thereafter as per feedback offered. The schedule for participants with 
system experience is provided in Appendix 4.17 and post feedback in Appendix 
4.18 as examples of questioning material.  
 
4.2.9 Pilot interviews 
Content and delivery of core and associated questions in interview schedules can 
improve through pilot testing (346). Individual face-to-face semi-structured 
interviews of approximately 35 minutes were piloted in Hospital B with a 
pharmacy technician who routinely utilised an automated medication storage and 
retrieval system, a ward nurse with no system experience, and a non-consultant 
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hospital doctor with previous experience of ePrescribing. Individuals were 
identified and recruited by the primary researcher who was familiar with 
participants.  Interviews were audio recorded and reviewed by SC and AT specific 
to the primary researcher’s interviewing skills and engagement with participants, 
as well as the quality of data generated via the structure, flow, and clarity of the 
interview schedules.  It also provided an opportunity to review the length of time 
to conduct interviews. Minor amendments were made to the interview schedules 
and the pilot interviews were excluded from data analysis as a select number of 
interviewees with experience had already been chosen. 
 
4.2.10 Data generation  
Interviews were arranged and conducted sequentially per hospital by the primary 
researcher commencing in Hospital B followed by Hospital A and Hospital C 
between January and February 2016. The interviews were held within the specific 
hospital premises since this location was suitable for participants. Prior to 
commencement, signed informed consent and copyright clearance were obtained 
from all participants (Appendix 4.5). Interviewees were again provided with 
background information on the qualitative research and why they had been 
selected for interview. Participants were informed that they could withdraw from 
the study at any time without giving a reason and that the audio recorder could 
be turned off at any time at their request. They were then requested to complete 
a short background questionnaire which contained questions on profession, 
grade, years of experience, countries of practice, and any experience with 
using/implementing ePrescribing, robotic pharmacy systems, and/or automated 
medication storage and retrieval systems in a hospital setting (Appendix 4.19). 
The research team felt capturing this data may be of benefit during analysis to 
establish any trends with the above characteristics and emerging themes.  
 
Interviews were guided by interview schedules which developed iteratively as 
they progressed to ensure true understanding of the data in order to direct the 
next stage of data generation (347). Associated probing and flexibility in 
interviewee responses were encouraged to ensure all relevant areas were 
discussed and to facilitate participants’ personal perceptions and experiences of 
system implementation. At the end of the interview, participants were provided 
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with the opportunity to contribute any additional information deemed relevant 
not previously discussed and to review their own transcript for credibility. 
All generated data were coded, anonymised, and securely stored. The signed 
consent forms were stored in a locked drawer in a hospital pharmacy office and 
the digital recordings, transcriptions, and all other electronic data were stored on 
an encrypted password protected computer. Access to data was restricted to the 
research team via a secure university network. Any records relating to the 
research will be destroyed after full dissemination of the research findings. 
 
4.2.11 Data management and analysis 
The two most commonly used transcribing techniques include naturalised, or 
verbatim, in which every utterance is captured in as much detail as possible, and 
denaturalised, in which grammar is corrected and interview noises such as 
pauses and stutters removed (348). In order to become immersed in the data, 
digital audio recordings of each interview were listened to several times and 
transcribed verbatim shortly after each interview by the primary researcher to 
allow further refining of the interview schedules as required. Audio recordings 
and transcribed data were coded for anonymity and verified for accuracy by SC 
and AT via allocating each research team member three transcripts for review 
against the recordings. This resulted in review of the first six transcripts. 
 
Given the focus of this research was to identify a priori themes underpinned by 
NPT constructs, a framework analysis approach was adopted to facilitate a neat 
set of a priori codes. Other healthcare studies have employed a similar method of 
analysis with NPT (349)(350)(351)(352). This approach was first developed in 
the 1980s by social policy researchers and has grown in popularity as a means of 
analysing qualitative data derived from healthcare research (353). Framework 
analysis is most commonly used for thematic analysis of semi-structured 
interview transcriptions and is especially suited for qualitative research with 
predefined objectives, consistent with this project design. It is used to organise 
and categorise interview transcriptions into emerging themes and involves five 
inter-related stages as previously described in Chapter 2: familiarisation; 
identifying a thematic framework; indexing; charting; and mapping and 
interpretation (353)(354). Data tend to be a true reflection of the interviewee 
statement usually presented as anecdotes or direct quotes. This reflects an 
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inductive approach where the process is iterative and develops in response to 
data analysis through open coding followed by refinement of themes.  
A summary of this approach is illustrated in Figure 4.2. Familiarisation involved 
the primary researcher transcribing the interviews verbatim and reading the 
transcriptions repeatedly whilst listening to the digital audio recordings. A 
thematic framework was identified by developing themes from re-reading the 
interview transcripts and highlighting significant quotes. Key words from the 
research objective identified some thematic codes as well as the recurrent 
themes from the transcripts. QSR NVivo11® qualitative data management 
software facilitated the sorting of codes during the indexing stage of data 
analysis. Charting was created by connecting the thematic codes according to 
how they related to each other by either merging or reducing themes. Mapping 
and interpretation involved searching for patterns, associations, concepts, and 
explanations of the data using verbatim quotes to illustrate themes.  
Figure 4.2:  Summary of the framework approach to data analysis in this 
research 
 
Independent analysis was conducted by the primary researcher and two other 
members of the research team [SC and AT] to confirm the trustworthiness of 
Framework 
Approach 
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emerging themes. This process involved dividing all transcripts equally among SC 
and AT, independently categorising potentially relevant quotes per NPT key 
constructs and components as either facilitators or barriers, and then comparing 
analysis with the primary researcher who analysed all transcriptions in a similar 
manner. Whilst very time consuming, this systematic approach enhanced rigour 
of data. No significant discrepancies were identified. Agreed thematic codes were 
then created by the primary researcher for each NPT component. Figure 4.3 
illustrates a summary of the method of data generation and analysis employed.  
 
 
 
Figure 4.3:  Qualitative process: method of data generation and analysis 
 
 
 
Interviews with 
nurses – pharmacy staff – doctors – IT managers 
Codes 
Illustrative quotes 
Key themes 
Framework 
analysis 
NPT 
Transcribing 
Verbatim 
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4.2.12 Promoting research quality  
Guba describes credibility, transferability, dependability, and confirmability as 
criteria used to enhance trustworthiness and rigour in qualitative research as 
previously detailed in Chapter 2 (355). Table 4.4 provides a framework of the 
quality employed throughout this research based on frameworks from Creswell 
(183), Stenton (255), and Guba (355).   
 
Table 4.4:  Quality framework in qualitative research adopted from frameworks 
from Creswell (183), Stenton (255), and Guba (355) 
Quality 
framework 
Method of application in this research 
Credibility 
 
Confidence in the 
'truth' of the 
findings 
 In order to reduce bias of design and data generation, prior to 
commencing this phase of the research, the primary researcher 
attended relevant training 
 In order to reduce interviewer bias, the primary researcher has 
no vested interest in findings which impact on either positive or 
negative perceptions towards system implementation  
 In order to reduce sampling bias, triangulation of data sources 
from an array of different professions, grades, and hospitals were 
invited for interview widening the spectrum of interviewees from 
those with no experience (pre-implementation) to those recently 
exposed (seven months post-implementation) to those with 
extensive experience (>10 years post-implementation)  
 Participants were informed of the possibility of withdrawal from 
the study at any stage of the research 
 All aspects of the research were reviewed by the research team 
who have vast experience in qualitative research 
 The personal experience and training of the primary researcher 
continued to broaden during this research to consider a more 
naturalistic human approach to system implementation and to 
understand the complexities involved through utilising NPT 
Transferability 
 
Demonstrating 
findings have 
applicability in 
other contexts 
 A description of contextual factors such as participants working 
environment is important to assist in transferability. Information 
such as the number of participants involved and where they were 
based, any restrictions in the type of participants who participated, 
the number and length of data collection interviews, and the time 
period over which data was generated was provided in order to 
convey the boundaries of the study 
 Analytical claims were made transparent by ensuring all 
emerging themes were rooted in raw data  
 Provision of quotes throughout the results section enables 
readers to contextualise and assess the relevance in their own 
context. The criteria for selection of quotes were representative of 
the most recurrent and poignant research findings  
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Quality 
framework 
Method of application in this research 
Dependability 
 
Showing findings 
are consistent 
and could be 
repeated 
 Dependability has been offered through the use of a qualitative 
method and detailing the processes within the study. Included 
were details of the research design, data generation, data analysis, 
and reflective appraisal of the research. This in-depth 
methodological description will allow the study be repeated 
 The interview schedule was embedded with theory and was 
tested and checked by the research team and five expert reviewers 
 The COREQ checklist for reporting in-depth interviews was 
applied 
Confirmability 
 
The extent to 
which findings 
are shaped by 
respondents and 
not researcher 
bias, motivation, 
or interest 
 Participants were provided the opportunity to review and 
comment on their transcripts 
 All transcripts were independently reviewed and analysed by 
members of the research team   
 Data analysis was considered from within and across different 
professional groups and hospitals facilitated by the framework 
approach and NVivo11© software for data management  
 Limitations of the method were made clear 
 Use of figures and tables assisted in demonstrating clear 
methods and interpretation of data 
  
4.3 Findings from the qualitative interviews: general analysis 
4.3.1 Participant demographics 
Twenty-four nurses, pharmacists, pharmacy technicians, doctors, and hospital IT 
managers were invited to participate in individual face-to-face semi-structured 
interviews. As illustrated in Figure 4.4, one hospital IT manager declined to 
participate without providing a reason. 
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Initial sample invited to participate: 
24 
9 nurses 6 doctors 6 pharmacy staff 3 IT managers 
3 nurses 
HOSPITAL A 
3 nurses 
HOSPITAL B 
 
3 nurses 
HOSPITAL C 
 
2 doctors 
HOSPITAL A 
 
2 doctors 
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Figure 4.4: Participant sample 
 
Data saturation was deemed to have occurred by the primary researcher and two 
other members of the research team [SC and AT] in terms of thematic ranges 
and hence further recruitment was not undertaken. All participants who accepted 
the invite to be interviewed completed a background questionnaire with results 
summarised in Table 4.5. The range of included participants provided diversity of 
professional and personal characteristics.  
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Table 4.5: Participant characteristics (n=23) 
Characteristics   
                                                  
n    
Sex 
     Female                                                           
     Male                                                               
 
16 
7 
 
 
Healthcare professionals 
     Doctors 
     Nurses 
     Pharmacists 
     Pharmacy technicians  
     Hospital IT managers 
 
 
6 
9 
4 
2 
2 
 
Grade 
        Senior 
Junior 
 
 
15 
8 
 
Years of experience in profession 
     < 1 year 
     1-5 years 
     6-10 years 
     11-15 years 
     16-20 years 
     21-25 years 
     26-30 years 
     31-35 years 
     >35 years 
 
 
1 
2 
2 
3 
5 
4 
2 
1 
3    
 
 
Practised in countries outside Ireland 
    
  Countries 
13     
 
United Kingdom 
Jersey Island 
Pakistan 
New Zealand 
Australia 
 
 
Experience of using/implementing ePrescribing 
 
4        
Experience of using/implementing robotic pharmacy systems 
 
 
1  
Experience of using/implementing automated medication 
storage and retrieval systems 
 
13  
 
The median years of professional work experience was 16-20 years and the 
majority of participants had practiced outside of Ireland and had system 
experience. Table 4.6 provides more detailed demographic data and codes for 
the 23 participants who agreed to be interviewed. 
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Table 4.6: Demographic data and codes for interviewees  
Profession (grade) Sex Years 
experience 
Experience 
abroad 
Experience with system 
implementation 
 
N1 – Nurse (junior) F 26-30 years No Automated storage & 
retrieval systems 
N2 – Nurse (manager) F >35 years No No 
N3 – Nurse (senior) F 31-35 years No No 
N4 – Nurse (manager) F 21-25 years No Automated storage & 
retrieval systems 
N5 – Nurse (senior) F 16-20 years Yes No 
N6 – Nurse (manager) F 26-30 years Yes Automated storage & 
retrieval systems 
N7 – Nurse (junior) F 16-20 years Yes No 
N8 – Nurse (junior) 
N9 – Nurse (manager) 
F 
F 
21-25 years 
>35 years 
Yes 
Yes 
Automated storage & 
retrieval systems 
Automated storage & 
retrieval systems 
 
P1 – Pharmacist (senior) F 11-15 years Yes ePrescribing, robotics, and 
automated storage & 
retrieval systems 
P2 – Pharm tech (junior) F 6-10 years No Automated storage & 
retrieval systems 
P3 – Pharmacist (junior) F <1 year No No 
P4 – Pharmacist (senior) F 16-20 years Yes Automated storage & 
retrieval systems 
P5 – Pharmacist (senior) M 16-20 years No Automated storage & 
retrieval systems 
P6 – Pharm tech (senior) F 11-15 years No Automated storage & 
retrieval systems 
 
D1 – Doctor NCHD M 1-5 years Yes ePrescribing 
D2 – Doctor (consultant) M 21-25 years Yes ePrescribing and 
automated storage & 
retrieval systems 
D3 – Doctor (NCHD) M 1-5 years Yes No 
D4 – Doctor (NCHD) M 11-15 years Yes No 
D5 – Doctor (consultant) F 21-25 years Yes No 
D6 – D6 – Doctor (consultant) M 16-20 years Yes ePrescribing 
 
IT1 - IT manager M >35 years No Automated storage & 
retrieval systems 
IT2 - IT manager F 6-10 years No Automated storage & 
retrieval systems 
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4.3.2 Interview and transcription length  
Interviews varied in length of time from 19 minutes to 78 minutes and the 
median time was 38 minutes. Transcriptions differed in length from 3275-14071 
words and the approximate time to complete was four months.  
 
4.3.3 Type of systems participants discussed  
Doctors mostly discussed ePrescribing systems, nurses and hospital IT managers 
mostly discussed automated medication storage and retrieval systems, and 
pharmacy participants mostly discussed automated medication storage and 
retrieval systems and robotic pharmacy systems, as illustrated in Table 4.7. 
 
Table 4.7: Type of systems participants discussed 
Profession   ePrescribing Robotic pharmacy 
systems 
Automated 
medication 
storage and 
retrieval 
systems 
 
Nurse (n=9) 
Experience 
No experience 
  
-  
1 
 
- 
- 
  
5 
3 
Pharmacy (n=6)  
Experience 
No experience 
 
- 
1 
 
1 
1 
 
4 
2 
Doctor (n=6) 
Experience 
No experience 
 
1 
3 
 
- 
- 
 
1 
2 
IT (n=2) 
Experience 
No experience 
 
 
- 
- 
 
- 
- 
  
  2 
  - 
 
4.4 Findings from the qualitative interviews: thematic analysis 
Eight key themes emerged from data analysis using NPT as a theoretical 
framework, as summarised in Table 4.8. 
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Table 4.8: Summary of key facilitator and barrier themes related to NPT constructs and components  
Key themes NPT constructs and 
components 
Facilitators Barriers 
Theme 1: Understanding of how electronic 
systems differ from manual practices and 
the value of system implementation 
Coherence: 
Differentiation  
Internalisation 
Patient safety  
Efficiency: 
- Stock control 
- Traceability 
- Accountability 
- Cost reduction 
- Integration 
Time inefficiencies 
Security issues 
Logistics of changing system 
 
Theme 2: A need to work together to build 
a shared sense of purpose for system 
implementation and have a clear 
understanding of individual roles and 
responsibilities 
Coherence:  
Communal 
specification  
Individual 
specification  
 
Work together to understand 
reasons for implementation 
 
Participants with experience 
had a clear understanding of 
their roles 
Limited communication on 
implementation 
 
Participants without experience had a 
limited understanding of requirements 
Theme 3: A need for clinical leadership, 
champions at ward level, and a 
multidisciplinary implementation team to 
promote buy-in 
 
Cognitive 
participation: 
Enrolment  
Activation 
Initiation  
Legitimation  
Clinical champions to promote 
benefits and engagement via 
effective communication  
 
Early adaptors 
 
Multidisciplinary team approach  
 
Older generation may not realise 
benefits as easily as younger generation 
 
Resist work changes: 
- Lack of prioritisation 
- Force of change  
- Limited involvement 
- Bureaucracy 
- Lack of recognition of professional 
roles 
Theme 4: A need for adequate training and 
organisational support 
 
Collective action:   
Skill set workability  
Contextual 
integration  
Sufficient training  
Sufficient support and 
resources  
Robust governance  
Training not sufficient  
Inadequate support 
No additional resources  
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Key themes NPT constructs and 
components 
Facilitators Barriers 
Operational guidelines  
Theme 5: A need for electronic systems to 
be easier to use than manual systems 
Colle Collective action:   
Interactional 
workability  
 
Light guided 
Ease of stock management  
 
Sufficient number of systems 
 
Mobile units nearer the patient 
 
Manual system easier as more patient-
focused and less task oriented 
 
Workflow issues e.g. time delays in 
queuing, limited accessibility, 
inadequate numbers/sizes of units 
resulting in delayed medication 
administration  
Theme 6: A need for a sense of confidence 
in system use 
Collective action: 
Relational integration 
Safety alerts 
Double checking 
Clear record 
Confident with familiarity 
Lack of confidence with identifying drugs  
 
Substantial time away from patients 
Theme 7: A need to use systems as 
intended 
Reflexive 
monitoring: 
Reconfiguration  
Alter system use for efficiency 
e.g. recheck chart before 
administration 
Not using system as trained e.g. trolley 
to carry drugs for multiple patients 
increasing risk of errors 
Theme 8: A need to measure and audit 
practice 
 
Reflexive 
monitoring: 
Communal appraisal  
Individual appraisal  
Systematization  
Auditing of practice e.g.  cost, 
time, end-user satisfaction   
Limited formal measures 
Unable to determine actuality from 
reality 
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Key themes are now described in more detail with associated subthemes on 
facilitators and barriers towards system implementation. 
 
Theme 1: Understanding of how electronic systems differ from manual 
practices and the value of system implementation 
Participants had a clear understanding of the aim of implementation, with key 
concepts of enhanced patient safety and efficiency evident. Concerns over the 
possible negative consequences of system adoption were also verbalised. 
 
Subtheme 1: Enhanced patient safety and efficiency 
Legibility of prescriptions, CDS, accurate drug selection, and reduced medication 
errors were perceived to improve patient safety with implementation.  
 
“There would be less errors in terms of not being able to read what the 
prescription is and the doses…I think safety has to be the biggest value you 
can get from it”. (Senior nurse N5) 
 
Stock control, traceability, accountability, cost containment, and integration of 
systems to enhance patient flow and communication between professionals were 
other perceived benefits.  
 
“If you have the systems right the way through from prescribing to 
dispensing, then you should have a continuous log that is retrievable”. 
(Consultant doctor D6) 
 
Limitations of the current manual system articulated by participants supported 
this theme, with an expectation of improved patient safety and better transfer of 
information with new work practices.   
 
“The current system is designed for loads of errors to occur, either in the 
prescription with illegibility issues or with the medications given, it is 
appallingly poor and inherently unsafe. Automated systems would be far 
more superior from a patient safety and workflow perspective”. (Consultant 
doctor D2) 
 
Subtheme 2: Negative consequences with electronic system implementation 
Participants expressed concern over possible negative variations between 
electronic and manual systems such as potential time inefficiencies, security 
issues, and logistics of changing from manual to automatic. 
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“Any electronic system, it doesn’t matter how streamlined you put it, it will 
be a hindrance because it will slow down processes”. (Consultant doctor D5) 
 
Theme 2: A need to work together to build a shared sense of purpose for 
system implementation and have a clear understanding of individual 
roles and responsibilities 
Participants perceived different professionals had differing ideas of the purpose of 
the system and that some individuals would work together to build a shared 
understanding of the reasons for implementation, and others would not. 
 
“I think different people have different ideas about a system. The 
management idea is often very different to the users’ idea, or the pharmacy 
aspect might be different to the nursing aspect”. (Senior pharmacist P1) 
 
“Some would work together and understand the long overdue reasons for 
implementation.  Others just wouldn’t want it”. (NCHD doctor D1) 
 
Subtheme 1: Understanding dependent on system experience 
Participants with system experience had a clear understanding of their roles, 
including responsibility for planning and monitoring implementation, delivering 
adequate training to end-users, and becoming familiar with policies and 
protocols.  
 
“My role is really to assist in planning for the implementation of the system 
and for monitoring the implementation of the system in relation to nursing 
practice”. (Nurse manager N6) 
 
“Well with pharmacy staff, they are responsible for stocking drugs and 
ensuring that expiry dates are entered correctly and things like that.  With 
us I suppose our responsibility is to ensure that we are removing the 
correct amount of drugs and we have put them in properly”. (Junior nurse 
N1) 
 
Participants without system experience had a limited understanding of what was 
required for implementation.  
 
“It is all theory to me, I know vaguely what electronic prescribing is but how 
actually it works, I don’t, it might be a more arduous task, I don’t know yet. 
So that is the fear I suppose”. (Senior nurse N5) 
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Subtheme 2: Limited communication 
A perception of limited communication with colleagues on implementation 
resulted in participants either unable to determine if there was a shared sense of 
purpose or believing there was not enough information available to have a 
comprehensive shared understanding. 
 
“Well I don’t know because I haven’t spoken to my working colleagues 
about it...this hasn’t been generally spoken about among my medical 
division, so I mean generally the thinking is from my colleagues that we are 
going down the road of becoming more technological, more IT.  But from a 
perspective of drugs, pharmacy this hasn’t been spoken about really”. 
(Nurse manager N2) 
 
Theme 3: A need for clinical leadership, champions at ward level, and a 
multidisciplinary implementation team to promote buy-in  
Evidence of both key stakeholders driving implementation and resistance to work 
practice changes with limited end-user involvement was apparent. A 
multidisciplinary team approach, clinical leadership, and champions at ward level 
were key concepts perceived to promote engagement with system 
implementation. Selecting early adaptors was also believed to be of benefit. 
 
“I think maybe having champions at ward level, where they are involved in 
all pre-discussions and planning meetings...try and get protected time for 
nursing to be part of the project implementation group to be more involved 
in the policies and reviewing what would work well for their ward.” (Senior 
pharmacist P1) 
 
Subtheme 1: Evidence of key individuals driving system implementation 
It was evident that key individuals in a managerial role were willing to initiate 
and drive system implementation via engagement with company representatives, 
business case submissions, and visiting other hospitals who had adopted 
systems. Having a good team to support implementation with effective 
communication and information sessions on projected benefits were mechanisms 
of promoting engagement.  
 
“I have a business case submitted into management at the minute for a 
medication storage and retrieval system and every week I send a reminder 
of the benefits, the safety implications, and the cost saving implications”. 
(Senior pharmacist P4) 
 
“You know it is getting the consultants from the prescriber’s point of view, 
the nurse prescribers, you know to buy-in and really having a working 
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group that actively promote it and look at the advantages and just keep 
reminding people, it is brain washing really”. (Senior nurse N5) 
 
Whilst participants believed it was right for them, and were interested, in getting 
involved in system implementation, they felt the younger generation could 
realise the benefits more easily.  
 
“All of the young nurses that are coming out now instead of in my 
generation, they are all up to speed with technology and it would become 
second nature to them”. (Nurse manager N2)  
 
Subtheme 2: Resistance to work practice changes 
Resistance to change due to force of change in practice, limited involvement with 
end-users, bureaucracy, and lack of prioritisation for implementation were 
viewed as barriers to active participation.  
 
“The culture of resistance is massive especially in an organisation like this 
where there are a lot of people employed for a long time”. (IT manager IT1) 
 
Nurses felt their professional role should be acknowledged more as a significant 
contributor to successful implementation. 
 
“I think that nursing staff is a hugely important stakeholder and that they 
should be on board and they should have that acknowledged. Nursing as a 
profession doesn’t get acknowledged enough with changes and moves”. 
(Junior nurse N7) 
 
Theme 4: A need for adequate training and organisational support 
Another key theme that emerged was the need for adequate training and 
organisational support for successful implementation. 
 
Subtheme 1: Training, resource investment, and robust governance  
Small group hands-on training sessions, superuser support, training in areas only 
applicable to the user, phased training per ward, and sufficient time to train and 
adjust to new work practices were viewed as beneficial. 
 
“You would have a core group of superusers that are the train the trainers 
type people and then people taught appropriate to their point of usage, 
because I don’t want training in every aspect of it that I am not going to be 
using because it will dilute what I remember of what is applicable to me”. 
(Senior nurse N5) 
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Resource investment and robust governance inclusive of developing and 
disseminating policies and protocols, contingency plans, and completing risk and 
competency assessments were also perceived as facilitators for successful 
system implementation. In addition, responsive end-user feedback during 
implementation emerged as beneficial.  
 
“You are going to need money, you are going to need resources. You would 
need your policies and protocols and what you are going to change”. 
(Consultant doctor D6) 
 
“I guess feedback is a big thing, we do have a book on the ward where 
nurses write down any issues and then we would feedback what the result 
was. Also nurses can feedback to the pharmacy staff or the nurse manager 
and we always take it on board...if I have any ideas for improvement or 
think something is not working I tend to feed this back to my manager and 
it is usually implemented.” (Junior pharmacy technician P2) 
 
Participants perceived operational guidelines assisted with supporting system 
implementation and understanding the effects of the new system on individuals’ 
roles and responsibilities and training needs. 
 
“Omnicell gave us their operational guidelines and then we drafted our own 
local guidelines where we outline the roles and responsibilities for all staff, 
from medical staff, nursing staff, pharmacy staff, IT staff, and then the 
company trainer and the out of hours support”. (Senior pharmacist P1) 
 
Subtheme 2: Inadequate resources and management support 
A number of participants believed there were no additional resources provided 
which slowed down work processes, especially if staff were not trained during 
initial implementation.  
 
“We haven’t gained any staff and that was something we had hoped would 
be looked at...very much the new staff are told ‘this is how you log in’ and 
then it is very much the staff on the ward will say ‘this is what you need to 
do’”. (Nurse manager N4) 
 
Participants perceived inadequate management support was provided with little 
consideration to the effects of system implementation on work practices. It was 
felt more engagement would have resulted in more responsibility and acceptance 
of system use. 
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“I think initially it was very much this is just something you are going to do 
and it was never really given the amount of thought of how much this was 
going to change the way the ward worked.  So in terms of nursing support I 
don’t feel there was a great deal there”. (Junior nurse N8) 
 
Theme 5: A need for electronic systems to be easier to use than manual 
systems 
Ease of use with guiding lights and enhanced efficiency in relation to stock 
availability were perceived as facilitators to adoption.  
 
“It is a huge turn around and they see the advantages and the time that 
was wasted every day for nurses sending down requisitions and the 
pharmacist ringing back questioning it and there was a whole conversation 
going on”. (Nurse manager N9) 
  
However, nurses felt the manual system was easier to use and more patient-
focused and interactive. The new system was viewed as more task oriented. 
 
“It is going back to a task, we have got to go and get the drugs from the 
machine, so it is a task, but before there was more of a subtle dynamic in it 
and maybe we weren’t even as aware of it. The drugs were very linked with 
patients, you had the visual cues”. (Nurse manager N6) 
 
Subtheme 1: Workflow delays 
Workflow issues and time delays in queuing to remove drugs from the system 
resulting in patients waiting for medicines were viewed as substantial barriers to 
system compatibility with existing practices. This was mainly due to inadequate 
numbers and sizes of units impacting on administering medication as prescribed, 
retrieving medications in an emergency, and discharging patients. Further delays 
in inputting controlled drugs and limited accessibility due to digital biometric 
fingerprint recognition issues, locum staff and healthcare assistants (HCAs) not 
having access privileges, and pharmacy technicians stocking the machine were 
also viewed as frustrating. Instalment of additional systems and mobile units 
nearer the patient was perceived as a key requirement.  
 
”You might have 31 patients to get their medicines for around that time 
with one point of access.  Previously on the ward we would have had at 
minimum six points of access. We need more systems in place”. (Nurse 
manager N6) 
 
“The problem is it is not big enough, there is not enough space in them”.  
(Senior pharmacist P5) 
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Pharmacy participants also believed the new system was more time consuming 
and involved more work than the manual system, such as two people re-stocking 
the machine and repeating work if the stock balance was incorrect. 
 
“It is more work with Omnicell without a doubt.  Even the time it takes to 
put stuff away. What happens if somebody puts the wrong thing in the 
wrong place, which can happen easily? So for a long time two people were 
going up and putting away the top up.” (Senior pharmacist P5) 
 
Theme 6: A need for a sense of confidence in system use 
Another key theme was the need for confidence in system use. Mixed 
perceptions of the system were evident. 
 
Subtheme 1: Confidence in system use with safety alerts and records  
Safety alerts such as gentamicin and vancomycin therapeutic drug monitoring 
and administration instructions, two people double checking stocked items in the 
machine, and comprehensive records of retrieved medication enhanced a sense 
of confidence and accountability in using the system.  
 
“I was having trouble reading a drug kardex as I often do and I went back 
to look what the person previously gave and they had given what to me it 
said”. (Junior nurse N8) 
 
In particular, assurance based on individuals becoming more familiar with the 
system was evident.  
 
“I think as people are getting more familiar and more confident with it they 
are getting to understand it better...staff who had a lot of angst in the 
beginning I know with speaking to them they are less anxious about it 
now”. (Nurse manager N6) 
 
Subtheme 2: Lack of confidence and substantial time away from patients 
Lack of confidence with identifying individual drugs when removed from the 
machine for patient administration was viewed as a key barrier. 
 
"When you have retrieved the drugs you are dispensing them into a pot, 
you actually can’t tell the difference between the different drugs unless you 
are familiar with them”. (Nurse manager N6) 
 
New work dynamics of substantial time away from patients and interruptions 
were viewed as other safety concerns. 
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"So now we spend a lot more time away from the patient getting medication 
for them and then the problem is once you leave that area, you’re pulled at 
for loads of other things. It is very distracting cause it takes your focus 
away for possibly 10 or 15 minutes...it hasn’t helped nursing in relation to 
one-to-one care with patients.”  (Nurse manager N4) 
 
Participants felt expectations were not met with system implementation.   
 
“We believed we were going to have this great pharmacy system and that 
every medication we wanted was going to be in it and there would be no 
delays administering drugs, there would be no delay in getting medication 
and it would be a safe system, but actually bar using what we are going to 
need in the machine the rest of the system stays the same”. (Nurse 
manager N4) 
 
Theme 7: A need to use systems as intended 
Nursing and pharmacy participants felt they reflected on work practices following 
system implementation and adjusted practices accordingly for efficiency 
purposes. This included discontinuing pre-ordering of drugs, more night time 
ordering of drugs, re-checking the medication chart at the bedside before drug 
administration, and altering the method items were double checked by pharmacy 
technicians when stocking the system. 
 
“Now we make sure that we check the drug kardexes again at the bedside, 
we had discussed that before, just to try and reduce errors”. (Junior nurse 
N1) 
 
Subtheme 1: Lack of using the system as trained and to its maximum benefit 
Various participants felt some individuals did not use the system as trained, such 
as removing more medication than requested leading to inaccuracies in drug 
amounts in the machine in comparison to what was reported.  
 
“It is not fool proof, you can find a way round it, so if you go in for 
Panadol®, you can take out two or three and tell it you took out one...we do 
know where stock is in theory, but we are still relying on people to remove 
things as they are supposed to.” (Senior pharmacist P5) 
 
Other alterations included accessing pharmacy outside of opening hours for 
drugs already stocked in the machine, gaining access to prohibited functions of 
the system, and storing stocked medication outside the machine. The use of a 
trolley to carry drugs for multiple patients at one time was perceived as 
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increasing the risk of errors and accessing the system for long periods. This was 
also viewed as an intermediary step in the electronic process. 
 
“In A&E they go from system to patient, but on the medical wards they use 
trolleys, so they remove the meds, put it into a specific trolley with specific 
drawers for the patients, so they could hold up the system for maybe an 
hour... there is an increased risk of errors, it should be system to patient 
but because of the size of the medical wards and only having one machine 
there is risk of errors in administering the wrong patient the wrong 
medication”. (Senior pharmacy technician P6) 
 
Lack of using the system to its maximum benefit was also perceived as a 
disadvantage, such as availing of CDS and integration of systems. 
 
“There are a lot more capabilities that we have yet to implement and there 
is also the possibility of linking other systems into it”. (IT manager IT2) 
 
Theme 8: A need to measure and audit practice 
Whilst not many formal methods of measuring the impact of system 
implementation were in place, reviewing financial reports, complaints, stock 
counts, and medication waste were believed to be effective ways of identifying 
facilitators and barriers to implementation.  
 
“We did a financial report in pharmacy in a three month period prior to the 
systems being installed and a three month period after and there was a cost 
saving of between 15–17%”. (Senior pharmacy technician P6) 
 
Auditing of practice was perceived as another way of identifying benefits or 
problems and in understanding the systems value and requirements for future 
improvements. This included time comparisons between the new and old system, 
end-user perceptions before and after system implementation, error rates, and 
level of training.  
 
“There was an audit done in the last few weeks and currently we are 
spending more time on the Omnicell than we would with the manual top up 
system, but that is because we have two members of staff going to the 
ward to fill the Omnicell so I think that is an issue around training as well so 
the managers plan is to get that down to one person”. (Junior pharmacy 
technician P2) 
 
Measuring and auditing practices were also viewed as important in determining 
actuality rather than perceptions. 
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“You have always got to bear in mind, what staff sometimes say isn’t 
always the reality, it could be a perception rather than the reality so that is 
why we have to bring in more measurement to see is it actually what is 
happening or is it what they think is happening so I have to do that, the two 
could be different”. (Nurse manager N6)  
 
4.5 Discussion 
This section provides an overview of key findings in relation to the research 
objectives, considers methodology strengths and weaknesses, and interprets 
findings inclusive of comparisons with published literature. 
 
4.5.1 Statement of key findings  
The objective of this phase of the research was to explore the perceptions of 
local key stakeholders towards the facilitators and barriers to implementing 
ePrescribing, robotic pharmacy systems, and automated medication storage and 
retrieval systems in public hospitals in Ireland using NPT as a theoretical 
framework. Twenty-three individual face-to-face semi-structured interviews were 
conducted with nurses, pharmacists, pharmacy technicians, doctors, and hospital 
IT managers in three different hospital settings in Ireland. Framework analysis 
aided data interpretation. Utilisation of NPT enabled systematic identification of 
key themes and all four constructs and components were significant to topics 
discussed during the interviews. As coherence and cognitive participation relate 
more to planning implementation (141), perceptions of participants without 
system experience dominated these constructs. Participants with system 
experience predominately provided insight into enactment and reflections on 
system adoption and use, with the addition of multiple comparisons to the 
manual medicines management system.   
 
Themes expressed by different professional groups with no experience and with 
varying levels of experience were on the whole consistent. Patient safety was the 
primary focus for all professional groups. The main difference included nurses 
overall rejection of system implementation, and others acceptance. Doctors were 
more interested in discussing ePrescribing, whilst all other professional groups 
focused on automated medication storage and retrieval systems.  Facilitators and 
barriers were collectively similar and not dependent on system type or 
experience. Demographic factors such as age, gender, seniority in role, and 
years of work experience were inconsequential to response patterns.  
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Findings from implementers and end-users’ perceptions of system adoption draw 
attention to issues around implementation which are multifactorial and complex 
at both an individual level and organisational level. Demonstration of coherence 
and cognitive participation were key drivers for success or failure at the initial 
stages of implementation. It was clear that individuals would engage and buy-in 
to implementation if the system was viewed as beneficial in improving work 
practices. Whilst some participants perceived key individuals were willing to drive 
implementation, force of change in practice, limited involvement, and lack of 
understanding of the impact of adoption on services were evident. Negative 
attitudes acted as obstacles to enrolment, such as beliefs that the system would 
disrupt the delivery of care, distrust in system use, and a culture of resistance to 
change. A range of strategies to initiate and legitimise participation in the 
implementation process included fostering a culture of clinical champions and 
selecting early adaptors for implementation with the support of a 
multidisciplinary team.  
 
Further operational work and investment in resources and ongoing staff, 
contingency, and policy support were needed by individuals and organisations to 
enhance implementation processes and facilitate collective action, particularly 
with the nursing profession. Providing a period of transition in which end-users 
can become familiar with and learn how to use the new system was also 
required. In terms of ease of use and confidence in the system, resistance was 
evident due to perceived added complexity, effort, and time. In particular, 
workflow issues with time away from patients, additional interruptions, and 
accessibility issues ultimately impinged on delayed administration of medication 
to patients. Findings from this study highlight the challenges of integrating new 
systems with existing work processes and the introduction of new risks. 
Participants felt medicines management would improve with the instalment of 
additional units nearer the patient. Incorporating workflow analysis into system 
design, integration of systems into the usual process of care, and minimising 
workflow interruptions were required to facilitate successful implementation.  
 
Participants understood ways of appraising the system post-implementation in 
order to consider its effect on work practices. Concerns with system usability led 
to the development of workarounds by end-users. As limited formal methods of 
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reviewing facilitators and barriers post adoption were identified, key themes 
which emerged within this study are predominantly participants’ perceptions and 
may not align with actuality. It is also possible that some benefits such as time 
savings may have been masked by other frustrations arising from complex work 
processes. A need to promote reflexive monitoring to evaluate the outcomes of 
system implementation on patient care and workflow was evident. 
 
4.5.2 Consideration of strengths and limitations  
There are numerous strengths to this study. As highlighted in the systematic 
review findings, limited published qualitative studies exist on facilitators and 
barriers to implementing electronic systems for medicines in hospitals (337). 
Findings have generated original knowledge and understanding in processes of 
system implementation. A rigorous approach was adopted to all aspects of this 
qualitative research and trustworthiness was evident throughout, as further 
described in Chapter 2 and Table 4.4 which are based on frameworks from 
Creswell (183), Stenton (255), and Guba (355).  In summary, members of the 
research team brought vast expertise to development of the methodology, 
coding of results, and interpretation of the findings; the research design was 
described clearly; the interview schedules were grounded in theory, reviewed by 
all research team members and five experts, and developed iteratively; and the 
coding framework and thematic analysis were independently reviewed by three 
members of the research team. COREQ was also applied which comprises a 32-
item checklist for reporting in-depth interviews. 
 
NPT was considered to be of benefit by all members of the research team in 
providing an explanatory theoretical framework for identifying factors that 
promote and inhibit system implementation and in understanding the 
complexities involved and work needed to be done. This is consistent with a 
qualitative systematic review of studies using NPT to research implementation 
processes by McEvoy et al which found strong endorsement of the benefits of 
using NPT as a conceptual framework to analyse implementation processes and 
inform recommendations to guide implementation work (344). They also 
identified scope for NPT to be used during the planning stages of implementation 
to explore the real-world context in which work will take place and provide data 
to cease planning if the likelihood of normalisation is low  (344). 
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Triangulation of data sources and investigators involved a variety of hospital 
sites, heterogeneous participants, and analysts in order to facilitate deeper 
understanding and ensure data were rich, robust, comprehensive, and well 
developed (356).  Findings from the systematic review were compared with those 
from the qualitative phase, thereby facilitating triangulation of research methods. 
Sampling bias was minimised using stratified purposive sampling which is a 
recognised sampling method (241)(242). Many papers in the qualitative 
systematic review by McEvoy et al of studies using NPT to research 
implementation processes included single-stakeholder perspectives with an 
emphasis on service providers rather than service users which was viewed as a 
limitation to inform implementation processes (344). This primary research 
included both implementers and end-users. To minimise reporting bias, 
participants were clearly informed of the research aim and given sufficient 
opportunity to contact the researcher and research team to clarify any issues. 
Participants were assured confidentiality and anonymity of data and informed 
there was no right or wrong response to questions.  Participants were also 
encouraged to share relevant views and experiences not covered by the 
interview schedule. It was clear that participants felt comfortable throughout the 
interviews, with comments such as “you better delete that” and “I probably 
shouldn’t say that but...” and “off the record...”. Interviews were audio recorded 
and transcribed verbatim shortly after each interview by the primary researcher 
to ensure recorded information accuracy. Transcriptions were thereafter 
reviewed for dependability by the primary researcher and two members of the 
research team and participants were also offered the opportunity to review their 
own interview transcript for further confirmability. In addition, a number of peer 
reviewed papers including conference proceedings were presented with 
constructive feedback. 
 
Reproducibility of the method employed can be achieved from clear descriptions 
of data generation and analysis processes. The phenomenon of interest was 
described in sufficient detail in order to evaluate the extent to which conclusions 
drawn can be transferable to other times, settings, situations, and populations. 
This included describing the structure of NPT constructs and emerging themes 
and subthemes, as well as the integration of concepts, relationships, and 
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interpretations. Trustworthiness was further established by comparing and 
contrasting findings and data interpretation supported by other authors.  
 
A researcher's background and position shapes what they choose to investigate, 
the angle of investigation, the method judged most adequate, the findings 
considered most appropriate, and the framing and communication of conclusions 
(357). From a personal stance, the primary researcher works as an antimicrobial 
pharmacist in a university teaching hospital in Ireland and has no bias or 
preconceived ideas to any potential outcomes of the study. Background 
knowledge into this research was gained through undergraduate and 
postgraduate degrees in pharmacy, clinical pharmacy, psychology, computer 
science, and IT; review of the literature; and previous work involvement in 
implementing an automated medication storage and retrieval system. A planned 
site visit was also conducted in 2015 in Hackensack University Medical Center, a 
900-bed teaching hospital in New Jersey in the USA, to view their award-winning 
closed loop medicines management system comprising ePrescribing, robotic 
pharmacy systems, and automated medication storage and retrieval systems 
within an integrated EHR.  
 
As the primary researcher’s interest in NPT only emerged during this research, 
bias in defending or justifying or refuting this theory was not an issue. The 
primary researcher was interested in identifying both facilitators and barriers to 
system implementation and therefore did not influence participants on either 
stance. The primary researcher has some experience of conducting individual 
face-to-face semi-structured interviews and analysing data using the framework 
approach as part of completing a master’s thesis in clinical pharmacy (135). 
Formal training in qualitative research was also completed, as listed in Appendix 
2.1. In addition, pilot interviews conducted with a pharmacy technician, ward 
nurse, and non-consultant hospital doctor with and without system experience 
permitted the primary researcher to gain more experience in interview 
techniques. Standard meetings via phone and videotelephony to discuss research 
matters and further direction were carried out approximately once weekly with 
the primary researcher and principal supervisor [SC], and with other members of 
the research team approximately once monthly or when required.  
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Some limitations also exist. It is acknowledged that conducting face-to-face 
interviews is labour intensive and can be costly depending on where interviews 
take place and how much travel is required. Much effort and time was spent 
understanding NPT constructs and their differences resulting in an initial concern 
of possible repetition of coding or miscoding of constructs leading to analysis not 
reflective of NPT. Similar views have been shared in the application of constructs 
and the overlap and difficulty of discerning the differences between components 
(358)(359), in addition to the efforts required in developing each of the 
constructs within the complexity of current organisational practices (360). 
However, findings from the qualitative systematic review of studies using NPT to 
research implementation processes by McEvoy et al assisted in coding 
participants with no system experience to coherence and cognitive participation 
and all four constructs to those with system experience (344).  
 
Whilst data saturation was considered to be achieved for the overall sample after 
23 interviews with eight nurses, four pharmacists, two pharmacy technicians, six 
doctors, and two hospital IT managers, there was no certainty that data 
saturation was achieved for each profession given the relatively small sample 
size included in the qualitative study. In addition, as the primary researcher was 
not familiar with all key stakeholders, pharmacy participants in two hospitals 
were requested to recommend a small number of potential invitees, possibly 
leading to sampling bias. Another possible limitation to this research was site 
triangulation from three acute general hospitals in the public sector in Ireland. 
Even though qualitative research findings do not aim to be transferable, there is 
a possibility that results may not be transferrable to other hospital settings such 
as private hospitals, tertiary hospitals, specialist hospitals, and hospitals outside 
of Ireland. It is hoped, nevertheless, that this robust, theory-driven research will 
provide relevant and applicable concepts for implementers planning adoption. 
 
4.5.3 Interpretation of findings 
Integrating new ways of working in hospitals has been challenging. Findings 
presented in Chapter 3 derived through analysis of a systematic review were 
similar to findings from this primary research. Healthcare professionals perceived 
systems improved patient safety and provided better access to patients’ drug 
records and that team leadership and hardware/software availability and 
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reliability were essential for successful implementation. Key barriers included 
hardware and network problems, altered work practices, and weakened 
interpersonal communication between healthcare professionals and with patients 
(337). There was more of a focus on ePrescribing systems in the systematic 
review and automated medication storage and retrieval systems in the primary 
research.  
 
Another systematic review on factors that promote or inhibit the implementation 
of eHealth by Mair et al published in 2012 using NPT as a conceptual framework 
included 37 review papers mainly of poor quality with a high potential for bias 
and from North America (141). Continued focus on organisational issues and 
problems related to eHealth systems workability were identified with little 
consideration to the broader social structures. Comparable with this primary 
research, little attention was given to work directed at making sense of eHealth 
systems, effects on roles and responsibilities, methods of engaging with 
professionals, and ensuring potential benefits of implementation were apparent 
through ongoing evaluation and feedback.  
 
An updated systematic review of systematic reviews on factors that influence the 
implementation of eHealth by Ross et al published in 2016 using CFIR as a 
conceptual framework identified 44 reviews mainly of poor quality and from 
North America and Europe (138). Similar to this primary research, the review 
acknowledged the multi-level complexity of eHealth implementation and 
identified findings were consistent across different eHealth systems. The fit of 
eHealth systems with existing organisational workflow was a key issue. Ross et al 
also highlighted the importance of policies, adequate infrastructure and 
resources, key stakeholder engagement, organisational readiness, and 
individuals’ knowledge and beliefs. Areas which received little attention included 
system trialability and relative priority of the systems. Expectations, adaptability, 
and cost were also a focus of the review, again consistent with findings from this 
primary research. In comparing findings from both systematic reviews by Mair et 
al (141) and Ross et al (138), many implementation challenges appeared to be 
consistent over time despite the rapidly changing field of eHealth, such as 
organisational issues and resourcing. However, there was more of a focus on 
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reflecting and evaluating implementation in the more recent systematic review 
(138) suggesting an increased awareness of the importance of this process.  
 
Demonstration of coherence and cognitive participation were key drivers for 
success, or lack of, at the initial stages of implementation. This is supported by 
Travaglia et al in 2009 who identified an initial failure to display coherence 
resulting in end-users not perceiving the new ways of working as helpful or 
relevant and an unwillingness to engage with the process (361). Several 
interviewees in this primary research cited legibility as an issue with manual 
systems which was also described by Cresswell et al in 2014 with regard to the 
impact of system adoption on individual users when evaluating medium-term 
consequences of implementing ePrescribing in two ‘early adopter’ hospitals in the 
UK (362). They identified advantages of greater legibility of prescriptions and 
more efficient processes with system implementation. Whilst interoperability was 
perceived as an advantage to enhance patient flow and communication between 
professionals in this primary research, a key finding by Cresswell et al involved 
issues with integration of systems in a more recent study in 2016 investigating 
the types of workarounds users employed and implications for patient safety in 
six UK hospitals (363). This led to ineffective information transfer resulting in 
lack of timely information and duplicate data entry (363). While integrated 
ePrescribing systems offered better usability, standalone systems provided 
greater flexibility and opportunity for interoperability with external systems as 
well as customisability to the needs of different user groups (363). 
 
Key themes relating to cognitive participation included the need for good 
leadership and support to facilitate buy-in which is consistent with a qualitative 
study by Rahman et al in 2010 on system providers and end-users perceptions of 
implementing a hospital information system (364). A study by Hardeep and 
collegues in 2015 on implementing ePrescribing and automated medication 
storage and retrieval systems in a UK hospital also found a well-designed 
project, multidisciplinary approach, and ongoing engagement facilitated a 
smooth manual to electronic transition (365). In relation to nursing input, a 
qualitative case study by Farre et al in 2017 on nurses’ role in the medication 
process prior to ePrescribing implementation identified the contribution of nurses 
to medicines management needed to be considered further in system design and 
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implementation, which is again parallel to this primary research finding (366). A 
similar study by Choo in 2010 found nurses should have a significant role in 
system design to ensure a smooth transition to system use (367). 
 
In terms of other NPT constructs, there was little evidence of collective action 
with no clear allocation of the processes of enacting the system. A need for 
considering adequate training, task allocation, and inter-professional 
communication was evident. Key stakeholders did not perceive overall time 
savings. Cresswell et al also found increased workloads related to poor software 
usability and shortcomings in the provision of a wider technology infrastructure 
such as difficulties accessing computers and lengthy log-in times (362). 
Organisational expectations of time savings for clinical staff were not met. In 
contrast, an Australian study by Westbrook et al published in 2013 reviewing 
doctors and nurses time spent on direct patient care, medication-related tasks, 
and interactions before and after the introduction of ePrescribing and automated 
medication storage and retrieval systems did not result in redistribution of time 
away from direct care or towards medication tasks (368). Another study by 
Darwesh et al was published in 2017 on the experience of using automated 
medication storage and retrieval systems to improve medication safety and 
management (369). Similar to this primary research, the authors found system 
implementation was difficult at the initial stages due to inadequate staff training 
but with familiarity and use it became easier. Recommendations included 
adequate HR support, a multidisciplinary approach to ensure a smooth transition 
from manual to electronic, and development of contingency plans (369). 
 
Findings from this primary research highlight the challenges of integrating new 
systems with existing work processes and the introduction of new risks which are 
aligned to other research (362)(370)(371)(372)(152). An early study by 
Redwood et al in 2001 found the introduction of an ePrescribing system in a UK 
hospital had the potential to give rise to new types of risks to patient safety 
(373). These included pick list juxtaposition errors, confusion of paper-based and 
electronic systems, and distractions and interruptions to workflow.  
 
A need to promote reflexive monitoring and evaluate the outcomes of system 
implementation on patient care and workflow was also evident. As highlighted in 
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this primary study, concerns with system usability can lead to the development 
of workarounds by users. Cresswell et al found informal practices not approved 
by management were employed by users due to perceived changes to 
professional roles, issues with usability and performance, and challenges relating 
to inaccessibility of systems (363). Formalised practices were promoted by 
management and occurred when systems posed threats to patient safety and 
workflow. Both types of workarounds involved using paper and other software 
systems as intermediaries, which often created new risks relating to a lack of 
efficient transfer of real-time information between different users (363).  
 
4.6 Further work 
Many potentially transferable themes have been identified and extend the 
evidence base. This will assist organisations to better plan for implementation of 
medication-related eHealth systems. A more systematic approach and further 
consideration to system implementation in hospitals in Ireland is required. 
Systematic reviews have highlighted papers are generally of poor quality and 
issues of implementation multifactorial. There may then be value in employing 
standardised tools such as NPT in the process of implementation. Areas of further 
research are described in Chapter 6. Findings from the introduction overview in 
Chapter 1, the systematic review findings in Chapter 3, and the qualitative 
interviews with local key stakeholders were used to facilitate the next phase of 
this research. These findings support the requirement to explore national key 
stakeholders and eHealth leads’ perceptions towards the facilitators and barriers 
of implementing electronic systems for medicines management in a hospital 
setting. 
 
4.7 Chapter summary 
Novel knowledge and understanding with regard to perceptions of local key 
stakeholders towards the facilitators and barriers of implementing ePrescribing, 
robotic pharmacy systems, and automated medication storage and retrieval 
systems in hospitals in Ireland has been generated. The mix of participants 
comprising senior and junior nurses, pharmacy staff, doctors, and hospital IT 
mangers with and without system experience perceived enhanced patient safety 
and efficiency as key facilitators to system implementation. They also felt the 
need to have clinical champions and a multidisciplinary implementation team to 
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promote engagement and cognitive participation. Key barriers included 
inadequate training and organisational support, and the need for ease and 
confidence in system use to achieve collective action. Integrating new ways of 
working was perceived as challenging, mainly due to difficulties in understanding 
the complexity of implementing electronic systems at both an individual level, 
such as education, training, and defined roles, and an organisational level, such 
as allocation of resources and ongoing support. 
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Chapter 5:  Interviews with national key stakeholders and eHealth leads 
 
5.1 Introduction 
Chapter 5 consists of further in-depth qualitative interviews with national key 
stakeholders and eHealth leads on their perceptions towards system 
implementation and complements the systematic review and local key 
stakeholder’s qualitative research findings. It provides depth and novel insight 
into issues involved in system implementation from a national strategic 
viewpoint. Underpinned by NPT, a description of the objective, method, results, 
and interpretation of findings is presented. 
 
5.1.1 Phase three objective 
 To explore the perceptions of national key stakeholders and eHealth leads 
towards the facilitators and barriers to implementing ePrescribing, robotic 
pharmacy systems, and automated medication storage and retrieval 
systems in public hospitals in Ireland using NPT as a theoretical framework.  
 
5.2 Method 
Method and the accompanying rationale for use described in detail in Chapter 4 
were similar to those employed in Chapter 5. To avoid repetition, only 
modifications of the method utilised for this phase are detailed in the following 
sections. 
  
5.2.1 Research design 
Conducting multiple individual face-to-face semi-structured interviews with 
national key stakeholders and eHealth leads using NPT as a theoretical 
framework provides rich original data owing to participants’ knowledge, 
experience, and vision for future adoption and adds to the evidence base from 
phase one and phase two research findings. NPT underpinned the research 
planning, data generation, and data analysis. 
 
5.2.2 Setting 
Interviews were conducted with national key stakeholders and eHealth leads 
involved in medicines management in a convenient location for participants 
throughout the country. 
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5.2.3 Research governance 
No national ethics committee for healthcare exists in Ireland. This research was 
conducted in accordance with the ethics and research governance policies of RGU 
(339) and the Royal College of Physicians in Ireland (RCPI). The research team 
agreed that the RCPI was a suitable forum to gain approval as it is broad in 
scope and ensures research is conducted according to best ethical practice (374). 
The project was approved initially by the ethical review panel of the School of 
Pharmacy and Life Sciences, RGU, and thereafter from the Research Ethics 
Committee in the RCPI (Appendix 5.1) which involved submission of: 
 
 A detailed research ethics application form with a signed declaration 
 A letter of invitation; participant information sheet; interview consent and 
copyright clearance form for participant and researcher; reply slip; letter of 
invitation reminder; and interview confirmation letter (similar to Appendices 
4.3-4.9) 
 A current CV 
 An ethical approval letter from the School of Pharmacy and Life Sciences at 
RGU (Appendix 4.11) 
 
5.2.4 Participant inclusion and exclusion criteria 
Individuals involved in the advancement of electronic systems for medicines 
management from a strategic or operational high-level were included in the 
sample. Hospital-based head of department leads in medicine and pharmacy with 
a special interest in system implementation were also included. Specialists 
working outside of this area of interest were excluded. 
 
5.2.5 Participant sample  
Purposive sampling was employed in order to identify a range of relevant 
heterogeneous key stakeholders for participation. Invited to participate were 
national key stakeholders and eHealth leads from hospital, government, 
regulatory, and academic settings. Most participants were professionally known 
to the primary researcher from attendance at various special interest meetings 
and conferences and were believed to be the most knowledgeable in the subject 
area of interest irrespective of professional background. The remaining six 
participants were identified through recommendations from government and 
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regulatory leads via verbal contact once they had agreed to participate. The 
research team was confident the risk of sampling bias was minimised as it was 
anticipated the type of invitees requested to participant would express many 
positive and negative perceptions of adoption and a clear vision for future 
implementation. 
 
5.2.6 Sample size 
A sample of 19 invitees comprising eight hospital-based leads, seven government 
leads, two regulatory leads, and two academics were invited to participate. The 
sample was expected to capture a broad variety of perceptions towards system 
implementation from the heterogeneous participants and assist the research 
team in identifying common and diverse themes and reaching data saturation.  
 
5.2.7 Invitation 
Project information was posted to national key stakeholders and eHealth leads 
work addresses. Participants were requested to mail the reply slip either 
accepting or rejecting participation, with the most convenient date, time, and 
location for taking part in the interviews along with the consent/copyright 
clearance form if they were willing to participate. Reminders were sent to non-
respondents two weeks after mailing the first invitation. A confirmation mail was 
then sent to participants who agreed to take part. 
 
5.2.8 Development of interview schedule 
An introductory general question around the participants’ role was sought 
followed by more focused semi-structured questions which endeavoured to 
explore participants’ perceptions on the topic. The schedule was developed 
specific to the four constructs of NPT as previously described: coherence (what is 
the work?), cognitive participation (who does the work?), collective action (how 
does the work get done?), and reflexive participation (how is the work 
understood?). Particular attention was paid to Creswell’s key recommendations in 
developing the qualitative research questions (Table 4.3). 
 
The initial interview schedule was developed by the primary researcher and 
reviewed several times for rigour and trustworthiness of content by all four other 
members of the research team [SC, AT, DS, and AS] who are experienced in 
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research using qualitative methods, as provided in Appendix 5.2. The schedule 
was then reviewed and refined further by the research team followed by the 
same five expert reviewers described in Chapter 4 (Appendix 5.3-5.4). 
 
5.2.9 Pilot interviews 
Individual face-to-face semi-structured pilot interviews of approximately 40 
minutes were conducted with two professionals with an interest in eHealth 
management. Individuals were identified and recruited by the primary researcher 
who was familiar with participants.  Minor amendments were made to the 
interview schedule and the pilot interviewees were excluded from data analysis 
as the research team felt these participants were not as well-informed as the 
participants purposely selected for interview and therefore may not contribute 
significantly to data analysis.  
 
5.2.10 Data generation  
Interviews were conducted between February and March 2016 post signed 
informed consent and copyright clearance. Participants were again provided with 
a background of the qualitative research and why they had been selected for 
interview. Interviewees were informed they could withdraw from the study at 
any time without giving a reason and that the audio recorder could be turned off 
at any time at their request. They were then asked to complete a short 
background questionnaire similar to Chapter 4 (Appendix 4.19). Interviews were 
guided by an interview schedule underpinned by NPT which was developed 
iteratively as the interviews progressed. At the end of each interview, 
participants were provided the opportunity to contribute any additional 
information deemed relevant not previously discussed and to review their own 
transcript for accuracy. All generated data were coded, anonymised, and 
securely stored. Any records relating to the research will be destroyed after full 
dissemination of the research findings. 
 
5.2.11 Data management and analysis 
Digital audio recordings of each interview were listened to several times and 
transcribed verbatim shortly after each interview by the primary researcher to 
allow further refining of the interview schedule as required. Audio recordings and 
transcribed data were coded for anonymity and verified for accuracy by two 
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other members of the research team [SC and AS] via allocating each member 
three transcripts each for review against the recordings.  
 
Framework analysis was adopted to facilitate a neat set of a priori codes. 
Independent analysis was conducted by the primary researcher and three other 
members of the research team [SC, DS, and AS] to confirm the trustworthiness 
of emerging themes. No significant discrepancies were identified. Agreed codes 
were then created by the primary researcher for each NPT component facilitated 
by NVivo 11© qualitative data management software.  
 
5.2.12 Promoting research quality  
The quality employed in this phase of the research is similar to the detailed 
description provided in Chapter 4. Differences include triangulation of data 
sources from an array of national key stakeholders and eHealth leads within 
hospital, government, regulatory, and academic backgrounds.  
 
5.3 Findings from the qualitative interviews: general analysis 
5.3.1 Participant demographics 
Nineteen hospital, government, regulatory, and academic key stakeholders and 
eHealth leads were invited to participant in individual face-to-face semi-
structured interviews. Three government professionals (one OCIO and two head 
of national acute public hospital services) did not respond to interview requests 
despite numerous attempts of contact (Figure 5.1).  
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Figure 5.1:  Participant sample 
 
After completing transcriptions of the audio recordings, data saturation was 
deemed to have occurred by the primary researcher and three members of the 
research team [SC, DS, and AS] in terms of thematic ranges and hence further 
recruitment was not undertaken as illustrated in Figure 5.2. The variety of 
included participants’ professional characteristics represented a wide range of 
views and perceptions.  
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Figure 5.2:  Steps towards confirmation of data saturation 
 
All participants who accepted to be interviewed completed the background 
questionnaire with results summarised in Table 5.1. The median years of 
professional work experience was 21-25 years and the majority of participants 
had practiced outside of Ireland and had system experience. 
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Table 5.1:  Participant characteristics 
Characteristics                                                    n   
 
 
Sex 
     Female                                                           
     Male                                                               
 
6 
10 
 
 
 
Healthcare professionals 
     Hospital-based leads 
     Government (HSE) leads 
     Regulatory 
     Academia 
    
 
8 
4 
2 
2 
 
Years of experience in profession 
     1-5 years 
     11-15 years 
     16-20 years 
     21-25 years 
     26-30 years 
     31-35 years 
     >35 years 
 
 
1 
2 
3 
3 
2 
4 
1 
 
 
Practised in countries outside Ireland 
     
Countries 
10 
 
United Kingdom 
USA 
Saudi Arabia 
Russia 
New Zealand 
 
 
Experience of using/implementing 
ePrescribing 
 
12  
Experience of using/implementing a robotic 
pharmacy system 
 
3  
Experience of using/implementing an 
automated medication storage and retrieval 
system  
 
3  
 
Table 5.2 provides more detailed demographic data and codes for the 16 
participants who agreed to be interviewed. However, to protect anonymity, 
demographic data is minimal. Hospital-based key stakeholders comprised five 
chief pharmacists leading on ICT at a local, national, and international level; a 
medical and IT trained consultant with a special interest in change in complex IT 
systems, clinical leadership, and process improvement; an IT specialist 
pharmacist (limited hospital-based IT specialist pharmacists employed in 
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Ireland); and an IT national lead. Government leads included two national 
medication safety leads and two healthcare IT experts in the OCIO.  
 
Table 5.2:  Demographic data and codes for interviewees  
Profession Sex Years 
experience 
Experience 
abroad 
Experience with 
system 
implementation 
Hospital-based  
leads 
 
Chief pharmacist 1 
 
 
 
 
Chief pharmacist 2 
Chief pharmacist 3 
Chief pharmacist 4 
Chief pharmacist 5 
 
 
Medical and IT 
consultant 
 
 
 
IT specialist 
pharmacist 
IT national lead 
 
 
 
Male 
 
 
 
 
Male 
Male 
Male 
Female 
 
 
Male 
 
 
 
 
Female 
 
Male 
 
 
 
26-30 years 
 
 
 
 
31-35 years 
11-15 years 
21-25 years 
26-30 years 
 
 
21-25 years 
 
 
 
 
1-5 years 
 
31-35 years 
 
 
 
No 
 
 
 
 
No 
No 
Yes 
Yes 
 
 
Yes 
 
 
 
 
No 
 
Yes 
 
 
 
 
ePrescribing, 
pharmacy robotics, 
and automated 
storage & retrieval 
system 
No 
No 
ePrescribing 
Pharmacy robotics and 
automated storage & 
retrieval systems 
ePrescribing, 
pharmacy robotics, 
and automated 
storage & retrieval 
systems 
ePrescribing 
 
ePrescribing 
Government leads 
 
Medication safety 
lead 1 
Medication safety 
lead 2 
OCIO 1 
OCIO 2 
 
 
Female 
 
Male 
 
Male 
Male 
 
 
16-20 years 
 
31-35 years 
 
31-35 years 
21-25 years 
 
 
Yes 
 
Yes 
 
No 
Yes 
 
 
ePrescribing 
 
ePrescribing 
 
No 
ePrescribing 
 
Regulatory leads 
 
Regulatory 1 
Regulatory 2 
 
 
Male 
Female 
 
 
11-15 years 
16-20 years 
 
 
Yes 
Yes 
 
 
No 
No 
 
Academic leads 
 
Academic 1 
Academic 2 
 
 
Female 
Female 
  
 
16-20 years 
>35 years 
 
 
No 
Yes 
 
 
ePrescribing 
ePrescribing 
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5.3.2 Interview and transcription length  
Interviews varied in length of time from 35 minutes to 77 minutes and the 
median time was 55 minutes. Transcriptions differed in length from 5528 words 
to 13700 words and the approximate time to complete was three months.  
 
5.4 Findings from the qualitative interviews: thematic analysis  
Five key themes emerged in this qualitative phase from data analysis, as 
summarised in Table 5.3. 
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Table 5.3:  Summary of key facilitator and barrier themes related to NPT constructs and components 
Themes NPT constructs and 
components (141) 
 
Facilitators Barriers 
Theme 1:  
Safety and efficiency of 
systems 
Coherence:  
Differentiation  
Internalisation 
Enhanced patient safety  
Enhanced efficiency 
Ease of use of system 
Enhanced accountability 
Interoperability/standardisation 
Financial gains 
 
Complex with potential to introduce new 
errors and reduce contact with patients 
Slow down workflow  
Legislation 
Cyber security 
Data protection 
Standardisation and integration of systems  
 
Theme 2:  
Understanding of need 
for system 
implementation 
 
 
Coherence:  
Communal specification  
Individual specification  
 
Enhanced multidisciplinary 
collaboration 
Building block initiatives 
Finance and autonomy for local 
implementation 
Lack of understanding of system 
implementation 
Lack of skills to use technology 
Theme 3:  
Leadership within an 
organisation 
Cognitive participation: 
Enrolment  
Activation 
Initiation  
Legitimation  
 
Effective leadership and drive 
Site champions 
Robust iterative process 
Lack of leadership and clear vision 
Theme 4:  
Need for system support 
 
 
Collective action:   
Skill set workability  
 
Contextual integration  
Adequate training 
Local initiatives 
Realisation of building blocks 
Attaining quick wins  
National drug database 
Contingency plans 
 
Inadequate support 
Lack of emphasise on training  
Implementation plans short on detail 
Poor expertise nationally 
Financial constraints 
Theme 5:  
Adequate system 
evaluation 
 
 
Reflexive monitoring: 
Systematization  
Ongoing evaluations e.g. 
prescribing analytics  
  
Auditing with feedback not embedded into 
system 
Testing at scale challenging 
Reconfiguration of work processes 
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Key themes are now described in more detail with associated subthemes on 
facilitators and barriers towards system implementation which emerged from data 
analysis using NPT as a theoretical framework. 
 
Theme 1: Safety and efficiency of systems 
Participants felt the current system in healthcare is in crisis and fraught with risk, 
quality, and efficiency issues mainly due to silo work processes which are largely 
paper-based. The predominant pharmacy system in hospitals in the public sector 
was thought to be poor regarding reporting intelligence with limited baseline or 
quantitative measurement facilities to track data on system performance. Lack of 
oversight or ability to analyse prescribing practices throughout the hospital 
setting inclusive of outpatients was also highlighted as an issue. Participants felt 
suboptimal finance was invested into healthcare IT resulting in no current benefit 
from ICT.  
 
Subtheme 1: Enhanced patient safety and workflow efficiency linked to electronic 
systems 
The consensus was to lean towards more technically enabled healthcare systems 
with an ultimate aim to improve patient safety and workflow efficiencies. 
Participants felt system implementation aligned with the eHealth Strategy which 
promotes optimising the availability of information at the point of clinical need, 
capturing information to the benefit of patient care and safety, and enabling 
integration of work processes and coordination of care in a way that ensures data 
protection. A perception that system implementation would complement the 
workforce to deploy healthcare professionals to clinical cognitive tasks and better 
use of their skill sets was also evident. 
 
“It will improve patient care and reduce inefficiencies of the system of 
walking around looking for pieces of paper, problems with the ambiguity 
around communication and handover”. (Chief pharmacist 3) 
 
“We want a uniform reporting system that allows us to do a better 
assessment on data analysis and expenditure”. (Medication safety lead 2) 
 
Core functionalities perceived to facilitate successful implementation included 
systems should be easy to use, intuitive, durable, modifiable, and alerts 
executed and managed appropriately to support good clinical care and reduce 
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the risks of adverse events. Visual graphical feedback as to when prescriptions 
are ordered and processed was viewed as an additional bonus. 
 
“It needs to be simple for the user to interact with, if you have to go 
through 10 screens to get to something, people get lost in it and it is prone 
to error”. (Chief pharmacist 5) 
 
“They need to be good and safe and match the workflow that you need. 
Understanding the complexity of the alerts issues should be considered with 
a lot of real consistent effort to try and keep them useful”. (Medication 
safety lead 1) 
 
Timely access by designated people to the required information with the 
appropriate security was another key facilitator to maximise patient care. 
Governance and accountability were also perceived to be enhanced. 
 
“These systems create more accountability. You don’t have to give lectures, 
you show staff they are out of line and they will behave differently just by 
default and that is powerful in itself.” (Chief pharmacist 1) 
 
Financial gains and a return on reputation of how the health service was viewed 
by the public were other perceived benefits to system implementation.  
 
“We spend about €2.14 billion on medicines in this country, 16% of total 
healthcare expenditure, of which €1.84 is in the community. An upfront cost 
in terms of millions would critically allow us to intervene in areas where we 
could improve cost effectiveness of prescribing and invest it back into the 
service”. (Medication safety lead 2) 
 
“An eHealth solution in Ireland can improve the reputation of the health 
system so whilst we talk about return on investment, there is also a return 
on reputation if we can have a digital healthcare system that makes it more 
efficient and safer then maybe we can improve how the health system is 
seen by the public”. (OCIO 1) 
 
Subtheme 2: Interoperability and standardisation of practices 
Interoperability and standardising practices were viewed as central tenets of risk 
reduction strategies in terms of medication safety. Streamlining ePrescribing 
processes using standardised communication pathways within secondary care 
and between primary and secondary care settings was thought to be useful in 
resolving much of the interface discrepancies and medication reconciliation 
issues on admission to hospital and in reducing medication wastage. A closed 
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loop medicines management system incorporated into an EHR with bar coding 
from the time of receipt of medication to drug administration was a future 
aspiration and believed to standardise the medicines management process. 
Easily customisable open technology was also perceived to be of great benefit in 
order to tailor technology to local needs. 
 
“You have got multiple different systems and so you must use technical 
standards for exchanging information. You can’t have everybody involved in 
making the decisions and yet if you want to get things working seamlessly 
nationally then you have to standardise some things”. (Academic 2) 
 
“Open technology as an approach would allow you to take this catalogue or 
framework and customise it”. (Medical and IT consultant) 
 
Subtheme 3: Potential reduction in patient safety and workflow issues 
Perceived barriers to system implementation included developing a system with 
complex and multiple functionalities which may distract from the fundamental 
aim of patient safety and efficiency and introduce new errors and loss of contact 
between patients and clinical staff. 
 
“One concern I would have is that you end up with a massive message 
centre with hundreds of messages and tasks for that individual clinician and 
that people get buried by it, so systems that flag the important issues and 
that basically allow people to only see what is most relevant so that we are 
not heading into the territory of alert fatigue”.  (Chief pharmacist 3) 
 
“These systems may reduce contact with the patient by spending more time 
with a computer screen”. (Academic 1) 
 
Participants felt systems were going to slow down workflow considerably during 
the initial period of implementation. 
 
“In the short run it is going to slow down working practices big time. There 
will be restriction of services, cancellation of elective procedures, resourcing 
issues to get us over the initial shock”. (Chief pharmacist 3) 
 
“So whilst it needs to be secure, the risk is you turn everybody off because 
it is a pain to actually remember your password that you have to change 
every 30 days.” (OCIO 1) 
 
Standardisation and integration of systems were perceived to be difficult as well 
as managing the transition from manual to electronic. Participants felt it was 
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important that systems were not implemented in isolation as standalone projects 
without consideration to how they fit into the overall workflow.  
 
“The challenge in all of these projects is how to get national or international 
standardisation, drug catalogues and local customisation right, because 
everybody works slightly differently”. (Medical and IT consultant) 
 
“Even within the HSE run hospitals, standardising things is difficult never 
mind taking into account the voluntaries and when you bring trusts along”. 
(Academic 2) 
 
Other perceived barriers to implementation included legislation, cyber security, 
and data protection in terms of who should have access to patient information 
and types of consent. 
 
“In Ireland you still require an ink signature and date for a prescription so a 
digital signature at this point isn’t acceptable.  So if you want to do away 
with the paper, you’ve got to change the law...there is a general consensus 
that we need to get a bit cleverer with cyber security and accept that at 
some point something will go wrong so how do we recover if something 
does go wrong”. (OCIO 1) 
 
“What happens if someone wants to opt out of consent so some of the 
information coming from the Data Protection Commissioner relates to not 
offering people the opt out clause. Also if somebody does consent to their 
information going into the system in this hospital, do they consent to their 
information flowing to other hospitals? There would be research with 
missing information from population based registries if they are only based 
on people who consent introducing bias so there is a definite need for 
legislation”. (Chief pharmacist 3) 
 
Theme 2: Understanding of need for system implementation  
Participants had mixed views on whether there was a shared sense of purpose 
for system implementation.  
 
Subtheme 1: Multidisciplinary collaboration and support 
The importance of true multidisciplinary collaboration between professionals was 
expressed as a key facilitator. 
 
“You see a multidisciplinary bunch of professionals and everyone is pulling 
in the same direction. There are a huge number of health professionals, IT 
professionals, hospital administrators across the public hospitals who are 
there to improve patient outcomes and I have seen tremendous levels of 
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engagement and consensus reached where I thought there never would be 
consensus cause everyone is there to improve outcomes for the patient”. 
(Chief pharmacist 3) 
 
Participants felt a shared sense of purpose was improving with HIQA stepping 
into the medicines management space, the appointment of the CIO to the HSE, 
and the creation of the national eHealth Strategy, eHealth Ireland, and the 
ePharmacy agenda. The challenge was to make it a current priority.  
 
“Two years ago I would have said there was no shared understanding 
having struggled to get investment for medicines management for many 
years, both via the HSE and locally through our hospital.  With the advent of 
the chief information officer into the HSE and the identification of 
ePharmacy as a key strategy, I think that that is now more realistic”. (Chief 
pharmacist 4) 
 
“We have traditionally lacked a strategic approach to medication in Ireland. 
The CIO is maybe creating more of a shared sense of purpose than there 
was before.  Also HIQA have done reports so those things give you some 
sense of shared purpose. I am not 100% sure every hospital accepts that, 
because we are all still competitive, whoever is the biggest hospital wants 
to be first with everything”. (Chief pharmacist 1) 
 
Subtheme 2: Mixed motivations and maturity with system implementation 
Other participants did not believe there was a strong sense of alignment with 
little understanding of the issues involved in system implementation. Mixed 
motivations and maturity and a widespread variation on the extent to which 
people are comfortable with technology was echoed as well as a lack of 
investment in local technology. 
 
“The hard task of implementation is not well understood here and there is a 
lot of learning to be done.” (Medical and IT consultant) 
 
“The gap is that hospital pharmacy hasn’t been recognised as an area where 
there is a need for a solution fairly quickly and therefore it hasn’t been 
resourced, it has just been stonewalled...there should be a commitment to 
try and form local technology hotspots for health, it would inform how we 
are going to do this nationally that is cost effective, that delivers big savings 
in terms of safety and time, so that hasn’t been done, it is not something 
they are aware of let alone consider important”. (Chief pharmacist 5) 
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Theme 3: Leadership within an organisation 
Signs of leadership and a future vision were evident from some key stakeholders. 
 
“There is a big push in the whole of Europe around ePharmacy and 
ePrescribing that I and other eHealth leads are taking part in...we have an 
ambition to have a full ePharmacy solution across the whole of Ireland by 
2020 but it is based a lot on business cases and approval around that 
space...the Department of Health has bought in to this, the medicines office 
has bought in to this, we are working with the Director General’s team, you 
know leadership of the HSE describes eHealth as being part of 
transformation. The secretary general last week stood on stage saying 
without a digital health solution the health system of Ireland can’t transform 
and therefore can’t actually support the people of Ireland, and in less than 
five years this thing becomes unaffordable without digital solutions”. (OCIO 
1) 
 
“There is a huge drive among people who work in this area to implement 
electronic systems, people are starting to see more of the value of these 
systems and the need to invest in them”. (IT pharmacist) 
 
Methods of implementing systems successfully included having the right 
leadership with a clear vision and desire as well as good project management 
abilities. A robust, iterative, and well structured process in place and treating 
implementation as a clinically led exchange project rather than solely as a 
technology task were thought necessary for the required outcome. The new 
public hospital group structure was another perceived opportunity to facilitate 
such developments.  
 
“Coming up with an agreed approach and understanding of what is required 
in order to make a business case and procure it. You need to link between 
procurement and eHealth and clinical sides and HR to say well it is not just 
an IT project. You also need pharmacists and a plan of how you are going to 
support them”. (Medication safety lead 1) 
  
“You need to identify your champions at site level, it cannot be an IT driven 
project, it will fail if it is an IT driven project, it has to be a business driven 
project”. (Regulatory 1) 
 
Subtheme 1: Lack of national leadership and a clear vision 
Some participants felt there was very little vision from a national strategic 
viewpoint and lack of understanding of the complexity and governance around 
implementation ultimately leading to a feeling of inadequate leadership and a 
lack of willingness to drive system adoption.  
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“You cannot do something about an issue unless you understand the issue 
properly. This comes back to national leadership, to understanding, I am 
not so sure that we have the leadership infrastructure there to harness the 
benefits of this approach”. (Medication safety lead 2) 
 
“We have had the engineers from the HSE out on numerous occasions to 
look at the same thing on behalf of a number of different hospitals but it is 
the same people. So there is that kind of replication, duplication, which I 
guess isn’t a great value add nationally. It would be a good idea if this was 
looked at in a systematic way by somebody or some group of people”. 
(Chief pharmacist 2) 
 
Lack of strong political leadership and having the confidence to make decisions 
were other perceived rate limiting steps in system implementation. 
 
“Healthcare is so politicised, you need to get that determination and the 
insistence on fighting for the budget”. (Academic 2) 
 
“I think we are very poor at making decisions and ourselves accountable 
particularly in this system. People are going to have to make decisions that 
may seem unpopular initially so it is about managing that”. (Chief 
pharmacist 5) 
 
“Reference pricing, which has turned out to be the largest impact we have 
had on prices of medicines in this country, was implemented in 2013, we 
first proposed it in 2003. It gives you some idea of the time frame for 
change, it can be long, laborious and frustrating and this comes down to 
people, either unwilling or probably unable to actually make a decision”. 
(Medication safety lead 2) 
 
Some individual hospitals had moved the eHealth agenda forward on their own 
initiative as the consensus was if people waited for a national system it may 
never happen or delay funding for local innovations.  
 
“The risk here is that if you get a message saying that there is a national 
EHR coming, people will wait. But what is needed is to stimulate local 
innovation with funding”. (Medical and IT consultant) 
 
“There is going to be no national ePrescribing initiative. So I guess having 
put ePrescribing in our hospital may have forced other people to follow as 
against sitting waiting for it to happen nationally when it may never 
happen. We have been doing our own thing for a long time.” (Chief 
pharmacist 2) 
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Theme 4: Need for system support 
A view that implementation is dependent on national guidance and support at the 
highest level was evident. Adequate training with regard to the use of electronic 
systems by means of engagement was viewed as key to successful 
implementation.  
 
“Support and engagement in terms of training and competency assessment 
for the use of the electronic systems is absolutely key”. (Academic 1) 
 
An agreed approach and developing local initiatives via local multidisciplinary 
teams with autonomy and adequate finance were other perceived advantages. 
Gated funding to ensure goals were achieved and for securing finance was 
another mechanism of gaining financial support. A transformation programme 
with the addition of staff to assist with implementation was emerging.  
 
“Funding needs to be put in place locally with local initiatives instead of 
waiting for national funding that may never come with its many layers”. 
(Chief pharmacist 2) 
 
“There are 288 staff members that are working along different parts of 
implementation so there is a big programme of trying to get the whole thing 
to come together. So we have a national service management team and a 
national project team that now look after things across the whole of 
Ireland”. (OCIO 1) 
 
Subtheme 1: Realisation of national key building blocks 
Realisation of key building blocks for supporting the safe and secure electronic 
transfer of information between prescribers and dispensers facilitated by the 
Knowledge and Information Strategy and the eHealth Strategy within eHealth 
Ireland was believed to be central to successful system implementation. Some of 
the enablers included IHIs, HIQA standards and specifications for exchanging 
information, a single drug file, and data protection legislation. Attaining quick 
wins and benefits at the initial stages and then progressively building upon that 
solid foundation in the future was viewed as a method to normalise system 
implementation. A good starting point was to review hospitals that have an 
appetite and track record in relation to implementing ICT and to learn from their 
successes.  
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“I think the HIQA standard around electronic transmission of prescriptions, 
we see other building blocks in terms of national decisions being made with 
regard to minimum data sets, looking at discharge communications, 
consideration of the national medicinal product catalogue and a drug 
dictionary, messaging standards to facilitate interoperability. These things 
are iterative and in time seeing the iterative realisation of what they can do 
and then building on the strengths of that and learning”. (Academic 1) 
 
Support for development of a national drug database for prescribing, dispensing, 
and administering medicines that can be interpreted in a standardised format 
and provides a benchmark for auditing and quality in all hospitals was perceived 
as another key enabler for successful implementation. This would allow the HSE 
to use business intelligence to analyse and understand the differences between 
public hospitals and manage drug budgets.  Participants believed the recently 
published standards and policy documents were not detailed enough to allow 
sufficient disaggregation of the product description for robust and flexible 
reporting and that an additional level of complexity should be considered to 
ensure a clear link between the prescribed drug and the dispensed and 
administered product.  
 
“The ICT strategies and polices coming out now are short on 
implementation detail. What we need is to get the pharmacy system right, 
get the drug file right, and you can link in your prescribing database into 
the product file and also tag on individualised clinical decision support. Then 
to make the jump to prescribing and administration is actually quite simple 
because in terms of prescribing you are linking the drug to the product and 
creating personalised prescribing lists for doctors. So really the pharmacy 
system is the building block”. (Chief pharmacist 4) 
 
“We would be hoping to put together a national drug file and work with the 
national falsified drug directive group who are putting together a database 
with barcodes”. (OCIO 2) 
 
Ongoing responsibility for acting and moving the agenda forward and anticipating 
practice changes and supporting workflow in stages was perceived as significant 
for successful system implementation.  
 
“The main players are the department who can set the policy, HIQA set the 
standards and it is up to the HSE to implement. You now also have eHealth 
Ireland and its programmes”. (Regulatory 1) 
 
“All systems will end up going through a peer review evaluation process. 
There will be a business case built up which will be checked by the eHealth 
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council before procurement in keeping with international best practice. 
There is robust structures in place”. (OCIO 2) 
 
Disaster recovery with an electronic document management and replications 
approach operated in a protocol driven environment was also viewed as 
important. Contingency plans for ongoing resolution of issues were equally 
viewed as significant.   
 
“You need to have contingency plans for downtime from the start because 
you are going to have to use paper in that time and how do you manage 
the patients to continue providing them with care if their electronic record is 
down”. (IT pharmacist) 
 
Subtheme 2: Lack of support by the HSE  
Medicines management systems were not perceived to be supported by the HSE. 
Lack of an emphasis on training staff on the procedures and use of IT systems 
was viewed as a challenge by participants. This was accentuated by both the 
complication of turnover of junior doctors every six months using different 
systems with different protocols and deciding which staff members to train if a 
phased approach was the preferred option.  
 
“There is going to be industrial relations issues, there are going to be 
resourcing issues, how do you train all of the staff in a hospital on a system 
without breaking a hospital? How do you free people up for training? How is 
that going to happen along with regular patient care?  The unions, so 
engagement, high-level with the main unions that represent staff in the 
health services”. (Chief pharmacist 3) 
 
Participants felt mechanisms of how to implement these systems were short on 
detail and that there was no opportunity to engage with system implementation 
from a national viewpoint. There was a sense of lack of expertise in relation to 
developing and implementing electronic systems for medicines management 
throughout the country. 
 
“The reason we have an eHealth strategy and are introducing identifiers is 
because Troika looked at healthcare, it wasn’t because the Department of 
Health was convinced that we desperately needed this. What we suffer from 
is implementation deficit disorder, so we have strategies to beat the band 
but when it comes to implementing them we are hopeless.”  (Academic 2) 
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“We don’t necessarily have that talent, we probably do if we scour the 
country and put a team together but I still think it is a significant challenge 
but if we use the people that have done this overseas and put a team 
together, I think it is very easily achievable and more along the lines of 
agile programming development”. (Chief pharmacist 5) 
 
Capital investment and financial constraints were viewed as significant barriers to 
system implementation with acknowledgement that Ireland was under resourced 
in comparison to other EU countries and lacked proper provision for long-term 
sustainability. Included were organisational and business engineering costs such 
as HR investment as well as hardware and software costs, licensing costs, and 
extra funding for additional functionalities and vendor fees. Participants believed 
there needed to be a better approach by government to invest in developing, 
testing, implementing, and maintaining systems.  
 
“The HSE has had the budget but because it has been so hard to get stuff 
through the Department of Finance, the HSE haven’t even managed to 
spend their ICT budget for the last four years...this requires a lot of ongoing 
maintenance so you have to make sure you have a permanent project team 
in place that is duly structured within the governance structure of the 
hospital”. (Chief pharmacist 4) 
 
“The biggest barrier has been that hospital pharmacists haven’t really 
figured out the right language to use when making business cases. If we 
can’t find a productivity or a value proposition within the business case then 
it falls on deaf ears...I am still suspicious that perhaps we might be using 
large multinationals to solve the problem at the cost of hundreds of millions 
where in fact if we use local sources and piloted it on a regional level we 
could demonstrate success very quickly for very little cost”. (Chief 
pharmacist 5)  
 
“If you take an IT project, about 25–30% is the hardware and the software 
costs, and 75–80% is the actual organisational cost of getting people 
involved, getting the project team going, doing all the training, the roll out, 
business process engineering”. (Academic 2) 
 
Theme 5: Need for system evaluation 
Ongoing risk assessments, benefits measurement, evaluation, validation, and 
interrogation of data were believed to be powerful mechanisms to establish 
quality improvement. Quantitative measurement such as collecting baseline 
metrics and reassessing post system implementation, and qualitative science 
such as narrative stories from the front line were methods of assessment. 
Participants felt this was an opportunity for universities to get involved in 
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presenting and publishing data on comparative studies, compliance rates, system 
impact, interview findings, and other areas of interest in a systematic manner for 
future learning. The ultimate aim was to capture data on prescribing analytics 
and medication use and demonstrate incremental patient-centered 
improvements over time. 
 
“It is not just a case of how it is performing compared to the way things 
were, it is how it is performing over time. So I think it is a continuous 
process of tracking a few key safety things, a few key flow things, a few key 
productivity things and a few quality things, ultimately it’s how do patients 
feel about the way that medicines are managed in hospitals and using their 
feedback to drive the way that we evaluate the system...in terms of flow, if 
we had real time communication of need we can be more responsive.  We 
could reduce the time delay between prescription and supply so it would 
contribute significantly to better inventory management and waste 
reduction, to quality and productivity, you are not duplicating work.” (Chief 
pharmacist 5) 
 
“The capacity to give consideration to performance use of the system, 
intermittent appraisal with regard to prevalence of errors and causation, 
everything in keeping with a progressive safety culture”. (Academic 1) 
 
“It would allow us at HSE level to have high visibility of prescribing and at a 
local level it would allow an overview of appropriate or inappropriate 
prescribing behaviours.” (Medication safety lead 2) 
 
Some participants felt auditing or communicating feedback to end-users was not 
strong or embedded into the Irish healthcare system. Testing at scale and 
reconfiguration of work processes were also perceived as challenging. 
 
“We have potential to go out and ask for compliance on standards and do 
analysis. It is very difficult because it is getting the right scale, if you test 
10 items but a million are being sent every day, is it specific?” (Regulatory 
1) 
 
“People will find workarounds in an IT system, so trying to get that 
information is the hard thing to try and stop that from happening so 
feedback is very important”. (IT pharmacist) 
 
5.5 Discussion 
Key findings are presented in this section in addition to the methodology 
strengths and weaknesses, and interpretation of findings inclusive of 
comparisons with published literature. 
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5.5.1 Statement of key findings  
The objective of this phase of the research was to explore national key 
stakeholders and eHealth leads’ perceptions towards implementing ePrescribing, 
robotic pharmacy systems, and automated medication storage and retrieval 
systems in hospitals in Ireland. Sixteen individual face-to-face semi-structured 
interviews were conducted with professional leads from hospital, government, 
regulatory, and academic settings in Ireland. Framework analysis and the 
application of NPT enabled systematic identification of key themes and aided 
data analysis and interpretation.  Participant characteristics outlined in Table 5.1 
did not impact on commonality and variability of interview responses which 
mostly centred on national and local eHealth initiatives required for 
implementation accompanied by a strong vision for future adoption, both positive 
and negative.  
 
System implementation is complex requiring interventions at a macro, meso, 
and micro-organisational level. Participants focused on integration of electronic 
systems for prescribing, dispensing, and administering medicines rather than a 
specific focus on individual systems. Perceived facilitators and barriers to 
implementing patient-centric EHRs were also volunteered in relation to overall 
system adoption. Coherence was displayed in the form of key stakeholders 
understanding the limitations of a manual medicines management system and 
the reasons for system implementation such as enhanced patient safety; 
workflow efficiencies; improvements in governance; interoperability and 
standardisation of work processes; and financial gains. Perceived barriers 
towards system implementation included the potential to implement complex 
systems with the introduction of new drug errors; loss of contact between clinical 
professionals and patients; initial time inefficiencies with new workflow practices; 
issues with the complexity of integration and standardisation of work processes; 
the need for legislative change; cyber security concerns; and data protection 
issues.  
 
Participants felt coherence and a shared sense of purpose was improving with 
the development of building block initiatives such as HIQA standards, the 
national eHealth strategy, eHealth Ireland, and the ePharmacy agenda. A 
clinically led iterative process was thought to facilitate cognitive participation and 
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successful system implementation. Whilst some participants felt key individuals 
demonstrated signs of leadership and were willing to collectively drive and enact 
system implementation and set future goals for ePharmacy solutions, 
predominant lack of understanding was perceived to prohibit system adoption 
and result in lack of investment in local technology. A sizable gap between 
advocating system use and policymakers’ perceived vision for widespread 
implementation inhibited cognitive participation. Participants felt system adoption 
was not supported at a high-level with inadequate leadership and decision-
making capabilities and a limited vision of the need for implementation or of the 
requirements for implementation.  
 
Work aimed at actively promoting, enacting, and maintaining systems included a 
requirement for investment in resources and having a multidisciplinary team 
approach with ongoing staff support, contingency support, and policy support. 
Disaster recovery and contingency plans for ongoing resolution of issues were 
also viewed as significant.  Change through local delivery teams supported by 
national resources facilitating local ownership of the implementation process was 
an additional perceived facilitator. Perceived challenges impeding on cognitive 
participation and collective action included little opportunity to engage with 
system implementation, lack of an emphasis on training staff on system use, and 
a sense of lack of expertise in relation to system development and 
implementation. Further details on requirements for implementation were 
needed.  
 
Reflexive monitoring was evident with a clear understanding of ways of 
appraising systems in order to assess their benefits and drawbacks and reflect on 
work practices. Automation of data capture for the purpose of records, research, 
auditing, and benchmarking was thought to facilitate business intelligence and 
enhance data analysis, improve prescribing practices, and assist with querying 
data and providing quick turnaround times of service provision and supply of 
medication in real time with prescribing. These processes were enhanced by 
investment in appraisal in the Irish healthcare system. 
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5.5.2 Consideration of strengths and limitations 
Numerous strengths and weaknesses detailed in Chapter 4 are comparable to 
this chapter as a similar methodology was applied. Triangulation of data sources 
involved a variety of national key stakeholders and eHealth leads from diverse 
backgrounds of hospital, government, regulatory, and academic settings. 
Findings from the systematic review and qualitative phase with local key 
stakeholders were compared with those from this qualitative phase thereby 
facilitating further triangulation of results. It is evident from the work completed 
to date that this area is under-researched and that findings will contribute to 
original knowledge. It is intended that this exploration will provide a unique 
insight into the various facilitators and barriers towards implementation of 
ePrescribing, robotic pharmacy systems, and automated medication storage and 
retrieval systems in hospitals in Ireland and make a significant contribution to 
the research subject. 
 
5.5.3 Interpretation of findings 
Reducing medication errors necessitates restructuring medicines management 
systems and streamlining patient care. Findings derived from the systematic 
review presented in Chapter 3 and qualitative interviews with local key 
stakeholders in Chapter 4 were similar to findings from this phase of the 
research and highlight comparable issues (337). A number of recurrent themes 
related to technical issues with implementation, inclusive of interoperability and 
integration of systems. Participants felt realising system benefits and mitigating 
safety risks were highly dependent on effective integration of systems to 
facilitate information exchange. 
 
National key stakeholders and eHealth leads focused more on interoperability 
and standardisation, building block initiatives, finance, and autonomy for local 
implementation using a robust agile iterative process. Issues of legislation, cyber 
security, and data protection were also emphasised as well as limited 
understanding at a high-level resulting in inadequate leadership and lack of a 
vision and willingness to drive implementation or make decisions. 
 
The importance of adequate infrastructure and resources and organisational 
readiness were also highlighted in systematic reviews on factors that promote 
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and inhibit the implementation of eHealth systems (138)(141). Limited attention 
was given to work directed at making sense of eHealth systems, methods of 
engaging with professionals, and ensuring potential benefits of implementation 
were apparent (141).  
 
In addition to research studies outlined in Chapter 4, Cresswell et al recently 
conducted round-table discussions with 21 participants from international 
multidisciplinary backgrounds including policymakers, healthcare organisation 
officials, and academic researchers (375). The aim was to investigate approaches 
to realising returns on investment from ePrescribing systems in UK hospitals and 
lessons that can be learned for future developments and implementation 
strategies within healthcare settings. Similar to this study, realising financial 
returns from ePrescribing systems was challenging with recommendations that 
future strategies should consider generating and analysing local and national 
data within and across hospitals to measure progress (375). Five key 
recommendations for the strategic deliberations of policymakers prior to 
embarking on the implementation of Hospital Electronic Prescribing and 
Medicines Administration (HEPMA) systems in Scotland were recently provided in 
another study by Cresswell et al in 2017 (376). These included methods of 
ensuring flexibility; optimising systems from the outset; developing and centrally 
sharing expertise; and maximising learning from experience (376).  This was 
echoed in a research based report by KPMG in 2012 on core concepts to support 
eHealth implementation which involved in-depth interviews with 39 eHealth 
leaders, planners, experts, and implementers from 15 countries worldwide (139). 
Similar to findings from Cresswell (376) and this primary research, a high value 
was placed on collaborative alignment and the importance of active participation 
in the development and operation of the system. They found aligning the 
interests and efforts of stakeholders was key to sustainable eHealth adoption.  
 
Evidence from many studies suggests more than half of IT projects fail to meet 
their estimated budget and/or timelines (377). Similar to this study findings, 
appropriate planning, an adequate mix of  IT implementation team members and 
non-IT decision makers and end-users, and appropriate training have been 
recommended to assist in a smooth implementation process (378)(379)(380). 
Another recent qualitative study by Mozaffar et al published in 2017 aimed to 
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understand the roots of unintended safety with the introduction of ePrescribing 
systems in six English hospitals (381). A taxonomy of factors underlying 
unintended safety threats included suboptimal system design and lack of support 
for complex medication administration regimens, lack of effective integration 
between different systems, and lack of effective automated decision support 
tools. Other factors included inappropriate use of systems and over reliance with 
the introduction of workarounds, and suboptimal implementation strategies 
resulting from lack of appropriate training and existence of partial roll outs/dual 
manual and electronic systems. A need for hospitals and suppliers to implement 
short term and long-term strategies to minimise unintended safety risks was 
recommended for successful implementation (381). 
 
Another comparative review of lessons learnt from ePrescribing implementation 
in Denmark, Finland, Sweden, England, and the USA was published by 
Samadbeik et al in 2017 (382). Similar to this study findings, recommendations 
included development of a national prescription database and system 
implementation to be part of the national healthcare infrastructure inclusive of 
government, legal, and financial incentives for better acceptance among relevant 
stakeholders (382). The expansion of standards and terminology to support 
interoperability frameworks and data exchange was also advocated (382).  
 
Given the continuously varying nature, leadership, and priorities of these 
complex systems in the health service provision, a key finding from this primary 
research was the importance of system interoperability and customisation to 
support changing needs and organisational contexts of use. This is comparable to 
a systematic review by Alexander and Staggers in 2009 on the designs of clinical 
technology which included 50 studies emphasising consideration to systems 
ergonomics (383).  
 
5.5.4 Further work 
Future work should explore key stakeholders’ experiences and views post system 
implementation to establish if anticipated benefits have been achieved. This is 
outlined in Chapter 6. 
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5.6 Chapter summary 
Technologies understood at implementation are more likely to normalise and 
have a positive impact on work practices than those not valued. System 
implementation is beginning to gain momentum with the ever increasing 
recognition of the need to enhance patient safety and improve efficiencies in 
healthcare delivery with the establishment of national eHealth initiatives. Careful 
strategic planning to accompany organisational changes with adoption is required 
in addition to ongoing, critical evaluation of progress.  
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Chapter 6:  General discussion  
 
6.1 Introduction   
This chapter provides a brief overview of the aim of the research along with a 
description of the different phases employed highlighting key findings and overall 
strengths and limitations of the programme of research. Interpretation, 
application, and impact of the findings are emphasised with requirements for 
further work in this pivotal area of medicines management. 
 
6.2 Aim, objectives, and key findings 
A reflective approach has been employed throughout this research with 
consideration to the research aim, objectives, systematic review findings, and 
implications for phase two and phase three. The overall process driven aim was 
to explore the facilitators and barriers towards implementation of electronic 
prescribing, dispensing, and administration of medicines in hospitals in Ireland. 
ePrescribing, robotic pharmacy systems, and automated medication storage and 
retrieval systems were the core systems of interest in this research. 
 
Chapter 1 introduces system implementation with a focus on policy documents 
from Ireland and internationally and the need for adoption. The aim and 
objectives are then offered inclusive of its novelty and contribution to original 
knowledge. Chapter 2 provides a critique of available methodologies and 
accompanying methods undertaken in research and justification of the choice of 
a qualitative methodology. A systematic review was conducted in phase one 
followed by a qualitative design in phase two and phase three. An illustration of 
the development of the doctoral research is provided in Figure 6.1, comprising 
international, local, and national explorations.  
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Figure 6.1:  Summary of research phases 
 
6.2.1 Phase one: systematic review 
Objectives 
 Identify and critically appraise the available evidence on healthcare 
professionals’ perceptions, attitudes, and views of the facilitators and 
barriers to implementing ePrescribing, electronic dispensing, and/or 
electronic administration of medicines in the hospital setting.  
 Synthesise and present the available evidence on healthcare professionals’ 
perceptions, attitudes, and views of the facilitators and barriers to 
implementing ePrescribing, electronic dispensing, and/or electronic 
administration of medicines in the hospital setting. 
 
Summary of key findings  
A narrative design was used in this phase of the research with key findings of 
improved patient safety and better access to patients’ drug records with system 
implementation. Team leadership, and hardware/software availability and 
reliability were essential for successful implementation. Key barriers included 
hardware and network problems, altered work practices such as time pressure on 
using the system, remote ordering as a potential risk for errors, and weakened 
interpersonal communication between healthcare professionals and with patients. 
Results from the systematic review identified few qualitative studies have been 
Phase one: systemic review - 
international  exploration 
Phase two: interviews with local key 
stakeholders - local exploration  
Phase three: interviews with national 
key stakeholders and ehealth leads  - 
national exploration 
  
188 
conducted on the topic of interest and findings assisted in developing the 
interview schedules for phase two and phase three of the research. 
 
Since completing this review, a systematic review of the literature on EHRs, 
ePrescribing, and medication errors from 2000-2014 was published by Qureshi et 
al in 2015 (384). Fifty-five of the 184 included studies focused on ePrescribing 
with similar key themes of converging evidence that ePrescribing systems 
supported by CDS resulted in enhanced patient safety, considerable reduction of 
serious medication errors, and increased workflow and cost efficiencies (384). 
Initial implementation challenges included high cost, extensive training needs, a 
variety of new medication errors such as selection errors, and change 
management issues inclusive of resistance to system use (384). A protocol for a 
systematic review of qualitative studies on perceptions and experiences of 
implementing, managing, using, and optimising ePrescribing systems in hospitals 
was also published by Farre et al in 2016 (385). Other related studies published 
since 2013 have been described in the interpretation sections in Chapter 4 and 
Chapter 5. 
 
6.2.2 Phase two: interviews with local key stakeholders 
Objective 
 To explore the perceptions of local key stakeholders towards the facilitators 
and barriers to implementing ePrescribing, robotic pharmacy systems, and 
automated medication storage and retrieval systems in public hospitals in 
Ireland using NPT as a theoretical framework.  
 
Summary of key findings 
Interpretive phenomenology was employed to achieve this objective with key 
themes of enhanced patient safety and efficiency which emerged as core divers 
to system implementation, as well as the need to have clinical champions and a 
multidisciplinary implementation team to promote engagement and cognitive 
participation. Key barriers included inadequate training and organisational 
support, and the need for ease and confidence in system use to achieve 
collective action.  
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6.2.3 Phase three: interviews with national key stakeholders and 
eHealth leads 
Objective 
 To explore the perceptions of national key stakeholders and eHealth leads 
towards the facilitators and barriers to implementing ePrescribing, robotic 
pharmacy systems, and automated medication storage and retrieval 
systems in public hospitals in Ireland using NPT as a theoretical framework.  
 
Summary of key findings 
Interpretative phenomenology was also used to achieve this objective with key 
themes of enhanced patient safety, workflow efficiencies, improvements in 
governance, and financial gains. The realisation of national key building blocks 
such as HIQA standards, the national eHealth strategy, eHealth Ireland, and the 
ePharmacy agenda, as well as a clinically led iterative process was thought to 
facilitate successful system implementation and collective action. Perceived 
barriers towards system implementation included the potential to expedite 
complex systems with the introduction of new drug errors, loss of contact 
between clinical professionals and patients, initial time inefficiencies with new 
workflow practices, issues with the complexity of integration and standardisation 
of work processes, the need for legislative change, cyber security concerns, and 
data protection issues. Participants felt system adoption was not supported at a 
high-level with inadequate leadership and decision-making capabilities and a 
limited vision of the need for implementation or of the requirements for 
implementation which inhibited coherence, cognitive participation, and collective 
action.  
 
6.3  Overall strengths and limitations of programme of research 
6.3.1 Originality 
All research phases are novel and contribute to original knowledge focusing on 
the structures and processes of implementing ePrescribing, robotic pharmacy 
systems, and automated medication storage and retrieval systems. There is a 
paucity of published research in this field internationally, and particularly in 
Ireland where this research was conducted. The systematic review conducted in 
phase one is the first published review on healthcare professionals’ perceptions, 
attitudes, and views of the facilitators and barriers to implementing ePrescribing, 
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electronic dispensing, and electronic administration of medicines in hospitals. No 
published studies have been conducted in Ireland focusing on system 
implementation processes, further contributing to original research for phase two 
and phase three. This work will form the basis for more research and contributes 
to developing system normalisation to support improved patient care and 
healthcare delivery.    
 
6.3.2 Study design  
Strengths include the adoption of a rigorous study design approach to minimise 
design bias and to ensure trustworthiness was evident in the systematic review 
and qualitative research components. The alignment of philosophical belief with 
the research aim and objectives put forward qualitative methodology as the most 
suitable approach.  
 
The systematic review in phase one of this research employed a narrative design 
and all studies included were qualitative in nature. Systematic reviews occupy 
the highest hierarchy in terms of quality of evidence and attempt to cover all 
known literature on the specific topic with explicit details of its design and 
method for future quality assessment. Interpretive phenomenology of individual 
face-to-face semi-structured interviews was selected for phase two and phase 
three of this research to facilitate in-depth rich data capture and analysis so that 
the perceptions of key stakeholders involved in system implementation could be 
fully understood and described within the constructs of NPT. In addition, all 
papers included in the systematic review used individual interviews as a research 
method, suggesting this would be a suitable method for data generation.  
 
NPT provided a valuable theoretical approach to identify facilitators and barriers 
to system implementation in hospitals in Ireland from both a local and national 
perspective. This sociological theory has been promoted widely to understand 
implementation and integration of innovation in healthcare settings and is 
particularly relevant for complex technology requiring a multitude of interactions 
between healthcare professionals, patients, and managers. The four constructs of 
coherence, cognitive participation, collective action, and reflexive monitoring 
were utilised throughout the qualitative phases.  
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Peer and academic scrutiny of the research project continued to be welcomed in 
order to refine the methods employed, develop a greater explanation of the 
research design, and strengthen arguments as necessary.  
 
Limitations included a lack of rigour in some of the included studies in the 
systematic review. The addition of all qualitative studies may also be viewed as 
another drawback.  However, it is increasingly recognised that qualitative studies 
which explore implementation of interventions have a significant role in ensuring 
data are of maximum value to practice (223)(330)(331). Limitations with the 
qualitative phases of this research are provided in the sections that follow. In 
addition, the inherent design of conducting face-to-face interviews was very 
labour intensive.  
 
6.3.3 Trustworthiness 
A wide range of databases were used to search the literature for inclusion in the 
systematic review. Three researchers working independently added to the rigour 
of the literature inclusion and exclusion decisions and strengthened the review 
process in terms of data extraction and quality rating. Structured data extraction 
forms ensured no relevant data were missed.  Development of a quality 
assessment form as per standard guidelines helped to ensure important 
elements around study quality were properly scrutinised. A narrative synthesis of 
findings allowed results to be tabulated and categorised in a comprehensive 
manner. An unambiguous, externally validated protocol documenting the process 
in every aspect of the systematic review allowed any deviations from the set 
procedures to be recorded which increased transparency. Trustworthiness was 
further established by interpretation of data and comparing and contrasting 
findings supported by other researchers.  
 
Frameworks for ensuring the trustworthiness and rigour of the qualitative 
research phases were put forward in the form of Guba’s four constructs: 
credibility; transferability; dependability; and confirmability (255).  
 
All aspects of the research were reviewed by the research team who have vast 
experience in qualitative research. The personal experience and training of the 
primary researcher continued to broaden during this research to consider a more 
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naturalistic human approach to system implementation and to understand 
systems ergonomics and the complexities involved through NPT. 
 
The qualitative method employed was clearly described within the study. 
Included were the research design; details of data generation, analysis, and 
interpretation; and reflective appraisal of the research. This in-depth 
methodological description should allow both studies in phase two and phase 
three to be repeated. The interview schedules were embedded in theory and 
were tested and checked by all members of the research team and five expert 
reviewers. Every transcription was independently reviewed and analysed by 
members of the research team and participants were given the opportunity to 
review and comment on their transcripts. Data analysis was considered from 
within and across different professional groups and settings facilitated by the 
framework approach and NVivo11© software for data management. 
Trustworthiness was enhanced from triangulation of data sources via multiple 
participants from diverse professions and settings, triangulation of data methods 
from combining the systematic review findings with the qualitative phases, and 
investigator triangulation from utilisation of several analysts. An initial concern of 
overlap with some of the NPT constructs and possible miscoding leading to 
analysis not reflective of NPT were alleviated from reviewing findings from the 
qualitative systematic review of studies using NPT to research implementation 
processes by McEvoy et al (344).  
 
A reflective commentary inclusive of progressive subjectivity and monitoring of 
the primary researchers developments via research experience and expanding 
research skills assisted in ensuring trustworthiness and credibility. Examination 
of previous research findings allowed comparisons and contrasts to be made to 
current findings with related rationale provided. A researcher's background and 
position shapes what they choose to investigate, the angle of investigation, the 
methods judged most adequate, the findings considered most appropriate, and 
the framing and communication of conclusions (357). From a personal stance, 
the primary researcher works as an antimicrobial pharmacist in a university 
teaching hospital in Ireland and has minimal bias or preconceived ideas to any 
potential outcomes of the study. Background knowledge into this research was 
gained through undergraduate and postgraduate degrees in pharmacy, clinical 
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pharmacy, psychology, computer science, and IT; review of the literature; and 
previous work in implementing an automated medication storage and retrieval 
system. A pre-organised visit was also conducted in 2015 in Hackensack 
University Medical Center, a 900-bed teaching hospital in New Jersey in the USA, 
to view their award-winning closed loop medicines management system 
comprising ePrescribing systems, robotic pharmacy systems, and ward-based 
automated medication storage and retrieval systems within an integrated EHR.  
 
The primary researcher has some experience in conducting individual face-to-
face semi-structured interviews and undertaking framework qualitative analysis, 
as part of a master’s thesis in clinical pharmacy (135). Formal training in 
qualitative research was also completed, as listed in Appendix 2.1. In addition, 
pilot interviews conducted in both qualitative phases permitted the primary 
researcher to gain more experience in interview techniques. Standard meetings 
via phone and videotelephony to discuss research matters and further direction 
were carried out approximately once weekly with the primary researcher and 
principal supervisor, and with other members of the research team once monthly 
or more if required.  
 
The main limitation was that much effort and time was spent understanding NPT 
constructs and their differences resulting in an initial concern of possible 
repetition of coding or miscoding of constructs leading to analysis not reflective 
of NPT. However, this was overcome by further review of the literature and 
guidance from the qualitative systematic review of studies using NPT to research 
implementation processes by McEvoy et al (344). 
 
6.3.4 Participant inclusion 
A range of relevant heterogeneous local and national key stakeholders were 
included for participation in the qualitative phases of this research using pre-
specified stratification factors in order to provide unique rich data. The main 
stratification factors employed in phase two were: potential key implementers 
and operational end-users working in a hospital before system adoption; key 
implementers and operational end-users working in a hospital after system 
implementation; profession; and grade. This included both senior and junior 
employees from nursing, pharmacy, medicine, and IT.  
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Individuals involved in the advancement of electronic systems for medicines 
management from a strategic or operational high-level were included in the 
sample in phase three of this research. Hospital-based leads in pharmacy and 
medicine with a special interest in system implementation were also included.  
 
6.3.5 Recruitment 
Purposive sampling was employed in order to identify local and national key 
stakeholders for participation who have knowledge of the investigated 
experience. This method of sampling was chosen to achieve maximum variability 
and enhance data quality. Most invitees were known by the primary researcher in 
both qualitative phases. The remaining professionals from multidisciplinary 
backgrounds were identified through recommendations from senior pharmacists 
in phase two and government and regulatory body leads in phase three via 
verbal contact once they had agreed to participate.  
 
A limitation of this approach is the recognition that this recruitment method is 
dependent on the opinions of those participants requested on whom they 
consider to be appropriate participants. The research team was confident the risk 
of sampling bias was minimised as it was anticipated the type of invitees would 
express many positive and negative perceptions of adoption and a clear vision 
for future implementation. 
 
6.3.6 Settings 
Three acute general hospitals in the public sector in Ireland were the focus for 
interviews in phase two of this research due to the nature and maturity of 
system implementation in order to capture a broad range of perspectives from 
participants with and without system experience. Site triangulation was achieved 
by the participation of a range of professionals within these hospitals so as to 
reduce the effect of local factors particular to one institution. Interviews in phase 
three were conducted with national key stakeholders and eHealth leads involved 
in medicines management in a convenient location for participants throughout 
the country. 
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6.3.7 Transferability 
Reproducibility of methods may be achieved from clear descriptions of data 
generation and analysis processes. The phenomenon of interest was described in 
sufficient detail in order to evaluate the extent to which conclusions drawn are 
transferable to other times, settings, situations, and populations. This included 
describing the structure of NPT constructs and emerging themes, and the 
integration of concepts, relationships, and interpretations.  
 
This research was completed in three acute hospitals in the public sector in 
Ireland with 23 local key stakeholders, and with 16 national key stakeholders 
and eHealth leads in a variety of locations.  Findings are potentially transferable 
to similar organisations within Ireland and other countries which have 
comparable healthcare systems.   
 
Limitations of the research data obtained from each phase have been highlighted 
throughout which include the relatively small sample size per professional group 
which may limit transferability of findings to other organisations. Another 
possible limitation in phase two was site triangulation from three acute general 
hospitals in the public sector in Ireland and the possibility that results may not 
be transferrable to other hospital settings such as private hospitals, tertiary 
hospitals, specialist hospitals, and hospitals outside of Ireland.  
 
6.3.8 Bias 
To reduce bias of design and data generation, prior to commencing all research 
phases, the primary researcher attended relevant training (Appendix 2.1). In 
order to minimise interviewer bias, the primary researcher has no vested interest 
in findings which impact on either positive or negative perceptions towards 
system implementation. As the primary researcher’s interest in NPT only 
emerged during this research, bias in defending or justifying or refuting this 
theory was not an issue. To reduce sampling bias, triangulation from an array of 
different professions, grades, and hospitals were invited for interview in phase 
two of this research widening the spectrum of interviewees from those with no 
system experience to those recently exposed to those with extensive experience. 
The risk of sampling bias was minimised in phase three of this research by the 
variety of participants from hospital, government, regulatory, and academic 
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backgrounds invited for interview as it was anticipated they would express many 
positive and negative perceptions and experiences of adoption as strategic leads 
and implementers. Sampling bias was also minimised using stratified purposive 
sampling which is a recognised sampling method (241)(242). To minimise 
reporting bias, participants were clearly informed of the research aim and given 
sufficient opportunity to contact the researcher and research team to clarify any 
issues. Participants were assured confidentiality and anonymity of data and 
informed that there was no right or wrong response to questions.  Participants 
were also encouraged to share relevant views and experiences not covered by 
the interview schedule. However, there is still a potential for participants to 
respond as they believed ‘right’ which is inherent in such a study design and may 
not be possible to overcome. 
 
Whilst data saturation was considered to be achieved for the overall samples in 
both qualitative phases, limitations included lack of certainty that data saturation 
was achieved for each profession given the smaller number of participants for 
each.  
 
6.4 Interpretation of findings within the three research phases 
Five papers were deemed appropriate for inclusion in the systematic review after 
screening 2566 titles. It was clear from this key finding that further explorative 
qualitative work in the form of individual face-to-face semi-structured interviews 
with key stakeholders would provide much needed novel in-depth information on 
facilitators and barriers to system implementation.  
 
Findings from the systematic review and qualitative phases with local and 
national key stakeholders were compared thereby facilitating further 
triangulation of results. Table 6.1 provides a summary of the main comparisons 
with all phases of this doctoral research and the main specific findings with 
interviews in Ireland. 
 
Similarities throughout the three phases included evidence of coherence with key 
facilitators of enhanced patient safety and efficiency supported by effective 
clinical leadership. Key barriers included workflow issues and weakened 
interpersonal communication between healthcare professionals and patients. 
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Strong engagement, communication, and getting the requisite buy-in from key 
stakeholders to proceed with the national strategic direction were needed to 
promote cognitive participation. Systems were required to be accessible, 
efficient, and not impact negatively on healthcare providers’ interaction amongst 
themselves and with patients to support collective action. The fit of the eHealth 
system with existing organisational workflow was another key priority for 
consideration. Significant resource investment was perceived to be needed for 
system adoption with early baselines measures to identify and champion 
progress and quick-wins, and encourage reflexive monitoring. Findings generated 
from both qualitative phases strongly emphasise the need for coherence, 
cognitive participation, collective action, and reflexive monitoring. 
 
There was a growing realisation of the need to consider ergonomics and a 
reciprocal relationship between technical, social, and organisational factors in 
order for new technology to become effectively embedded in organisational 
workflow. This is further described by other researchers (140)(386) and depicted 
in Figure 6.2 adopted from Holden et al (112). The general structure of the 
human factors model is that sociotechnical work systems produce work 
processes which shape outcomes. 
 
 
Figure 6.2:  Human factors framework adopted from Holden et al (112) 
 
Work system factors consist of healthcare professionals’ perceptions towards 
electronic systems for medicines management. Task factors comprise the 
complexity of system use. Technology factors include the design of the 
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technology and its accessibility and reliability. Organisation factors comprise the 
availability of the technology, the cost of the technology, and the social influence 
imposed by the technology on healthcare professionals’ workflow. Internal 
environment factors include lighting, clutter, and noise in the area where the 
technology is placed. External environment factors incorporate financial, 
motivational, and training support offered by management and clinical leaders. 
These factors interact to shape the performance of the medication management 
system. Processes can be decomposed into tasks such as learning how to use the 
technology, adjusting workflows to compliment the technology, auditing to 
understand the system and alter processes if necessary, and communicating its 
impact to implementers, managers, and end-users. Performance of each task 
may be shaped by unique configurations of work system factors. From a clinical 
perspective, the main outcomes include accuracy, workflow efficiency, cost 
reduction, satisfaction with the system, and resultant reduction in medication 
errors. This research doctoral could be further extended with an emphasis on the 
above ergonomics specific to electronic systems for medicines management and 
the need to have a high-quality system design for long-term effectiveness. 
 
Differences in findings from the three research phases included no study in the 
systematic review utilised NPT as a theoretical framework. National key 
stakeholders and eHealth leads focused more on realisation of national key 
building blocks, standardisation of terminology, and interoperability. Issues of 
legislation, cyber security, and data protection were also emphasised.  
 
These results, inclusive of the current systems in place, suggest that more 
medication error prevention strategies are required in Ireland such as the 
effective use of eHealth in the prescribing, dispensing, and administration of 
medicines in hospitals.  
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Table 6.1:  Main findings in research phases: comparisons with all phases and 
specific findings with interviews in Ireland 
 
Comparisons with 
systematic review and 
local and national 
interviews 
 
Specific findings with 
local and national 
interviews in Ireland 
 
Key facilitators 
to system 
implementation 
 
A potential to enhance 
patient safety 
 
Better access to patients’ 
drug records 
 
Effective leadership and 
clinical champions 
 
Adequate staff training 
 
Hardware/software 
availability and reliability 
A potential to enhance 
efficiency  
- Safety alerts 
- Stock control 
- Traceability 
- Accountability 
- Cost reduction 
- Integration/ 
  standardisation 
 
Multidisciplinary team 
approach  
 
Robust governance  
 
Robust iterative process 
 
Sufficient support 
 
Finance and autonomy for 
local implementation 
 
Early adaptors 
 
Attaining quick wins  
 
Contingency plans 
 
Ongoing auditing and 
evaluations 
 
Key barriers to 
system 
implementation 
 
Technical problems 
 
New drug errors 
 
Weakened interpersonal 
communication 
 
Workflow issues e.g. time 
delays in queuing, limited 
accessibility, inadequate 
numbers/sizes of units, S 
substantial time away 
from patients  
 
Not using the system as 
trained 
 
Security issues 
 
Inadequate support or 
Resist work 
changes e.g. force of 
change, bureaucracy, lack 
of recognition of 
professional roles 
 
Integration and 
standardisation issues 
 
Legislation, cyber 
security, and data 
protection issues  
 
Implementation plans 
short on detail 
 
Poor expertise nationally 
 
Lack of emphasise on 
  
200 
 
Comparisons with 
systematic review and 
local and national 
interviews 
 
Specific findings with 
local and national 
interviews in Ireland 
 
resources 
 
Implementation roll out 
 
Cost  and financial 
constraints 
 
training  
 
Testing at scale 
challenging 
 
Lack of confidence with 
identifying drugs  
 
Limited formal 
audits/measures 
 
 
6.5 Key recommendations for future system implementation in 
hospitals in Ireland 
The key recommendations points from triangulation of the findings from the 
three phases in this doctoral research include: 
 
 System implementation provides the potential to enhance patient safety 
and efficiency in healthcare delivery. It offers the potential to improve 
governance in the medicines management process by increasing traceability 
and enhancing accountability 
 Work since 2013 has been made with the publication of the eHealth 
Strategy and development of national key building block initiatives to 
facilitate system implementation such as HIQA standards around 
interoperability and the ePharmacy agenda. This needs to be further 
progressed and realised inclusive of consideration to legislation, data 
protection, and security concerns. A focus on details around implementation 
is required 
 Clinical champions and experts with leadership qualities and a vision for 
future implementation are required at a national and local level to drive the 
eHealth agenda forward. An effective multidisciplinary team, staff 
engagement, and open communication is important for realising a shared 
sense of purpose and in understanding the benefits of system 
implementation 
 Systems should be designed to facilitate interoperability and be easy to use, 
reliable, and readily available 
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 Organisational support in the form of adequate finance and autonomy for 
local initiatives is needed. The vision is not for duplication but for innovation 
to assist early adaptors in attaining quick wins which will map future 
successes or failures of system adoption 
 Sufficient training and staffing is required for implementation 
 Testing at scale, contingency plans, and ongoing evaluations will assist in 
determining success or otherwise of system implementation  
 
6.6 Impact of findings 
Actively demonstrating the impact of research is significant to ensure continued 
investment in the research base. The Research Councils UK (RCUK) defines 
research impact as “the demonstrable contribution that excellent research makes 
to society and the economy through fostering global economic performance, 
increasing effectiveness of public services and policy and enhancing quality of 
life, health and creative output” (387). The RCUK Review of Pathways to Impact 
focuses on various academic, economic, and societal impacts, as provided in 
Figure 6.3 (387).  
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Figure 6.3:  Pathways to impact by Research Councils UK    
 
6.6.1 Academic impact 
This process-based doctoral research mainly impacted the pathway ‘Enhancing 
the knowledge economy’ and has directly impacted on the principal researcher in 
terms of overall research training inclusive of in-depth understanding of 
paradigms, qualitative methodology and methods, and NPT. Development of 
skills included designing, generating, analysing, and interpreting systematic 
review and qualitative data, use of electronic analysis software NVivo©, use of 
electronic reference management systems, enhancement of time management 
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skills, and development of written and oral presentation skills. Multiple 
individuals were also exposed to this research as a direct consequence of 
interview participation.  
 
Applying a participatory approach in system design and providing sufficient user 
support through training were key lessons learnt. System implementers should 
systematically plan for all aspects of the implementation process inclusive of staff 
training, support, workflow changes, and communication. This requires a high-
level of collaboration and negotiation across departments and between IT, end-
users, and management. 
 
6.6.2 Economic and societal impacts 
This research mainly impacted ‘Improving health and wellbeing’ and ‘Changing 
organisational culture and practices’ which aligns with the research findings. The 
economic impact was not within the scope of this work and as such was not 
considered. 
 
Government initiatives and strategies in recent years in Ireland have 
recommended system implementation in hospitals to enhance patient safety and 
improve efficiencies in healthcare delivery.  Findings are novel and highlight 
effective ways of implementing systems in the hospital environment which can 
be used to inform and influence future policy and practice developments for 
successful system adoption. It is anticipated that implementers, end-users, and 
evaluators will use key findings when planning, implementing, and maintaining 
these systems.  
 
6.6.3 Pathway to impact 
The advancement of knowledge has been achieved via a unique exploration of 
system implementation and transfer of knowledge by sharing findings as 
described in the output section and with individual participants in phase two and 
phase three. Dissemination with further peer reviewed paper publications as well 
as oral and posters presentations at national and international conferences is 
planned. 
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6.7 Further work  
While there is no overarching framework in relation to the adoption of eHealth 
innovations, a number of strategies have been found to be effective for 
successful implementation inclusive of ascertaining end-users’ attitudes towards 
the system; effective communication between implementers and end-users; 
strategic project management and effective leadership; and continuous 
evaluation and quality improvement initiatives. Multiple future research areas 
should be considered both locally and nationally by government bodies. The 
following key priority research questions emerged from the findings and 
limitations of this doctoral research. 
 
6.7.1 Healthcare professionals’ views and experiences of the impact of 
implementing an ePrescribing and robotic pharmacy system on 
work practices in a public hospital in Ireland 
Since completing this research, a tertiary hospital in the public sector in Dublin 
has implemented a robotic pharmacy system and plans to implement 
ePrescribing throughout the hospital in 2018. Evaluating healthcare 
professionals’ views and experiences of system implementation would facilitate 
knowledge in this area. 
 
Research Question: What are healthcare professionals’ views and experiences of 
the impact of implementing an ePrescribing and robotic pharmacy system on 
work practices in a public hospital in Ireland?   
 
Research philosophy: This study adopts an interpretivist paradigm by exploring 
in-depth perceptions of healthcare professionals. 
 
Methodology and method: Application of a qualitative design with individual face-
to-face semi-structured interviews via purposive sampling with doctors, 
pharmacists, pharmacy technicians, nurses, IT managers, and relevant senior 
individuals involved in decision-making or implementation across the hospital 
using TDF as a theoretical framework. The interview schedule will be informed 
from the findings of this research.  
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Key outcome measures: These will include participants’ views and experiences 
of: tolerability, implementation, suitability, feasibility, impact on patient care and 
work processes, and sustainability. 
 
Likely impact: Assist future implementers on learning lessons from early 
adaptors of ePrescribing and robotic pharmacy systems. 
 
6.7.2 Patient perceptions of an EHR 
Patient perceptions were excluded from this research as implementation plans 
and processes are still at a preliminary stage in Ireland and the research team 
agreed to first focus on providers directly involved in medicines management 
processes. In addition, the research team felt patients would be more interested 
in EHR implementation which encompasses their entire medial history as well as 
medication history rather than the process of implementation of ePrescibing, 
robotic pharmacy systems, and automated medication storage and retrieval 
systems. EHRs enable a fundamental patient-centric connection between 
healthcare providers and patients by providing the exchange of health information 
electronically to improved healthcare quality and delivery. Additional research 
could now centre on patients’ perceptions of the facilitators and barriers to EHR 
implementation. 
 
Research Question: What are patients’ perceptions of the facilitators and barriers 
to the implementation of an EHR in Ireland?  
 
Research Philosophy: This study adopts a pragmatic approach, both quantifying 
and exploring the effects of system implementation. 
 
Methodology and method: A sequential mixed methodology combining a cross-
sectional survey followed by phenomenology with individual interviews will be 
employed to establish patients’ perceptions of EHR implementation. A 
quantitative design questionnaire will be provided to patients via convenience 
sampling using NPT as a theoretical framework. Post analysis of questionnaire 
data, qualitative interviews using purposive sampling will further explore 
patients’ perceptions facilitating triangulation of methods with findings from the 
survey.  
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Key outcome measures: Patient perceptions of the facilitators and barriers to 
system implementation inclusive of aim and purpose, involvement in the process, 
data protection, and implications of EHR. 
 
Likely impact: Improve the future adoption of EHR with an ultimate aim to 
enhance patient care.  
 
6.8 Conclusion  
Findings have generated original data which can inform future policy and practice 
developments for successful system implementation in the hospital environment. 
The use of NPT has highlighted individual and organisational facilitators and 
barriers to the normalisation of these complex electronic systems into routine 
work which requires consideration to interventions inclusive of engagement, 
education, training, and support. Findings generated from both qualitative 
phases strongly emphasise the need for coherence, cognitive participation, 
collective action, and reflexive monitoring. Similarities throughout the research 
phases included key facilitators of enhanced patient safety and efficiency and key 
barriers of workflow issues. Assessing and fostering readiness for technological 
innovation also appears to be particularly important for successful adoption. 
There was more of an emphasis on realisation of national key building blocks, 
standardisation of terminology, and interoperability verbalised by national key 
stakeholders and eHealth leads. While this research was conducted in Ireland, 
there is potential for wider impact which will be facilitated by ongoing 
dissemination of the research findings. Many potentially transferable themes 
have been identified and extend the evidence base. This will assist organisations 
to better plan for implementation of medication-related eHealth systems. 
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Appendices 
 
Appendix 2.1: Relevant training completed by primary researcher during 
the course of the PhD 
 
Relevant certificates completed since commencing doctoral research 
- PgCert in Research Methods Module 1 & Module 2 Aberdeen (2014, 2012) 
- Research Board Critical Appraisal Certificate Dublin (2013) 
- Advanced  Statistical Modeling Certificate Dublin (2013) 
- Introduction to Evidence-Based Healthcare - Joanna Briggs Institute Certificate 
Aberdeen (2013) 
- EBSCOhost Research Database Tutorials (2013) 
- EBSCOhost Health Tutorials (2013) 
- Statistical Research Methods and Sample Size Certificate Dublin (2012)  
- The Social Research Association Designing a Qualitative Study Certificate London 
(2012) 
- The Social Research Association Qualitative Data Collection: Interviewing 
Certificate London (2012) 
- Hospital Pharmacy Association of Ireland Clinical Skills Certificate Part 1, Part 2, 
and Part 3 Dublin (2012) 
- Certificate on the Audit Cycle Dublin (2012) 
 
Relevant conference and meeting attendance since commencing doctoral 
research 
- Galway University Hospitals Research Day 2017 
- Hospital Pharmacy Association of Ireland Annual Conference Dublin (2017, 2016, 
2015, 2014, 2013, 2012) 
- Healthcare Informatics Society of Ireland Annual Conference, Scientific 
Symposium & Exhibition Dublin (2016, 2014, 2012) 
- Royal Academy of Medicine in Ireland Healthcare Informatics Meeting Dublin 
(2016, 2015) 
- Royal Pharmaceutical Conference Birmingham (2016) 
- 7th Annual National Hospital Pharmacy Forum Dublin (2016) 
- All Staff Meeting Council of the Clinical Information Officers Galway (2016) 
- Council of the Clinical Information Officers Dublin (2016) 
- All Ireland Pharmacy Workshop and Conference Dundalk (2015, 2012) 
- eHealth Ireland Ecosystem Meeting Dublin (2015) 
- Health Services Research & Pharmacy Practice Conference 
Aberdeen/Lancaster/Cork (2014, 2013, 2012) 
- European Society of Clinical Pharmacy Symposium Copenhagen (2014) 
- Reducing Medication Errors in Healthcare Services Conference Dublin (2014) 
- Health Economics and Outcomes Research for the 21st Century Pharmacist Galway 
(2014) 
- International Pharmaceutical Federation (FIP) World Congress Dublin (2013) 
- Critical Analysis Workshop Dublin (2013) 
- Electronic Prescribing in hospitals: moving forward. Healthcare Conferences 
London (2013) 
- Irish Centre for Continuing Pharmaceutical Education Meetings Dublin (2013, 
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Appendix 3.1: Systematic review protocol registered with PROSPERO 
 
Healthcare professionals’ perceptions of the facilitators and barriers to 
implementing electronic prescribing, dispensing, and administration of 
medicines in hospitals: a systematic review 
 
Diana Hogan-Murphy, Scott Cunningham, Antonella Tonna, Alison Strath 
 
 
Citation 
Diana Hogan-Murphy, Scott Cunningham, Antonella Tonna, Alison Strath. Healthcare 
professionals’ perceptions of the facilitators and barriers to implementing electronic 
prescribing, dispensing, and administration of medicines in hospitals: a systematic 
review. PROSPERO 2013:CRD42013004427 Available  from:  
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013004427 
 
 
Review question(s) 
 
What are healthcare professionals’ perceptions of the barriers and facilitators to 
implementing electronic prescribing, dispensing, and administration of medicines in 
hospitals? 
 
Searches 
 
The following electronic databases will be searched for relevant studies: 
 
 MEDLINE 
 CINAHL 
 PsycINFO 
 International Pharmaceutical Abstracts 
 Pharmline 
 The Cochrane Library (all databases) 
 DARE 
 The Health Technology Assessment Database 
 PsycARTICLES 
 
Without too many different search concepts, a wide variety of search terms will be 
combined within each concept. Both free-text and subject headings will be used such as 
Medical subject heading (MeSH) descriptors including electronic prescribing or e-
prescribing or ePrescribing or electronic dispensing or automated dispensing systems or 
electronic administration and the descriptor medicines management and/or eHealth or 
health information technology or health information and communications technology or 
health ICT and the text words facilitators, barriers, perceptions, attitudes, views, beliefs, 
experiences, healthcare professionals, clinicians, nurses, pharmacists and hospitals. 
 
The bibliographies of included studies will be scrutinised for additional references not 
identified by other means. Studies will also be retrieved by citation searching, hand-
searching key journals and conference proceedings and, if necessary, contacting study 
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authors for full texts if abstracts are only available. It is anticipated that searching 
databases and registers that include unpublished studies, such as records of ongoing 
research, conference proceedings and theses, will reduce the impact of publication bias. 
 
Alternative spellings including US and British English variants, abbreviations, synonyms, 
geographical variation, and changes in terminology over time will be accounted for when 
selecting free text terms. 
 
Study selection: 
 
• Stage 1: The titles and abstracts of identified studies will be screened by the primary 
researcher and the principal supervisor for relevance to the topic. Studies considered 
not relevant will be excluded. Studies involving the topic, but perhaps considered not 
relevant, will be passed to the research team for consideration. 
• Stage 2: Full text/papers will be sought for all studies appearing to meet the inclusion 
criteria and a final selection will be made by the full team before data extraction and 
synthesis by the primary researcher and principal supervisor. 
 
A flow chart will be produced to facilitate transparency of the process. 
 
Language: studies published in the English language will be considered. 
 
Types of study to be included 
 
Inclusion criteria: 
 
The types of studies to be included in this review will consist of any study which has 
researched healthcare professionals’ perceptions of the various barriers and facilitators to 
implementing electronic prescribing, dispensing, and administration of medicines in the 
hospital setting. It is planned at the outset to search for a broad range of study types 
including any: 
 
• evaluative study design e.g. randomised controlled trials (RCTs) and derivatives 
• quasi-experimental studies e.g. non-RCTs, before, and after studies 
• observational studies e.g. cohort, case-control, case series, and cross-sectional 
studies 
• qualitative studies 
• qualitative/narrative reviews 
• systematic reviews 
 
 
Where relevant qualitative/narrative/systematic reviews are identified, these will be 
summarised and results will be supplemented with results from relevant primary studies 
not included in the reviews. 
 
Exclusion criteria: 
 
Summaries of the literature for the purpose of information or commentary, editorial 
discussions and papers whose abstracts identify them as reviews but lack supporting 
evidence in the main text will be excluded. 
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Condition or domain being studied 
 
Implementation of information technology in healthcare is influenced at the micro-level 
by interpersonal factors such as individuals' attitudes and beliefs; at the meso-level by 
the operational aspects of implementation such as readiness and resources; and at the 
macro-level by socio-political forces. At a macro-level, many countries including 
Australia, Canada, the US and the UK have been at the forefront of attempts to embed 
eHealth into routine healthcare, with the UK investing £12.4 billion over 10 years. 
However, despite political commitment and substantial investment, there has been 
significant variability in the success of different eHealth implementations across the NHS. 
Difficulties in eHealth implementation are an international phenomenon, with similar 
problems being widely reported. An important theme in much recent work has been the 
problem of resistance or refractory behaviours of healthcare professionals and the 
assumption that their attitudes to eHealth are the root problem. This systematic review 
therefore aims to explore healthcare professionals’ perceptions of the various barriers 
and facilitators to implementing electronic prescribing, dispensing, and administration of 
medicines in the hospital setting. As there is much published literature on the impact of 
information technology in medicines management, such as effects on medication errors 
and cost, implementation processes rather than outcomes will be the main focus of this 
research. 
 
Participants/ population 
 
Inclusion criteria: 
All clinicians, nurses, pharmacists, and allied healthcare professionals such as dieticians, 
podiatrists physiotherapists, and pharmacy technicians involved in prescribing, 
dispensing, and/or administration of medicines. 
 
 
Exclusion criteria: 
 
Non-healthcare professionals and healthcare professionals not working in the hospital 
environment. 
 
Intervention(s), exposure(s) 
 
Inclusion criteria: 
 
An exploration of healthcare professionals’ perceptions of the various barriers and 
facilitators to implementing electronic prescribing, dispensing, and administration of 
medicines in the hospital setting. Perceptions include healthcare professionals’ attitudes, 
beliefs and views. 
 
Exclusion criteria: 
 
This phenomenon of interest is limited to healthcare professionals’ perceptions towards 
the implementation of electronic prescribing, electronic dispensing and electronic 
administration of medicines and excludes other eHealth strategies such as electronic 
medical records, unique patient identifiers, clinical decision support systems, 
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computerised provider order entry and electronic discharge prescriptions. Other 
medicines management strategies are excluded such as the monitoring of patients. 
Studies that focus on perceptions of eHealth and medicines management other than 
implementation, for example, clinical and fiscal outcomes and effects on patients and 
resources will also be excluded. 
 
Comparator(s)/ control 
 
Not applicable. 
 
Context 
 
Inclusion criteria: 
 
Any hospital setting. 
 
Exclusion criteria: 
 
Non hospital setting including nursing homes, rehab and step-down units. 
 
Outcome(s) 
 
Primary outcomes 
 
Identify and review the literature to explore healthcare professionals’ perceptions, 
attitudes, and views of the barriers and facilitators to implementing electronic 
prescribing, electronic dispensing, and/or electronic administration of medicines in the 
hospital setting. 
Synthesize available evidence to identify, describe and understand healthcare 
professionals’ perceptions, attitudes and views of the barriers and facilitators to 
implementing electronic prescribing, electronic dispensing and/or electronic 
administration of medicines in the hospital setting. 
 
Secondary outcomes 
None. 
 
Data extraction, (selection and coding) 
 
Citations will be downloaded into RefWorks and screened by the primary reviewer. All 
papers deemed relevant will be double screened by the principal supervisor. In case of 
disagreement about inclusion or exclusion of a given paper, all reviewers (four in total) in 
the research team will read the paper and reach agreement through discussion. 
 
Data will be extracted from studies identified using Microsoft Word on the basis of review 
objectives and methods; databases searched within the review; inclusion and exclusion 
criteria of the review; number of papers identified, and number included in the review. 
 
Risk of bias (quality) assessment 
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The primary researcher will review the literature to identify studies relating to healthcare 
professionals perceptions’ of the various barriers and facilitators to implementing 
electronic prescribing, dispensing, and administration of medicines in the hospital setting. 
All types of studies in the inclusion criteria will be independently assessed for quality by 
the primary researcher and a proportion of the assessments will be double-checked by 
the principal supervisor. Disagreement will be resolved by consensus or by consulting the 
remaining research team members if necessary. Study quality will initially be critically 
appraised using key concepts from the Joanna Briggs Institute reviewers' manual and the 
Joanna Briggs Institute comprehensive systematic review training programme, the 
Centre for Reviews and Dissemination guidance for undertaking systematic reviews in 
healthcare, the Cochrane Handbook for Systematic Reviews of Interventions, and the 
Critical Appraisal of Systematic Reviews. Thereafter, studies will be critically appraised 
using the Critical Appraisal Skills Programme (CASP) of qualitative studies, systematic 
reviews, randomised controlled trials, cohort, and case-controlled studies. If necessary a 
table will be used to record study quality or risk of bias. 
 
Strategy for data synthesis 
 
Data synthesis will involve the collation, combination, and summary of the findings. 
Findings will most likely be synthesised through a narrative approach using text and 
tables. If both quantitative and qualitative studies are identified, these results will be 
reported separately and will follow the Centre for Reviews and Dissemination guidance 
for undertaking reviews in healthcare for tabulating study type. A separate table may be 
used to record study quality or risk of bias. In view of these studies and the data that will 
be included, a meta-analysis is unlikely to be necessary or possible. 
 
Analysis of subgroups or subsets 
 
Depending upon the literature findings, a sub-group analysis will be considered, for 
example, comparing the perceptions of both medical clinicians and pharmacists. 
 
Dissemination plans 
 
- Presentations to the Senior Management Team and Drugs and Therapeutics 
Committee in local hospital 
- Abstract submissions to the Healthcare Informatics Society of Ireland, Hospital 
Pharmacy Association of Ireland, Health Services Research in Pharmacy Practice 
 
Review team 
 
Ms Diana Hogan-Murphy, Robert Gordon University 
Dr Scott Cunningham, Robert Gordon University 
Dr Antonella Tonna, Robert Gordon University 
Professor Alison Strath, Robert Gordon University 
 
Anticipated or actual start date: 09 May 2013 
 
Anticipated completion date: 11 December 2013 
 
Conflicts of interest: None known 
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Language: English 
 
Country: Ireland 
 
Subject index terms status 
Subject indexing assigned by CRD 
 
Subject index terms: Electronic Prescribing; Health Personnel; Humans; Pharmacy 
Service, Hospital 
 
Stage of review: Ongoing 
 
Date of registration in PROSPERO: 14 May 2013 
 
Date of publication of this revision: 24 March 2014 
 
 
 
Stage of review at time of this submission Started  Completed 
Preliminary searches Yes  Yes 
Piloting of the study selection process No  No 
Formal screening of search results against 
eligibility criteria 
No  No 
Data extraction No  No 
Risk of bias (quality) assessment No  No 
Data analysis No  No 
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Appendix 3.2: Medline search string 
 
MEDLINE Search terms (limit English language) # retrieved 
1 MH healthcare professionals+ 10131 
2 MH health care professionals+ 55845 
3 MH healthcare providers+ 11311 
4 MH health care providers+ 56554 
5 Healthcare N8 profession* 8735 
6 Health care N8 profession* 18849 
7 Health profession* 53526 
8 Healthcare N8 provider* 8663 
9 Health care N8 provider* 22783 
10 Health provider* 27832 
11 MH doctors+ 256 
12 doctor* 85559 
13 MH clinicians+ 852 
14 Clinician* 117975 
15 MH physicians+ 69339 
16 Physician* 356522 
17 MH pharmacists+ 8848 
18 Pharmacist* 18896 
19 Chemist 1171 
20 Druggist* 94 
21 Apothecary* 130 
22 Hospital N8 pharmacist* 1605 
23 Dietician* 861 
24 Nutritionist* 1470 
25 Pharm* N8 technician* 638 
26 Chiropodist* 111 
27 Podiatrist*  535 
28 Physiotherapist* 3427 
29 MH nurse+ 517 
30 Nurse OR nurses 204514 
31 Dentist OR dentists 32841 
32 Radiographer* 861 
33 Optometrist* 1503 
34 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 
12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 
21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 
30 or 31 or 32 or 33 
(MH healthcare professionals+ OR MH health care 
professionals+ OR MH healthcare providers+ OR MH 
health care providers+ OR Healthcare N8 profession* 
OR Health care N8 profession* OR Health profession* 
OR Healthcare N8 provider* OR Health care N8 
provider* OR Health provider* OR MH doctors+ OR 
doctor* OR MH clinicians+ OR Clinician* OR MH 
physicians+ OR Physician* OR MH pharmacists+ OR 
801733 
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MEDLINE Search terms (limit English language) # retrieved 
Pharmacist* OR Chemist OR Druggist* AND 
Apothecary* OR hospital N8 pharmacist* OR Dietician* 
OR Nutritionist* OR Pharm* N8 technician* OR 
Chiropodist* OR Podiatrist* OR Physiotherapist* OR 
MH nurse+ OR (Nurse OR nurses) OR (Dentist OR 
dentists) OR Radiographer* OR Optometrist*) 
35 MH electronic prescribing+ 386 
36 e-prescri* OR eprescri* 697 
37 Robot* AND pharmacy OR medic* 1190 
38 Electronic transfer of prescription* 9 
39 ETP 552 
40 Electron* N8 prescri* 1085 
41 E N8 prescri* 484 
42 MH electronic administration+ 11941 
43 electronic administ* 466 
44 automated dispens* 259 
45 automated dispens* system* 57 
46 ((electronic administ*) AND (medic* OR drug* or 
tablet* OR remed* OR treat* OR dos*)) 
379 
47 ((bar N5 code N5 administ*) AND (medic* OR drug* 
or tablet* OR remed* OR treat* OR dos*)) 
69 
48 electron* N8 prescrib* 791 
49 e N8 prescrib* 386 
50 ((e N8 admin*) AND (medic* OR drug* or tablet OR 
remed* OR treat* OR dos*)) 
7340 
51 Ehealth* 915 
52 E health* 4160 
53 Health information technolog* 2603 
54 HIT 13138 
55 Mobile technolog* 801 
56 Mobile health* 2287 
57 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 
44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 
53 or 54 or 55 or 56 
(MH electronic prescribing+ OR e-prescri* AND 
eprescri* OR robot* AND pharmacy OR medic* OR 
electronic transfer of prescription* OR ETP OR 
Electron* N8 prescri* OR E N8 prescri* OR MH 
electronic administration+ OR electronic administ* OR 
automated dispens* OR automated dispens* system* 
OR ((electronic administ*) AND (medic* OR drug* or 
tablet* OR remed* OR treat* OR dos*)) OR ((bar N5 
code N5 administ*) AND (medic* OR drug* or tablet* 
OR remed* OR treat* OR dos*)) OR electron* N8 
prescrib* OR e N8 prescrib* OR ((e N8 admin*) AND 
(medic* OR drug* or tablet OR remed* OR treat* OR 
dos*)) OR Ehealth* OR E health* OR Health 
information technolog* OR HIT OR Mobile technolog* 
23743 
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MEDLINE Search terms (limit English language) # retrieved 
OR Mobile health*) 
58 34 + 57 
((MH healthcare professionals+ OR MH health care 
professionals+ OR MH healthcare providers+ OR MH 
health care providers+ OR Healthcare N8 profession* 
OR Health care N8 profession* OR Health profession* 
OR Healthcare N8 provider* OR Health care N8 
provider* OR Health provider* OR MH doctors+ OR 
doctor* OR MH clinicians+ OR Clinician* OR MH 
physicians+ OR Physician* OR MH pharmacists+ OR 
Pharmacist* OR Chemist OR Druggist* AND 
Apothecary* OR hospital N8 pharmacist* OR Dietician* 
OR Nutritionist* OR Pharm* N8 technician* OR 
Chiropodist* OR Podiatrist* OR Physiotherapist* OR 
MH nurse+ OR (Nurse OR nurses) OR (Dentist OR 
dentists) OR Radiographer* OR Optometrist*) AND 
(MH electronic prescribing+ OR e-prescri* AND 
eprescri* OR robot* AND pharmacy OR medic* OR 
electronic transfer of prescription* OR ETP OR 
Electron* N8 prescri* OR E N8 prescri* OR MH 
electronic administration+ OR electronic administ* OR 
automated dispens* OR automated dispens* system* 
OR ((electronic administ*) AND (medic* OR drug* or 
tablet* OR remed* OR treat* OR dos*)) OR ((bar N5 
code N5 administ*) AND (medic* OR drug* or tablet* 
OR remed* OR treat* OR dos*)) OR electron* N8 
prescrib* OR e N8 prescrib* OR ((e N8 admin*) AND 
(medic* OR drug* or tablet OR remed* OR treat* OR 
dos*)) OR Ehealth* OR E health* OR Health 
information technolog* OR HIT OR Mobile technolog* 
OR Mobile health*)) 
2881 
59 MH hospital+ 21481 
60 Hospital* 2447403 
61 Secondary N3 care 4526 
62 Tertiary N3 care 24932 
63 Ward* 69871 
64 59 or 59 or 60 or 61 or 62 or 63 
(MH hospital+ OR hospital* OR secondary N3 care OR 
tertiary N3 care OR ward*) 
2497834 
65 58 AND 64 
((MH healthcare professionals+ OR MH health care 
professionals+ OR MH healthcare providers+ OR MH 
health care providers+ OR Healthcare N8 profession* 
OR Health care N8 profession* OR Health profession* 
OR Healthcare N8 provider* OR Health care N8 
provider* OR Health provider* OR MH doctors+ OR 
doctor* OR MH clinicians+ OR Clinician* OR MH 
physicians+ OR Physician* OR MH pharmacists+ OR 
Pharmacist* OR Chemist OR Druggist* AND 
991 
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MEDLINE Search terms (limit English language) # retrieved 
Apothecary* OR hospital N8 pharmacist* OR Dietician* 
OR Nutritionist* OR Pharm* N8 technician* OR 
Chiropodist* OR Podiatrist* OR Physiotherapist* OR 
MH nurse+ OR (Nurse OR nurses) OR (Dentist OR 
dentists) OR Radiographer* OR Optometrist*) AND 
(MH electronic prescribing+ OR e-prescri* AND 
eprescri* OR robot* AND pharmacy OR medic* OR 
electronic transfer of prescription* OR ETP OR 
Electron* N8 prescri* OR E N8 prescri* OR MH 
electronic administration+ OR electronic administ* OR 
automated dispens* OR automated dispens* system* 
OR ((electronic administ*) AND (medic* OR drug* or 
tablet* OR remed* OR treat* OR dos*)) OR ((bar N5 
code N5 administ*) AND (medic* OR drug* or tablet* 
OR remed* OR treat* OR dos*)) OR electron* N8 
prescrib* OR e N8 prescrib* OR ((e N8 admin*) AND 
(medic* OR drug* or tablet OR remed* OR treat* OR 
dos*)) OR Ehealth* OR E health* OR Health 
information technolog* OR HIT OR Mobile technolog* 
OR Mobile health*) AND (MH hospital+ OR hospital* 
OR secondary N3 care OR tertiary N3 care OR ward*)) 
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Appendix 3.3: Blank data extraction form 
 
Heading Subheading  For completion by reviewers 
 Citation   
 
 Name of Reviewer   
 Eligible? Does the evidence 
fit within the scope 
of the review?  
Yes    No    Unclear 
 Reviewers’ rating As matrix  
 Typology   
 Participants Evidence from HC 
professionals 
 
 Study aims What were the 
study’s aims and 
purpose? 
 
 Key findings What are the key 
study findings? 
 
 Evaluation 
summary 
Draw together 
brief comments on 
the study as a 
whole and its 
strengths and 
weaknesses. Is 
further work 
required? What 
are its implications 
for policy, practice 
and theory, if any? 
 
 HC professionals’ 
perspective 
Does the study 
report on the 
experience of HC 
professionals? How 
were they involved 
in the study (e.g. 
as advisors for the 
research, in the 
design and 
execution of the 
study, in 
dissemination)? 
 
Ethical 
standards 
 Was ethical 
committee 
approval obtained? 
Was informed 
consent obtained? 
Does the study 
Ethical approval: Yes No 
Unclear  
Informed consent: Yes No 
Unclear  
Ethical issues addressed: Yes 
No Unclear  
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Heading Subheading  For completion by reviewers 
address ethical 
issues adequately? 
Has confidentiality 
been maintained? 
Confidentiality maintained: 
Yes No Unclear 
Context Aims Are the aims and 
purpose of the 
study clearly 
stated? 
Yes    No    Unclear 
Setting Setting What is the 
geographical and 
care setting for the 
study? 
Urban   Rural   Mixed 
Tertiary Specialised General 
Community Regional 
UNKNOWN 
 Rationale What is the 
rationale and 
appropriateness 
for this choice? 
 
 Detail Is there sufficient 
detail about the 
setting? 
Yes    No    Unclear 
 Timing Over what period 
did the data 
collection take 
place? 
 
Sample Inclusion criteria Who was included 
in the study? 
Setting? Process 
 
 Exclusion criteria Who was excluded 
from the study? 
 
 Selection How was the 
sample selected? 
Were there any 
factors that 
influenced how the 
sample was 
selected (e.g. 
access, timescale 
issues)? 
 
 Size What is the size of 
the sample and 
groups comprising 
the study? 
 
 Appropriateness Is the sample 
appropriate in 
terms of its ability 
to meet the aims 
of the study, the 
depth of data that 
it enabled to be 
collected, and its 
Yes    No    Unclear 
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Heading Subheading  For completion by reviewers 
breadth? 
Data collection Methods What data 
collection methods 
were used? Was 
the data collection 
adequately 
described and 
rigorously 
conducted? 
Interview 
Focus group 
Observation 
Mixed methods 
Yes    No    Unclear 
 Role of researcher What is the role of 
the researcher 
within the setting? 
Are there any 
potential conflicts 
of interest? 
 
 Data analysis How is the data 
analysed? How 
adequate is the 
description of the 
data analysis? Is 
adequate evidence 
provided to 
support the 
analysis (e.g. use 
of original data, 
iterative analysis, 
efforts to establish 
validity and 
reliability)? Is the 
study set in 
context in terms of 
findings and 
relevant theory? 
 
 Researcher’s 
potential bias 
Are the 
researchers’ own 
position, 
assumptions, and 
possible biases 
outlined? Indicate 
how they could 
affect the study in 
terms of analysis 
and interpretation 
of the data 
 
 Reflexivity Are the findings 
substantiated by 
the data and has 
consideration been 
given to any 
Yes    No    Unclear 
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Heading Subheading  For completion by reviewers 
limitations of the 
methods or data 
that may have 
affected the 
results? 
Outcomes Outcomes What outcome 
measures were 
adopted? What 
was the impact of 
the study for HC 
professionals, 
organisation 
responsible for 
service? 
 
Findings Themes   
 Conclusions   
 Opinions What this person 
argues 
 
Policy & 
practice 
Generalisability To what extent are 
the study findings 
generalisable? 
What is the 
country of study? 
How applicable are 
the study findings 
to the system in 
the UK/Ireland? 
Are the 
conclusions 
justified? 
 
 Implications for 
policy 
  
 Implications for 
practice 
  
Other 
comment 
Format   
 Links to other 
references to be 
followed up 
  
Decision Name of second 
reviewer 
  
 Agreement with 
reviewer 
  
 Inclusion   
 Date   
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Appendix 3.4: Data extraction form for included paper (310) 
Heading Subheading  For completion by reviewers 
 Citation  Physicians’ perceptions of 
possibilities and obstacles 
prior to implementing a 
computerised drug prescribing 
support system 
 Name of 
Reviewer 
Diana Hogan-Murphy 
and Scott 
Cunningham 
 
 Eligible? Does the evidence fit 
within the scope of 
the review?  
Yes    No    Unclear 
 Reviewers’ 
rating 
As matrix 8 
 Typology  Primary research case studies  
Descriptive accounts 
 Participants Evidence from HC 
professionals 
Physicians 
 Study aims What were the study’s 
aims and purpose? 
To identify physicians’ 
perceptions of possibilities and 
obstacles prior to 
implementing a computerised 
drug prescribing support 
system 
 Key findings What are the key 
study findings? 
Possibilities: patient drug 
history, pharmacological 
knowledge, information 
access, and time saving. 
Obstacles: technical problems, 
shortage of computers, 
diminishing patient contact, 
routines and habit 
Gaining access to patient drug 
history enables physicians to 
carry out work in a 
professional way – a need the 
computerised prescription 
support system was not 
developed for and thus cannot 
fulfil. Alerts and producer-
independent drug information 
are valuable in reducing 
workload. However, technical 
prerequisites form the base for 
a successful implementation. 
Time must be given to adapt 
to new ways of working. 
 Evaluation Draw together brief Excellent detail on methods 
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Heading Subheading  For completion by reviewers 
summary comments on the 
study as a whole and 
its strengths and 
weaknesses. Is 
further work required? 
What are its 
implications for policy, 
practice and theory, if 
any? 
and data collection and 
analysis. Implications for 
policy practice and theory are 
unknown as setting in an ED 
and not a general medical or 
surgical ward but a good mix 
of patients? No documentation 
of bias and little mention of 
limitations bar ‘we do not 
argue that the results can be 
generalised to a large group’. 
Themes in line with other 
research 
A useful qualitative study that 
seems well described and 
executed. It only includes 
physicians from one setting. 
Limited detail on recruitment 
and other aspects of method. 
Clear description of approach 
to analysis. 
 HC 
professionals’ 
perspective 
Does the study report 
on the experience of 
HC professionals? 
How were they 
involved in the study 
(e.g. as advisors for 
the research, in the 
design and execution 
of the study, in 
dissemination)? 
Yes – physicians. Possible 
end-users if system 
implemented but not clear 
Ethical 
standards 
 Was ethical 
committee approval 
obtained? Was 
informed consent 
obtained? Does the 
study address ethical 
issues adequately? 
Has confidentiality 
been maintained? 
Ethical approval: Yes No 
Unclear but unclear why done 
retrospectively 
A retrospective application 
was sent to the Ethics 
Committee at Karolinska 
Institute which raised no 
objections to the study 
Informed consent: Yes No 
Unclear  
Participants were informed of 
the aims of the study and that 
participation was voluntary 
and could be discontinued if 
they wished 
Ethical issues addressed: Yes 
No Unclear  
Confidentiality maintained: 
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Heading Subheading  For completion by reviewers 
Yes No Unclear 
Context Aims Are the aims and 
purpose of the study 
clearly stated? 
Yes    No    Unclear 
Setting Setting What is the 
geographical and care 
setting for the study? 
Urban   Rural   Mixed 
Tertiary Specialised General 
Community Regional 
UNKNOWN 
General Hospital in Stockholm 
city in the largest ED in the 
Nordic countries 
 
 Rationale What is the rationale 
and appropriateness 
for this choice? 
Not stated but possibly to 
explore physicians’ 
perceptions of possibilities and 
obstacles prior to 
implementing a computerised 
drug prescribing support 
system in ED. Largest ED in 
the Nordic countries with 
approximately 90,000 visitors 
per year 
 Detail Is there sufficient 
detail about the 
setting? 
Yes    No    Unclear 
 
 Timing Over what period did 
the data collection 
take place? 
Autumn 2002 for 30 minutes – 
individual interviews 
Sample Inclusion criteria Who was included in 
the study? Setting? 
Process 
21 ED physicians competent in 
handling internal medicine, 
general surgery, orthopaedics, 
gynaecology and ENT  
 Exclusion 
criteria 
Who was excluded 
from the study? 
Not stated – all agreed to 
participant 
 Selection How was the sample 
selected? Where there 
any factors that 
influenced how the 
sample was selected 
(e.g. access, 
timescale issues)? 
Physicians who were trained in 
the Janus prescribing support 
system  
Says 21 inv in A&E project – 
not clear if extra or same as 
those mentioned above 
 Size What is the size of the 
sample and groups 
comprising the study? 
21 ED physicians  
 Appropriateness Is the sample 
appropriate in terms 
of its ability to meet 
the aims of the study, 
the depth of data that 
Yes    No    Unclear 
21 qualitative interviews 
should reach saturation 
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Heading Subheading  For completion by reviewers 
is enabled to be 
collected, and its 
breadth? 
Data 
collection 
Methods What data collection 
methods were used? 
Was the data 
collection adequately 
described and 
rigorously conducted? 
Interview 
Focus group 
Observation 
Mixed methods 
Yes    No    Unclear 
A semi-structured interview 
manual with 3 main questions. 
Interviews were carried out at 
the physicians workplace and 
tape recorded for later 
verbatim transcription. The 
identity of the informants was 
removed during transcription 
to guarantee confidentiality. 
All physicians agreed to 
participate and weer 
interviewed individually for 
approximately 30 minutes. 
They could discontinue if they 
wished and retrospective 
ethical approval was sought 
with no objections 
 Role of 
researcher 
What is the role of the 
researcher within the 
setting? Are there any 
potential conflicts of 
interest? 
Data collection, analysis and 
dissemination but not stated 
 Data analysis How is the data 
analysed? How 
adequate is the 
description of the data 
analysis? Is adequate 
evidence provided to 
support the analysis 
(e.g. use of original 
data, iterative 
analysis, efforts to 
establish validity and 
reliability)? Is the 
study set in context in 
terms of findings and 
relevant theory? 
Clear steps and description 
but no mention of who was inv 
? multiple people to check / 
validate – not clear 
An inductive thematic analysis 
was performed. Analysed in 5 
steps by 3 independent 
individuals with different 
backgrounds. 1. Transcripts 
were read to acquire a good 
grasp of the whole and 
quotations relevant to the 
research questions were 
marked 
2. The marked text was sorted 
into different themes. When 
opinions differed between 
group members, they returned 
to the texts and discussed 
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Heading Subheading  For completion by reviewers 
them until an agreement was 
reached (negotiated 
consensus) 
3. The group identified 15 
themes initially: These were 
then classified as ‘possibilities’ 
or ‘obstacle’ 
4. Themes were combined into 
4 descriptive categories for 
both possibilities and 
obstacles: thus, certain 
themes were considered to 
have a common origin and/or 
to be related 
5. Description categories were 
named from an overall 
perspective  
 Researcher’s 
potential bias 
Are the researchers’ 
own position, 
assumptions, and 
possible biases 
outlined? Indicate 
how they could affect 
the study in terms of 
analysis and 
interpretation of the 
data 
No potential researchers bias 
outlined but researchers not 
directly involved with 
implementation 
 Reflexivity Are the findings 
substantiated by the 
data and has 
consideration been 
given to any 
limitations of the 
methods or data that 
may have affected the 
results? 
Yes    No    Unclear 
Not much limitations 
considered re methods  
Outcomes Outcomes What outcome 
measures were 
adopted? What was 
the impact of the 
study for HC 
professionals, 
organisation 
responsible for 
service? 
Categories / themes from 
analysis … relating to 
possibilities and obstacles … 
To provide a rich picture of the 
opinions of physicians from 
the ED of a computerised 
prescription support system. 
Important impact as findings 
in line with other research 
Findings Themes  Theme 1: Possibilities: patient 
drug history, pharmacological 
knowledge, information 
access, and time saving. 
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Heading Subheading  For completion by reviewers 
Theme 2: Obstacles: technical 
problems, shortage of 
computers, diminishing patient 
contact, routines and habit 
 Conclusions  Basic need to gain access to 
DH, alerts valuable …tech 
prerequisites that form basis 
of success imp… no matter 
how useful the system…time 
must be given to users to 
adapt 
 
Physicians need to gain access 
to the drug history of patients. 
Alerts for 
interactions/pregnancy/breast-
feeding and producer-
independent drug information 
are seen as valuable functions 
to reduce the workload of 
physicians workload. However, 
it is technical pre requisitions 
that form the base for 
successful implementation, n 
matter how useful the system 
is perceived to be. Time must 
be given to users to adapt to 
new ways of working 
 
 Opinions What this person 
argues 
There are no shortcuts in the 
implementation of a 
computerised prescription 
support system  
Policy & 
practice 
Generalisability To what extent are 
the study findings 
generalisable? What is 
the country of study? 
How applicable are 
the study findings to 
the system in the 
UK/Ireland? Are the 
conclusions justified? 
Authors themselves indicate 
limited generalisability due to 
one location 
Setting in an ED department – 
however all types of patients 
seen in this environment 
therefore generalisable. Good 
number of participants 
included. Study in Sweden. 
Different system but general 
comments and results in line 
with other studies. 
Conclusions are justified in line 
with research conducted 
 Implications for 
policy 
 Yes – clear messages for 
policymakers – tech imp and 
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Heading Subheading  For completion by reviewers 
time / resource needed for 
adaptation … 
Possible 
 Implications for 
practice 
 Useability v tech / time to imp 
Possible 
Other 
comments 
Format  Very well formatted and 
constructed 
 Links to other 
references to be 
followed up 
 None 
Decision Name of second 
reviewer 
 SC 
 Agreement with 
reviewer 
 Yes 
 Inclusion  YES 
 Date  17 Dec 2013 DHM and SC 
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Appendix 3.5: Blank quality assessment form 
 
Citation  
1) Was there a clear statement of the aim of the research? 
Yes / No / Partial 
 
2) Was a qualitative methodology appropriate? 
Yes / No / Partial 
 
3) Was the research design appropriate to address the aim of the research? 
Yes / No / Partial 
 
4) Was the recruitment strategy appropriate to the aim of the research? 
Yes / No / Partial 
 
5) Were data generated in a way that addressed the research issue? 
Yes / No / Partial 
 
6) Was the relationship between researcher and participants adequately considered? 
Yes / No / Partial 
 
7) Were ethical issues taken into consideration? 
Yes / No / Partial 
 
8) Was the data analysis sufficiently rigorous? 
Yes / No / Partial 
 
9) Was there a clear statement of findings? 
Yes / No / Partial 
 
10) How valuable is the research? 
 
Summary 
 
Inclusion/Exclusion in SR 
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Appendix 3.6: Quality assessment form with included paper (310) 
Citation: Rahmner BP, Andersén-Karlsson E, Arnhjort T, Eliasson M, Gustafsson L, 
Jacobsson L, Ovesjo M, Rosenqvist U, Sjoviker S, Tomson G, Holmstrom I. Physicians’ 
perceptions of possibilities and obstacles prior to implementing a computerised drug 
prescribing support system. International Journal of Health Care Quality and Assurance 
incorporating Leadership in Health Services. 2004;17:173–9. 
1) Was there a clear statement of the aim of the research? 
Yes / No / Partial 
The aim of the research was clearly stated inclusive if it's relevance and 
importance in the background information. The aim of the study is set in the 
context of existing knowledge and understanding. New areas for investigation are 
not outlined. 
2) Was a qualitative methodology appropriate? 
Yes / No / Partial 
A qualitative method is appropriate in order to identify and interpret physicians’ 
perceptions of possibilities and obstacles prior to implementing a computerised 
prescription system with decision support. 
3) Was the research design appropriate to address the aim of the 
research? 
Yes / No / Partial 
The researchers have justified the research design and discussed how they 
decided which method to use in order to identify physicians perceptions and 
obstacles. However, no limitations of research design outlined. The implications 
for the study evidence is evident as well as the use of quality criteria inclusive of 
credibility, dependability, confirmability and transferability as explained in the 
discussion of the method section. 
4) Was the recruitment strategy appropriate to the aims of the research? 
Yes / No / Partial 
The researchers have explained how the ED participants were selected which was 
after training in the prescribing support system. They have not explicitly 
explained why physicians were the most appropriate participants to provide 
access to the type of knowledge sought by the study - presumably because they 
prescribe. They have discussed recruitment and that all physicians in the ED 
agreed to participate. A comprehensive description of the study location 
characteristics is provided but no detail is provided of exactly how and why this 
hospital and ED were chosen. The rationale for the selection of target sample and 
settings are not provided such as the basis for inclusions and exclusions. Sample 
size is discussed. 
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5) Were data generated in a way that addressed the research issue? 
Yes / No / Partial 
The setting for data collection was justified and it is clear how data were collected 
using individual interviews. The researchers have justified the methods chosen 
and have made the methods explicit using a semi-structured interview manual 
and that interviews took place in the physicians’ workplace. It is unknown if the 
methods were modified during the study and the researchers have not discussed 
saturation of data. The form of data is clear which was tape recorded and they 
have discussed who conducted data collection and demonstrated, through 
portrayal and use of data, that depth, detail and richness were achieved in 
collection. 
6) Was the relationship between researcher and participants adequately 
considered? 
Yes / No / Partial 
The researchers appear to have critically examined their own role, potential bias 
and influence during formulation of the 3 main research questions (not leading) 
and data collection, including sample recruitment and choice of location which 
was clearly detailed. However, no reasons provided why only physicians were 
interviewed. There is no evidence of how the researchers responded to events 
during the study and whether they considered the implications of any changes in 
the research design.  
7) Were ethical issues taken into consideration? 
Yes / No / Partial 
There are sufficient details provided of how the research was explained to 
participants for the reader to assess whether ethical standards were maintained. 
The researchers have partially discussed issues raised by the study around 
informed consent and confidentiality but not on how they have handled the 
effects of the study on the participants during and after the study or of data 
management and protection. Ethical approval was applied for retrospectively 
which 'raised no objections' to the study - not documented why a retrospective 
application was sought. 
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8) Was the data analysis sufficiently rigorous? 
Yes / No / Partial 
There is an in-depth description of the analysis process provided using an 
inductive thematic analysis and it is very clear how the categories and themes 
were derived from the data. The researchers have explained how the data 
presented were selected from the original sample to demonstrate the analysis 
process using verbatim quotes. There is sufficient data presented to support the 
findings. Whilst contradictory data are not taken into account, the researchers 
have critically examined their own role, potential bias and influence during 
analysis and selection of data for presentation using 3 independent individuals 
with different backgrounds and increasing the study's reliability.   
9) Was there a clear statement of findings? 
Yes / No / Partial 
The findings are explicit and there is adequate discussion of the evidence for the 
researcher’s findings but not against. The researchers have discussed the 
credibility of their findings using triangulation but not in relation to respondent 
validation. The findings are discussed in relation to the original research aim and 
the background literature review summarises knowledge to date and key issues 
raised by previous research. There is a description of an appraisal criteria used in 
the quality in the discussion of the method section. A clearly constructed thematic 
account is provided with key messages highlighted and summarised. There is no 
discussion of the limitations of study in meeting aims. 
10) How valuable is the research? 
The researchers discuss the contribution the study makes to existing knowledge 
and understanding as well as the value of the findings in relation to current 
practice and relevant research-based literature. They have not identified new 
areas where research is necessary. The researchers have discussed how the 
findings can be transferred to other populations by stating that they do not argue 
that the results can be generalised to a larger group other than ED. The strengths 
of the data sources and methods are discussed but not the weaknesses or 
limitations of evidence and what remains unknown and unclear. 
Summary 
Excellent detail on methods and data collection and analysis. Implications for 
policy practice and theory are unknown as setting in an ED and not a general 
medical or surgical ward but a good mix of patients enter ED. No documentation 
of bias and no mention of limitations. Themes in line with other research. Overall, 
a very useful qualitative study well described and executed with a clear 
description of approach to analysis. 
Inclusion/Exclusion 
Inclusion 
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Appendix 3.7: Data extraction form summary of papers excluded 
Source Reason for exclusion Rating 
A network collaboration 
implementing technology to 
improve medication 
dispensing and 
administration in critical 
access hospitals (313) 
Not much detail or depth into methods 
or analysis. Conclusions based on 
literature rather than primary 
qualitative research results/analysis. 
Some insightful aspects to successful 
implication for policy and practice but 
robustness appears to be an issue 
therefore drawing conclusions difficult. 
Seems to draw many conclusions that 
are possibly not directly relating to the 
results. Difficult to determine how 
these conclusions were drawn. Also 
refers to some aspects such as 
improved safety which are difficult to 
quantity since insufficient data is 
provided. 
 
The key message appears to be to 
employ HIT to improve patient care 
quality and safety but much of the 
conclusion refers to references rather 
than the primary qualitative research 
conducted 
4 
Learning lessons from 
electronic prescribing 
implementations in 
secondary care (313) 
 
No great depth in methods e.g. how 
many interviewers, how many 
interviewees declined, how data 
collected and analysed, confidentiality, 
results generic ie no account on who 
said what or comparisons/contracts of 
themes from different disciplines. 
Future work required. Possible 
implications for policy, practice and 
theory 
3-4 
E-Prescribing Collaboration 
in Massachusetts: Early 
Experiences from Regional 
Prescribing Projects (314) 
Not really a primary research paper – 
first part on primary care is largely 
descriptive not inclusion of aim/ 
objective/methods. Second part is the 
same but some useful background 
information relating to barriers but 
since again not done with robust 
research methods this would be of use 
simply for information not inc in SR. 
 
Vague descriptions of pilot sites, no 
clarification if views were from the 
3-4 
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Source Reason for exclusion Rating 
authors, clinicians or ‘office staff’. No 
mention of selection number, 
interviews or focus groups in 3 sites. 
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Appendix 4.1: Research project proforma 
 
 
SCHOOL OF PHARMACY  
RESEARCH PROJECT PROFORMA FOR ETHICAL APPROVAL 
 
Title 
Exploring the facilitators and barriers towards implementation of electronic 
prescribing, dispensing, and administration of medicines in hospitals in Ireland 
 
Academic Staff 
Diana Hogan-Murphy, Dr Scott Cunningham (principal supervisor), Antonella Tonna, 
Derek Stewart, Alison Strath 
 
External Collaborator(s)  
Anita Weidmann 
 
Research question, aim and objectives 
Research question 
What are the facilitators and barriers towards implementation of electronic 
prescribing, dispensing, and administration of medicines in hospitals in Ireland? 
 
Research aim 
To explore the various facilitators and barriers towards implementation of electronic 
prescribing, dispensing, and administration of medicines in hospitals in Ireland 
 
Objectives 
 
Phase 1 Objective - Systematic Review 
 Identify and critically review the literature to explore healthcare professionals’ 
perceptions, attitudes, and views of the facilitators and barriers to implementing 
electronic prescribing, electronic dispensing, and/or electronic administration of 
medicines in the hospital setting.  
  
 Synthesise available evidence to identify, describe, and understand healthcare 
professionals’ perceptions, attitudes, and views of the facilitators and barriers to 
implementing electronic prescribing, electronic dispensing and/or electronic 
administration of medicines in the hospital setting.  
 
Phase 2 Objective – National and Local Exploration 
 To explore the perceptions of eHealth national leads, national key stakeholders and 
local key stakeholders towards the facilitators and barriers to system implementation 
in hospitals in Ireland. 
  
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 To explore the experiences and vision of eHealth national leads, national key 
stakeholders, and local key stakeholders towards system implementation in hospitals 
in Ireland. 
 
It is anticipated that end-users, implementers, and evaluators will use these 
recommendations when planning, implementing and maintaining these systems post 
communication of results to relevant stakeholders in the Department of Health, the 
Health Service Executive and all hospital trusts. As this area is dynamic in nature, 
implementation recommendations need to take the evolving nature of systems into 
account.     
 
Background 
There are increasing opportunities in the hospital setting to improve medicines 
management due to advances in eHealth such as the use of electronic prescribing 
and automated dispensing systems in order to reduce medication errors. Whilst 
numerous studies advocate the use of eHealth in improved efficiency and 
effectiveness of information management and decision-making within the health 
service, their rate of adoption in practice to date has been slow.  
 
Prompted by the lack of qualitative research into healthcare professionals’ 
perceptions of the various facilitators and barriers towards implementation of 
electronic prescribing, dispensing, and administration of medicines in hospitals, the 
aim of this research is to explore the various facilitators and barriers towards system 
implementation in hospitals in Ireland. Mixed methods are utilised to gain original 
insight into the views of healthcare professionals, eHealth national leads, national key 
stakeholders, and local key stakeholders on system implementation. 
 
A systematic review of the literature was conducted using the Cochrane Handbook for 
Systematic Reviews of Interventions and the PRISMA statement as a guide in order 
to enhance trustworthiness and robustness. Key facilitators to system 
implementation identified from the review included increased patient safety and 
better access to patients’ drug history whilst key barriers involved technical problems 
such as perceptions of a slow system and poor functionality as well as weakened 
interpersonal communication between healthcare professionals and with patients.  
 
The next phase of this research will involve conducting individual face-to-face 
interviews with eHealth national leads, national key stakeholders and local key 
stakeholders in order to explore their views and experiences for system 
implementation. Results from the systematic review and qualitative methods will be 
amalgamated and recommendations developed for successful system 
implementation. It is hoped that findings will be used to improve the current system 
in hospitals in Ireland and maximise the implementation and potential use of these 
systems in the future. 
 
Ethics 
Prior to commencing data collection, ethical approval will be sought by the Ethical 
Review Panel of the School of Pharmacy & Life Sciences at Robert Gordon University, 
the Regional Health Research Advisory Committee in the North East in Ireland,, and 
any other committee deemed necessary. Throughout this study, the research ethics 
and governance policies at Robert Gordon University and the participating 
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organisations and hospitals will be adhered to by prioritising the dignity, rights, 
safety and well being of the participants at all times and by using and protecting the 
research data appropriately (41-42). The Irish Data Protection (Amendment) Act 
2003 will also be adhered to. This primarily states that data may only be used for the 
specific purposes for which it is collected, that data must not be disclosed to other 
parties without the consent of the individual to whom it concerns, that individuals 
have a right of access to the information held about them, and that adequate security 
measures are in place for holding personal information. Furthermore, in accordance 
with this Act, data will not be retained for longer than necessary in order to fulfil the 
purpose for which the data was originally collected. 
 
Setting 
Interviews will be conducted in hospitals, offices, or in a convenient location for the 
participants.  
Sampling 
Both purposive sampling and snowball sampling will be employed in order to identify 
a range of relevant heterogeneous eHealth national leads, national key stakeholders 
and local key stakeholders for participation. This method yields a sample through 
referrals made among individuals who share characteristics that are of interest to the 
investigator. As part of the development process, the primary researcher will initially 
invite for interview eHealth national leads followed by national key stakeholder and 
finally local key stakeholders.  
 
For the purpose of this research, eHealth national leads are defined as individuals 
from the Department of Health and the Health Executive Service who are primarily 
involved in national hospital eHealth strategies, policies, guidelines and projects. 
National key stakeholders are individuals who are involved in/have a special interest 
in the implementation of eHealth strategies both nationally and regionally. Local key 
stakeholders are individuals who are involved in/have a special interest in the 
implementation of eHealth strategies locally. XX General Hospital and two other 
comparable general hospitals with a similar case-mix will be the focus for interviews 
with local key stakeholders.   
 
The primary researcher and supervisory team do not feel that bias has been 
introduced by the type of participants invited for participation as the objectives of 
this qualitative research are to explore both the facilitators and barriers and 
experiences of eHealth national leads, national key stakeholders and local key 
stakeholders towards implementation of electronic prescribing, dispensing, and 
administration of medicines in Ireland. Whilst participants are involved in/have a 
special interest in system implementation and are most likely interested in 
progressing and advancing these systems, it is anticipated that they will express 
many positive and negative views and experiences of adoption.  
 
With a sample frame of approximately 50, it is expected that this purposive and 
snowball technique will capture a broad variety of attributes, behaviours and 
experiences from different participants and assist the primary researcher and 
supervisory team in identifying common and diverse themes evident across the 
sample. In addition, the adoption of research methods and theories well established 
as well as the development of an early familiarity with the culture of participants 
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prior to data collection will promote confidence. This will be achieved via consultation 
of appropriate documents. 
 
Method of data collection 
An individual face-to-face semi-structured interview will be conducted with national 
eHealth leads, national key stakeholders and local key stakeholders until data 
saturation has been reached. It is anticipated that up to ten national eHealth leads, 
20 national key stakeholders and 20 local key stakeholders will be included.  
Interviewing both national eHealth leads and national key stakeholders on the 
various facilitators and barriers to system implementation will provide rich original 
data owing to their knowledge, experience and vision for future adoption. From a 
local perspective, the supervisory team believed that local key stakeholders would be 
of equal benefit in understanding their views of system implementation from an 
individual and organisational viewpoint.  Site triangulation will be achieved by the 
participation of a range of professionals within several comparable hospitals so as to 
reduce the effect of local factors particular to one institution. Findings can then be 
understood within the context of the particular characteristics of the organisation.  
 
Conducting face-to-face individual interviews was believed to be more superior in this 
setting than employing other methods such as individual phone interviews or focus 
groups as it facilitates more detailed data sharing and data retrieval by participants. 
However, it is acknowledged that this method is both labour intensive and costly.  
 
Piloting & trustworthiness of research 
As part of the piloting and trustworthy exercise, an interview schedule will be 
developed by the primary researcher and agreed with the supervisory team in order 
to facilitate the individual face-to-face interviews. This will be informed by a literature 
search. In order to establish if the semi-structured questions in the interview 
schedule appear to be trustworthy to the research objective, and to verify if these 
questions reflect relevant data from the systematic review and literature review, it 
will be tested for face and content trustworthiness by all members of the supervisory 
team. Through an inductive approach amendments will be made as necessary. 
 
A local consultant doctor, senior pharmacist and senior management team member 
will be requested to pilot and comment on the format and content of the open-ended 
and closed-ended questions. Data from the pilot will not be included in the final 
dataset. Amendments will be made as necessary in consultation with the supervisory 
team. 
 
Data generation 
Participants will initially be invited to participate in the research via a letter of 
information which will provide an overview of the study. If they accept to be 
interviewed, they will then be requested to sign two consent forms, a copy for the 
participant and a copy for the primary researcher, confirming that they have agreed 
to participate in the study, that the interview will be audio-recorded and that use of 
anonymous quotations may be used in this research and/or further publications. A 
follow-up telephone conversation will ensue and once a convenient time and location 
is arranged for each of the individual face-to-face semi-structured interviews to take 
place, all participants will be sent a confirmation email of the time and place of the 
scheduled interview and a reminder to bring the signed consent forms. To assist in 
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ensuring the honesty and integrity of participants, the independent status of the 
interviewer will be emphasised in order to encourage frankness. Reassurance that all 
information provided by the participants will be strictly confidential and that 
withdrawal from the study at any time is permissible will be documented in the 
information letter and reiterated verbally during the interview schedule. Participants 
will also be informed that this research has been approved by the ethical review 
panel of the School of Pharmacy & Life Sciences at Robert Gordon University, the 
Regional Health Research Advisory Committee in the North East and any other 
committee as necessary. If the signed consent forms have not been delivered, the 
participants will be requested to sign them again. 
 
Individual interviews will then be carried out with each participant over approximately 
45 minutes by the primary researcher. An interview schedule will be used to facilitate 
each of the interviews in order to maintain consistency between participants and to 
retrieve reliable data. Questions will be both open-ended and closed-ended based on 
results from the systematic review, literature review and relevant questions relating 
to their views and experiences for system implementation inclusive of facilitators and 
barriers to successful implementation. Where contradictions emerge through iterative 
questioning, the primary researcher will discard that data. Frequent debriefing and 
collaborative sessions between the primary researcher and the supervisory team in 
order to develop ideas and interpretations and receive constructive criticism will take 
place. 
 
Discussions will be audio-recorded, transcribed verbatim within 48 hours of each 
interview, read several times and analysed by the primary researcher using the 
Normalisation Process Theory. Data will be coded to the 4 constructs and overall 
degree of normalisation in order to develop a coding framework. This framework will 
then be tested and if necessary refined by the research team and reapplied to the 
previously coded interviews and all subsequent interviews by the research team. 
NVivo 10 will be used to facilitate data management. This software provides a range 
of analysis frameworks for importing, classifying and arranging data. 
 
To enhance the trustworthiness and reduce any bias of the findings, 10% of the 
transcripts will be independently reviewed by the principal supervisor who has 
experience in qualitative analysis. 
 
Data storage and analysis 
All data collected and analysed will be stored on a personal password protected 
computer with encryption, firewall protection and anti-virus software only accessible 
by the primary researcher. Consent forms will be scanned, saved and destroyed in 
accordance with the Irish Data Protection (Amendment) Act 2003.   
 
Digital recordings of interviews will be on SD media card; media files will be 
transferred immediately after interviews for storage & transcription and media cards 
will be wiped clean. The recordings of all interviews will be destroyed after 
transcription has been checked. Transcriptions will be stored in a locked cupboard 
and destroyed 5 years after publication. All computer files will be password protected. 
Names will not be recorded as part of the interviews – each participant will be 
allocated a code and described by that code throughout. Participants can also ask 
that the recorder is switched off at any time and can also withdraw from the study at 
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any time, without giving any reason. 
Outcome measures 
Outcome measures will include analysis of the various views, experiences and vision 
of interviewees inclusive of the facilitators and barriers to system implementation in 
hospitals in Ireland.  Results from the systematic review and qualitative methods will 
be amalgamated and recommendations developed for successful system 
implementation.  
 
Dissemination of results 
Results will be communicated via post and an email to all participants and thereafter 
presented at both national and international conferences and published in appropriate 
high impact factor journals. 
 
Theoretical underpinning 
The research objective terms inclusive of explore, views, experiences, barriers, 
facilitators, reject the positivist paradigm which is typically quantitative in nature and 
reflects the interpretivist/constructivist paradigm which is typically qualitative in 
nature. This allows reality to be socially constructed where the researcher tends to 
rely upon the participants’ views of the phenomenon of interest. Although 
interpretive, which can be considered subjective, the primary researcher will make 
every effort to represent the participant’s voice. Triangulation, independent reviewing 
of a proportion of the transcripts and the extent to which the primary researcher 
admits her own predispositions will be emphasised in order to reduce the effect of 
bias. This will help to ensure that research findings are the result of the experiences 
and ideas of the participants rather than the characteristics and preferences of the 
primary researcher.  
 
Frameworks for ensuring the trustworthiness and rigour of this qualitative research 
will be addressed in the form of Guba’s four constructs: credibility, transferability, 
dependability and cofirmability.  
 
Triangulation involving the use of mixed methods inclusive of findings from the 
systematic review, individual semi-structured interviews and supporting data will be 
integrated to enhance credibility. This will assist in understanding the views, attitudes 
and behaviours of both system end-users and professionals responsible for the 
management and delivery of these systems and to enhance the contextual data 
relating to the individual organisations.  
 
Peer and academic scrutiny of the research project will continue to be welcomed in 
order to refine the methods employed, develop a greater explanation of the research 
design and strengthen arguments as necessary. A reflective commentary inclusive of 
progressive subjectivity and monitoring of the primary researchers developments via 
research experience and expanding research skills will assist in ensuring 
trustworthiness and credibility. Examination of previous research findings will allow 
comparisons and contrasts be made to current findings with reasons provided.  
 
A description of contextual factors such as participants working environment is 
important to assist in transferability. Information such as the number of participants 
involved and where they are based, any restrictions in the type of participants who 
will participate, the number and length of the data collection sessions and the time 
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period over which the data will be collected will be provided in order to convey the 
boundaries of the study.  
 
Dependability will be offered through the use of mixed methods and detailing the 
processes within the study. Included will be the research design and its 
implementation, details of data gathering and reflective appraisal of the research. 
This in-depth methodological description will allow the study to be repeated.  
 
The audit trail inclusive of how recommendations were gathered and processed as 
well as how the theoretical concepts inherent in the research objectives were applied 
throughout the research will be represented schematically. 
 
The personal experience and training of the primary researcher has continued to 
broaden during this research to consider a more naturalistic human approach to 
system implementation and to understand the complexities involved through the 
Normalisation Process Theory (NPT). This sociological theory has been widely 
promoted to understand implementation and integration of innovation in healthcare 
settings. It focuses on work that individuals and organisations must execute for a 
new technology or practice to become embedded and sustained in routine practice 
and is used as a conceptual framework to explore the gap between health research 
evidence, policy and practice.  
 
The four concepts of the theory include: 
 Coherence: the process and work of sense-making and understanding that 
individuals and organisations have to experience in order to promote or inhibit the 
routine embedding of a practice. 
 Cognitive Participation: the process and work that individuals and organisations have 
to experience in order to enrol individuals to engage with the new practice. 
 Collective Action: the work that individuals and organisations have to execute to 
enact the new practice. 
 Reflexive Monitoring: the work inherent in the informal and formal appraisal of a new 
practice when implemented in order to assess its advantages and disadvantages and 
develop users’ comprehension of the effects of a practice. 
 
Given its sociological origins, this theory does not focus on the relationship between 
individual attitudes, intentions and behavioural outcomes but pays attention to how 
knowledge is held, transferred and created within and across professional groups. It 
also seeks to understand the work that clinicians, implementers and patients alike 
have to engage in to implement new knowledge in practice. 
 
The provisions described above and throughout this ethical performa report using 
appropriate paradigms and theories will be embedded within this qualitative research 
in order to enhance its trustworthiness. 
Novelty of research 
All phases of this research are novel inclusive of the systematic review and 
qualitative methods. It is evident from the work completed to date that this area is 
under-researched and that findings will contribute to original knowledge. It is 
intended that this exploration will provide a unique insight into the various facilitators 
and barriers towards implementation of electronic prescribing, dispensing, and 
administration of medicines in hospitals in Ireland and make a significant contribution 
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to the research subject. 
 
Impact of research 
It is anticipated that findings will be used to improve the current system and 
maximise the potential use of electronic prescribing, dispensing, and administration 
of medicines in the hospital setting in Ireland in the future. It is planned that end-
users, implementers and evaluators will use the recommendations provided when 
planning, implementing and maintaining these systems.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
282 
Appendix 4.2: RESSA form 
 
 
 
The aim of the University’s Research Ethics Policy is to establish and promote 
good ethical practice in the conduct of academic research. The questionnaire is 
intended to enable researchers to undertake an initial self-assessment of ethical 
issues in their research. Ethical conduct is not primarily a matter of following 
fixed rules; it depends on researchers developing a considered, flexible and 
thoughtful practice.  
 
The questionnaire aims to engage researchers discursively with the ethical 
dimensions of their work and potential ethical issues, and the main focus of any 
subsequent review is not to ‘approve’ or ‘disapprove’ of a project but to make 
sure that this process has taken place. 
 
The Research Ethics Policy is available at:  
www.rgu.ac.uk/credo/staff/page.cfm?pge=10193  
 
Research Student 
Name 
Diana Hogan-Murphy 
Study Coordinator Scott Cunningham 
Research Project 
Title 
Exploring the facilitators and barriers towards 
implementation of electronic prescribing, dispensing, and 
administration of medicines in hospitals in Ireland 
Research Institute/ 
School/Centre  
Robert Gordon University – IHW  
 
Parts 1-5: To be completed by the Research Student 
 
Part 6: To be completed by the Principal Supervisor 
 
 
PART 1: DESCRIPTIVE QUESTIONS 
1
. 
Does the research involve, or does information in the research 
relate to: 
[see Guidance Note 1] 
Y
e
s 
N
o 
 (a) individual human subjects X  
 (b) groups (e.g. families, communities, crowds)  X 
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 (c) organisations X  
 (d) animals?  X 
 Please provide further details: 
  
 Individual face-to-face semi-structured interviews will be conducted with eHealth 
national leads and both national and local key stakeholders in order to explore 
their perceptions and experiences towards the implementation of electronic 
prescribing, dispensing, and administration of medicines in hospitals in Ireland 
 
2
. 
Will the research deal with information which is private or 
confidential?  
[see Guidance Note 2] 
Y
e
s 
N
o 
x  
 Please provide further details: 
 eHealth national leads and key stakeholders will initially be invited to 
participate in the research via a letter of invitation which will provide an 
overview of the study. Included in this letter will be a participant information 
sheet, two consent and copyright clearance forms and a reply slip stating a 
convenient time and location for the interview to take place. If the invitee 
accepts the invitation to be interviewed, they will be requested to sign two 
consent forms, a copy for themselves and a copy for the primary researcher, 
confirming that they have agreed to participate in the study, that the 
interview will be audio-recorded and that use of anonymous quotations may 
be used in this research and/or further publications.  
All data collected will be anonymised, stored on a password protected PC 
with anti-virus software and firewall protection, encrypted and and only 
accessible by the research team within a secure university network. The 
names of all the interviewees will be coded with numbers in order to protect 
their identity. The codes will only be known to the primary researcher and 
interviewees will only be referred to by number during the audio digital 
recordings and transcripts. 
 
PART 2: THE IMPACT OF THE RESEARCH 
3
. 
In the process of doing the research, is there any potential for 
harm to be done to, or costs to be imposed on: [see Guidance 
Note 3(i)] 
Y
e
s 
N
o 
 (a) research participants?  x 
 (b) research subjects? [see Guidance Note 3(ii)]  x 
 (c) you, as the researcher?  x 
 (d) third parties? [see Guidance Note 3(iii)]  x 
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 Please state what you believe are the implications of the research: 
  
4
. 
When the research is complete, could negative consequences 
follow: 
Y
e
s 
N
o 
 (a) for research subjects  x 
 (b) or elsewhere? [see Guidance Note 4]  x 
 Please state what you believe are the consequences of the research: 
  
 
PART 3: ETHICAL PROCEDURES 
5
. 
Does the research require informed consent or approval from: 
[see Guidance Note 5(i)] 
Y
e
s 
N
o 
 (a) research participants? x  
 (b) research subjects? [see Guidance Note 5(ii)]  x 
 (c) external bodies? [see Guidance Note 5(iii)] x  
 If you answered yes to any of the above, please explain your answer: 
 This project will be approved by the ethical review panel at Robert Gordon 
University and the Dublin North East ethical advisory board. Once approved, 
a written informed consent and copyright form will be posted to each 
participant which will need to be completed, signed and returned to the 
primary researcher prior to the face-to-face interviews being conducted. 
Receipt of the completed consent and copyright form will signify informed 
consent. 
 
6
. 
Are there reasons why research subjects may need safeguards or 
protection? [see Guidance Note 6] 
Y
e
s 
N
o 
 x 
 
If you answered yes to any of the above, please state the reasons and 
indicate the measures to be taken to address them: 
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7
. 
Are specified procedures or safeguards required for recording, 
management, or storage of data? [see Guidance Note 7] 
Y
e
s 
N
o 
x  
 If you answered yes to any of the above, please give details: 
 All data collected will be anonymised, stored on a password protected work 
PC with anti-virus software and firewall protection, encrypted and only 
accessible by the research team via a secure university network. The names 
of all the interviewees will be coded with numbers in order to protect their 
identity. The codes will only be known to the primary researcher 
interviewees and will only be referred to by number during the audio digital 
recordings and transcripts. 
 
 
PART 4: THE RESEARCH RELATIONSHIP 
8
. 
Does the research require you to give or make undertakings to 
research participants or subjects about the use of data? [see 
Guidance Note 8] 
Y
e
s 
N
o 
x  
 If you answered yes to the above, please outline the likely undertakings: 
 Reassurance that all information provided by the participants will be strictly 
confidential and that withdraw from the study at any time will be stated. 
9
. 
Is the research likely to be affected by the relationship with a 
sponsor, funder or employer? [see Guidance Note 9] 
Y
e
s 
N
o 
 x 
 
If you answered yes to the above, please identify how the research may be 
affected: 
  
 
PART 5: OTHER ISSUES 
1
0
. 
Are there any other ethical issues not covered by this form which 
you believe you should raise? 
Y
e
s 
N
o 
 x 
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STATEMENT BY STUDENT 
I believe that the information I have given in this form is correct, and 
that I have addressed the ethical issues as fully as possible at this stage. 
Signatur
e: 
Diana Hogan-Murphy 
D
a
t
e
: 
28/10/2014 
 
If any ethical issues arise during the course of the research, students should complete a 
further RESSA form. 
 
The Research Ethics Policy is available at www.rgu.ac.uk/credo/staff/page.cfm?pge=10193. 
 
PART 6: TO BE COMPLETED BY THE PRINCIPAL SUPERVISOR 
1
1
. 
Does the research have potentially negative implications for the 
University?  
[see Guidance Note 10] 
Y
e
s 
N
o 
  
 If you answered yes to the above, please explain your answer: 
  
1
2
. 
Are any potential conflicts of interest likely to arise in the course 
of the research? [see Guidance Note 11] 
Y
e
s 
N
o 
  
 If you answered yes to the above, please identify the potential conflicts: 
  
1
3
. 
Are you satisfied that the student has engaged adequately with 
the ethical implications of the work? [see Guidance Note 12] 
Y
e
s 
N
o 
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 If you answered no to the above, please identify the potential issues: 
  
1
4
. 
Appraisal: Please select one of the following 
 
i. The research project should proceed in its present form – no further 
action is required 
 
 
ii. The research project requires ethical review by the University’s 
Research Ethics Sub-Committee 
 
 
iii. The project needs to be returned to the student for modification 
prior to further action 
 
 
iv. The research project requires ethical review by an external body  
(N.B. Question 5 above). If this applies, please give these details: 
 
 
Title of External Body providing 
ethical review 
 
 Address of External Body  
 
Anticipated date when external 
Body may consider project 
 
AFFIRMATION BY PRINCIPAL SUPERVISOR 
I have read the student’s responses and have discussed ethical issues 
arising with the student. I can confirm that, to the best of my 
understanding, the information presented by the student is correct and 
appropriate to allow an informed judgement on whether further ethical 
approval is required. 
Signature: 
 
Date: 23/11/2014 
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Appendix 4.3: Letter of invitation 
 
Date 
 
Key stakeholders’ perceptions towards the implementation of electronic 
prescribing, dispensing, and administration of medicines in the hospital setting. 
 
Dear  
As part of research for a PhD through The Robert Gordon University in Scotland, I am a 
senior pharmacist in Cavan General Hospital currently undertaking a study on the above 
title. The objectives of this qualitative research are to explore your perceptions and 
experiences on the various facilitators and barriers towards system implementation.  
Your participation will help inform successful system implementation in order to reduce 
medication errors and cost and optimise patient care and efficiency. Taking part will 
involve an individual face-to-face semi-structured interview not lasting more than 45 
minutes at a location convenient to you. Enclosed are further details of the study and 
information regarding your participation in the interview. If you are interested in 
participating in this study, please return the enclosed consent and copyright clearance 
form as well as the reply slip regarding a suitable time and place to conduct the interview 
in the enclosed envelope.  
 
If you have any questions, please do not hesitate to contact me on 0868114674 or email 
dianahoganmurphy@gmail.com. Alternatively, you can contact my primary supervisory 
Dr Scott Cunningham on +44122462533 or email s.cunningham@rgu.ac.uk. 
 
Yours sincerely, 
 
 
 
_____________________________________ 
Diana Hogan-Murphy, PhD Student, School of Pharmacy & Life Sciences, The Robert 
Gordon University 
Research team: Diana Hogan-Murphy, Dr Scott Cunningham, Dr Antonella Tonna, Prof 
Derek Stewart, Prof Alison Strath 
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Appendix 4.4: Participant information sheet 
 
Before you decide to take part in this study, I kindly request you to carefully read the 
information provided below relating to this project. This will assist you in understanding 
why the research is being conducted and what it will involve. Please feel free to discuss 
this with others or ask me about any matters you may find unclear. Thank you for your 
time in reading this. 
 
1. What is the purpose of the study? 
The aim of this research is to explore your perceptions and experiences on the various 
facilitators and barriers towards the implementation of electronic prescribing, dispensing, 
and administration of medicines in the hospital setting.  The study and your participation 
will help inform successful implementation in order to reduce medication errors and cost 
and optimise patient care and efficiency.  
 
2. Why have I been chosen? 
You have been selected because you are a key stakeholder in the area of electronic 
prescribing, dispensing and/or administration of medicines and could provide very useful 
information on the subject matter. 
 
3. Do I have to take part? 
Participation in the interview is voluntary. Your decision to participate will not affect your 
relationship with the University or the research team. If you decide to take part, you will 
be requested to sign a consent and copyright clearance form. You are still free to 
withdraw from the study at any time and without giving a reason. 
 
4. What should I do if I take part? 
If you are willing to take part, please complete and return the consent and copyright 
clearance form as well as the reply slip specifying a suitable date, time and venue 
convenient to you in the envelope provided. You will have agreed to participate in an 
individual face-to-face interview that will last no longer than 45 minutes.  
 
5. What will happen to the results of the research study? 
Results of the research study will be disseminated at conferences and submitted for 
publication to healthcare journals. A brief report of the result of the study will be 
available in 2017 and you may obtain a free copy from the RGU contact list provided 
below. 
 
6. What are the possible benefits of taking part? 
You will have the opportunity to express your views and experiences on the facilitators 
and barriers to system implementation. Your views may play an important role relating 
to the future provision of system implementation. 
 
7. Will my taking part in this study be confidential? 
With your permission, data will be audio recorded and transcribed into an electronic 
document. All transcripts, data analysis and reporting of the study results will be 
anonymous and stored securely with password protection on a computer only accessible 
to me and the research team.  
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8. Who has reviewed the study? 
This study has been reviewed and approved by the Ethical Review Panel of the School of 
Pharmacy & Life Sciences at Robert Gordon University and three Irish Regional Ethics 
Committees. 
 
9. Who is organising and funding the research? 
This research is being organised by the School of Pharmacy and Life Sciences, The Robert 
Gordon University, Aberdeen. The PhD student is not supported by a grant. 
 
10. What if I have a complaint?  
If you have a complaint about the way you have been approached or treated during this 
study, please contact me or alternatively my principal supervisor Dr Scott Cunningham. 
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Appendix 4.5: Interview consent and copyright clearance form for 
participant 
 
Title of the project: Key stakeholders’ perceptions towards the implementation of 
electronic prescribing, dispensing, and administration of medicines in the hospital setting. 
 
Name of the principal researcher: Diana Hogan-Murphy, School of Pharmacy & Life 
Sciences, The Robert Gordon University, Aberdeen. Email: 
dianahoganmurphy@gmail.com 
 
1. I confirm that I have read and understand the information sheet 
dated 15/01/2016 for the above study. I have had the opportunity to 
consider the information and ask questions with satisfactory 
answers. 
 
2. I understand that my participation includes my involvement in an 
individual face-to-face interview lasting 45 minutes or less. 
 
3. I agree that the interview will be audio recorded and transcribed into 
an electronic document. 
 
 
4. I understand that my name will not be included anywhere in the 
report of the findings and grant copyright permission on the 
understanding that my confidentiality will be protected. 
 
5. I understand that all material will be preserved for the life of the 
research project and may be used in publications, education, 
lectures and broadcasting. I understand that all contributions will be 
anonymised and that all data collected will be stored on a password 
protected computer with anti-virus software and firewall protection, 
encrypted and only accessible by the research team. 
 
6. I understand that my participation in this study is entirely voluntary 
and I am free to withdraw at any time without giving a reason. 
 
 
7. I agree to take part in the above study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
______________________    ______________  _________________________ 
Name of participant                 Date                           Signature 
 
 
_______________________    _____________    ________________________ 
Researcher             Date                            Signature 
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Appendix 4.6: Interview consent and copyright clearance form for 
researcher 
 
Title of the project: Key stakeholders’ perceptions towards the implementation of 
electronic prescribing, dispensing, and administration of medicines in the hospital setting. 
 
Name of the principal researcher: Diana Hogan-Murphy, School of Pharmacy & Life 
Sciences, The Robert Gordon University, Aberdeen. Email: 
dianahoganmurphy@gmail.com 
 
1. I confirm that I have read and understand the information sheet 
dated 15/01/2016 for the above study. I have had the opportunity 
to consider the information and ask questions with satisfactory 
answers. 
 
2. I understand that my participation includes my involvement in an 
individual face-to-face interview lasting 45 minutes or less. 
 
3. I agree that the interview will be audio recorded and transcribed 
into an electronic document. 
 
4. I understand that my name will not be included anywhere in the 
report of the findings and grant copyright permission on the 
understanding that my confidentiality will be protected. 
 
5. I understand that all material will be preserved for the life of the 
research project and may be used in publications, education, 
lectures and broadcasting. I understand that all contributions will 
be anonymised and that all data collected will be stored on a 
password protected computer with anti-virus software and firewall 
protection, encrypted and only accessible by the research team. 
 
6. I understand that my participation in this study is entirely 
voluntary and I am free to withdraw at any time without giving a 
reason. 
 
 
7. I agree to take part in the above study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
______________________    ______________  _________________________ 
Name of participant                 Date                           Signature 
 
 
_______________________    _____________    ________________________ 
Researcher             Date                            Signature 
 
  
293 
Appendix 4.7: Reply slip 
 
I will be available on the following date, time and place 
 
Date: ____________________ Time: __________________________  
 
Venue:___________________________________________________ 
 
Telephone number: 
_________________________________________(work/mobile/home) 
Email address: ____________________________________________ 
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Appendix 4.8: Letter of invitation reminder 
 
 
 
Date  
 
Dear 
 
This is a reminder to invite you to take part in an individual face-to-face interview. To 
date, I have not received a reply from you. I apologise if you have recently returned the 
reply slip. As outlined in the first letter, the aim of this research is to explore your views 
and experiences on the various facilitators and barriers towards the implementation of 
electronic prescribing, dispensing, and administration of medicines in the hospital setting.  
The study and your participation will help inform successful system implementation in 
order to reduce medication errors and cost and optimise patient care and efficiency. The 
interview will last no longer than 45 minutes. If you are willing to take part, please 
complete and send the consent and copyright clearance form as well as the reply slip in 
the pre-paid envelope by....(date).  
 
If you have any questions, please do not hesitate to contact me on 0868114674 or email 
dianahoganmurphy@gmaul.com. Alternatively please contact my principal supervisor Dr 
Scott Cunningham on +44122462533 or email s.cunningham@rgu.ac.uk.  
 
Yours sincerely, 
 
__________________________________________ 
 
Diana Hogan-Murphy, B.A., H.Dip(Comp.Sci.); M.A.(I.T.); B.Sc.(Pharm); M.Sc.(Clinical 
Pharm) 
PhD Student 
School of Pharmacy & Life Sciences 
Research team: Diana Hogan-Murphy, Dr Scott Cunningham, Dr Antonella Tonna, Prof 
Derek Stewart, Prof Alison Strath  
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Appendix 4.9: Interview confirmation letter 
 
 
 
Date  
 
Dear  
 
Thank you for agreeing to take part in an individual face-to-face interview on Thursday at 
approximately 1.30pm. As previously advised, the aim of this research is to explore your 
views and experiences on the various facilitators and barriers towards the 
implementation of electronic prescribing, dispensing, and administration of medicines in 
the hospital setting.  The study and your participation will help inform successful system 
implementation in order to reduce medication errors and cost and optimise patient care 
and efficiency.  
 
If you cannot attend for any reason, please contact me on 0868114674 or via email 
dianahoganmurphy@gmail.com. Thank you again for agreeing to take part. I look 
forward to meeting you on Thursday. 
 
Yours sincerely, 
 
__________________________________ 
 
Diana Hogan-Murphy, PhD student 
School of Pharmacy & Life Sciences  
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Appendix 4.10: Response from ethical approval application in RGU 
 
ROBERT GORDON UNIVERSITY 
SCHOOL OF PHARMACY AND LIFE SCIENCES 
ETHICAL APPROVAL FORM FOR UNDERGRADUATE, TAUGHT MSc, PhD AND EXTERNAL PROJECTS 
 
SECTION 1 – to be completed  
 
Research Student Name Diana Hogan-Murphy 
Study Coordinator Scott Cunningham 
Research Project Title 
Exploring the facilitators and barriers towards implementation of electronic prescribing, 
dispensing, and administration of medicines in hospitals in Ireland 
 
SECTION 2 – to be completed by the School Research Ethics Committee                   Date submitted to panel: 24.11.14 
 
Indicate Yes or No to 
each question and 
comment as appropriate. 
 Panel member 1 Panel member 2 Panel member 3 
 
Student Response 
Is the research question 
clear?  
Yes YES Yes 
No change 
Is the project scientifically 
robust? 
Yes YES 
Yes. However, the letter 
of information for the 
interviews claims that it 
is “planned that end-
users implementers and 
evaluators will use 
these findings… but the 
how is not shown. 
Please note addition 
highlighted in red on 
page 2 
 
Letter of information 
has altered to: 
- Letter of Invitation 
- Letter of Invitation 
Reminder (if 
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Indicate Yes or No to 
each question and 
comment as appropriate. 
 Panel member 1 Panel member 2 Panel member 3 
 
Student Response 
applicable) 
- Interview 
Confirmation Letter 
- Interview Participant 
Information Sheet 
- Interview Consent 
and Copyright 
Clearance Form 
- Interview Schedule 
Are the procedures for 
obtaining informed consent 
clear and appropriate? If an 
audit does the student have 
approved access to 
information? 
No, why is consent not 
being sought initially 
and reiterated if needed 
at each stage. From the 
executive summary 
appears consent is not 
obtained until interview.  
Confirmation of ethic 
approval is surely 
required prior to this 
data collection. The 
Letter of information 
does provide this 
information but it is not 
apparent from the 
executive summary or 
the RESSA form. 
YES – WOULD BE 
USEFUL FOR CONSENT 
FORM TO BE INCLUDED 
IN THE SUBMISSION 
Yes. 
Please note changes in 
red on page 8 under 
data generation and: 
- Letter of Invitation 
- Letter of Invitation 
Reminder (if 
applicable) 
- Interview 
Confirmation Letter 
- Interview Participant 
Information Sheet 
- Interview Consent 
and Copyright 
Clearance Form 
- Interview Schedule 
Is the extent of participant 
involvement clear? 
No, “multiple individual 
face-to-face- semi-
structured interviews” 
No information provided 
on number of interviews 
each participant will be 
YES Yes. 
Please note changes in 
red on page 6 under 
method of data 
collection. 
 
As this is a qualitative 
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Indicate Yes or No to 
each question and 
comment as appropriate. 
 Panel member 1 Panel member 2 Panel member 3 
 
Student Response 
involved with.  Or the 
actual number of 
participants involved or 
required to provide 
POWER to the study. 
study, the team felt 
that power is not a 
factor. 
Are the recruitment 
procedures ethical and 
appropriate? 
No, a degree of clarity 
required in both the 
RESSA form and 
Executive summary.  
Why is everything being 
passed by to the head 
of ethics?   
NO – NOT CLEAR HOW 
MANY PEOPLE MAY BE 
APPROACHED AND 
WHO KEY 
STAKEHOLDERS ARE 
Yes. What is the 
difference between the 
local/ national 
stakeholders and health 
professionals? 
Panel member 1: 
please note change in 
red on page 4 under 
ethics and data 
generation on page 12 
as well as addition of 
ethics to the 
participation 
information sheet and 
interview schedule 
 
Panel member 2 and 3:  
Please note change in 
red to sampling page 4 
and method of data 
collection page 6 
Are the inclusion and 
exclusion criteria relevant 
and appropriate? 
No 
NO – NO CLEAR 
STATEMENT OF 
INCLUSION/EXCLUSION 
CRITERIA APPARENT IN 
SUBMISSION. IN FULL 
PROPOSAL THERE ARE 
CRITERIA FOR 
SYSTEMATIC REVIEW 
OF LITERATURE ONLY. 
Mainly implied. Does 
the choice of 
participants not 
introduce a bias if they 
have a “special interest” 
in the introduction or 
advancement of 
electronic prescribing 
etc? 
Panel member 1 and 2: 
Please note change in 
red under setting and 
sampling on page 4 
 
Panel member 3:  
The team felt that the 
invitees represent a 
population who are 
experts or very 
knowledgeable in this 
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Indicate Yes or No to 
each question and 
comment as appropriate. 
 Panel member 1 Panel member 2 Panel member 3 
 
Student Response 
area and so would 
hugely contribute to 
this field. We felt no 
bias would be apparent 
as these participants 
have no doubt been 
faced with many 
obstacles and barriers 
as well as facilitators 
Is the extent and type of 
participant involvement 
ethical? 
(consider issues of 
unnecessary invasiveness, 
exposure, undue stress, 
anxiety and concern, 
inappropriate time 
commitments) 
Partially, the 
information provided in 
the letter of information 
makes no reference to 
follow up with the 
participants 
YES Yes 
The team felt due to 
the limitation of a PhD 
re time and personnel, 
no follow up could be 
facilitated. However, 
please note number 6 
in the participant 
information sheet and 
mention of results in 
the interview schedule 
Are there clear procedures 
for ensuring compliance 
with the Data Protection 
Act? 
Yes YES 
Mostly yes. Where will 
the password protected 
PC be based (is it work 
related or personal)? 
Please note change in 
red to data storage and 
analysis page 8 – work 
is better as information 
is also stored on  
network in case the 
hardware on a personal 
PC is destroyed and not 
retrievable 
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Please check the boxes 
below with your decision 
Panel member 1 Panel member 2 Panel member 3 
1.  Approved – submit to LREC / 
MREC as appropriate and provide 
copy of approval letter to 
supervisor OR provide supervisor 
with evidence that submission 
not necessary 
   
2.  NOT Approved – MINOR 
ISSUES approval subject to 
submitting a response, to ethics 
review panel via supervisor, 
addressing minor issues outlined 
above 
   
3.  NOT approved – MAJOR 
ISSUES serious issues of concern 
to be addressed and whole 
proposal to be resubmitted via 
supervisor for further ethical 
review. 
   
4.  NOT approved – UNETHICAL 
the study is unethical and a re-
submission will not be 
considered. 
   
Comments:   Please pay careful attention to the comments, particularly with reference to participant information before 
resubmission. 
 
  
  
301 
SECTION 3  - OVERALL ETHICAL DECISION to be completed by Chair of School Research Ethics Committee 
1.  Approved – submit to LREC / MREC as appropriate and provide copy of approval letter to supervisor OR  
      provide supervisor with evidence that submission to LREC / MREC not necessary   
2.  NOT Approved – MINOR ISSUES: subject to submitting a response, to ethics review panel via supervisor, addressing minor issues outlined above 
 
3. NOT approved – MAJOR ISSUES: there are serious issues of concern to be addressed and whole proposal to be resubmitted via supervisor for 
further ethics panel review.  
4. NOT approved – UNETHICAL: the study is completely unethical and a re-submission will not be considered.  Signed (on behalf of the School 
Research Ethics Committee)  Dr     Date: 16.12.14    
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Appendix 4.11: Ethical approval RGU 
 
School of Pharmacy and Life Sciences Research 
Ethics Committee 
Date 26th January 2015 
 
Research Project Title 
Exploring the facilitators and barriers towards 
implementation of electronic prescribing, dispensing, 
and administration of medicines in hospitals in Ireland 
 
Dear Diane, 
 
The School Research Ethics Committee has reassessed your application and the 
decision is that there are no ethical issues with your project.  
 
I can now confirm that you are able to proceed with your research and any further 
ethics applications.  
 
Should there be any amendments to this project during the research we would advise 
you to consult with the convener of the ethics committee as to whether a further 
ethical review would be required.  
We wish you success with your project. 
 
Regards 
 
Convener of the School Ethics Review Panel  
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Appendix 4.12: Letter to the general manager on research for information 
 
 
General Manager 
Address  
 
Date 
 
Re: Key stakeholders’ perceptions towards the implementation of electronic 
prescribing, dispensing, and administration of medicines in the hospital setting. 
 
Dear  
 
As part of research for a PhD through the Robert Gordon University in Scotland, I am a senior 
pharmacist in Cavan General Hospital currently undertaking a study on the above title. The 
objective of this qualitative research is to explore the perceptions of key stakeholders on the 
various facilitators and barriers towards system implementation.   
 
I would like to inform you that I wish to invite local key stakeholders in XX General Hospital to 
participant in a short individual face-to-face interview for this study. Participation will help 
inform successful system implementation in order to reduce medication errors and cost and 
optimise patient care and efficiency. It is planned that end-users, implementers and evaluators 
will use these findings when planning, implementing and maintaining electronic systems for 
prescribing, dispensing, and administering medicines in hospitals in Ireland.  
 
If you have any queries, please do not hesitate to contact me on 0868114674 or email 
dianahoganmurphy@gmail.com. Alternatively, you can contact my primary supervisory Dr 
Scott Cunningham on +44122462533 or email s.cunningham@rgu.ac.uk. 
 
Yours sincerely, 
 
______________________________________________ 
 
Diana Hogan-Murphy, PhD Student, School of Pharmacy & Life Sciences, Robert Gordon 
University, Aberdeen, UK 
Research team: Diana Hogan-Murphy, Dr Scott Cunningham, Dr Antonella Tonna, Prof Derek 
Stewart, Prof Alison Strath  
  
304 
Appendix 4.13: Ethical approval Hospital A 
 
 
 
         11TH January 2016    
Ms. Diana Hogan-Murphy 
Senior Pharmacist – Antimicrobial 
Pharmacy Department 
Cavan General Hospital 
 
 
 Re: Key Stakeholders perceptions, experiences and vision towards the implementation 
of electronic prescribing, dispensing, and administration of medicines in the hospital 
setting. 
========================================================================== 
 
Dear Diana,       
 
With reference to application listed above, your application has been considered by members of 
LUH Ethics Committee and I am happy on behalf of Letterkenny University Hospital Ethics 
Committee to grant Chairman’s approval.   
 
Please do not hesitate to contact me if you require any further information. 
 
Yours sincerely 
 
 
________________________ 
General Manager 
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Appendix 4.14: Ethical approval Hospital B 
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Appendix 4.15: Ethical approval Hospital C 
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Appendix 4.16: Initial draft of interview schedule 
Initial Questions 
1. Do you have any experience of implementing or using electronic prescribing, 
dispensing and/or administration systems in this hospital or other hospitals? 
2. IF YES AND ONLY FOR ONE MANAGEMENT INTERVIEWEE: Can u inform me how the 
project was initiated? How was the functional specification agreed? What was the 
procurement process e.g. business case? What was the contracting process?  
3. IF NO AND ONLY FOR MANAGEMENT INTERVIEWEES: How do you anticipate the 
project would be initiated? How do you feel the functional specification would be 
agreed? What would you envisage the procurement process to be e.g. business case? 
How would you envisage the contracting process? How would you envisage it to be 
implemented e.g. phased or all at once? 
4. What functionality do you feel is required for optimisation? 
 
Agree with interviewee on which aspect/systems will be the primary focus of the 
remaining questions - however each part cannot be viewed in isolation but are likely to 
have an impact on other parts of the system 
Local Key stakeholders 
Coherence: 
1. Can you highlight the differences between the traditional paper-based system and the 
electronic system? How did you/will you envisage organising your workload prior to, 
during and after implementation? [Differentiation - Distinguish the intervention from 
current ways of working]. 
2. What have you done/will you do to ensure that you/end users understand the benefits 
of the system for you/them and your/their work practices? How did you/will you work 
with staff in order to build a shared understanding of the aims, objectives, and 
expected benefits of these systems? Is there anything in particular that you have 
done/will do to promote or facilitate the implementation process? What sort of 
barriers did you/would you expect to encounter?  [Communal specification – 
collectively agree the purpose of the intervention]. 
3. What have you done/will you do to help you understand your specific tasks and 
responsibilities around implementing these systems? [Individual specification – 
individually understand what the intervention requires of them]. 
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4. What do you think are the values, benefits, importance with the implementation of 
these systems in; this hospital or any hospital, for the patient, for you individually, for 
your profession, for the organisation. [Internalisation – construct potential value of 
the intervention for their work]. 
Cognitive participation: 
1. Who were/will be the key people responsible for implementing these systems and 
bringing them into practice? How was this/will this be completed e.g project initiation, 
identifying functional specification, system choice, business case, procurement, 
implementation, setting up systems, procedures, and protocols and engaging with 
others to ensure success? [Initiation]. 
2. How did you/will you promote end users to engage with the process and encourage 
them to be involved and that they can make a valid contribution? [Enrolment]. 
3. How did you/will you consider that staff may need to reorganize their work practices 
in order to contribute to the work involved in these new systems and join in on 
delivering these systems? [Legitimisation]. 
4. How did management promote the use of these systems and did you feel this 
engaged you with the process? What were/will be the actions and procedures needed 
to sustain the system? [Activation]. 
Collective action: 
1. How did/will you and end users work together and allocate certain tasks required by 
the system in order to embed this system into routine practice? [Interactional 
workability]. 
2. What sort of training did/will you/end users receive in order to be accountable and 
maintain confidence in using the system and in each others work 
capabilities? Was/Will the training be adequate? [Relational integration]. 
3. Who allocated/will allocate the role end users would have in using the system? Was 
there/do you feel there will be any difference in capabilities between staff e.g. all had 
the same amount of training/responsibilities or were there super users? [Skill set 
workability]. 
4. Who managed and allocated/will manage and allocate material and human resources 
for the implementation of this system? How were/will protocols, policies and 
procedures be executed? Was the system/do you feel the system will be adequately 
supported by the hospital? [Contextual integration]. 
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Reflexive monitoring: 
1. Do you think these systems are of value and important? What sort of priority was/is 
implementing these systems for you? How was/will effectiveness and usefulness of 
the system be determined e.g. end user satisfaction survey, cost analysis, time 
analysis? How was/will measurement of clinical outcomes and adherence to formulary 
be measured? [Systemization]. 
2. How did/will you and end users work together to evaluate if the system was working 
adequately and the effects are worthwhile for themselves? How was the change 
implemented e.g. phased, all one go? [Communal appraisal]. 
3. How did/will you assess whether the effects of the system are worthwhile for you 
individually? How did/will you evaluate the impact of the system on other tasks? 
[Individual appraisal].  
4. Did you/will you redefine procedures or modify work practices for you or end users in 
response to their appraisal of the system? If so how did/will you do this? 
[Reconfiguration]. 
FUTURE VISION 
1. What is your vision towards the implementation of electronic prescribing, dispensing, 
and administration in Ireland/this hospital in the future?  
2. How can this vision be realised?  
3. What do you feel is necessary to support the planning, implementation and use of 
these IT systems prior to their introduction nationally/regionally/locally? 
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Appendix 4.17: Interview schedule with expert comments 
SEMI-STRUCTURED INTERVIEW SCHEDULE – LOCAL KEY STAKEHOLDERS’ PERCEPTIONS TOWARDS THE IMPLEMENTATION OF 
ELECTRONIC  SYSTEMS FOR MEDICINES IN THE HOSPITAL SETTING 
ELECTRONIC SYSTEM IMPLEMENTED 
BASED ON THE NORMALIZATION PROCESS THEORY 
Reviewer 1: Add the below comment re introduction 
Can you tell me a little bit more about your role in this organization and in relation to the implementation of electronic systems for 
prescribing/dispensing/administration of medicines? 
Action/Revised questions: 
Added above comment 
Core Questions Probe Questions (will also include: can you elaborate/tell me a bit 
more about that for close-ended questions if required) 
For external reviewers, probe questions are detailed. Final probe 
questions may just have words rather than long questions 
Comments and revised questions 
after external review comments 
 
1.  Can you highlight what 
difference the electronic 
system has made to work 
practices in comparison to the 
traditional system? 
 What are the overall aims of the electronic system in relation to 
the manual system? 
 
 What sort of benefits did you expect from using/implementing 
the electronic system in comparison to the traditional system? 
Have they been realised? 
 
 What sort of challenges did you expect from using/implementing 
the electronic system in comparison to the traditional system? 
Have they been realised? If so how were they overcome? How do 
you feel they can be prevented? 
 
Comment on: 
 Did you have to make significant 
changes to your work practices in order 
to use/implement the system? 
  
Reviewer 2 – if so what were they 
and did you anticipate them 
necessary? Benefits and 
disbenefits.  
 
Research team action/revised 
question 
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 Did you have to make significant changes to your work practices 
in order to use/implement the system?    
 Did you have to make significant 
changes to your work practices in order 
to use/implement the system? If so 
what were they? 
2.  From your personal 
perspective, do you believe 
there is a shared sense of its 
purpose among users?  
 Do you feel there was a rationale for implementing the system? 
 Do you feel system-users understand the aims and expected 
benefits of the system? 
 How was the rationale for implementing the system promoted 
and disseminated? 
 Has this been effective in involving system-users with the 
process? 
 Do you feel system-users engage with it easily? 
 What facilitators/barriers were encountered and actions taken? 
Comments on: 
 From your personal perspective, do you 
believe there is a shared sense of its 
purpose among system users? 
 Reviewer 4: specify ‘its’ 
 
 Do you feel system-users engage with it 
easily? 
Reviewer 5: I am not too clear what 
this question is asking – is system 
easy to use or are users keen to use 
the system? 
 
 What facilitators/barriers were 
encountered and actions taken? 
Reviewer 4:  in relation to 
implementation? 
 
Research team action/revised 
question 
 From your personal perspective, do you 
believe there is a shared sense of the 
purpose of these systems among 
system users? 
 Do you feel system-users engage with 
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the system willingly? 
 What facilitators were encountered and 
actions taken in relation to 
implementation? 
 What barriers were encountered and 
actions taken in relation to 
implementation? 
3.  Can you describe to me how 
the system was implemented in 
your hospital? 
 What training have you received in order to use the system? 
 What training have you organised in order to implement the 
system? (for managers) 
 Is training compulsory for all users? 
 Who provided the training? 
 How did you find the training? 
 What did the training involve? 
 What parts of the training worked well and what did not? 
 Has the training assisted you in using/implementing the system? 
 What has the training been like since implementation? 
 How often is it provided? 
 Is the training adequate? 
 Do all system-users have the same amount of training and 
responsibilities? Are there super users e.g. select staff in 
pharmacy or on the wards? 
Comments on: 
 How did you find the training? 
Reviewer 5: Perhaps – was 
sufficient training provided or how 
was the level of training- not 
enough, about right or too much? 
 
  What has the training been like 
since implementation? 
Reviewer 5: Is this additional 
training for existing users or 
training for new users? So perhaps 
had training been provided since 
implementation and ask more 
details about existing or for new 
users? 
 
Research team action/revised 
question 
 Can you describe to me the training 
that was provided in your hospital in 
order to facilitate implementation? 
  
314 
 How did you find the training? Was 
sufficient training provided? 
 What has the training been like since 
implementation? Has your training been 
updated?  Are you aware what training 
is provided for new staff members?  
4.  Do you feel the system is 
adequately supported by the 
hospital? 
 Were there any extra resources provided for implementation e.g. 
staff, time for training? 
 Are there any protocols or policies on the roles and 
responsibilities of pharmacy/nursing/management/IT/system 
provider in implementing/using/sustaining the system? 
 How are these protocols or policies implemented locally? 
 How is competency in using the system assured? 
 How do you work together in order to embed this system into 
routine practice? 
 What barriers/facilitators were encountered and actions taken? 
Comment on: 
 What barriers/facilitators were 
encountered and actions taken? 
Reviewer 4: In relation to? 
 
Research team action/revised 
question 
 What facilitators were encountered 
and actions taken in relation to 
implementation e.g. contingency plans, 
system support for ongoing system 
sustainability? 
 What barriers were encountered and 
actions taken in relation to 
implementation e.g. contingency plans, 
system support crucial for ongoing 
system sustainability? 
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5.  How do you and your work 
colleagues evaluate if the 
system is working effectively?  
 How is the effectiveness, efficiency and usefulness of the 
system determined e.g. end-user satisfaction surveys, cost 
analysis, time analysis? 
Comment on: 
 How is the effectiveness, efficiency 
and usefulness of the system 
determined e.g. end-user satisfaction 
surveys, cost analysis, time analysis? 
Reviewer 5: Any impact on      
patients? 
 
Supervisory team action/revised 
question 
 How is the effectiveness, efficiency 
and usefulness of the system 
determined e.g. end-user satisfaction 
surveys, cost analysis, time analysis, 
impact on patients? 
6.  How have you evaluated 
whether the system is 
beneficial for you personally? 
 What sort of priority was implementing/using the system for 
you? 
 What impact has using the system had on other work tasks? 
 How has the system been working? 
 Do you think the system is of benefit? 
 Do you think the system has enhanced patient safety? 
 What functionality of the system do you feel is required for 
optimising drug administration? 
Comments on: 
 How has the system been working? 
Reviewer 5: Perhaps -have you 
encountered any difficulties with 
the system and if so can you 
describe them? Could you resolve 
them? 
 Do you think the system has 
enhanced patient safety? 
Reviewer 2 - Does this question tie 
up with main question which 
relates to “beneficial for you 
personally” This relates to patient 
benefit? 
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Research team action/revised 
question 
 Remove question 
 Do you think the system has 
enhanced your ability to provide 
improved quality of care? 
7.  What were your perceptions 
of the system once it had been 
implemented for a while? 
 What advice would you give to other hospitals thinking of 
implementing the system? 
No comments 
8.  Have you/system users 
been given an opportunity to 
provide feedback about the 
system? 
 If so in what manner? 
 Have work practices been modified since feedback? 
No comments 
Future vision 
Looking towards the future, 
what is your vision towards the 
implementation of eHealth in 
general? 
No comments 
 What is your vision towards the implementation of electronic prescribing, dispensing, and administration 
of medicines in Ireland? 
 What is your vision towards the implementation of electronic prescribing, dispensing, and administration 
of medicines in this hospital? 
 How do you feel this can be realised e.g  financial support, policies, protocols, leadership, buy-in, 
penalties for poor performance, money follows the patient? 
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Appendix 4.18: Interview schedule after expert comments 
 
SEMI-STRUCTURED INTERVIEW SCHEDULE – LOCAL KEY STAKEHOLDERS’ PERCEPTIONS TOWARDS THE IMPLEMENTATION OF 
EELCTRONIC  SYSTEMS FOR DISPENSING AND ADMINISTERING MEDICINES IN THE HOSPITAL SETTING 
ELECTRONIC SYSTEM IMPLEMENTED 
BASED ON THE NORMALIZATION PROCESS THEORY 
Introduction: 
Can you tell me a little bit more about your role in this organisation and in relation to the implementation of electronic systems for 
prescribing/dispensing/administration of medicines? 
Core Questions Probe Questions  Constructs 
1.  Based on your experiences, 
can you highlight what 
difference the electronic system 
has made to your working 
practices in comparison to the 
traditional system? 
 What are the overall aims/vision/mission/values of the 
electronic system in relation to the manual system? 
 What sort of benefits did you expect from 
using/implementing the electronic system in comparison to 
the traditional system? Have they been realised? 
 What sort of challenges did you expect from 
using/implementing the electronic system in comparison to 
the traditional system? Have they been realised? If so how 
were they overcome? How do you feel they can be 
prevented? 
 Did you have to make significant changes to your work 
practices in order to use/implement the system? If so what 
were they? 
COHERENCE – Differentiation 
 
 
 
 
COGNITIVE PARTICIPATION – 
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Enrolment 
2.  From your personal 
perspective, do you believe 
there is a shared sense of the 
purpose of these systems 
among users?  
 Do you feel there was a rationale for implementing the 
system? 
 Do you feel system-users understand the aims and 
expected benefits of the system? 
 How was the rationale for implementing the system 
promoted and disseminated? 
 Has this been effective in involving system-users with the 
process? 
 Do you feel system-users engage with the system willingly? 
COHERENCE - Communal specification 
and Internalization 
COGNITIVE PARTICIPATION–
Activation 
COGNITIVE PARTICIPATION - 
Legitimation 
3.  Can you describe to me the 
training that was provided in 
your hospital in order to 
facilitate implementation?  
 What training have you received in order to use the system? 
 What training have you organised in order to implement the 
system? (for managers) 
 Is training compulsory for all users? 
 Who provided the training? 
 How did you find the training? Was sufficient training 
provided?  
 What did the training involve? 
 What parts of the training worked well and what did not? 
 Has the training assisted you in using/implementing the 
system? 
 What has the training been like since implementation? Has 
your training been updated?  
 Are you aware if new staff members are provided the same 
amount of training as staff that were trained when the 
system was first introduced? 
  How often is it provided? 
 Do all system-users have the same amount of training and 
responsibilities? Are there super users e.g. select staff in 
pharmacy or on the wards? 
COHERENCE - Individual specification 
 
 
COGNITIVE PARTICIPATION – 
Initiation 
COLLECTIVE ACTION - Relational 
integration 
 
COLLECTIVE ACTION - Skill set 
workability 
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4.  Do you feel the system is 
adequately supported by the 
hospital? 
 Were there any extra resources provided for implementation 
e.g. staff, time for training? 
 Are there any protocols or policies on the roles and 
responsibilities of 
pharmacy/nursing/management/IT/system provider in 
implementing/using/sustaining the system? 
 How are these protocols or policies implemented locally? 
 How is competence in using the system assured? 
 How do you work together in order to embed this system 
into routine practice? 
 How are changes in drug dictionaries/formularies 
maintained? 
 What facilitators were encountered and actions taken in 
relation to implementation e.g. contingency plans, system 
support crucial for ongoing system sustainability? 
 What barriers were encountered and actions taken in 
relation to implementation? 
COLLECTIVE ACTION - Contextual 
integration 
 
 
 
REFLEXIVE MONITORING - Communal 
appraisal 
5.  How do you and your work 
colleagues evaluate if the 
system is working effectively?  
 How is the effectiveness, efficiency and usefulness of the 
system determined e.g. end-user satisfaction surveys, cost 
analysis, time analysis, impact on patients? 
COLLECTIVE ACTION - Interactional 
workability + REFLEXIVE 
MONITORING – Systemization 
6.  How have you evaluated 
whether the system is 
beneficial for you personally? 
 What sort of priority was implementing/using the system for 
you? 
 What impact has using the system had on other work tasks? 
 Have you encountered any difficulties with the system and if 
so can you describe them? Could you resolve them? 
 Do you think the system is of benefit? 
 Do you think the system has enhanced your ability to 
improve the quality of patient care? 
 What functionality of the system do you feel is required for 
optimising drug administration? 
REFLEXIVE MONITORING - Individual 
appraisal 
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7.  What were your perceptions 
of the system once it had been 
implemented for a while? 
 What advice would you give to other hospitals thinking of 
implementing the system? 
REFLEXIVE MONITORING - 
Systemization 
8.  Have you/system users 
been given an opportunity to 
provide feedback about the 
system? 
 If so in what manner? 
 Have work practices been modified since feedback? 
 Has there been reporting of medication administration 
improvements since system implementation? 
REFLEXIVE MONITORING - 
Reconfiguration 
Future vision 
Looking towards the future, 
what is your vision towards the 
implementation of eHealth in 
general? 
 What is your vision towards the implementation of electronic prescribing, dispensing, and 
administration of medicines in Ireland? 
 What is your vision towards the implementation of electronic prescribing, dispensing, and 
administration of medicines in this hospital? 
 How do you feel this can be realised e.g  financial support, policies, protocols, leadership, buy-in, 
penalties for poor performance, money follows the patient? 
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Appendix 4.19: Background questionnaire 
 
 
1. You have been practising in your profession for  
□ < 1 year  □ 11-15 years   □ 26-30 years 
□ 1-5 years  □ 16-20 years  □ 31-35 years 
□ 6-10 years  □ 21-25 years   □ >35 years  
 
2. You have also practised in countries other than Ireland  
□ No □ Yes, please specify countries:___________________________________ 
 
3. You have experience of implementing/using ePrescribing systems 
□ No □ Yes, please specify where and what systems:______________________ 
 
4. You have experience of implementing/using eDispensing systems e.g pharmacy 
robotic systems 
□ No □ Yes, please specify where and what systems:______________________ 
 
5. You have experience of implementing/using automated medication storage and 
retrieval systems e.g. Pyxis or Omnicell 
□ No □ Yes, please specify where and what systems:__________________ 
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Appendix 5.1: Ethical approval RCPI 
 
 
 
  
323 
Appendix 5.2: Initial draft of interview schedule 
Initial Questions 
5. Do you have any experience of implementing or using electronic prescribing, 
dispensing and/or administration systems in this hospital or other hospitals? 
6. IF YES AND ONLY FOR ONE MANAGEMENT INTERVIEWEE: Can u inform me how the 
project was initiated? How was the functional specification agreed? What was the 
procurement process e.g. business case? What was the contracting process?  
7. IF NO AND ONLY FOR MANAGEMENT INTERVIEWEES: How do you anticipate the 
project would be initiated? How do you feel the functional specification would be 
agreed? What would you envisage the procurement process to be e.g. business case? 
How would you envisage the contracting process? How would you envisage it to be 
implemented e.g. phased or all at once? 
8. What functionality do you feel is required for optimisation? 
 
Agree with interviewee on which aspect/systems will be the primary focus of the 
remaining questions - however each part cannot be viewed in isolation but are likely to 
have an impact on other parts of the system 
Cognitive participation: 
5. Who were/will be the key people responsible for implementing these systems and 
bringing them into practice? How was this/will this be completed e.g project initiation, 
identifying functional specification, system choice, business case, procurement, 
implementation, setting up systems, procedures, and protocols and engaging with 
others to ensure success? [Initiation]. 
6. How did you/will you promote end-users to engage with the process and encourage 
them to be involved and that they can make a valid contribution? [Enrolment]. 
7. How did you/will you consider that staff may need to reorganize their work practices 
in order to contribute to the work involved in these new systems and join in on 
delivering these systems? [Legitimisation]. 
8. How did you promote the use of these systems to others? What were/will be the 
actions and procedures needed to sustain the system? [Activation]. 
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Collective action: 
5. How did/will you and end-users work together and allocate certain tasks required by 
the system in order to embed this system into routine practice? [Interactional 
workability]. 
6. What sort of training did/will you and end-users receive in order to be accountable 
and maintain confidence in using the system and in each others work 
capabilities? Was the training be adequate? [Relational integration]. 
7. Who allocated/will allocate the role end-users would have in using the system? Was 
there/do you feel there will be any difference in capabilities between staff e.g. all had 
the same amount of training/responsibilities or were there super users? [Skill set 
workability]. 
8. Who managed and allocated/will manage and allocate material and human resources 
for the implementation of this system? How were/will protocols, policies and 
procedures be executed? Was the system/do you feel the system will be adequately 
supported by the hospital? [Contextual integration]. 
Reflexive monitoring: 
5. Do you think these systems are of value and important? What sort of priority was/is 
implementing these systems for you? How was/will effectiveness and usefulness of 
the system be determined e.g. end-user satisfaction survey, cost analysis, time 
analysis? How was/will measurement of clinical outcomes and adherence to formulary 
be measured? [Systemization]. 
6. How did/will you and end-users work together to evaluate if the system was working 
adequately and the effects are worthwhile for themselves? How was the change 
implemented e.g. phased, all one go? [Communal appraisal]. 
7. How did/will you assess whether the effects of the system are worthwhile for you 
individually? How did/will you evaluate the impact of the system on other tasks? 
[Individual appraisal].  
8. Did you/will you redefine procedures or modify work practices for you or end-users in 
response to their appraisal of the system? If so how did/will you do this? 
[Reconfiguration]. 
FUTURE VISION 
4. What is your vision towards the implementation of electronic prescribing, dispensing, 
and administration in Ireland/this hospital in the future?  
5. How can this vision be realised?  
6. What do you feel is necessary to support the planning, implementation and use of 
these IT systems prior to their introduction nationally/regionally/locally? 
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Appendix 5.3: Interview schedule with expert comments 
SEMI-STRUCTURED INTERVIEW SCHEDULE – NATIONAL KEY STAKEHOLDERS/eHEALTH LEADS PERCEPTIONS TOWARDS 
THE IMPLEMENTATION OF ELECTRONIC  SYSTEMS FOR PRESCRIBING, DISPENSING, AND ADMINISTERING MEDICINES IN 
THE HOSPITAL SETTING 
BASED ON THE NORMALIZATION PROCESS THEORY 
Core Questions Probe Questions (will also include: can you 
elaborate/tell me a bit more about that for close-
ended questions if required) 
For external review, probe questions are detailed. 
Final probe questions may just have words rather 
than long questions 
Comments and Revised Questions after 
external review comments 
Introduction: 
Can you tell me a little bit more about your specific national role with regard to electronic prescribing/dispensing/administration of 
medicines in hospitals in Ireland?  
1. Given your role, from a 
national viewpoint, can you 
highlight what difference you 
think electronic systems 
would make to working 
practices in hospitals in 
Ireland in comparison to the 
current manual systems? 
 What are the overall aims/vision/mission/values 
of these systems in relation to the manual 
systems? 
 How do these align to the EHealth strategy for 
Ireland? 
 What advantages can these systems bring in 
comparison to the manual systems? 
 Do you have concerns regarding the transition 
from manual to electronic systems?  
 What functionality of these systems do you feel is 
Comments on: 
 What functionality of these systems do you feel 
is required? 
Reviewer 2 – potentially a very long 
answer 
    Reviewer 4 – I do not understand the 
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required? question 
Supervisory team action/revised question: 
 Question removed 
2. From a strategic national 
viewpoint, to what extent do 
you believe there is a shared 
sense of its purpose among 
national and local key 
stakeholders? 
 What steps have been taken to 
ensure/develop/embed a shared sense of its 
purpose? 
 Have any issues been encountered/overcome in 
relation to its shared sense of purpose? 
 To date how has the aim/vision/mission been 
disseminated nationally? 
 What barriers/facilitators have been 
encountered/anticipated and actions taken? 
Comments on: 
 From a strategic national viewpoint, to what 
extent do you believe there is a shared sense of 
its purpose among national and local key 
stakeholders? 
Reviewer 4 – Explain ‘its’ 
 What steps have been taken to 
ensure/develop/embed a shared sense of its 
purpose? 
Reviewer 4 – Explain ‘its’ 
 Have any issues been encountered/overcome in 
relation to its shared sense of purpose? 
Reviewer 4 – Explain ‘its’ 
 To date how has the aim/vision/mission been 
disseminated nationally? 
Reviewer 4 – In relation to? 
 What barriers/facilitators have been 
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encountered/anticipated and actions taken? 
 
 Reviewer 4 – In relation to? 
Supervisory team action/revised question: 
 From a strategic national viewpoint, to what 
extent do you believe there is a shared sense of 
purpose for system implementation among 
national and local key stakeholders? 
 What steps have been taken to 
ensure/develop/embed a shared sense of 
purpose for system implementation? 
 Have any issues been encountered/overcome in 
relation to this shared sense of purpose? 
 To date how has the aim/vision/mission 
regarding system implementation been 
disseminated nationally? 
 What facilitators/barriers have been 
encountered/anticipated and actions taken in 
relation to system implementation? 
3.  From a national 
perspective, what is in place 
to support the development, 
implementation and 
sustainability of these 
systems at local levels?  
 
 What has been put in place at a national level or 
to guide local levels? In relation to… 
o Project initiation 
o Identifying functional specification 
o System choice 
o Business case 
o Procurement 
o Setting up systems 
o Procedures/protocols 
Comments on: 
 From a national perspective, what is in place to 
support the development, implementation and 
sustainability of these systems at local levels? 
 Reviewer 4 – What are ‘these’? 
 What has been put in place at a national level 
or to guide local levels? In relation to…… 
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    Reviewer 5 - Staffing requirements for 
system           support? 
System maintenance and upgrades? 
 What barriers/facilitators have been 
encountered/anticipated and actions taken? 
Reviewer 4: In relation to all of the above? 
Supervisory team action/revised question: 
From a national perspective, what is in place to 
support the development, implementation and 
sustainability of these systems at local levels? 
 What has been put in place at a national level 
or to guide local levels? In relation to… 
o Project initiation 
o Identifying functional specification 
o System choice 
o Business case 
o Procurement 
o Setting up systems 
o Procedures/protocols 
o Staffing requirements for system 
support 
o System maintenance and upgrades 
 What facilitators/barriers have been 
encountered/anticipated and actions taken in 
relation to supporting system implementation 
e.g. contingency plans, system support  for 
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ongoing system sustainability? 
4. Given your national role, 
do you feel these systems are 
adequately supported locally 
through national initiatives? 
 
 Are there any policies/standard operating 
procedures that have been developed at the 
national level to support implementation?  
 Is there any guidance on the roles and 
responsibilities for different professionals/staff 
grades? 
 Is there any guidance on the specific tasks to be 
undertaken? 
 What barriers/facilitators have been 
encountered/anticipated and action taken? 
Comments on: 
 Are there any policies/standard operating 
procedures that have been developed at the 
national level to support implementation?  
 
Reviewer 1: to support and monitor 
implementation 
Reviewer 4: to support implementation of? 
 Is there any guidance on the roles and 
responsibilities for different professionals/staff 
grades? 
Reviewer 4: in terms of implementation? 
 Is there any guidance on the specific tasks to 
be undertaken? 
Reviewer 4: in terms of implementation? 
 What barriers/facilitators have been 
encountered/anticipated and action taken? 
Reviewer 4: in terms of implementation? 
Reviewer 4: Does this section only refer to 
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implementation? Need to specify 
Supervisory team action/revised question: 
 What national initiatives do you feel need to be 
in place to support local implementation? 
 Are there any policies/standard operating 
procedures that have been developed at the 
national level to support and monitoring local 
system implementation?  
 Is there any guidance on the roles and 
responsibilities for different professionals/staff 
grades in terms of implementation? 
 Is there any guidance on the specific tasks to 
be undertaken in terms of implementation? 
 What facilitators have been 
encountered/anticipated and actions taken in 
relation to implementation? 
 What barriers have been 
encountered/anticipated and actions taken in 
relation to implementation? 
 Merge question 3 and question 4 
5.  What is your view on how 
these systems will be 
evaluated?  
 Are there any plans/is there any guidance or 
specification on how the effectiveness, efficiency 
and usefulness of these systems will be 
determined? 
 What barriers/facilitators have been 
encountered/anticipated and actions taken? 
Comments on: 
 What barriers/facilitators have been 
encountered/anticipated and actions taken? 
 
Reviewer 4: in relation to evaluation? 
 
Supervisory team action/revised question: 
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 What barriers have been 
encountered/anticipated and actions taken in 
relation to evaluating theses systems? 
 What facilitators have been 
encountered/anticipated and actions taken in 
relation to evaluating theses systems? 
6.  Post-implementation, 
what do you feel are the 
expectations for effects on 
the health services?  
 
 Patient care/safety 
 Staff working practices 
 Resources 
 
Comment on: 
Reviewer 4: other? 
Supervisory team action/revised question: 
 Patient care/safety 
 Staff working practices 
 Resources 
 Other 
7.  From a national 
perspective, what sort of 
challenges have you 
encountered in implementing 
these systems?   
 Did you anticipate these barriers ? 
 How do you feel they can be overcome /used to 
beneficial effect? 
 How do you feel they can be prevented 
/enhanced? 
 What have been the main lessons learned? 
No comments 
 
8. To what extent have 
national and local key 
stakeholders been given an 
opportunity to provide 
feedback on these electronic 
systems or are we not at that 
stage yet? 
 If so in what manner?  
 How did you/national leads react to the 
feedback? 
No comments 
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Future vision 
Looking towards the future, 
what is your vision towards 
the implementation of eHealth 
in general? 
 What is your vision towards the implementation of electronic prescribing, dispensing, and 
administration of medicines in hospitals in Ireland? 
 How do you feel this can be realised e.g  financial support, policies, protocols, leadership, buy-in, 
penalties for poor performance, money follows the patient? 
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Appendix 5.4: Interview schedule after expert comments 
SEMI-STRUCTURED INTERVIEW SCHEDULE – NATIONAL KEY STAKEHOLDERS/eHEALTH LEADS PERCEPTIONS TOWARDS 
THE IMPLEMENTATION OF ELECTRONIC  SYSTEMS FOR PRESCRIBING, DISPENSING, AND ADMINISTERING MEDICINES IN 
THE HOSPITAL SETTING 
BASED ON THE NORMALIZATION PROCESS THEORY 
Core Questions Probe Questions Constructs 
Introduction: 
Can you tell me a little bit more about your role with regard to electronic prescribing/dispensing/administration of medicines in 
hospitals in Ireland?  
1. Given your role, from a 
national viewpoint, can you 
highlight what difference you 
think electronic systems 
would make to working 
practices in hospitals in 
Ireland in comparison to the 
current manual systems? 
 What are the overall aims/vision/mission/values of these 
systems in comparison to manual systems? 
 How do these align to the eHealth strategy for Ireland? 
 What advantages can these systems bring in comparison to 
the manual systems? 
 Do you have concerns regarding the transition from manual 
to electronic systems?  
 What functionality of these systems do you feel is required to 
be effective? 
COHERENCE - Differentiation  
2. From a strategic viewpoint, 
to what extent do you believe 
there is a shared sense of 
purpose for system 
implementation among 
national and local key 
stakeholders? 
 What steps have been taken to ensure/develop/embed a 
shared sense of purpose for system implementation? 
 Have any issues been encountered/overcome in relation to 
this shared sense of purpose? 
 To date how has the aim/vision/mission regarding system 
implementation been disseminated nationally? 
 What facilitators have been encountered/anticipated and 
actions taken in relation to system implementation? 
COHERENCE - Communal 
specification and Internalization 
 
COGNITIVE PARTICIPATION - 
Activation 
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 What barriers have been encountered/anticipated and actions 
taken in relation to system implementation? 
3.  From a national 
perspective, what has been 
put in place to support the 
development, implementation 
and sustainability of these 
systems at local levels? 
 In relation to…… 
o Project initiation 
o Identifying functional specification 
o System choice 
o Business case 
o Procurement 
o Setting up systems 
o Procedures/protocols 
o Staff roles and responsibilities 
o Staffing requirements for system support 
o System maintenance and upgrades 
 What national initiatives do you feel need to be in place to 
support local implementation? 
 What facilitators have been encountered/anticipated and 
actions taken in relation to supporting system implementation 
e.g. contingency plans, system support crucial for ongoing 
system sustainability? 
 What barriers have been encountered/anticipated and actions 
taken in relation to supporting system implementation? 
COGNITIVE PARTICIPATION – 
Initiation 
 
COLLECTIVE ACTION – Relational 
integration 
 
COHERENCE – Internalization 
  
COLLECTIVE ACTION – Contextual 
integration 
4.  What is your view on how 
these systems will be 
evaluated?  
 Are there any plans/is there any guidance or specification on 
how the effectiveness, efficiency and usefulness of these 
systems will be determined? 
 What facilitators have been encountered/anticipated and 
actions taken in relation to evaluating theses systems? 
 What barriers have been encountered/anticipated and actions 
taken in relation to evaluating theses systems? 
COLLECTIVE ACTION - Interactional 
workability + REFLEXIVE 
MONITORING – Systemization 
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5.  What are your 
expectations post system 
implementation on its effects 
on the health services?  
 Patient care/safety 
 Staff working practices 
 Resources 
 Other 
REFLEXIVE MONITORING - 
Individual appraisal 
 
6.  From a national 
perspective, what sort of 
challenges have you 
encountered in implementing 
these systems?   
 Did you anticipate these barriers? 
 How do you feel they can be overcome /used to beneficial 
effect? 
 How do you feel they can be prevented /enhanced?  
 What have been the main lessons learned? 
REFLEXIVE MONITORING - 
Systemization 
7. To what extent have 
national and local key 
stakeholders been given an 
opportunity to provide 
feedback on these electronic 
systems or are we not at that 
stage yet? 
 If so in what manner?  
 How did you/national leads react to the feedback? 
REFLEXIVE MONITORING -
Reconfiguration 
Future vision 
Looking towards the future, 
what is your vision towards 
the implementation of eHealth 
in general? 
 What is your vision towards the implementation of electronic prescribing, dispensing, and 
administration of medicines in hospitals in Ireland? 
 How do you feel this can be realised e.g  financial support, policies, protocols, leadership, buy-in, 
penalties for poor performance, money follows the patient? 
  
 
